PMID,Title,Authors,Citation,First Author,Journal/Book,Publication Year,Create Date,PMCID,NIHMS ID,DOI
"36581592","Corrigendum to ""Factors of importance for discontinuation of thiazides associated with hyponatremia in Sweden - a population-based register study""","","Pharmacoepidemiol Drug Saf. 2023 Mar;32(3):395. doi: 10.1002/pds.5588. Epub 2022 Dec 29.","","Pharmacoepidemiol Drug Saf","2023","2022/12/29","","","10.1002/pds.5588"
"36527437","Federated analyses of multiple data sources in drug safety studies","Gedeborg R, Igl W, Svennblad B, Wilén P, Delcoigne B, Michaëlsson K, Ljung R, Feltelius N.","Pharmacoepidemiol Drug Saf. 2023 Mar;32(3):279-286. doi: 10.1002/pds.5587. Epub 2022 Dec 30.","Gedeborg R","Pharmacoepidemiol Drug Saf","2023","2022/12/17","","","10.1002/pds.5587"
"36527432","Use patterns of systemic immunomodulators in the United States before and after dupilumab approval in adults with atopic dermatitis","Anand P, Schneeweiss S, Mostaghimi A, Schneeweiss MC.","Pharmacoepidemiol Drug Saf. 2023 May;32(5):567-576. doi: 10.1002/pds.5586. Epub 2022 Dec 28.","Anand P","Pharmacoepidemiol Drug Saf","2023","2022/12/17","PMC10073264","NIHMS1859247","10.1002/pds.5586"
"36524772","Pharmacogenetics of warfarin and healthcare costs - Real-world data analysis","Lähteenmäki J, Vuorinen AL, Lehto M, Niemi M, Forsberg MM.","Pharmacoepidemiol Drug Saf. 2023 Mar;32(3):382-386. doi: 10.1002/pds.5585. Epub 2022 Dec 22.","Lähteenmäki J","Pharmacoepidemiol Drug Saf","2023","2022/12/16","","","10.1002/pds.5585"
"36495188","Validation of safety outcomes in routinely collected data: Lessons learned from a multinational postapproval safety study","Arena PJ, Huang K, Löfling L, Bahmanyar S, Mo J, Schachterle SE, Nunes AP, Smits E, Juuti R, Hoti F, Korhonen P, Adelborg K, Sundbøll J, Rasmussen TR, Løkke A, Ehrenstein V.","Pharmacoepidemiol Drug Saf. 2023 May;32(5):592-596. doi: 10.1002/pds.5582. Epub 2022 Dec 29.","Arena PJ","Pharmacoepidemiol Drug Saf","2023","2022/12/10","","","10.1002/pds.5582"
"36479785","Recent tapering from long-term opioid therapy and odds of opioid-related hospital use","Mazurenko O, Blackburn J, Zhang P, Gupta S, Harle CA, Kroenke K, Simon K.","Pharmacoepidemiol Drug Saf. 2023 May;32(5):526-534. doi: 10.1002/pds.5581. Epub 2022 Dec 12.","Mazurenko O","Pharmacoepidemiol Drug Saf","2023","2022/12/08","","","10.1002/pds.5581"
"36464785","Prospective validation of a dynamic prognostic model for identifying COVID-19 patients at high risk of rapid deterioration","Lin KJ, D'Andrea E, Desai RJ, Gagne JJ, Liu J, Wang SV.","Pharmacoepidemiol Drug Saf. 2023 May;32(5):545-557. doi: 10.1002/pds.5580. Epub 2022 Dec 19.","Lin KJ","Pharmacoepidemiol Drug Saf","2023","2022/12/05","PMC9877647","","10.1002/pds.5580"
"36458420","Validation of algorithms to select patients with multiple myeloma and patients initiating myeloma treatment in the national Veterans Affairs Healthcare System","La J, DuMontier C, Hassan H, Abdallah M, Edwards C, Verma K, Ferri G, Dharne M, Yildirim C, Corrigan J, Gaziano JM, Do NV, Brophy MT, Driver JA, Munshi NC, Fillmore NR.","Pharmacoepidemiol Drug Saf. 2023 May;32(5):558-566. doi: 10.1002/pds.5579. Epub 2022 Dec 28.","La J","Pharmacoepidemiol Drug Saf","2023","2022/12/02","","","10.1002/pds.5579"
"36448210","Recommendations on the calculation of confidence intervals for sequence symmetry analyses","Lund LC, Hallas J.","Pharmacoepidemiol Drug Saf. 2023 Mar;32(3):392-394. doi: 10.1002/pds.5578. Epub 2022 Dec 8.","Lund LC","Pharmacoepidemiol Drug Saf","2023","2022/11/30","","","10.1002/pds.5578"
"36444965","Impact of direct-acting antiviral treatment for hepatitis C on cardiovascular diseases and extrahepatic cancers","Lam L, Fontaine H, Lapidus N, Dorival C, Bellet J, Larrey D, Nahon P, Diallo A, Cagnot C, Lusivika-Nzinga C, Téoulé F, Hejblum G, Bourlière M, Pol S, Carrat F; ANRS/AFEF Hepather study group.","Pharmacoepidemiol Drug Saf. 2023 Apr;32(4):486-495. doi: 10.1002/pds.5576. Epub 2022 Dec 5.","Lam L","Pharmacoepidemiol Drug Saf","2023","2022/11/29","","","10.1002/pds.5576"
"36444481","Prescribed anti-glaucoma medication consumption and road traffic crash","Lu L, Contrand B, Schweitzer C, Gadegbeku B, Delcourt C, Lagarde E.","Pharmacoepidemiol Drug Saf. 2023 May;32(5):535-544. doi: 10.1002/pds.5577. Epub 2022 Dec 16.","Lu L","Pharmacoepidemiol Drug Saf","2023","2022/11/29","","","10.1002/pds.5577"
"36424189","Potentially inappropriate medications in nursing homes and the community older adults using the French health insurance databases","Drusch S, Le Tri T, Ankri J, Michelon H, Zureik M, Herr M.","Pharmacoepidemiol Drug Saf. 2023 Apr;32(4):475-485. doi: 10.1002/pds.5575. Epub 2022 Dec 2.","Drusch S","Pharmacoepidemiol Drug Saf","2023","2022/11/24","","","10.1002/pds.5575"
"36420643","Validation of claims-based algorithms to identify non-live birth outcomes","Zhu Y, Bateman BT, Hernandez-Diaz S, Gray KJ, Straub L, Reimers RM, Manning-Geist B, Yoselevsky E, Taylor LG, Ouellet-Hellstrom R, Ma Y, Qiang Y, Hua W, Huybrechts KF.","Pharmacoepidemiol Drug Saf. 2023 Apr;32(4):468-474. doi: 10.1002/pds.5574. Epub 2022 Nov 30.","Zhu Y","Pharmacoepidemiol Drug Saf","2023","2022/11/24","","","10.1002/pds.5574"
"36401747","Investigating drug safety in pregnancy based on the German Pharmacoepidemiological Research Database (GePaRD): A proof-of-concept analysis on the association between valproate and spina bifida","Haug U, Kollhorst B, Schink T, Thöne K, Dathe K, Schaefer C, Onken M.","Pharmacoepidemiol Drug Saf. 2023 Feb;32(2):148-157. doi: 10.1002/pds.5573. Epub 2022 Nov 30.","Haug U","Pharmacoepidemiol Drug Saf","2023","2022/11/19","","","10.1002/pds.5573"
"36401739","A review of pregnancy and lactation postmarketing studies required by the FDA","Krastein J, Sahin L, Yao L.","Pharmacoepidemiol Drug Saf. 2023 Mar;32(3):287-297. doi: 10.1002/pds.5572. Epub 2022 Dec 21.","Krastein J","Pharmacoepidemiol Drug Saf","2023","2022/11/19","","","10.1002/pds.5572"
"36394182","Healthcare system engagement and algorithm-identified cancer incidence following initiation of a new medication","D'Arcy ME, Stürmer T, Sandler RS, Baron JA, Jonsson-Funk ML, Troester MA, Lund JL.","Pharmacoepidemiol Drug Saf. 2023 Mar;32(3):321-329. doi: 10.1002/pds.5556. Epub 2022 Nov 30.","D'Arcy ME","Pharmacoepidemiol Drug Saf","2023","2022/11/17","PMC9931672","NIHMS1851178","10.1002/pds.5556"
"36382802","Impact of lifestyle and socioeconomic position on use of non-steroidal anti-inflammatory drugs: A population-based cohort study","Bonnesen K, Ehrenstein V, Grønkjaer MS, Pedersen L, Lash TL, Schmidt M.","Pharmacoepidemiol Drug Saf. 2023 Apr;32(4):455-467. doi: 10.1002/pds.5571. Epub 2022 Nov 22.","Bonnesen K","Pharmacoepidemiol Drug Saf","2023","2022/11/16","","","10.1002/pds.5571"
"36380400","Imputing missing covariates in time-to-event analysis within distributed research networks: A simulation study","Li D, Wong J, Li X, Toh S, Wang R.","Pharmacoepidemiol Drug Saf. 2023 Mar;32(3):330-340. doi: 10.1002/pds.5563. Epub 2022 Nov 30.","Li D","Pharmacoepidemiol Drug Saf","2023","2022/11/16","","","10.1002/pds.5563"
"36377036","Associations of prenatal exposure to non-steroidal anti-inflammatory drugs with preterm birth and small for gestational age infants among women with autoimmune disorders","Delker E, Kelly A, Chambers C, Johnson D, Bandoli G.","Pharmacoepidemiol Drug Saf. 2023 Feb;32(2):225-237. doi: 10.1002/pds.5570. Epub 2022 Nov 27.","Delker E","Pharmacoepidemiol Drug Saf","2023","2022/11/15","","","10.1002/pds.5570"
"36369928","More extreme duplication in FDA Adverse Event Reporting System detected by literature reference normalization and fuzzy string matching","Hung E, Hauben M, Essex H, Zou C, Bright S.","Pharmacoepidemiol Drug Saf. 2023 Mar;32(3):387-391. doi: 10.1002/pds.5555. Epub 2022 Dec 9.","Hung E","Pharmacoepidemiol Drug Saf","2023","2022/11/12","","","10.1002/pds.5555"
"36357173","Longitudinal effects of using and discontinuing central nervous system medications on cognitive functioning","Koch E, Johnell K, Kauppi K.","Pharmacoepidemiol Drug Saf. 2023 Apr;32(4):446-454. doi: 10.1002/pds.5569. Epub 2022 Nov 20.","Koch E","Pharmacoepidemiol Drug Saf","2023","2022/11/10","","","10.1002/pds.5569"
"36351883","Understanding the variability of pharmaco-epidemiological studies assessing the risk of appendicitis with mRNA COVID-19 vaccines","Jambon-Barbara C, Bernardeau C, Cracowski JL, Khouri C.","Pharmacoepidemiol Drug Saf. 2023 Jan;32(1):87-90. doi: 10.1002/pds.5560. Epub 2022 Nov 18.","Jambon-Barbara C","Pharmacoepidemiol Drug Saf","2023","2022/11/09","PMC9877887","","10.1002/pds.5560"
"36351880","Assessing medical product safety during pregnancy using parameterizable tools in the sentinel distributed database","Lyons JG, Suarez EA, Fazio-Eynullayeva E, Maro JC, Corey C, Li J, Toh S, Shinde MU.","Pharmacoepidemiol Drug Saf. 2023 Feb;32(2):158-215. doi: 10.1002/pds.5568. Epub 2022 Dec 14.","Lyons JG","Pharmacoepidemiol Drug Saf","2023","2022/11/09","","","10.1002/pds.5568"
"36349482","Identification of rheumatoid arthritis in German claims data using different algorithms: Validation by cross-sectional patient-reported survey data","Callhoff J, Albrecht K, Marschall U, Strangfeld A, Hoffmann F.","Pharmacoepidemiol Drug Saf. 2023 May;32(5):517-525. doi: 10.1002/pds.5562. Epub 2022 Dec 8.","Callhoff J","Pharmacoepidemiol Drug Saf","2023","2022/11/09","","","10.1002/pds.5562"
"36349471","High-dimensional propensity scores for empirical covariate selection in secondary database studies: Planning, implementation, and reporting","Rassen JA, Blin P, Kloss S, Neugebauer RS, Platt RW, Pottegård A, Schneeweiss S, Toh S.","Pharmacoepidemiol Drug Saf. 2023 Feb;32(2):93-106. doi: 10.1002/pds.5566. Epub 2022 Nov 22.","Rassen JA","Pharmacoepidemiol Drug Saf","2023","2022/11/09","PMC10099872","","10.1002/pds.5566"
"36345837","A data-informed approach using individualised dispensing patterns to estimate medicine exposure periods and dose from pharmaceutical claims data","Bharat C, Degenhardt L, Pearson SA, Buizen L, Wilson A, Dobbins T, Gisev N.","Pharmacoepidemiol Drug Saf. 2023 Mar;32(3):352-365. doi: 10.1002/pds.5567. Epub 2022 Nov 30.","Bharat C","Pharmacoepidemiol Drug Saf","2023","2022/11/08","","","10.1002/pds.5567"
"36345809","Effectiveness research in oncology with electronic health record data: A retrospective cohort study emulating the PALOMA-2 trial","Merola D, Young J, Schrag D, Lin KJ, Alwardt S, Schneeweiss S.","Pharmacoepidemiol Drug Saf. 2023 Apr;32(4):426-434. doi: 10.1002/pds.5565. Epub 2022 Nov 14.","Merola D","Pharmacoepidemiol Drug Saf","2023","2022/11/08","PMC10038825","NIHMS1853224","10.1002/pds.5565"
"36333979","Social media for early characterization of pandemic symptoms: A qualitative analysis of patient-reported COVID-19 experiences","Khashei M, Janiczak S, St Clair C, Liu W, Song JJ, Hua W, Falconer M, Eworuke E.","Pharmacoepidemiol Drug Saf. 2023 Mar;32(3):341-351. doi: 10.1002/pds.5564. Epub 2022 Nov 11.","Khashei M","Pharmacoepidemiol Drug Saf","2023","2022/11/05","PMC9877633","","10.1002/pds.5564"
"36331361","A new analytic tool for assessing the impact of the US Food and Drug Administration regulatory actions","Lu CY, Hou L, Kolonoski J, Petrone AB, Zhang F, Corey C, Huang TY, Bradley MC.","Pharmacoepidemiol Drug Saf. 2023 Mar;32(3):298-311. doi: 10.1002/pds.5552. Epub 2022 Nov 15.","Lu CY","Pharmacoepidemiol Drug Saf","2023","2022/11/04","","","10.1002/pds.5552"
"36309966","Off-label low dose amitriptyline for insomnia disorder: Patient-reported outcomes","Bakker MH, Hugtenburg JG, Smits MG, van der Horst HE, Slottje P.","Pharmacoepidemiol Drug Saf. 2023 Apr;32(4):435-445. doi: 10.1002/pds.5561. Epub 2022 Nov 20.","Bakker MH","Pharmacoepidemiol Drug Saf","2023","2022/10/30","","","10.1002/pds.5561"
"36305574","Detection of drug safety signal of drug-induced neutropenia and agranulocytosis in all-aged patients using electronic medical records","Sun C, Zhao L, Yuan Y, Xiang Y, Liu A.","Pharmacoepidemiol Drug Saf. 2023 Apr;32(4):416-425. doi: 10.1002/pds.5559. Epub 2022 Nov 6.","Sun C","Pharmacoepidemiol Drug Saf","2023","2022/10/28","","","10.1002/pds.5559"
"36300999","Trends and regional variations in prescriptions dispensed to stimulate uterine contractions at the end of pregnancy in Belgium: A community-based study from 2003 to 2018","Larcin L, Karakaya G, Rygaert X, Van Wilder P, Lamy C, Demyttenaere B, Damase-Michel C, Kirakoya-Samadoulougou F.","Pharmacoepidemiol Drug Saf. 2023 Feb;32(2):216-224. doi: 10.1002/pds.5558. Epub 2022 Nov 6.","Larcin L","Pharmacoepidemiol Drug Saf","2023","2022/10/27","","","10.1002/pds.5558"
"36300575","Exposure to nitrosatable drugs during pregnancy and childhood cancer: A matched case-control study in Denmark, 1996-2016","Sirirungreung A, Hansen J, He D, Huang X, Ritz B, Heck JE.","Pharmacoepidemiol Drug Saf. 2023 Apr;32(4):496-505. doi: 10.1002/pds.5557. Epub 2022 Dec 8.","Sirirungreung A","Pharmacoepidemiol Drug Saf","2023","2022/10/27","PMC10038857","NIHMS1860512","10.1002/pds.5557"
"36269007","Utilization of nonguideline concordant antibiotic treatment following acute otitis media in children in the United States","McGrath LJ, Frost HM, Newland JG, O'Neil CA, Sahrmann JM, Ma Y, Butler AM.","Pharmacoepidemiol Drug Saf. 2023 Feb;32(2):256-265. doi: 10.1002/pds.5554. Epub 2022 Nov 2.","McGrath LJ","Pharmacoepidemiol Drug Saf","2023","2022/10/21","PMC9877117","NIHMS1844582","10.1002/pds.5554"
"36251280","Development of a multivariate prediction model to identify individual case safety reports which require clinical review","Gosselt HR, Bazelmans EA, Lieber T, van Hunsel FPAM, Härmark L.","Pharmacoepidemiol Drug Saf. 2022 Dec;31(12):1300-1307. doi: 10.1002/pds.5553. Epub 2022 Oct 21.","Gosselt HR","Pharmacoepidemiol Drug Saf","2022","2022/10/17","","","10.1002/pds.5553"
"36251264","Quality of rheumatoid arthritis recording in United Kingdom Clinical Practice Research Datalink Aurum","Vasilakis-Scaramozza C, Hagberg KW, Persson R, Yelland E, Williams T, Myles P, Jick SS.","Pharmacoepidemiol Drug Saf. 2023 Jan;32(1):73-77. doi: 10.1002/pds.5551. Epub 2022 Oct 24.","Vasilakis-Scaramozza C","Pharmacoepidemiol Drug Saf","2023","2022/10/17","","","10.1002/pds.5551"
"36224724","A systematic review and meta-analysis of observational studies of the association between the use of incretin-based therapies and the risk of pancreatic cancer","Hidayat K, Zhou YY, Du HZ, Qin LQ, Shi BM, Li ZN.","Pharmacoepidemiol Drug Saf. 2023 Feb;32(2):107-125. doi: 10.1002/pds.5550. Epub 2022 Dec 11.","Hidayat K","Pharmacoepidemiol Drug Saf","2023","2022/10/13","","","10.1002/pds.5550"
"36222554","Development and validation of case-finding algorithms to identify acute pancreatitis in the Veterans Health Administration","Wang LL, Dobkin J, Salgado S, Kaplan DE, Yang YX.","Pharmacoepidemiol Drug Saf. 2022 Dec;31(12):1294-1299. doi: 10.1002/pds.5549. Epub 2022 Oct 20.","Wang LL","Pharmacoepidemiol Drug Saf","2022","2022/10/12","PMC9729430","NIHMS1842087","10.1002/pds.5549"
"36218170","Methods for drug safety signal detection using routinely collected observational electronic health care data: A systematic review","Coste A, Wong A, Bokern M, Bate A, Douglas IJ.","Pharmacoepidemiol Drug Saf. 2023 Jan;32(1):28-43. doi: 10.1002/pds.5548. Epub 2022 Nov 2.","Coste A","Pharmacoepidemiol Drug Saf","2023","2022/10/11","PMC10092128","","10.1002/pds.5548"
"36216785","Core concepts in pharmacoepidemiology: Key biases arising in pharmacoepidemiologic studies","Acton EK, Willis AW, Hennessy S.","Pharmacoepidemiol Drug Saf. 2023 Jan;32(1):9-18. doi: 10.1002/pds.5547. Epub 2022 Oct 20.","Acton EK","Pharmacoepidemiol Drug Saf","2023","2022/10/10","","","10.1002/pds.5547"
"36215113","HARmonized Protocol Template to Enhance Reproducibility of hypothesis evaluating real-world evidence studies on treatment effects: A good practices report of a joint ISPE/ISPOR task force","Wang SV, Pottegård A, Crown W, Arlett P, Ashcroft DM, Benchimol EI, Berger ML, Crane G, Goettsch W, Hua W, Kabadi S, Kern DM, Kurz X, Langan S, Nonaka T, Orsini L, Perez-Gutthann S, Pinheiro S, Pratt N, Schneeweiss S, Toussi M, Williams RJ.","Pharmacoepidemiol Drug Saf. 2023 Jan;32(1):44-55. doi: 10.1002/pds.5507. Epub 2022 Oct 10.","Wang SV","Pharmacoepidemiol Drug Saf","2023","2022/10/10","PMC9771861","NIHMS1820677","10.1002/pds.5507"
"36180248","Effect of tramadol and DOACs with special attention to dabigatran on concomitant use, on the risk of mayor bleeding using BIFAP database in Spain","Burgos-Gonzalez A, Huerta C, Peñalver MJ, Sordo L, Pulido J, Soriano LC.","Pharmacoepidemiol Drug Saf. 2023 Apr;32(4):397-406. doi: 10.1002/pds.5525. Epub 2022 Sep 30.","Burgos-Gonzalez A","Pharmacoepidemiol Drug Saf","2023","2022/09/30","","","10.1002/pds.5525"
"36148859","Abstracts of the 38th International Conference on Pharmacoepidemiology: Advancing Pharmacoepidemiology and Real-World Evidence for the Global Community, August 26-28, 2022, Copenhagen, Denmark","","Pharmacoepidemiol Drug Saf. 2022 Sep;31 Suppl 2:3-678. doi: 10.1002/pds.5518.","","Pharmacoepidemiol Drug Saf","2022","2022/09/23","","","10.1002/pds.5518"
"36129396","Examining the potential direct cardiovascular benefit of tumor-necrosis factor inhibitor in rheumatoid arthritis: Natural and controlled direct effect analyses","Yoshida K, Harrold LR, Middaugh N, Guan H, Stryker S, Karis E, Solomon DH.","Pharmacoepidemiol Drug Saf. 2023 Apr;32(4):407-415. doi: 10.1002/pds.5546. Epub 2022 Oct 13.","Yoshida K","Pharmacoepidemiol Drug Saf","2023","2022/09/21","","","10.1002/pds.5546"
"36129372","Record linkage of claims and cancer registries data-Evaluation of a deterministic linkage approach based on indirect personal identifiers","Kollhorst B, Reinders T, Grill S, Eberle A, Intemann T, Kieschke J, Meyer M, Nennecke A, Rathmann W, Pigeot I.","Pharmacoepidemiol Drug Saf. 2022 Dec;31(12):1287-1293. doi: 10.1002/pds.5545. Epub 2022 Oct 6.","Kollhorst B","Pharmacoepidemiol Drug Saf","2022","2022/09/21","","","10.1002/pds.5545"
"36125097","Anti-osteoporosis medication dispensing by clinical commissioning groups in England - an ecological study of variability in practice and of the effect of the Covid-19 pandemic","Janjua SS, Boardman HF, Sami A, Johansen A, Toh LS, Javaid KM.","Pharmacoepidemiol Drug Saf. 2023 Feb;32(2):248-255. doi: 10.1002/pds.5544. Epub 2022 Sep 30.","Janjua SS","Pharmacoepidemiol Drug Saf","2023","2022/09/20","PMC10092162","","10.1002/pds.5544"
"36125081","Regarding: Webster-Clark M., et al. Alternative analytic and matching approaches for the prevalent new-user design: a simulation study. Pharmacoepidemiol Drug Saf, 31, pp. 796-803; 2022","Dell'Aniello S, Renoux C, Suissa S.","Pharmacoepidemiol Drug Saf. 2022 Dec;31(12):1317-1318. doi: 10.1002/pds.5543. Epub 2022 Sep 30.","Dell'Aniello S","Pharmacoepidemiol Drug Saf","2022","2022/09/20","","","10.1002/pds.5543"
"36125022","Mobile apps for quick adverse drug reaction report: A scoping review","Parracha ER, Advinha AM, Lopes MJ, Oliveira-Martins S.","Pharmacoepidemiol Drug Saf. 2023 Jan;32(1):19-27. doi: 10.1002/pds.5542. Epub 2022 Sep 30.","Parracha ER","Pharmacoepidemiol Drug Saf","2023","2022/09/20","PMC10092107","","10.1002/pds.5542"
"36111444","Telemedicine use among patients with metastatic breast cancer during the COVID-19 pandemic: Differences by race, age, and region","Calip GS, Cohen A, Rohrer R, Wang X, Wang X, Webster A, Wu A, Griffith SD, Showalter TN, Miksad RA.","Pharmacoepidemiol Drug Saf. 2023 Jan;32(1):66-72. doi: 10.1002/pds.5541. Epub 2022 Oct 4.","Calip GS","Pharmacoepidemiol Drug Saf","2023","2022/09/16","PMC10091805","","10.1002/pds.5541"
"36089808","Partition testing for real-world evidence studies","Cafri G, Wood J, Gagne J.","Pharmacoepidemiol Drug Saf. 2022 Dec;31(12):1280-1286. doi: 10.1002/pds.5540. Epub 2022 Sep 20.","Cafri G","Pharmacoepidemiol Drug Saf","2022","2022/09/12","","","10.1002/pds.5540"
"36089797","Medicine use in children aged under 12 years-Population survey in Finland","Kesti J, Saastamoinen L, Lavikainen P, Sepponen K.","Pharmacoepidemiol Drug Saf. 2023 Feb;32(2):266-276. doi: 10.1002/pds.5539. Epub 2022 Sep 21.","Kesti J","Pharmacoepidemiol Drug Saf","2023","2022/09/12","PMC10087337","","10.1002/pds.5539"
"36076345","Kidney function and prescribed dose in middle-aged and older patients starting selective serotonin reuptake inhibitors","Zhu N, Lisinski A, Lagerberg T, Johnell K, Xu H, Carrero JJ, Chang Z.","Pharmacoepidemiol Drug Saf. 2022 Oct;31(10):1091-1101. doi: 10.1002/pds.5515. Epub 2022 Aug 10.","Zhu N","Pharmacoepidemiol Drug Saf","2022","2022/09/09","PMC9545078","","10.1002/pds.5515"
"36073295","Evaluating awareness, knowledge and practice of healthcare professionals following implementation of a revised pregnancy prevention programme for isotretinoin in Ireland: A multi-stakeholder cross-sectional study","Hughes JE, Buckley N, Looney Y, Kirwan G, Mullooly M, Bennett KE.","Pharmacoepidemiol Drug Saf. 2023 Feb;32(2):137-147. doi: 10.1002/pds.5538. Epub 2022 Oct 5.","Hughes JE","Pharmacoepidemiol Drug Saf","2023","2022/09/08","PMC10092126","","10.1002/pds.5538"
"36070795","Antibiotic utilisation in primary and revision total hip replacement patients: A registry linkage cohort study of 106 253 patients using the Australian Orthopaedic Association National Joint Replacement Registry","de Steiger RN, Pratt NL, Gulyani A, Duszynski KM, Inacio MC, Graves SE, Smith PN; Improving Joint Replacement Outcomes in Australia using National Data Linkage Study Working Group.","Pharmacoepidemiol Drug Saf. 2023 Feb;32(2):238-247. doi: 10.1002/pds.5522. Epub 2022 Sep 7.","de Steiger RN","Pharmacoepidemiol Drug Saf","2023","2022/09/07","","","10.1002/pds.5522"
"36065046","Thromboembolic events after Ad.26.COV2.S COVID-19 vaccine: Reports to the Vaccine Adverse Event Reporting System","Woo EJ, Mba-Jonas A, Thomas A, Baer B, Day B, Kim Y, Gomez-Lorenzo M, Nair N.","Pharmacoepidemiol Drug Saf. 2022 Nov;31(11):1174-1181. doi: 10.1002/pds.5523. Epub 2022 Sep 5.","Woo EJ","Pharmacoepidemiol Drug Saf","2022","2022/09/06","PMC9538147","","10.1002/pds.5523"
"36057777","Core concepts in pharmacoepidemiology: Validation of health outcomes of interest within real-world healthcare databases","Weinstein EJ, Ritchey ME, Lo Re V 3rd.","Pharmacoepidemiol Drug Saf. 2023 Jan;32(1):1-8. doi: 10.1002/pds.5537. Epub 2022 Sep 14.","Weinstein EJ","Pharmacoepidemiol Drug Saf","2023","2022/09/04","PMC9772105","NIHMS1834178","10.1002/pds.5537"
"36053913","Accuracy and validity of reported opioid prescription days' supply","Miracle DK, Slavova S, Brown JR, Dasgupta N, Harris S, Freeman PR.","Pharmacoepidemiol Drug Saf. 2022 Dec;31(12):1253-1261. doi: 10.1002/pds.5528. Epub 2022 Aug 30.","Miracle DK","Pharmacoepidemiol Drug Saf","2022","2022/09/02","PMC9729389","NIHMS1830402","10.1002/pds.5528"
"36039726","Role of private prescriptions in the long-term use of benzodiazepines and Z-drugs: A patient-related follow-up study","Grimmsmann T, Himmel W.","Pharmacoepidemiol Drug Saf. 2023 Jan;32(1):60-65. doi: 10.1002/pds.5536. Epub 2022 Sep 27.","Grimmsmann T","Pharmacoepidemiol Drug Saf","2023","2022/08/30","","","10.1002/pds.5536"
"36029480","Glucosamine and lower mortality and cancer incidence: Selection bias in the observational studies","Suissa K, Hudson M, Suissa S.","Pharmacoepidemiol Drug Saf. 2022 Dec;31(12):1272-1279. doi: 10.1002/pds.5535. Epub 2022 Sep 9.","Suissa K","Pharmacoepidemiol Drug Saf","2022","2022/08/27","","","10.1002/pds.5535"
"35999648","Antidepressant exposures associated with exploratory behavior among young children reported to United States poison control centers, 2000-2020","Francis M, Spiller HA, Badeti J, Casavant MJ, Michaels NL, Zhu M, Smith GA.","Pharmacoepidemiol Drug Saf. 2022 Nov;31(11):1206-1216. doi: 10.1002/pds.5534. Epub 2022 Sep 6.","Francis M","Pharmacoepidemiol Drug Saf","2022","2022/08/23","","","10.1002/pds.5534"
"35996833","Adverse events in the digital age and where to find them","Di Giovanni R, Cochrane A, Parker J, Lewis DJ.","Pharmacoepidemiol Drug Saf. 2022 Nov;31(11):1131-1139. doi: 10.1002/pds.5532. Epub 2022 Sep 9.","Di Giovanni R","Pharmacoepidemiol Drug Saf","2022","2022/08/23","","","10.1002/pds.5532"
"35996832","A systematic review of whether COVID-19 randomized controlled trials reported on demographic and clinical characteristics","Pak J, Lund JL, Keil A, Westreich D, Stürmer T, Wohl D, Farel C, Drummond MB, Webster-Clark M.","Pharmacoepidemiol Drug Saf. 2022 Dec;31(12):1219-1227. doi: 10.1002/pds.5533. Epub 2022 Oct 5.","Pak J","Pharmacoepidemiol Drug Saf","2022","2022/08/23","PMC9538362","NIHMS1831708","10.1002/pds.5533"
"35996825","Joint longitudinal trajectories of pain intensity and opioid prescription in veterans with back pain","Buta E, Gordon KS, Gueorguieva R, Becker WC, Heapy A, Bathulapalli H, Zeng Q, Redd D, Brandt C, Goulet J.","Pharmacoepidemiol Drug Saf. 2022 Dec;31(12):1262-1271. doi: 10.1002/pds.5531. Epub 2022 Sep 27.","Buta E","Pharmacoepidemiol Drug Saf","2022","2022/08/23","","","10.1002/pds.5531"
"35989512","Pre- and post-stroke oral antithrombotics and mortality in patients with ischaemic stroke","García Rodríguez LA, Gaist D, Balabanova Y, Brobert G, Sharma M, Cea Soriano L.","Pharmacoepidemiol Drug Saf. 2022 Nov;31(11):1182-1189. doi: 10.1002/pds.5530. Epub 2022 Sep 9.","García Rodríguez LA","Pharmacoepidemiol Drug Saf","2022","2022/08/22","PMC9825966","","10.1002/pds.5530"
"35984046","Visualizations throughout pharmacoepidemiology study planning, implementation, and reporting","Gatto NM, Wang SV, Murk W, Mattox P, Brookhart MA, Bate A, Schneeweiss S, Rassen JA.","Pharmacoepidemiol Drug Saf. 2022 Nov;31(11):1140-1152. doi: 10.1002/pds.5529. Epub 2022 Sep 9.","Gatto NM","Pharmacoepidemiol Drug Saf","2022","2022/08/19","PMC9826437","","10.1002/pds.5529"
"35976191","Identification of pregnancies in healthcare data: A changing landscape","Margulis AV, Huybrechts K.","Pharmacoepidemiol Drug Saf. 2023 Jan;32(1):84-86. doi: 10.1002/pds.5526. Epub 2022 Sep 3.","Margulis AV","Pharmacoepidemiol Drug Saf","2023","2022/08/17","","","10.1002/pds.5526"
"35976190","Meta-analysis with sample-standardization in multi-site studies","Shu D, Webster-Clark M, Platt RW, Toh S.","Pharmacoepidemiol Drug Saf. 2023 Jan;32(1):56-59. doi: 10.1002/pds.5527. Epub 2022 Sep 2.","Shu D","Pharmacoepidemiol Drug Saf","2023","2022/08/17","","","10.1002/pds.5527"
"35959980","Artificial intelligence in pharmacovigilance: A regulatory perspective on explainability","Pinheiro LC, Kurz X.","Pharmacoepidemiol Drug Saf. 2022 Dec;31(12):1308-1310. doi: 10.1002/pds.5524. Epub 2022 Sep 8.","Pinheiro LC","Pharmacoepidemiol Drug Saf","2022","2022/08/12","","","10.1002/pds.5524"
"35924394","Metformin, pioglitazone and gout risk","Liao KF, Hwang BF, Kuo YH, Liu CS, Lai SW.","Pharmacoepidemiol Drug Saf. 2022 Oct;31(10):1127-1128. doi: 10.1002/pds.5516. Epub 2022 Aug 10.","Liao KF","Pharmacoepidemiol Drug Saf","2022","2022/08/04","","","10.1002/pds.5516"
"35914898","Prescribing and Research in Medicines Management - PRIMM 33rd Annual Scientific Meeting, Manchester, UK, 10 June 2022, Personomics: Putting the Patient at the Centre of Prescribing and Medicines Use","","Pharmacoepidemiol Drug Saf. 2022 Aug;31 Suppl 1:3-26. doi: 10.1002/pds.5499.","","Pharmacoepidemiol Drug Saf","2022","2022/08/01","","","10.1002/pds.5499"
"35909259","A cohort study to assess risk of cutaneous small vessel vasculitis among users of different oral anticoagulants","Ajao A, Cosgrove A, Eworuke E, Mohamoud M, Zhang R, Shapira O, Kolonoski J, Connolly JG.","Pharmacoepidemiol Drug Saf. 2022 Nov;31(11):1164-1173. doi: 10.1002/pds.5514. Epub 2022 Aug 15.","Ajao A","Pharmacoepidemiol Drug Saf","2022","2022/08/01","PMC9872093","NIHMS1862717","10.1002/pds.5514"
"35909258","Incidence and outcomes of adverse drug reactions to first-line anti-tuberculosis drugs and their effects on the quality of life: A multicenter prospective cohort study","Choi H, Park HA, Hyun IG, Kim JH, Hwang YI, Jang SH, Sim YS, Shin TR, Ko Y, Ban GY, Hong JY, Lee CY, Lee MG, Choi JH.","Pharmacoepidemiol Drug Saf. 2022 Nov;31(11):1153-1163. doi: 10.1002/pds.5513. Epub 2022 Aug 9.","Choi H","Pharmacoepidemiol Drug Saf","2022","2022/08/01","","","10.1002/pds.5513"
"35871766","Novel methods for pregnancy drug safety surveillance in the FDA Sentinel System","Suarez EA, Nguyen M, Zhang D, Zhao Y, Stojanovic D, Munoz M, Liedtka J, Anderson A, Liu W, Dashevsky I, Cole D, DeLuccia S, Menzin T, Noble J, Maro JC.","Pharmacoepidemiol Drug Saf. 2023 Feb;32(2):126-136. doi: 10.1002/pds.5512. Epub 2022 Aug 10.","Suarez EA","Pharmacoepidemiol Drug Saf","2023","2022/07/25","","","10.1002/pds.5512"
"35864719","Attention to risk information in direct-to-consumer prescription drug print ads: An eye-tracking study","Aikin KJ, Sullivan HW, Caporaso A, Hoverman V, Yan T, Williams D, Crafts J.","Pharmacoepidemiol Drug Saf. 2023 Mar;32(3):312-320. doi: 10.1002/pds.5511. Epub 2022 Jul 31.","Aikin KJ","Pharmacoepidemiol Drug Saf","2023","2022/07/22","","","10.1002/pds.5511"
"35819240","Core concepts in pharmacoepidemiology: Measures of drug utilization based on individual-level drug dispensing data","Rasmussen L, Wettermark B, Steinke D, Pottegård A.","Pharmacoepidemiol Drug Saf. 2022 Oct;31(10):1015-1026. doi: 10.1002/pds.5490. Epub 2022 Aug 11.","Rasmussen L","Pharmacoepidemiol Drug Saf","2022","2022/07/12","PMC9545237","","10.1002/pds.5490"
"35811396","Indirect covariate balance and residual confounding: An applied comparison of propensity score matching and cardinality matching","Fortin SP, Schuemie M.","Pharmacoepidemiol Drug Saf. 2022 Dec;31(12):1242-1252. doi: 10.1002/pds.5510. Epub 2022 Jul 20.","Fortin SP","Pharmacoepidemiol Drug Saf","2022","2022/07/11","","","10.1002/pds.5510"
"35791700","Comparison of drug prescribing before and during the COVID-19 pandemic: A cross-national European study","Selke Krulichová I, Selke GW, Bennie M, Hajiebrahimi M, Nyberg F, Fürst J, Garuolienė K, Poluzzi E, Slabý J, Yahni CZ, Altini M, Fantini MP, Kočí V, McTaggart S, Pontes C, Reno C, Rosa S, Pedrola MT, Udovič M, Wettermark B.","Pharmacoepidemiol Drug Saf. 2022 Oct;31(10):1046-1055. doi: 10.1002/pds.5509. Epub 2022 Jul 18.","Selke Krulichová I","Pharmacoepidemiol Drug Saf","2022","2022/07/06","PMC9350215","","10.1002/pds.5509"
"35790047","Pioglitazone use in Australia and the United Kingdom following drug safety advisories on bladder cancer risk: An interrupted time series study","Kemp-Casey A, Mintzes B, Morrow RL, Dormuth CR, Souverein PC, Roughead EE.","Pharmacoepidemiol Drug Saf. 2022 Oct;31(10):1039-1045. doi: 10.1002/pds.5508. Epub 2022 Jul 27.","Kemp-Casey A","Pharmacoepidemiol Drug Saf","2022","2022/07/05","PMC9546180","","10.1002/pds.5508"
"35790044","Performance characteristics of code-based algorithms to identify urinary tract infections in large United States administrative claims databases","Fortin SP, Swerdel J, Sarnecki M, Doua J, Colasurdo J, Geurtsen J.","Pharmacoepidemiol Drug Saf. 2022 Sep;31(9):953-962. doi: 10.1002/pds.5492. Epub 2022 Jul 4.","Fortin SP","Pharmacoepidemiol Drug Saf","2022","2022/07/05","","","10.1002/pds.5492"
"35780391","Potentially inappropriate medication use by level of polypharmacy among US Veterans 49-64 and 65-70 years old","Guillot J, Rentsch CT, Gordon KS, Justice AC, Bezin J.","Pharmacoepidemiol Drug Saf. 2022 Oct;31(10):1056-1074. doi: 10.1002/pds.5506. Epub 2022 Jul 15.","Guillot J","Pharmacoepidemiol Drug Saf","2022","2022/07/03","PMC9464694","NIHMS1820626","10.1002/pds.5506"
"35753071","Development and performance characteristics of novel code-based algorithms to identify invasive Escherichia coli disease","Fortin SP, Hernandez Pastor L, Doua J, Sarnecki M, Swerdel J, Colasurdo J, Geurtsen J.","Pharmacoepidemiol Drug Saf. 2022 Sep;31(9):983-991. doi: 10.1002/pds.5505. Epub 2022 Jul 10.","Fortin SP","Pharmacoepidemiol Drug Saf","2022","2022/06/26","","","10.1002/pds.5505"
"35753061","Time-related biases in perinatal pharmacoepidemiology: A systematic review of observational studies","Ukah UV, Aibibula W, Platt RW, Dayan N, Reynier P, Filion KB.","Pharmacoepidemiol Drug Saf. 2022 Dec;31(12):1228-1241. doi: 10.1002/pds.5504. Epub 2022 Jul 24.","Ukah UV","Pharmacoepidemiol Drug Saf","2022","2022/06/26","","","10.1002/pds.5504"
"35751621","Using structural topic modelling to reveal patterns in reports on opioid drugs in a pharmacovigilance database","Lösch L, Brown P, van Hunsel F.","Pharmacoepidemiol Drug Saf. 2022 Sep;31(9):1003-1006. doi: 10.1002/pds.5502. Epub 2022 Jul 6.","Lösch L","Pharmacoepidemiol Drug Saf","2022","2022/06/25","","","10.1002/pds.5502"
"35751619","Use of α1-adrenoceptor antagonists tamsulosin and alfuzosin and the risk of Alzheimer's disease","Latvala L, Tiihonen M, Murtola TJ, Hartikainen S, Tolppanen AM.","Pharmacoepidemiol Drug Saf. 2022 Oct;31(10):1110-1120. doi: 10.1002/pds.5503. Epub 2022 Jul 6.","Latvala L","Pharmacoepidemiol Drug Saf","2022","2022/06/25","PMC9542191","","10.1002/pds.5503"
"35747938","Artificial intelligence in pharmacovigilance: Do we need explainability?","Hauben M.","Pharmacoepidemiol Drug Saf. 2022 Dec;31(12):1311-1316. doi: 10.1002/pds.5501. Epub 2022 Jul 19.","Hauben M","Pharmacoepidemiol Drug Saf","2022","2022/06/24","","","10.1002/pds.5501"
"35729705","Machine learning for improving high-dimensional proxy confounder adjustment in healthcare database studies: An overview of the current literature","Wyss R, Yanover C, El-Hay T, Bennett D, Platt RW, Zullo AR, Sari G, Wen X, Ye Y, Yuan H, Gokhale M, Patorno E, Lin KJ.","Pharmacoepidemiol Drug Saf. 2022 Sep;31(9):932-943. doi: 10.1002/pds.5500. Epub 2022 Jul 5.","Wyss R","Pharmacoepidemiol Drug Saf","2022","2022/06/21","PMC9541861","","10.1002/pds.5500"
"35726806","Validity of claims data for identifying cancer incidence in the Japan public health center-based prospective study for the next generation","Ihira H, Goto A, Yamagishi K, Iso H, Iwasaki M, Sawada N, Tsugane S; JPHC-NEXT Study Group.","Pharmacoepidemiol Drug Saf. 2022 Sep;31(9):972-982. doi: 10.1002/pds.5494. Epub 2022 Jun 25.","Ihira H","Pharmacoepidemiol Drug Saf","2022","2022/06/21","","","10.1002/pds.5494"
"35713292","Risk of volume depletion events with concomitant use of sodium glucose co-transporter 2 inhibitors and loop diuretics: A self-controlled case series study","Lewellyan CM, Spoutz P, Schaefer M, Patterson ME.","Pharmacoepidemiol Drug Saf. 2022 Oct;31(10):1102-1109. doi: 10.1002/pds.5496. Epub 2022 Jul 1.","Lewellyan CM","Pharmacoepidemiol Drug Saf","2022","2022/06/17","","","10.1002/pds.5496"
"35713281","Delayed pregnancy detection and return to fertility with extended levonorgestrel-containing oral contraceptives: A real world setting cohort study","Kaplan S, Bertoia ML, Lass A, Wang FT, Evans A, Dhanda S, Roy D, Seeger JD.","Pharmacoepidemiol Drug Saf. 2023 Jan;32(1):78-83. doi: 10.1002/pds.5497. Epub 2022 Jun 30.","Kaplan S","Pharmacoepidemiol Drug Saf","2023","2022/06/17","","","10.1002/pds.5497"
"35695189","Association between opioid therapy trajectories and potential opioid-related adverse health events","Hayes CJ, Koonce RM, Gressler LE, Hu B, Williams JS, Martin BC.","Pharmacoepidemiol Drug Saf. 2022 Oct;31(10):1075-1090. doi: 10.1002/pds.5495. Epub 2022 Jun 30.","Hayes CJ","Pharmacoepidemiol Drug Saf","2022","2022/06/13","PMC10052807","NIHMS1881734","10.1002/pds.5495"
"35689300","The role of prenatal exposure to antidepressants, anxiolytic, and hypnotics and its underlying illness on the risk of miscarriage using BIFAP database","Kitchin Á, Huerta C, Llorente-García A, Martínez D, Ortega P, Cea-Soriano L.","Pharmacoepidemiol Drug Saf. 2022 Aug;31(8):901-912. doi: 10.1002/pds.5488. Epub 2022 Jun 18.","Kitchin Á","Pharmacoepidemiol Drug Saf","2022","2022/06/10","PMC9543237","","10.1002/pds.5488"
"35689299","Systematically exploring repurposing effects of antihypertensives","Shahn Z, Spear P, Lu H, Jiang S, Zhang S, Deshmukh N, Xu S, Ng K, Welsch R, Finkelstein S.","Pharmacoepidemiol Drug Saf. 2022 Sep;31(9):944-952. doi: 10.1002/pds.5491. Epub 2022 Jun 21.","Shahn Z","Pharmacoepidemiol Drug Saf","2022","2022/06/10","PMC9545793","","10.1002/pds.5491"
"35689298","Ileus in patients treated with immune checkpoint inhibitors: A retrospective, pharmacovigilance study using Food and Drug Administration Adverse Event Reporting System database","Gao S, He Z, Zhu J, Liang D, Zhao W, Yang S, Jiang W, Qiu K, Yu X, Wu J.","Pharmacoepidemiol Drug Saf. 2022 Nov;31(11):1199-1205. doi: 10.1002/pds.5493. Epub 2022 Jul 6.","Gao S","Pharmacoepidemiol Drug Saf","2022","2022/06/10","","","10.1002/pds.5493"
"35670124","Validation of international classification of diseases, tenth revision, clinical modification diagnosis codes for heart failure subtypes","Pocobelli G, Ichikawa L, Yu O, Green BB, Meyers K, Gray R, Shea M, Chubak J.","Pharmacoepidemiol Drug Saf. 2022 Sep;31(9):992-997. doi: 10.1002/pds.5489. Epub 2022 Jun 29.","Pocobelli G","Pharmacoepidemiol Drug Saf","2022","2022/06/07","","","10.1002/pds.5489"
"35670103","Very high PD-L1 expression as a prognostic indicator of overall survival among patients with advanced non-small cell lung cancer receiving anti-PD-(L)1 monotherapies in routine practice","Shah M, Hubbard RA, Mamtani R, Marmarelis ME, Hennessy S.","Pharmacoepidemiol Drug Saf. 2022 Oct;31(10):1121-1126. doi: 10.1002/pds.5487. Epub 2022 Jun 22.","Shah M","Pharmacoepidemiol Drug Saf","2022","2022/06/07","PMC9464674","NIHMS1814303","10.1002/pds.5487"
"35670078","Antibacterial-associated acute kidney injury among older adults: A post-marketing surveillance study using the FDA adverse events reporting system","Chinzowu T, Chyou TY, Nishtala PS.","Pharmacoepidemiol Drug Saf. 2022 Nov;31(11):1190-1198. doi: 10.1002/pds.5486. Epub 2022 Jun 23.","Chinzowu T","Pharmacoepidemiol Drug Saf","2022","2022/06/07","PMC9795977","","10.1002/pds.5486"
"35638368","Positive predictive values of hematological procedure codes in the Danish National Patient Registry-A population-based validation study","Lauritsen TB, Nørgaard JM, Christensen ME, Dalton SO, Østgård LSG.","Pharmacoepidemiol Drug Saf. 2022 Sep;31(9):963-971. doi: 10.1002/pds.5485. Epub 2022 Jun 20.","Lauritsen TB","Pharmacoepidemiol Drug Saf","2022","2022/05/31","PMC9545071","","10.1002/pds.5485"
"35638365","Initiation of antidepressant medication in people with type 2 diabetes living in the United Kingdom-A retrospective cohort study","Pal K, Sharma M, Mukadam NM, Petersen I.","Pharmacoepidemiol Drug Saf. 2022 Aug;31(8):892-900. doi: 10.1002/pds.5484. Epub 2022 Jun 10.","Pal K","Pharmacoepidemiol Drug Saf","2022","2022/05/31","PMC9542279","","10.1002/pds.5484"
"35622900","Identification of pregnancies and infants within a US commercial healthcare administrative claims database","Bertoia ML, Phiri K, Clifford CR, Doherty M, Zhou L, Wang LT, Bertoia NA, Wang FT, Seeger JD.","Pharmacoepidemiol Drug Saf. 2022 Aug;31(8):863-874. doi: 10.1002/pds.5483. Epub 2022 Jun 7.","Bertoia ML","Pharmacoepidemiol Drug Saf","2022","2022/05/27","PMC9546262","","10.1002/pds.5483"
"35621007","Core concepts in pharmacoepidemiology: Fundamentals of the cohort and case-control study designs","Pottegård A.","Pharmacoepidemiol Drug Saf. 2022 Aug;31(8):817-826. doi: 10.1002/pds.5482. Epub 2022 Jun 7.","Pottegård A","Pharmacoepidemiol Drug Saf","2022","2022/05/27","PMC9545534","","10.1002/pds.5482"
"35611675","Profiling real-world data sources for pharmacoepidemiologic research: A call for papers","Li X, Lo Re V 3rd, Toh S.","Pharmacoepidemiol Drug Saf. 2022 Sep;31(9):929-931. doi: 10.1002/pds.5481. Epub 2022 Jul 3.","Li X","Pharmacoepidemiol Drug Saf","2022","2022/05/25","","","10.1002/pds.5481"
"35595539","Corrigendum","","Pharmacoepidemiol Drug Saf. 2022 Jul;31(7):815. doi: 10.1002/pds.5479. Epub 2022 May 20.","","Pharmacoepidemiol Drug Saf","2022","2022/05/20","","","10.1002/pds.5479"
"35587029","Risk of delirium associated with antimuscarinics in older adults: A case-time-control study","Nishtala PS, Chyou TY.","Pharmacoepidemiol Drug Saf. 2022 Aug;31(8):883-891. doi: 10.1002/pds.5480. Epub 2022 May 25.","Nishtala PS","Pharmacoepidemiol Drug Saf","2022","2022/05/19","PMC9545361","","10.1002/pds.5480"
"35569136","Myopericarditis following COVID-19 mRNA vaccination","Mungmunpuntipantip R, Wiwanitkit V.","Pharmacoepidemiol Drug Saf. 2022 Aug;31(8):926. doi: 10.1002/pds.5478. Epub 2022 May 27.","Mungmunpuntipantip R","Pharmacoepidemiol Drug Saf","2022","2022/05/15","PMC9347481","","10.1002/pds.5478"
"35569118","Use of prescription medications with cardiovascular adverse effects among older adults in the United States","Ozenberger K, Alexander GC, Shin JI, Whitsel EA, Qato DM.","Pharmacoepidemiol Drug Saf. 2022 Oct;31(10):1027-1038. doi: 10.1002/pds.5477. Epub 2022 May 27.","Ozenberger K","Pharmacoepidemiol Drug Saf","2022","2022/05/15","PMC9545984","","10.1002/pds.5477"
"35560969","The acute effects of azithromycin use on cardiovascular mortality as compared with amoxicillin-clavulanate in US Veterans","DerSarkissian M, Young-Xu Y, Duh MS, Bhak RH, Palmetto N, Mortensen E, Anzueto A, Nguyen C, Cheng M, Frajzyngier V, Park S, Lax A, Weatherby LB, Walker AM.","Pharmacoepidemiol Drug Saf. 2022 Aug;31(8):840-850. doi: 10.1002/pds.5451. Epub 2022 May 24.","DerSarkissian M","Pharmacoepidemiol Drug Saf","2022","2022/05/13","","","10.1002/pds.5451"
"35560855","Parity in female authorship in Australian pharmacoepidemiology research leveraging medicine dispensing data: How well are we doing?","de Oliveira Costa J, Pearson SA, Donnolley N, Bailey B, Hollingworth S, Stanford T, Pratt N.","Pharmacoepidemiol Drug Saf. 2022 Sep;31(9):1010-1012. doi: 10.1002/pds.5450. Epub 2022 May 20.","de Oliveira Costa J","Pharmacoepidemiol Drug Saf","2022","2022/05/13","","","10.1002/pds.5450"
"35560685","Considerations for observational study design: Comparing the evidence of opioid use between electronic health records and insurance claims","Young JC, Dasgupta N, Stürmer T, Pate V, Jonsson Funk M.","Pharmacoepidemiol Drug Saf. 2022 Aug;31(8):913-920. doi: 10.1002/pds.5452. Epub 2022 May 23.","Young JC","Pharmacoepidemiol Drug Saf","2022","2022/05/13","PMC9271595","NIHMS1807620","10.1002/pds.5452"
"35535630","Bayesian symmetry analysis","Lund LC.","Pharmacoepidemiol Drug Saf. 2022 Sep;31(9):1007-1009. doi: 10.1002/pds.5449. Epub 2022 May 18.","Lund LC","Pharmacoepidemiol Drug Saf","2022","2022/05/10","","","10.1002/pds.5449"
"35505634","Association between different diabetes medication classes and risk of Parkinson's disease in people with diabetes","Sunnarborg K, Tiihonen M, Huovinen M, Koponen M, Hartikainen S, Tolppanen AM.","Pharmacoepidemiol Drug Saf. 2022 Aug;31(8):875-882. doi: 10.1002/pds.5448. Epub 2022 May 11.","Sunnarborg K","Pharmacoepidemiol Drug Saf","2022","2022/05/04","PMC9542001","","10.1002/pds.5448"
"35505623","A cross-sectional survey to evaluate prescribers' knowledge and understanding of safety messages following Dengvaxia® product information update","Almas MF, Toussi M, Valero E, Moureau A, Marcelon L.","Pharmacoepidemiol Drug Saf. 2022 Jul;31(7):758-768. doi: 10.1002/pds.5447. Epub 2022 May 13.","Almas MF","Pharmacoepidemiol Drug Saf","2022","2022/05/04","PMC9325459","","10.1002/pds.5447"
"35505471","Alternative analytic and matching approaches for the prevalent new-user design: A simulation study","Webster-Clark M, Mavros P, Garry EM, Stürmer T, Shmuel S, Young J, Girman C.","Pharmacoepidemiol Drug Saf. 2022 Jul;31(7):796-803. doi: 10.1002/pds.5446. Epub 2022 May 13.","Webster-Clark M","Pharmacoepidemiol Drug Saf","2022","2022/05/04","","","10.1002/pds.5446"
"35484637","Trends in antipsychotic use for youth with attention-deficit/hyperactivity disorder and disruptive behavior disorders","dosReis S, Saini J, Hong K, Reeves G, Spence OM.","Pharmacoepidemiol Drug Saf. 2022 Jul;31(7):810-814. doi: 10.1002/pds.5445. Epub 2022 May 3.","dosReis S","Pharmacoepidemiol Drug Saf","2022","2022/04/28","","","10.1002/pds.5445"
"35471704","Real-world data: Assessing electronic health records and medical claims data to support regulatory decision-making for drug and biological products","Girman CJ, Ritchey ME, Lo Re V 3rd.","Pharmacoepidemiol Drug Saf. 2022 Jul;31(7):717-720. doi: 10.1002/pds.5444. Epub 2022 May 3.","Girman CJ","Pharmacoepidemiol Drug Saf","2022","2022/04/26","PMC9320939","","10.1002/pds.5444"
"35470515","Evaluating the population-level effects of oxycodone restrictions on prescription opioid utilization in Ontario","Rudoler D, Kurdyak P, Gomes T, Huang A, Jones W, Littleford S, Paracha N, Fischer B.","Pharmacoepidemiol Drug Saf. 2022 Jul;31(7):769-778. doi: 10.1002/pds.5442. Epub 2022 May 6.","Rudoler D","Pharmacoepidemiol Drug Saf","2022","2022/04/26","","","10.1002/pds.5442"
"35460142","International trends in prescription opioid sales among developed and developing economies, and the impact of the COVID-19 pandemic: A cross-sectional analysis of 66 countries","Gomes T, Kim KC, Suda KJ, Garg R, Tadrous M.","Pharmacoepidemiol Drug Saf. 2022 Jul;31(7):779-787. doi: 10.1002/pds.5443. Epub 2022 Apr 30.","Gomes T","Pharmacoepidemiol Drug Saf","2022","2022/04/23","PMC9088547","","10.1002/pds.5443"
"35426202","COVID-19 pharmacotherapy utilization patterns during pregnancy: International Registry of Coronavirus Exposure in Pregnancy","Westhoff WJ, Smith LH, Wyszynski DF, Hernandez-Diaz S.","Pharmacoepidemiol Drug Saf. 2022 Jul;31(7):804-809. doi: 10.1002/pds.5440. Epub 2022 Apr 24.","Westhoff WJ","Pharmacoepidemiol Drug Saf","2022","2022/04/15","PMC9088478","","10.1002/pds.5440"
"35426193","Applying mixture cure survival modeling to medication persistence analysis","Cai C, Love BL, Yunusa I, Reeder CE.","Pharmacoepidemiol Drug Saf. 2022 Jul;31(7):788-795. doi: 10.1002/pds.5441. Epub 2022 Apr 27.","Cai C","Pharmacoepidemiol Drug Saf","2022","2022/04/15","","","10.1002/pds.5441"
"35404496","Risk of myopericarditis following COVID-19 mRNA vaccination in a large integrated health system: A comparison of completeness and timeliness of two methods","Sharff KA, Dancoes DM, Longueil JL, Johnson ES, Lewis PF.","Pharmacoepidemiol Drug Saf. 2022 Aug;31(8):921-925. doi: 10.1002/pds.5439. Epub 2022 Apr 16.","Sharff KA","Pharmacoepidemiol Drug Saf","2022","2022/04/11","PMC9088632","","10.1002/pds.5439"
"35384126","How measurements affected by medication use are reported and handled in observational research: A literature review","Choi J, Dekkers OM, le Cessie S.","Pharmacoepidemiol Drug Saf. 2022 Jul;31(7):739-748. doi: 10.1002/pds.5437. Epub 2022 May 4.","Choi J","Pharmacoepidemiol Drug Saf","2022","2022/04/06","PMC9321697","","10.1002/pds.5437"
"35384111","Antibiotic use in children before, during and after hospitalisation","Thaulow CM, Blix HS, Nilsen RM, Eriksen BH, Wathne JS, Berild D, Harthug S.","Pharmacoepidemiol Drug Saf. 2022 Jul;31(7):749-757. doi: 10.1002/pds.5438. Epub 2022 Apr 19.","Thaulow CM","Pharmacoepidemiol Drug Saf","2022","2022/04/06","PMC9320961","","10.1002/pds.5438"
"35373865","Categorization of COVID-19 severity to determine mortality risk","Garry EM, Weckstein AR, Quinto K, Bradley MC, Lasky T, Chakravarty A, Leonard S, Vititoe SE, Easthausen IJ, Rassen JA, Gatto NM.","Pharmacoepidemiol Drug Saf. 2022 Jul;31(7):721-728. doi: 10.1002/pds.5436. Epub 2022 May 9.","Garry EM","Pharmacoepidemiol Drug Saf","2022","2022/04/04","PMC9088650","","10.1002/pds.5436"
"35366035","Influenza vaccination during pregnancy and risk of selected major structural noncardiac birth defects, National Birth Defects Prevention Study 2006-2011","Palmsten K, Suhl J, Conway KM, Kharbanda EO, Ailes EC, Cragan JD, Nestoridi E, Papadopoulos EA, Kerr SM, Young SG, DeStefano F, Romitti PA; National Birth Defects Prevention Study.","Pharmacoepidemiol Drug Saf. 2022 Aug;31(8):851-862. doi: 10.1002/pds.5435. Epub 2022 Apr 22.","Palmsten K","Pharmacoepidemiol Drug Saf","2022","2022/04/02","","","10.1002/pds.5435"
"35366030","A risk classification model for prioritising the management of quality issues relating to substandard medicines in Singapore","Ang PS, Teo DCH, Toh YL, Ng MSY, Choong CT, Phuah DST, Tan DHM, Tan FM, Tan MSH, Koh ST, Thinn WM, Poh JWW, Dorajoo SR.","Pharmacoepidemiol Drug Saf. 2022 Jul;31(7):729-738. doi: 10.1002/pds.5434. Epub 2022 Apr 27.","Ang PS","Pharmacoepidemiol Drug Saf","2022","2022/04/02","","","10.1002/pds.5434"
"35324035","Association between pre-admission anticoagulation and in-hospital death, venous thromboembolism, and major bleeding among hospitalized COVID-19 patients in Japan","Adomi M, Kuno T, Komiyama J, Taniguchi Y, Abe T, Miyawaki A, Imai S, Morita K, Saito M, Ohbe H, Kamio T, Tamiya N, Iwagami M.","Pharmacoepidemiol Drug Saf. 2022 Jun;31(6):680-688. doi: 10.1002/pds.5433. Epub 2022 Apr 7.","Adomi M","Pharmacoepidemiol Drug Saf","2022","2022/03/24","PMC9088474","","10.1002/pds.5433"
"35320606","Hormonal contraception use before and after breast cancer diagnosis: A nationwide drug utilization study","Mørch LS, Friis S, Meaidi A, Dehlendorff C, Skovlund CW, Duun-Henriksen AK.","Pharmacoepidemiol Drug Saf. 2022 Jun;31(6):706-709. doi: 10.1002/pds.5431. Epub 2022 Apr 1.","Mørch LS","Pharmacoepidemiol Drug Saf","2022","2022/03/23","","","10.1002/pds.5431"
"35320605","Cardiovascular events and all-cause mortality in patients with chronic obstructive pulmonary disease using olodaterol and other long-acting beta2-agonists","Rebordosa C, Farkas DK, Montonen J, Laugesen K, Voss F, Aguado J, Bothner U, Rothman KJ, Zint K, Mines D, Ehrenstein V.","Pharmacoepidemiol Drug Saf. 2022 Aug;31(8):827-839. doi: 10.1002/pds.5432. Epub 2022 May 13.","Rebordosa C","Pharmacoepidemiol Drug Saf","2022","2022/03/23","PMC9545725","","10.1002/pds.5432"
"35297128","Validation of actinic keratosis diagnosis and treatment codes among veterans living with HIV","Supapannachart KJ, Kwon CW, Tushe S, Guest JL, Chen SC, Yeung H.","Pharmacoepidemiol Drug Saf. 2022 Sep;31(9):998-1002. doi: 10.1002/pds.5430. Epub 2022 Mar 28.","Supapannachart KJ","Pharmacoepidemiol Drug Saf","2022","2022/03/17","PMC9378463","NIHMS1789705","10.1002/pds.5430"
"35297119","Pandemic vaccine testing: Combining conventional and challenge studies","Gerhard T, Strom BL, Eyal N.","Pharmacoepidemiol Drug Saf. 2022 Jun;31(6):710-715. doi: 10.1002/pds.5429. Epub 2022 Mar 31.","Gerhard T","Pharmacoepidemiol Drug Saf","2022","2022/03/17","PMC9313872","","10.1002/pds.5429"
"35285110","Valproate utilisation trends among women of childbearing potential in Ireland between 2014 and 2019: A drug utilisation study using interrupted time series","Hughes JE, Buckley N, Looney Y, Curran S, Mullooly M, Bennett K.","Pharmacoepidemiol Drug Saf. 2022 Jun;31(6):661-669. doi: 10.1002/pds.5427. Epub 2022 Mar 31.","Hughes JE","Pharmacoepidemiol Drug Saf","2022","2022/03/14","PMC9315025","","10.1002/pds.5427"
"35285107","Proton pump inhibitors may enhance the risk of citalopram- and escitalopram-associated sudden cardiac death among patients receiving hemodialysis","Assimon MM, Pun PH, Al-Khatib SM, Brookhart MA, Gaynes BN, Winkelmayer WC, Flythe JE.","Pharmacoepidemiol Drug Saf. 2022 Jun;31(6):670-679. doi: 10.1002/pds.5428. Epub 2022 Mar 24.","Assimon MM","Pharmacoepidemiol Drug Saf","2022","2022/03/14","PMC9064943","NIHMS1788744","10.1002/pds.5428"
"35253307","Statin use and the risk of progression to vision threatening diabetic retinopathy","Meer E, Bavinger JC, Yu Y, Hua P, McGeehan B, VanderBeek BL.","Pharmacoepidemiol Drug Saf. 2022 Jun;31(6):652-660. doi: 10.1002/pds.5426. Epub 2022 Mar 15.","Meer E","Pharmacoepidemiol Drug Saf","2022","2022/03/07","","","10.1002/pds.5426"
"35247021","Evaluating opioid analgesic prescribing limits: A narrative review","Seitz AE, Janiszewski KA, Guy GP Jr, Tapscott RT, Einstein EB, Meyer TE, Tierney J, Staffa J, Jones CM, Compton WM.","Pharmacoepidemiol Drug Saf. 2022 Jun;31(6):605-613. doi: 10.1002/pds.5425. Epub 2022 Mar 17.","Seitz AE","Pharmacoepidemiol Drug Saf","2022","2022/03/05","PMC9078148","NIHMS1791265","10.1002/pds.5425"
"35225407","Effectiveness and use of reverse transcriptase polymerase chain reaction point of care testing in a large-scale COVID-19 surveillance system","Mack CD, Wasserman EB, Hostler CJ, Solomon G, Anderson DJ, Walton P, Hawaldar K, Myers E, Best M, Eichner D, Mayer T, Sills A.","Pharmacoepidemiol Drug Saf. 2022 May;31(5):511-518. doi: 10.1002/pds.5424. Epub 2022 Mar 11.","Mack CD","Pharmacoepidemiol Drug Saf","2022","2022/02/28","PMC9088538","","10.1002/pds.5424"
"35224801","Validity of identification algorithms combining diagnostic codes with other measures for acute ischemic stroke in MID-NET®","Tanigawa M, Kohama M, Nonaka T, Saito A, Tamiya A, Nomura H, Kataoka Y, Okauchi M, Tamiya T, Inoue R, Nakayama M, Suzuki T, Uyama Y, Yokoi H.","Pharmacoepidemiol Drug Saf. 2022 May;31(5):524-533. doi: 10.1002/pds.5423. Epub 2022 Mar 9.","Tanigawa M","Pharmacoepidemiol Drug Saf","2022","2022/02/28","","","10.1002/pds.5423"
"35224798","The risk of melanoma with rasagiline compared with other antiparkinsonian medications: A retrospective cohort study in the United States medicare database","Johannes CB, Saltus CW, Kaye JA, Calingaert B, Kaplan S, Gordon MF, Andrews EB.","Pharmacoepidemiol Drug Saf. 2022 Jun;31(6):643-651. doi: 10.1002/pds.5422. Epub 2022 Apr 6.","Johannes CB","Pharmacoepidemiol Drug Saf","2022","2022/02/28","PMC9321028","","10.1002/pds.5422"
"35218107","Validation of diagnostic coding for interstitial lung diseases in an electronic health record system in Hong Kong","Ye Y, Hubbard R, Li GH, Ho SC, Sing CW, Cheung CL, Lam DCL.","Pharmacoepidemiol Drug Saf. 2022 May;31(5):519-523. doi: 10.1002/pds.5421. Epub 2022 Mar 9.","Ye Y","Pharmacoepidemiol Drug Saf","2022","2022/02/26","","","10.1002/pds.5421"
"35194891","Sex differences in the utilization of drugs for COVID-19 treatment among elderly residents in a sample of Italian nursing homes","Spini A, Crescioli G, Donnini S, Ziche M, Collini F, Gemmi F, Virgili G, Vannacci A, Lucenteforte E, Gini R, Lombardi N, Roberto G.","Pharmacoepidemiol Drug Saf. 2022 May;31(5):489-494. doi: 10.1002/pds.5420. Epub 2022 Feb 28.","Spini A","Pharmacoepidemiol Drug Saf","2022","2022/02/23","PMC9088595","","10.1002/pds.5420"
"35191114","Background rates of five thrombosis with thrombocytopenia syndromes of special interest for COVID-19 vaccine safety surveillance: Incidence between 2017 and 2019 and patient profiles from 38.6 million people in six European countries","Burn E, Li X, Kostka K, Stewart HM, Reich C, Seager S, Duarte-Salles T, Fernandez-Bertolin S, Aragón M, Reyes C, Martinez-Hernandez E, Marti E, Delmestri A, Verhamme K, Rijnbeek P, Horban S, Morales DR, Prieto-Alhambra D.","Pharmacoepidemiol Drug Saf. 2022 May;31(5):495-510. doi: 10.1002/pds.5419. Epub 2022 Feb 27.","Burn E","Pharmacoepidemiol Drug Saf","2022","2022/02/22","PMC9088543","","10.1002/pds.5419"
"35187734","Population-based prevalence of polypharmacy and patterns of medication use in southwestern Iran: A cross-sectional study","Taherifard E, Mohammadi Z, Molavi Vardanjani H, Pakroo M, Emaminia M, Rahimi Z, Danehchin L, Abolnezhadian F, Malihi R, Paridar Y, Hariri S, Hashemi F, Cheraghian B, Mard A, Shayesteh AA, Poustchi H.","Pharmacoepidemiol Drug Saf. 2022 May;31(5):592-603. doi: 10.1002/pds.5418. Epub 2022 Mar 7.","Taherifard E","Pharmacoepidemiol Drug Saf","2022","2022/02/21","","","10.1002/pds.5418"
"35141978","Association between tramadol use and seizures: A nationwide case-case-time-control study","Park S, Lee H, Kim JH, Jeon HL, Shin JY.","Pharmacoepidemiol Drug Saf. 2022 Jun;31(6):614-622. doi: 10.1002/pds.5417. Epub 2022 Feb 17.","Park S","Pharmacoepidemiol Drug Saf","2022","2022/02/10","","","10.1002/pds.5417"
"35137491","Stability of individual dementia diagnoses in routine care: Implications for epidemiological studies","Riedel O, Braitmaier M, Langner I.","Pharmacoepidemiol Drug Saf. 2022 May;31(5):546-555. doi: 10.1002/pds.5416. Epub 2022 Feb 17.","Riedel O","Pharmacoepidemiol Drug Saf","2022","2022/02/09","","","10.1002/pds.5416"
"35124852","Drug interactions in hospital prescriptions in Denmark: Prevalence and associations with adverse outcomes","Leal Rodríguez C, Kaas-Hansen BS, Eriksson R, Biel JH, Belling KG, Andersen SE, Brunak S.","Pharmacoepidemiol Drug Saf. 2022 Jun;31(6):632-642. doi: 10.1002/pds.5415. Epub 2022 Feb 22.","Leal Rodríguez C","Pharmacoepidemiol Drug Saf","2022","2022/02/06","PMC9303679","","10.1002/pds.5415"
"35122354","Utility of fertility procedures and prenatal tests to estimate gestational age for live-births and stillbirths in electronic health plan databases","Taylor LG, Bird ST, Stojanovic D, Toh S, Maro JC, Fazio-Eynullayeva E, Petrone AB, Rajbhandari R, Andrade SE, Haynes K, McMahill-Walraven CN, Shinde M, Lyons JG.","Pharmacoepidemiol Drug Saf. 2022 May;31(5):534-545. doi: 10.1002/pds.5414. Epub 2022 Feb 22.","Taylor LG","Pharmacoepidemiol Drug Saf","2022","2022/02/05","","","10.1002/pds.5414"
"35092329","Overview of the European post-authorisation study register post-authorization studies performed in Europe from September 2010 to December 2018","Sultana J, Crisafulli S, Almas M, Antonazzo IC, Baan E, Bartolini C, Bertuccio MP, Bonifazi F, Capuano A, Didio A, Ehrenstein V, Felisi M, Ferrajolo C, Fontana A, Francisca R, Fourrier-Reglat A, Fortuny J, Gini R, Hyeraci G, Hoeve C, Kontogiorgis C, Isgrò V, Lalagkas PN, L'Abbate L, Layton D, Landi A, Narduzzi S, Roque Pereira L, Poulentzas G, Rafaniello C, Roberto G, Scondotto G, Sportiello L, Toma M, Toussi M, Verhamme K, Volpe E, Trifirò G; On behalf the Working Group 3 of ENCePP (Inventory of EU data sources and methodological approaches for multisource studies).","Pharmacoepidemiol Drug Saf. 2022 Jun;31(6):689-705. doi: 10.1002/pds.5413. Epub 2022 Feb 11.","Sultana J","Pharmacoepidemiol Drug Saf","2022","2022/01/29","PMC9303697","","10.1002/pds.5413"
"35092316","Transparency of high-dimensional propensity score analyses: Guidance for diagnostics and reporting","Tazare J, Wyss R, Franklin JM, Smeeth L, Evans SJW, Wang SV, Schneeweiss S, Douglas IJ, Gagne JJ, Williamson EJ.","Pharmacoepidemiol Drug Saf. 2022 Apr;31(4):411-423. doi: 10.1002/pds.5412. Epub 2022 Feb 12.","Tazare J","Pharmacoepidemiol Drug Saf","2022","2022/01/29","PMC9305520","","10.1002/pds.5412"
"35088492","Trends in the use of disease-modifying therapies among reproductive-aged women with multiple sclerosis in the United States from 2010 to 2019","Duchesneau ED, Kinlaw AC, Jonsson Funk M, Pate V, Lund JL.","Pharmacoepidemiol Drug Saf. 2022 Apr;31(4):481-487. doi: 10.1002/pds.5411. Epub 2022 Feb 7.","Duchesneau ED","Pharmacoepidemiol Drug Saf","2022","2022/01/28","","","10.1002/pds.5411"
"35088482","Sampling in the case-time-control design among drug users when outcome prevents further treatment","Madsen JEH, Hallas J, Delvin T, Scheike T, Pipper C.","Pharmacoepidemiol Drug Saf. 2022 Apr;31(4):404-410. doi: 10.1002/pds.5410. Epub 2022 Feb 7.","Madsen JEH","Pharmacoepidemiol Drug Saf","2022","2022/01/28","","","10.1002/pds.5410"
"35084792","Management of epilepsy in Lebanon: Medication reviews and drug-related problems","Mroueh L, Al-Hajje A, Salameh P, Preux PM, Boumediene F, Ratsimbazafy V, Jost J.","Pharmacoepidemiol Drug Saf. 2022 May;31(5):583-591. doi: 10.1002/pds.5409. Epub 2022 Feb 11.","Mroueh L","Pharmacoepidemiol Drug Saf","2022","2022/01/27","","","10.1002/pds.5409"
"35049110","The impact of regulatory restrictions on pregabalin use in Saudi Arabia: An interrupted time series analysis","Althunian TA, Alomran MI, Alsagri GM, Alrasheed MM, Alshammari TM.","Pharmacoepidemiol Drug Saf. 2022 May;31(5):577-582. doi: 10.1002/pds.5408. Epub 2022 Feb 22.","Althunian TA","Pharmacoepidemiol Drug Saf","2022","2022/01/20","","","10.1002/pds.5408"
"35019190","Core concepts in pharmacoepidemiology: Confounding by indication and the role of active comparators","Sendor R, Stürmer T.","Pharmacoepidemiol Drug Saf. 2022 Mar;31(3):261-269. doi: 10.1002/pds.5407. Epub 2022 Jan 27.","Sendor R","Pharmacoepidemiol Drug Saf","2022","2022/01/12","PMC9121653","NIHMS1771064","10.1002/pds.5407"
"34985178","Evolving channeling in prescribing SGLT-2 inhibitors as first-line treatment for type 2 diabetes","Shin H, Schneeweiss S, Glynn RJ, Patorno E.","Pharmacoepidemiol Drug Saf. 2022 May;31(5):566-576. doi: 10.1002/pds.5406. Epub 2022 Jan 17.","Shin H","Pharmacoepidemiol Drug Saf","2022","2022/01/05","PMC8989653","NIHMS1785423","10.1002/pds.5406"
"34965012","Impact on In- and Out-of-Hospital Drug Prescriptions of Including a More Expensive Me-Too Antidepressant in a Hospital Drug Formulary: a Controlled Longitudinal Study","Carracedo-Martínez E, Vázquez-Mourelle R, Figueiras A, Piñeiro-Lamas M.","Pharmacoepidemiol Drug Saf. 2022 May;31(5):556-565. doi: 10.1002/pds.5405. Epub 2022 Jan 18.","Carracedo-Martínez E","Pharmacoepidemiol Drug Saf","2022","2021/12/29","","","10.1002/pds.5405"
"34957616","Data sources for drug utilization research in Latin American countries-A cross-national study: DASDUR-LATAM study","Lopes LC, Salas M, Osorio-de-Castro CGS, Leal LF, Doubova SV, Cañás M, Dreser A, Acosta A, Baldoni AO, de Cássia Bergamaschi C, Mota DM, Gómez-Galicia DL, Sepúlveda-Viveros D, Delgado EN, da Costa Lima E, Chandia FV, Ferre F, Marin GH, Olmos I, Zimmermann IR, Fulone I, Roldán-Saelzer J, Sánchez-Salgado JC, Castro-Pastrana LI, de Souza LJC, Beltrán MM, Silva MT, Mena MB, de França Fonteles MM, Urtasun MA, Tarapués M, Hernández PG, Medero N, Herrera-Comoglio R, Barberato-Filho S, Galvão TF, Luiza VL, Santa-Ana-Tellez Y, Rodríguez-Tanta Y, Elseviers M.","Pharmacoepidemiol Drug Saf. 2022 Mar;31(3):343-352. doi: 10.1002/pds.5404. Epub 2022 Jan 13.","Lopes LC","Pharmacoepidemiol Drug Saf","2022","2021/12/27","","","10.1002/pds.5404"
"34953160","A comparison of confounder selection and adjustment methods for estimating causal effects using large healthcare databases","Benasseur I, Talbot D, Durand M, Holbrook A, Matteau A, Potter BJ, Renoux C, Schnitzer ME, Tarride JÉ, Guertin JR.","Pharmacoepidemiol Drug Saf. 2022 Apr;31(4):424-433. doi: 10.1002/pds.5403. Epub 2022 Jan 7.","Benasseur I","Pharmacoepidemiol Drug Saf","2022","2021/12/25","PMC9304306","","10.1002/pds.5403"
"34919294","Assessing adverse event reports of hysteroscopic sterilization device removal using natural language processing","Mao J, Sedrakyan A, Sun T, Guiahi M, Chudnoff S, Kinard M, Johnson SB.","Pharmacoepidemiol Drug Saf. 2022 Apr;31(4):442-451. doi: 10.1002/pds.5402. Epub 2021 Dec 21.","Mao J","Pharmacoepidemiol Drug Saf","2022","2021/12/17","","","10.1002/pds.5402"
"34913208","Validation of diagnosis codes to identify hospitalized COVID-19 patients in health care claims data","Kluberg SA, Hou L, Dutcher SK, Billings M, Kit B, Toh S, Dublin S, Haynes K, Kline A, Maiyani M, Pawloski PA, Watson ES, Cocoros NM.","Pharmacoepidemiol Drug Saf. 2022 Apr;31(4):476-480. doi: 10.1002/pds.5401. Epub 2022 Jan 3.","Kluberg SA","Pharmacoepidemiol Drug Saf","2022","2021/12/16","","","10.1002/pds.5401"
"34908211","Accuracy of identifying diagnosis of moderate to severe chronic kidney disease in administrative claims data","Paik JM, Patorno E, Zhuo M, Bessette LG, York C, Gautam N, Kim DH, Kim SC.","Pharmacoepidemiol Drug Saf. 2022 Apr;31(4):467-475. doi: 10.1002/pds.5398. Epub 2021 Dec 23.","Paik JM","Pharmacoepidemiol Drug Saf","2022","2021/12/15","PMC8917076","NIHMS1772717","10.1002/pds.5398"
"34907614","Biases associated with epidermal necrolysis reporting in pharmacovigilance: An exploratory analysis using World Health Organization VigiBase","Bettuzzi T, Ingen-Housz-Oro S, Maison P, de Prost N, Wolkenstein P, Lebrun-Vignes B, Sbidian E.","Pharmacoepidemiol Drug Saf. 2022 Apr;31(4):434-441. doi: 10.1002/pds.5399. Epub 2021 Dec 28.","Bettuzzi T","Pharmacoepidemiol Drug Saf","2022","2021/12/15","","","10.1002/pds.5399"
"34907612","Validity of self-reports of medication treatment of depression in general population surveys","Mojtabai R, Amin-Esmaeili M.","Pharmacoepidemiol Drug Saf. 2022 Apr;31(4):461-466. doi: 10.1002/pds.5400. Epub 2021 Dec 21.","Mojtabai R","Pharmacoepidemiol Drug Saf","2022","2021/12/15","","","10.1002/pds.5400"
"34897888","Initiation of quarterly palmitate paliperidone in French clinical practice: Results from the observational, cross-sectional OPTIMUS study","Gary C, Déal C, Boursicot-Beuzelin J, Falissard B, Giordana JY, Fakra E, Samalin L, Bouju S.","Pharmacoepidemiol Drug Saf. 2022 Mar;31(3):334-342. doi: 10.1002/pds.5397. Epub 2022 Jan 6.","Gary C","Pharmacoepidemiol Drug Saf","2022","2021/12/13","","","10.1002/pds.5397"
"34894377","Use of negative control outcomes to assess the comparability of patients initiating lipid-lowering therapies","Levintow SN, Orroth KK, Breskin A, Park AS, Flores-Arredondo JH, Dluzniewski P, Navar AM, Sørensen HT, Brookhart MA.","Pharmacoepidemiol Drug Saf. 2022 Apr;31(4):383-392. doi: 10.1002/pds.5396. Epub 2021 Dec 20.","Levintow SN","Pharmacoepidemiol Drug Saf","2022","2021/12/11","","","10.1002/pds.5396"
"34894368","The impact of tightened prescribing restrictions on proton pump inhibitor use in Australia: An evaluation using interrupted time series analysis","Daniels B, Schaffer A, Buckley NA, Bruno C, Jun M, Pearson SA, Zoega H.","Pharmacoepidemiol Drug Saf. 2022 Mar;31(3):370-378. doi: 10.1002/pds.5395. Epub 2021 Dec 21.","Daniels B","Pharmacoepidemiol Drug Saf","2022","2021/12/11","","","10.1002/pds.5395"
"34888983","Association between a usual source of care and influenza vaccination rates among pregnant women","Toth JM, Nsiah I, Nair S, Ramachandran S.","Pharmacoepidemiol Drug Saf. 2022 Mar;31(3):361-369. doi: 10.1002/pds.5394. Epub 2021 Dec 21.","Toth JM","Pharmacoepidemiol Drug Saf","2022","2021/12/10","","","10.1002/pds.5394"
"34882894","SARS-CoV-2 vaccine-related adverse events in Zimbabwe: The need to strengthen pharmacovigilance in resource-limited settings","Murewanhema G, Dzinamarira T, Madziva R, Herrera H, Musuka G.","Pharmacoepidemiol Drug Saf. 2022 Mar;31(3):379-380. doi: 10.1002/pds.5393. Epub 2021 Dec 26.","Murewanhema G","Pharmacoepidemiol Drug Saf","2022","2021/12/09","","","10.1002/pds.5393"
"34881477","Comparison of the incidence of bleeding between baloxavir marboxil and other anti-influenza drugs among outpatients with influenza virus infection: A retrospective cohort study using an employment-based health insurance claims database in Japan","Hara A, Hara K, Komeda T, Ogura E, Miyazawa S, Kobayashi C, Fujiwara M, Yoshida M, Urushihara H.","Pharmacoepidemiol Drug Saf. 2022 Jun;31(6):623-631. doi: 10.1002/pds.5392. Epub 2021 Dec 23.","Hara A","Pharmacoepidemiol Drug Saf","2022","2021/12/09","PMC9303239","","10.1002/pds.5392"
"34881470","Comparing LASSO and random forest models for predicting neurological dysfunction among fluoroquinolone users","Ellis DE, Hubbard RA, Willis AW, Zuppa AF, Zaoutis TE, Hennessy S.","Pharmacoepidemiol Drug Saf. 2022 Apr;31(4):393-403. doi: 10.1002/pds.5391. Epub 2021 Dec 28.","Ellis DE","Pharmacoepidemiol Drug Saf","2022","2021/12/09","","","10.1002/pds.5391"
"34859532","High-risk opioid analgesic dispensing to adolescents 12-18 years old in South Carolina: 2010-2017","Basco WT Jr, McCauley JL, Zhang J, Marsden JE, Simpson KN, Heidari K, Mauldin PD, Ball SJ.","Pharmacoepidemiol Drug Saf. 2022 Mar;31(3):353-360. doi: 10.1002/pds.5389. Epub 2021 Dec 9.","Basco WT Jr","Pharmacoepidemiol Drug Saf","2022","2021/12/03","","","10.1002/pds.5389"
"34817916","Association between antidepressant use in pregnancy and gestational diabetes mellitus: Results from the Norwegian Mother, Father and Child Cohort Study","Lupattelli A, Barone-Adesi F, Nordeng H.","Pharmacoepidemiol Drug Saf. 2022 Feb;31(2):247-256. doi: 10.1002/pds.5388. Epub 2021 Dec 8.","Lupattelli A","Pharmacoepidemiol Drug Saf","2022","2021/11/24","","","10.1002/pds.5388"
"34802175","Patient characteristics and safety outcomes in new users of ticagrelor and clopidogrel-An observational cohort study in Sweden","Linder M, Andersen M.","Pharmacoepidemiol Drug Saf. 2022 Feb;31(2):235-246. doi: 10.1002/pds.5387. Epub 2021 Dec 4.","Linder M","Pharmacoepidemiol Drug Saf","2022","2021/11/21","","","10.1002/pds.5387"
"34800063","Validity of a model using routinely collected data for identifying infections following gastric, colon, and liver cancer surgeries","Yamana H, Tsuchiya A, Horiguchi H, Morita S, Kuroki T, Nakai K, Nishimura H, Jo T, Fushimi K, Yasunaga H.","Pharmacoepidemiol Drug Saf. 2022 Apr;31(4):452-460. doi: 10.1002/pds.5386. Epub 2022 Jan 25.","Yamana H","Pharmacoepidemiol Drug Saf","2022","2021/11/20","","","10.1002/pds.5386"
"34757665","Nonsteroidal anti-inflammatory drugs associated acute kidney injury in hospitalized children: A systematic review and meta-analysis","Gong J, Ma L, Li M, Ma L, Chen C, Zhao S, Zhou Y, Cui Y.","Pharmacoepidemiol Drug Saf. 2022 Feb;31(2):117-127. doi: 10.1002/pds.5385. Epub 2021 Nov 24.","Gong J","Pharmacoepidemiol Drug Saf","2022","2021/11/10","","","10.1002/pds.5385"
"34757641","US emergency department visits for acute harms from over-the-counter cough and cold medications, 2017-2019","Mital R, Lovegrove MC, Moro RN, Geller AI, Weidle NJ, Lind JN, Budnitz DS.","Pharmacoepidemiol Drug Saf. 2022 Feb;31(2):225-234. doi: 10.1002/pds.5384. Epub 2021 Nov 24.","Mital R","Pharmacoepidemiol Drug Saf","2022","2021/11/10","","","10.1002/pds.5384"
"34748234","Trends in benzodiazepine and alternative hypnotic use in relation with multimorbidity among older adults in Quebec, Canada","Gosselin E, Simard M, Lunghi C, Sirois C.","Pharmacoepidemiol Drug Saf. 2022 Mar;31(3):322-333. doi: 10.1002/pds.5383. Epub 2021 Nov 23.","Gosselin E","Pharmacoepidemiol Drug Saf","2022","2021/11/08","","","10.1002/pds.5383"
"34738294","Where to begin? Thirty must-read papers for newcomers to pharmacoepidemiology","Pottegård A, Morin L, Hallas J, Gerhard T, Winterstein AG, Perez-Gutthann S, Tadrous M.","Pharmacoepidemiol Drug Saf. 2022 Feb;31(2):257-259. doi: 10.1002/pds.5382. Epub 2021 Nov 17.","Pottegård A","Pharmacoepidemiol Drug Saf","2022","2021/11/05","","","10.1002/pds.5382"
"34738287","Utilization trend of gastric acid-suppressing agents in relation to analgesics","Kirmizi NI, Aydin V, Akici A.","Pharmacoepidemiol Drug Saf. 2022 Mar;31(3):314-321. doi: 10.1002/pds.5381. Epub 2021 Nov 17.","Kirmizi NI","Pharmacoepidemiol Drug Saf","2022","2021/11/05","","","10.1002/pds.5381"
"34729863","RE: Gout and sodium-glucose cotransporter-2 inhibitors","Lund LC, Højlund M, Henriksen DP, Hallas J, Kristensen KB.","Pharmacoepidemiol Drug Saf. 2022 Jan;31(1):114-115. doi: 10.1002/pds.5380. Epub 2021 Nov 14.","Lund LC","Pharmacoepidemiol Drug Saf","2022","2021/11/03","","","10.1002/pds.5380"
"34729853","Do contemporary antiretrovirals increase the risk of end-stage liver disease? Signals from patients starting therapy in the North American AIDS Cohort Collaboration on Research and Design","Young J, Lo Re V 3rd, Kim HN, Sterling TR, Althoff KN, Gebo KA, Gill MJ, Horberg MA, Mayor AM, Moore RD, Silverberg MJ, Klein MB; North American AIDS Cohort Collaboration on Research and Design (NA-ACCORD) of IeDEA.","Pharmacoepidemiol Drug Saf. 2022 Feb;31(2):214-224. doi: 10.1002/pds.5379. Epub 2021 Nov 23.","Young J","Pharmacoepidemiol Drug Saf","2022","2021/11/03","PMC9089458","NIHMS1753702","10.1002/pds.5379"
"34714965","Defining the duration of the dispensation of oral anticoagulants in administrative healthcare databases","Sinyavskaya L, Renoux C, Durand M.","Pharmacoepidemiol Drug Saf. 2022 Jan;31(1):105-109. doi: 10.1002/pds.5378. Epub 2021 Nov 11.","Sinyavskaya L","Pharmacoepidemiol Drug Saf","2022","2021/10/29","","","10.1002/pds.5378"
"34708900","General practitioner prescribing trends among pediatric patients in the United Kingdom: 1998-2018","Masarwa R, Lefebvre C, Platt RW, Filion KB.","Pharmacoepidemiol Drug Saf. 2022 Mar;31(3):302-313. doi: 10.1002/pds.5377. Epub 2021 Nov 9.","Masarwa R","Pharmacoepidemiol Drug Saf","2022","2021/10/28","","","10.1002/pds.5377"
"34687257","Response to letter to the editor regarding ""Development and validation of a predictive model algorithm to identify anaphylaxis in adults with type 2 diabetes in U.S. administrative claims data""","Beachler DC, Taylor DH, Anthony MS, Yin R, Li L, Saltus CW, Li L, Shaunik A, Walsh KE, Rothman KJ, Johannes CB, Aroda VR, Carr W, Goldberg P, Accardi A, O'Shura JS, Sharma K, Juhaeri J, Lanes S, Wu C.","Pharmacoepidemiol Drug Saf. 2022 Jan;31(1):110-111. doi: 10.1002/pds.5376. Epub 2021 Oct 27.","Beachler DC","Pharmacoepidemiol Drug Saf","2022","2021/10/23","","","10.1002/pds.5376"
"34687250","Use of antidepressants and risk of repeat self-harm in older adults 75+ with nonfatal self-harm: A 1-year prospective national study","Hedna K, Montuori C, Forte A, Pompili M, Waern M.","Pharmacoepidemiol Drug Saf. 2022 Feb;31(2):206-213. doi: 10.1002/pds.5375. Epub 2021 Nov 2.","Hedna K","Pharmacoepidemiol Drug Saf","2022","2021/10/23","","","10.1002/pds.5375"
"34676940","Effect of regulatory interventions on agomelatine use in Spain: A multiple intervention time-series analysis in a nationwide electronic healthcare record database","González-Bermejo D, Castillo-Cano B, Rodríguez-Pascual A, García-Martín MF, Álvarez-Gutiérrez A, Montero-Corominas D, Huerta-Álvarez C.","Pharmacoepidemiol Drug Saf. 2022 Mar;31(3):294-301. doi: 10.1002/pds.5374. Epub 2021 Nov 8.","González-Bermejo D","Pharmacoepidemiol Drug Saf","2022","2021/10/22","","","10.1002/pds.5374"
"34668261","Gout and sodium-glucose cotransporter-2 inhibitors","Lai SW.","Pharmacoepidemiol Drug Saf. 2022 Jan;31(1):112-113. doi: 10.1002/pds.5373. Epub 2021 Nov 14.","Lai SW","Pharmacoepidemiol Drug Saf","2022","2021/10/20","","","10.1002/pds.5373"
"34657356","A systematic, concept-based method of developing the exposure measure for drug safety and effectiveness studies","Kuramoto LK, Sobolev BG, Rosner J, Brasher PMA, Azoulay L, Cragg JJ.","Pharmacoepidemiol Drug Saf. 2022 Jan;31(1):13-21. doi: 10.1002/pds.5372. Epub 2021 Oct 29.","Kuramoto LK","Pharmacoepidemiol Drug Saf","2022","2021/10/17","","","10.1002/pds.5372"
"34657354","Generalizability and accuracy of IBM MarketScan health risk assessment instrument data for augmentation of commercial claims data","Albogami Y, Wei YJ, Winterstein AG.","Pharmacoepidemiol Drug Saf. 2022 Jan;31(1):100-104. doi: 10.1002/pds.5371. Epub 2021 Oct 21.","Albogami Y","Pharmacoepidemiol Drug Saf","2022","2021/10/17","","","10.1002/pds.5371"
"34634166","For consideration by pharmacoepidemiologists","Edlavitch SA, Tilson HH.","Pharmacoepidemiol Drug Saf. 2021 Dec;30(12):1619-1620. doi: 10.1002/pds.5365. Epub 2021 Oct 11.","Edlavitch SA","Pharmacoepidemiol Drug Saf","2021","2021/10/11","","","10.1002/pds.5365"
"34628689","Risk of major congenital malformations associated with first-trimester exposure to propulsives: A health administrative database study in Japan","Ishikawa T, Obara T, Akazawa M, Noda A, Oyanagi G, Morishita K, Miyakoda K, Nishigori H, Kawame H, Yaegashi N, Kuriyama S, Mano N.","Pharmacoepidemiol Drug Saf. 2022 Feb;31(2):196-205. doi: 10.1002/pds.5370. Epub 2021 Oct 20.","Ishikawa T","Pharmacoepidemiol Drug Saf","2022","2021/10/10","","","10.1002/pds.5370"
"34623723","Multimorbidity measures from health administrative data using ICD system codes: A systematic review","Simard M, Rahme E, Calfat AC, Sirois C.","Pharmacoepidemiol Drug Saf. 2022 Jan;31(1):1-12. doi: 10.1002/pds.5368. Epub 2021 Oct 19.","Simard M","Pharmacoepidemiol Drug Saf","2022","2021/10/08","","","10.1002/pds.5368"
"34623720","Validity of claims-based algorithms to identify neurodevelopmental disorders in children","Straub L, Bateman BT, Hernandez-Diaz S, York C, Zhu Y, Suarez EA, Lester B, Gonzalez L, Hanson R, Hildebrandt C, Homsi J, Kang D, Lee KWK, Lee Z, Li L, Longacre M, Shah N, Tukan N, Wallace F, Williams C, Zerriny S, Mogun H, Huybrechts KF.","Pharmacoepidemiol Drug Saf. 2021 Dec;30(12):1635-1642. doi: 10.1002/pds.5369. Epub 2021 Oct 15.","Straub L","Pharmacoepidemiol Drug Saf","2021","2021/10/08","PMC8578450","NIHMS1746917","10.1002/pds.5369"
"34611961","Predicting obesity and smoking using medication data: A machine-learning approach","Ali S, Na R, Waterhouse M, Jordan SJ, Olsen CM, Whiteman DC, Neale RE.","Pharmacoepidemiol Drug Saf. 2022 Jan;31(1):91-99. doi: 10.1002/pds.5367. Epub 2021 Oct 17.","Ali S","Pharmacoepidemiol Drug Saf","2022","2021/10/06","","","10.1002/pds.5367"
"34611960","Pharmacological and epidemiological considerations while constructing treatment episodes using observational data: A simulation study","Pazzagli L, Andersen M, Sessa M.","Pharmacoepidemiol Drug Saf. 2022 Jan;31(1):55-60. doi: 10.1002/pds.5366. Epub 2021 Oct 15.","Pazzagli L","Pharmacoepidemiol Drug Saf","2022","2021/10/06","","","10.1002/pds.5366"
"34570942","Exploring parity in female authorship of pharmacoepidemiology articles: A case study of the Canadian Network for Observational Drug Effect Studies and its citing articles","Sketris IS, Traynor RL, Helwig M, Burland E, Stewart SA.","Pharmacoepidemiol Drug Saf. 2022 Jan;31(1):82-90. doi: 10.1002/pds.5364. Epub 2021 Oct 25.","Sketris IS","Pharmacoepidemiol Drug Saf","2022","2021/09/27","","","10.1002/pds.5364"
"34558772","The use of uncertain exposure-A method to define switching and add-on in pharmacoepidemiology","Pazzagli L, Linder M, Reutfors J, Brandt L.","Pharmacoepidemiol Drug Saf. 2022 Jan;31(1):28-36. doi: 10.1002/pds.5363. Epub 2021 Oct 1.","Pazzagli L","Pharmacoepidemiol Drug Saf","2022","2021/09/24","","","10.1002/pds.5363"
"34558760","Physician adjudication of angioedema diagnosis codes in a population of patients with heart failure prescribed angiotensin-converting enzyme inhibitor therapy","Mansi ET, Johnson ES, Thorp ML, Go AS, Lee MS, Shen AY, Park KJ, Budzynska K, Markin A, Sung SH, Thompson JH, Slaughter MT, Luong TQ, An J, Reynolds K, Roblin DW, Cassidy-Bushrow AE, Kuntz JL, Schlienger RG, Behr S, Smith DH.","Pharmacoepidemiol Drug Saf. 2021 Dec;30(12):1630-1634. doi: 10.1002/pds.5361. Epub 2021 Oct 1.","Mansi ET","Pharmacoepidemiol Drug Saf","2021","2021/09/24","","","10.1002/pds.5361"
"34553438","Evaluation of the key prescription sequence symmetry analysis assumption using the calcium channel blocker: Loop diuretic prescribing cascade","Vouri SM, Morris EJ, Usmani SA, Reise R, Jiang X, Pepine CJ, Manini TM, Malone DC, Winterstein AG.","Pharmacoepidemiol Drug Saf. 2022 Jan;31(1):72-81. doi: 10.1002/pds.5362. Epub 2021 Oct 6.","Vouri SM","Pharmacoepidemiol Drug Saf","2022","2021/09/23","PMC8688319","NIHMS1743348","10.1002/pds.5362"
"34545981","Harnessing medicines data at low cost to deliver better and safer care","Hollingworth SA, Richards GC, MacKenna B, Goldacre B.","Pharmacoepidemiol Drug Saf. 2021 Dec;30(12):1621-1623. doi: 10.1002/pds.5360. Epub 2021 Sep 25.","Hollingworth SA","Pharmacoepidemiol Drug Saf","2021","2021/09/21","","","10.1002/pds.5360"
"34529312","Evaluating the association between antidepressant dose trajectories and treatment augmentation in pediatric depression","Spence O, Reeves G, dosReis S.","Pharmacoepidemiol Drug Saf. 2022 Feb;31(2):176-186. doi: 10.1002/pds.5358. Epub 2021 Sep 28.","Spence O","Pharmacoepidemiol Drug Saf","2022","2021/09/16","","","10.1002/pds.5358"
"34529297","Cost-effectiveness analysis of treatment with varenicline for nicotine dependence compared with smoking cessation without pharmacotherapy in the real world","Fujita T, Babazono A, Jiang P, Jamal A, Li Y.","Pharmacoepidemiol Drug Saf. 2022 Feb;31(2):187-195. doi: 10.1002/pds.5359. Epub 2021 Sep 25.","Fujita T","Pharmacoepidemiol Drug Saf","2022","2021/09/16","","","10.1002/pds.5359"
"34505314","Off-label drug use in neonates and infants in Spain: A five-year observational study","Lizano-Díez I, Kargodorian J, Piñero-López MÁ, Lastra CF, Mariño EL, Modamio P.","Pharmacoepidemiol Drug Saf. 2022 Mar;31(3):270-282. doi: 10.1002/pds.5354. Epub 2021 Sep 24.","Lizano-Díez I","Pharmacoepidemiol Drug Saf","2022","2021/09/10","","","10.1002/pds.5354"
"34499394","A strategy for assessment and validation of major bleeding cases in a primary health care database in Spain","de Burgos-Gonzalez A, Bryant V, Maciá-Martinez MA, Huerta C.","Pharmacoepidemiol Drug Saf. 2021 Dec;30(12):1696-1702. doi: 10.1002/pds.5357. Epub 2021 Sep 27.","de Burgos-Gonzalez A","Pharmacoepidemiol Drug Saf","2021","2021/09/09","","","10.1002/pds.5357"
"34498338","Perinatal pharmacoepidemiology: How often are key methodological elements reported in publications?","Margulis AV, Kawai AT, Anthony MS, Rivero-Ferrer E.","Pharmacoepidemiol Drug Saf. 2022 Jan;31(1):61-71. doi: 10.1002/pds.5353. Epub 2021 Sep 29.","Margulis AV","Pharmacoepidemiol Drug Saf","2022","2021/09/09","","","10.1002/pds.5353"
"34498314","Emulation of a randomized controlled trial in ulcerative colitis with US and French claims data: Infliximab with thiopurines compared to infliximab monotherapy","Kirchgesner J, Desai RJ, Schneeweiss MC, Beaugerie L, Kim SC, Schneeweiss S.","Pharmacoepidemiol Drug Saf. 2022 Feb;31(2):167-175. doi: 10.1002/pds.5356. Epub 2021 Sep 26.","Kirchgesner J","Pharmacoepidemiol Drug Saf","2022","2021/09/09","","","10.1002/pds.5356"
"34496108","The relationship between 19-year trends in medication use and changes in physical function among women in the mid-life: A Study of Women's Health Across the Nation pharmacoepidemiology study","Solomon DH, Santacroce L, Colvin A, Lian Y, Ruppert K, Yoshida K.","Pharmacoepidemiol Drug Saf. 2022 Mar;31(3):283-293. doi: 10.1002/pds.5355. Epub 2021 Sep 21.","Solomon DH","Pharmacoepidemiol Drug Saf","2022","2021/09/08","PMC8825744","NIHMS1738961","10.1002/pds.5355"
"34464494","Risk of neuropsychiatric adverse events associated with varenicline treatment for smoking cessation among Dutch population: A sequence symmetry analysis","Wang Y, van Boven JFM, Bos JHJ, Schuiling-Veninga CCM, Boezen HM, Wilffert B, Hak E.","Pharmacoepidemiol Drug Saf. 2022 Feb;31(2):158-166. doi: 10.1002/pds.5351. Epub 2021 Sep 9.","Wang Y","Pharmacoepidemiol Drug Saf","2022","2021/08/31","PMC9292305","","10.1002/pds.5351"
"34453456","Proton pump inhibitors long term use-trends and patterns over 15 years of a large health maintenance organization","Rosenberg V, Tzadok R, Chodick G, Kariv R.","Pharmacoepidemiol Drug Saf. 2021 Nov;30(11):1576-1587. doi: 10.1002/pds.5352. Epub 2021 Sep 6.","Rosenberg V","Pharmacoepidemiol Drug Saf","2021","2021/08/28","","","10.1002/pds.5352"
"34435407","Use of hydrochlorothiazide in Denmark following publication of skin cancer risk findings","Pottegård A, Bech BH, Pedersen SA, Christensen B.","Pharmacoepidemiol Drug Saf. 2021 Nov;30(11):1611-1616. doi: 10.1002/pds.5350. Epub 2021 Aug 30.","Pottegård A","Pharmacoepidemiol Drug Saf","2021","2021/08/26","","","10.1002/pds.5350"
"34435406","Prevalence and distribution of high-risk prescription opioid use in the United States, 2011-2016","McCormick CD, Dadiomov D, Trotzky-Sirr R, Qato DM.","Pharmacoepidemiol Drug Saf. 2021 Nov;30(11):1532-1540. doi: 10.1002/pds.5349. Epub 2021 Sep 6.","McCormick CD","Pharmacoepidemiol Drug Saf","2021","2021/08/26","","","10.1002/pds.5349"
"34431155","Abstracts of the 37th International Conference on Pharmacoepidemiology & Therapeutic Risk Management, Virtual, August 23, 2021","","Pharmacoepidemiol Drug Saf. 2021 Aug;30 Suppl 1:3-439. doi: 10.1002/pds.5305.","","Pharmacoepidemiol Drug Saf","2021","2021/08/25","","","10.1002/pds.5305"
"34418227","Validity of hospital ICD-10-GM codes to identify anaphylaxis","de Sordi D, Kappen S, Otto-Sobotka F, Kulschewski A, Weyland A, Gutierrez L, Fortuny J, Reinold J, Schink T, Timmer A.","Pharmacoepidemiol Drug Saf. 2021 Dec;30(12):1643-1652. doi: 10.1002/pds.5348. Epub 2021 Sep 1.","de Sordi D","Pharmacoepidemiol Drug Saf","2021","2021/08/21","","","10.1002/pds.5348"
"34418198","Acute kidney injury identification for pharmacoepidemiologic studies: Use of laboratory electronic acute kidney injury alerts versus electronic health records in Hospital Episode Statistics","Savino M, Plumb L, Casula A, Evans K, Wong E, Kolhe N, Medcalf JF, Nitsch D.","Pharmacoepidemiol Drug Saf. 2021 Dec;30(12):1687-1695. doi: 10.1002/pds.5347. Epub 2021 Aug 31.","Savino M","Pharmacoepidemiol Drug Saf","2021","2021/08/21","","","10.1002/pds.5347"
"34409675","Letter to the Editor re Beachler, et al, 2021","Gruber S, Carrell DS, Floyd JS, Nelson JC, Hazlehurst BL, Heagerty PJ.","Pharmacoepidemiol Drug Saf. 2021 Dec;30(12):1735-1736. doi: 10.1002/pds.5342. Epub 2021 Sep 16.","Gruber S","Pharmacoepidemiol Drug Saf","2021","2021/08/19","","","10.1002/pds.5342"
"34396634","Drug exposure misclassification in pharmacoepidemiology: Sources and relative impact","Hempenius M, Groenwold RHH, de Boer A, Klungel OH, Gardarsdottir H.","Pharmacoepidemiol Drug Saf. 2021 Dec;30(12):1703-1715. doi: 10.1002/pds.5346. Epub 2021 Sep 7.","Hempenius M","Pharmacoepidemiol Drug Saf","2021","2021/08/16","PMC9292927","","10.1002/pds.5346"
"34390285","Association between inhaled corticosteroid use and COVID-19 outcomes","Husby A, Pottegård A, Hviid A.","Pharmacoepidemiol Drug Saf. 2021 Nov;30(11):1486-1492. doi: 10.1002/pds.5345. Epub 2021 Aug 24.","Husby A","Pharmacoepidemiol Drug Saf","2021","2021/08/14","PMC8441753","","10.1002/pds.5345"
"34382718","Trend changes of national zolpidem users and exposure cases after FDA drug safety communications","Zhou EH, Feng Z, Pinnow E, Lee J, Bak D, Ready T, Dal Pan GJ.","Pharmacoepidemiol Drug Saf. 2021 Nov;30(11):1551-1559. doi: 10.1002/pds.5344. Epub 2021 Aug 23.","Zhou EH","Pharmacoepidemiol Drug Saf","2021","2021/08/12","","","10.1002/pds.5344"
"34382713","Using multiple random index dates with the reverse waiting time distribution improves precision of estimated prescription durations","Bødkergaard K, Selmer RM, Hallas J, Kjerpeseth LJ, Skovlund E, Støvring H.","Pharmacoepidemiol Drug Saf. 2021 Dec;30(12):1727-1734. doi: 10.1002/pds.5340. Epub 2021 Sep 3.","Bødkergaard K","Pharmacoepidemiol Drug Saf","2021","2021/08/12","","","10.1002/pds.5340"
"34382707","Association between adherence to warfarin and thrombotic events in patients with antiphospholipid syndrome in Japan: A claims-based retrospective cohort study","Byambajav T, Waki T, Miura K, Tanaka-Mizuno S.","Pharmacoepidemiol Drug Saf. 2022 Feb;31(2):149-157. doi: 10.1002/pds.5343. Epub 2021 Aug 24.","Byambajav T","Pharmacoepidemiol Drug Saf","2022","2021/08/12","","","10.1002/pds.5343"
"34382278","Use of sedating medications around nursing home admission in Denmark","Pottegård A, Lundby C, Jarbøl DE, Larsen SP, Hoppe BC, Hoffmann H, Thompson W.","Pharmacoepidemiol Drug Saf. 2021 Nov;30(11):1560-1565. doi: 10.1002/pds.5341. Epub 2021 Aug 22.","Pottegård A","Pharmacoepidemiol Drug Saf","2021","2021/08/12","","","10.1002/pds.5341"
"34378828","Validation of a claims-based algorithm for identifying non-infectious pneumonitis in patients diagnosed with lung cancer","Neibart SS, Portal DE, Malhotra J, Jabbour SK, Roy JA, Strom BL.","Pharmacoepidemiol Drug Saf. 2021 Dec;30(12):1624-1629. doi: 10.1002/pds.5339. Epub 2021 Aug 23.","Neibart SS","Pharmacoepidemiol Drug Saf","2021","2021/08/11","PMC8578340","NIHMS1732090","10.1002/pds.5339"
"34375473","Core concepts in pharmacoepidemiology: Violations of the positivity assumption in the causal analysis of observational data: Consequences and statistical approaches","Zhu Y, Hubbard RA, Chubak J, Roy J, Mitra N.","Pharmacoepidemiol Drug Saf. 2021 Nov;30(11):1471-1485. doi: 10.1002/pds.5338. Epub 2021 Aug 24.","Zhu Y","Pharmacoepidemiol Drug Saf","2021","2021/08/10","PMC8492528","NIHMS1732059","10.1002/pds.5338"
"34363294","Cinacalcet and gastrointestinal bleeding risk in patients receiving hemodialysis","Liu J, Guo H, Lin TC, Wetmore JB, Bradbury BD, Gilbertson DT, Nieman K, Peng Y, Sprafka JM, Dluzniewski PJ.","Pharmacoepidemiol Drug Saf. 2022 Feb;31(2):141-148. doi: 10.1002/pds.5337. Epub 2021 Aug 19.","Liu J","Pharmacoepidemiol Drug Saf","2022","2021/08/07","","","10.1002/pds.5337"
"34350651","Prescribing and Research in Medicines Management - PRIMM 32nd Annual Scientific Meeting, Virtual, 11 June 2021: Big Data: Is it the Future of Medicines Optimisation?","","Pharmacoepidemiol Drug Saf. 2021 Aug;30 Suppl 2:3-20. doi: 10.1002/pds.5315.","","Pharmacoepidemiol Drug Saf","2021","2021/08/05","","","10.1002/pds.5315"
"34322934","Utilization of opioid versus non-opioid analgesics in Medicaid and CHIP enrolled children with current asthma","Nair AA, Farber HJ, Chen H.","Pharmacoepidemiol Drug Saf. 2021 Nov;30(11):1520-1531. doi: 10.1002/pds.5336. Epub 2021 Aug 8.","Nair AA","Pharmacoepidemiol Drug Saf","2021","2021/07/29","","","10.1002/pds.5336"
"34302707","Increasing rates of buprenorphine diversion in the United States, 2002 to 2019","Buttram ME, Kurtz SP, Margolin ZR, Severtson SG.","Pharmacoepidemiol Drug Saf. 2021 Nov;30(11):1514-1519. doi: 10.1002/pds.5334. Epub 2021 Jul 31.","Buttram ME","Pharmacoepidemiol Drug Saf","2021","2021/07/24","","","10.1002/pds.5334"
"34292648","A framework for the use of biological medicines in the free state province, South Africa","Mocke-Richter M, Walubo A, van Rooyen C.","Pharmacoepidemiol Drug Saf. 2021 Nov;30(11):1601-1610. doi: 10.1002/pds.5332. Epub 2021 Jul 28.","Mocke-Richter M","Pharmacoepidemiol Drug Saf","2021","2021/07/22","","","10.1002/pds.5332"
"34292640","Method used to identify adenomyosis and potentially undiagnosed adenomyosis in a large, U.S. electronic health record database","Loughlin AM, Chiuve SE, Reznor G, Doherty M, Missmer SA, Chomistek AK, Enger C.","Pharmacoepidemiol Drug Saf. 2021 Dec;30(12):1675-1686. doi: 10.1002/pds.5333. Epub 2021 Jul 29.","Loughlin AM","Pharmacoepidemiol Drug Saf","2021","2021/07/22","","","10.1002/pds.5333"
"34278660","The use of narrative electronic prescribing instructions in pharmacoepidemiology: A scoping review for the International Society for Pharmacoepidemiology","Romanelli RJ, Schwartz NRM, Dixon WG, Rodriguez-Watson C, Sauer BC, Albright D, Marcum ZA.","Pharmacoepidemiol Drug Saf. 2021 Oct;30(10):1281-1292. doi: 10.1002/pds.5331. Epub 2021 Jul 28.","Romanelli RJ","Pharmacoepidemiol Drug Saf","2021","2021/07/19","PMC8419095","NIHMS1725708","10.1002/pds.5331"
"34258812","Effect of ICD-9-CM to ICD-10-CM coding system transition on identification of common conditions: An interrupted time series analysis","Hsu MC, Wang CC, Huang LY, Lin CY, Lin FJ, Toh S.","Pharmacoepidemiol Drug Saf. 2021 Dec;30(12):1653-1674. doi: 10.1002/pds.5330. Epub 2021 Jul 27.","Hsu MC","Pharmacoepidemiol Drug Saf","2021","2021/07/14","","","10.1002/pds.5330"
"34251721","Prescriptions of analgesics during chronic cancer disease trajectories: A complete national cohort study","Fredheim OM, Skurtveit S, Sjøgren P, Aljabri B, Hjellvik V.","Pharmacoepidemiol Drug Saf. 2021 Nov;30(11):1504-1513. doi: 10.1002/pds.5329. Epub 2021 Jul 30.","Fredheim OM","Pharmacoepidemiol Drug Saf","2021","2021/07/12","","","10.1002/pds.5329"
"34251702","Bias of time-varying exposure effects due to time-varying covariate measurement strategies","Penning de Vries BBL, Groenwold RHH.","Pharmacoepidemiol Drug Saf. 2022 Jan;31(1):22-27. doi: 10.1002/pds.5328. Epub 2021 Aug 1.","Penning de Vries BBL","Pharmacoepidemiol Drug Saf","2022","2021/07/12","PMC9292390","","10.1002/pds.5328"
"34245206","Uncommon side effects of common drugs in patients with familial dysautonomia","Perl L, Hakimian D, Maayan C, Rekhtman D, Fried E, Salmon-Divon M, Sapozhnikov DM, Cheishvili D.","Pharmacoepidemiol Drug Saf. 2022 Feb;31(2):128-140. doi: 10.1002/pds.5326. Epub 2021 Jul 16.","Perl L","Pharmacoepidemiol Drug Saf","2022","2021/07/10","","","10.1002/pds.5326"
"34245081","Hepatitis B vaccine and risk of acute myocardial infarction among individuals with diabetes mellitus","Wong K, Bruxvoort K, Slezak J, Hsu JY, Reynolds K, Sy LS, Jacobsen SJ.","Pharmacoepidemiol Drug Saf. 2021 Oct;30(10):1441-1446. doi: 10.1002/pds.5327. Epub 2021 Jul 17.","Wong K","Pharmacoepidemiol Drug Saf","2021","2021/07/10","","","10.1002/pds.5327"
"34245078","Utilization of drugs with reports on potential efficacy or harm on COVID-19 before, during, and after the first pandemic wave","Enners S, Gradl G, Kieble M, Böhm M, Laufs U, Schulz M.","Pharmacoepidemiol Drug Saf. 2021 Nov;30(11):1493-1503. doi: 10.1002/pds.5324. Epub 2021 Jul 21.","Enners S","Pharmacoepidemiol Drug Saf","2021","2021/07/10","PMC8441787","","10.1002/pds.5324"
"34227170","Differential frequency in imaging-based outcome measurement: Bias in real-world oncology comparative-effectiveness studies","Adamson BJS, Ma X, Griffith SD, Sweeney EM, Sarkar S, Bourla AB.","Pharmacoepidemiol Drug Saf. 2022 Jan;31(1):46-54. doi: 10.1002/pds.5323. Epub 2021 Jul 21.","Adamson BJS","Pharmacoepidemiol Drug Saf","2022","2021/07/06","PMC9290806","","10.1002/pds.5323"
"34216500","Use of a mobile app to capture supplemental health information during pregnancy: Implications for clinical research","Rothschild CW, Dublin S, Brown JS, Klasnja P, Herzig-Marx C, Reynolds JS, Wyner Z, Chambers C, Martin D.","Pharmacoepidemiol Drug Saf. 2022 Jan;31(1):37-45. doi: 10.1002/pds.5320. Epub 2021 Jul 16.","Rothschild CW","Pharmacoepidemiol Drug Saf","2022","2021/07/03","","","10.1002/pds.5320"
"34216049","Association between methylphenidate and risk of myocardial infarction: A multinational self-controlled case series study","Jeong HE, Lee H, Lai EC, Liao TC, Man KKC, Wong ICK, Coghill D, Chi MH, Hsieh CY, Shin JY.","Pharmacoepidemiol Drug Saf. 2021 Oct;30(10):1458-1467. doi: 10.1002/pds.5322. Epub 2021 Jul 13.","Jeong HE","Pharmacoepidemiol Drug Saf","2021","2021/07/03","","","10.1002/pds.5322"
"34212435","Assessing polypharmacy in the older population: Comparison of a self-reported and prescription based method","Van der Heyden J, Berete F, Renard F, Vanoverloop J, Devleesschauwer B, De Ridder K, Bruyère O.","Pharmacoepidemiol Drug Saf. 2021 Dec;30(12):1716-1726. doi: 10.1002/pds.5321. Epub 2021 Jul 16.","Van der Heyden J","Pharmacoepidemiol Drug Saf","2021","2021/07/02","","","10.1002/pds.5321"
"34181291","Use of intravenous iron and risk of anaphylaxis: A multinational observational post-authorisation safety study in Europe","Fortuny J, von Gersdorff G, Lassalle R, Linder M, Overbeek J, Reinold J, Toft G, Timmer A, Dress J, Blin P, Droz-Perroteau C, Ehrenstein V, Franzoni C, Herings R, Kollhorst B, Moore N, Odsbu I, Perez-Gutthann S, Schink T, Rascher K, Rasouliyan L, Rothman KJ, Saigi-Morgui N, Schaller M, Smits E, Forstner M; Intravenous Iron Consortium; Bénichou J, Bircher AJ, Garbe E, Rampton DS, Gutierrez L.","Pharmacoepidemiol Drug Saf. 2021 Oct;30(10):1447-1457. doi: 10.1002/pds.5319. Epub 2021 Jul 12.","Fortuny J","Pharmacoepidemiol Drug Saf","2021","2021/06/28","PMC8457074","","10.1002/pds.5319"
"34180569","Bipolar disorder prevalence and psychotropic medication utilisation in Hong Kong and the United Kingdom","Ng VWS, Man KKC, Gao L, Chan EW, Lee EHM, Hayes JF, Wong ICK.","Pharmacoepidemiol Drug Saf. 2021 Nov;30(11):1588-1600. doi: 10.1002/pds.5318. Epub 2021 Jul 8.","Ng VWS","Pharmacoepidemiol Drug Saf","2021","2021/06/28","PMC7613092","EMS150066","10.1002/pds.5318"
"34173286","Major bleeding in users of direct oral anticoagulants in atrial fibrillation: A pooled analysis of results from multiple population-based cohort studies","van den Ham HA, Souverein PC, Klungel OH, Platt RW, Ernst P, Dell'Aniello S, Schmiedl S, Grave B, Rottenkolber M, Huerta C, Martín Merino E, León-Muñoz LM, Montero D, Andersen M, Aakjaer M, De Bruin ML, Gardarsdottir H.","Pharmacoepidemiol Drug Saf. 2021 Oct;30(10):1339-1352. doi: 10.1002/pds.5317. Epub 2021 Jul 22.","van den Ham HA","Pharmacoepidemiol Drug Saf","2021","2021/06/26","PMC8456818","","10.1002/pds.5317"
"34170057","Development and validation of case-finding algorithms to identify prosthetic joint infections after total knee arthroplasty in Veterans Health Administration data","Weinstein EJ, Stephens-Shields A, Loabile B, Yuh T, Silibovsky R, Nelson CL, O'Donnell JA, Hsieh E, Hanberg JS, Akgün KM, Tate JP, Lo Re V 3rd.","Pharmacoepidemiol Drug Saf. 2021 Sep;30(9):1184-1191. doi: 10.1002/pds.5316. Epub 2021 Jul 5.","Weinstein EJ","Pharmacoepidemiol Drug Saf","2021","2021/06/25","PMC8343957","NIHMS1721677","10.1002/pds.5316"
"34169607","Prevalence of prescription opioid use during pregnancy in eight US health plans during 2001-2014","Pocobelli G, Dublin S, Bobb JF, Albertson-Junkans L, Andrade S, Cheetham TC, Salgado G, Griffin MR, Raebel MA, Smith D, Li DK, Pawloski PA, Toh S, Taylor L, Hua W, Horn P, Trinidad JP, Boudreau DM.","Pharmacoepidemiol Drug Saf. 2021 Nov;30(11):1541-1550. doi: 10.1002/pds.5312. Epub 2021 Jul 7.","Pocobelli G","Pharmacoepidemiol Drug Saf","2021","2021/06/25","","","10.1002/pds.5312"
"34156119","An investigation on the association between sodium glucose co-transporter 2 inhibitors use and acute pancreatitis: A VigiBase study","Frent I, Bucsa C, Leucuta D, Farcas A, Mogosan C.","Pharmacoepidemiol Drug Saf. 2021 Oct;30(10):1428-1440. doi: 10.1002/pds.5313. Epub 2021 Jun 29.","Frent I","Pharmacoepidemiol Drug Saf","2021","2021/06/22","","","10.1002/pds.5313"
"34155708","Evaluation of more than one billion outpatient prescriptions and eight-year trend showing a remarkable reduction in antibiotic prescription in Turkey: A success model of governmental interventions at national level","Aksoy M, Isli F, Kadi E, Varimli D, Gursoz H, Tolunay T, Kara A, Unal S, Alp Mese E.","Pharmacoepidemiol Drug Saf. 2021 Sep;30(9):1242-1249. doi: 10.1002/pds.5311. Epub 2021 Jul 1.","Aksoy M","Pharmacoepidemiol Drug Saf","2021","2021/06/22","","","10.1002/pds.5311"
"34146372","Polypharmacy and the risk of drug-drug interactions and potentially inappropriate medications in hospital psychiatry","Wolff J, Hefner G, Normann C, Kaier K, Binder H, Hiemke C, Toto S, Domschke K, Marschollek M, Klimke A.","Pharmacoepidemiol Drug Saf. 2021 Sep;30(9):1258-1268. doi: 10.1002/pds.5310. Epub 2021 Jun 24.","Wolff J","Pharmacoepidemiol Drug Saf","2021","2021/06/19","","","10.1002/pds.5310"
"34145696","Development and evaluation of a proxy for baseline ECOG PS in advanced non-small cell lung cancer, bladder cancer, and melanoma: An electronic health record study","Sadetsky N, Chuo CY, Davidoff AJ.","Pharmacoepidemiol Drug Saf. 2021 Sep;30(9):1233-1241. doi: 10.1002/pds.5309. Epub 2021 Jun 24.","Sadetsky N","Pharmacoepidemiol Drug Saf","2021","2021/06/19","","","10.1002/pds.5309"
"34101945","Risk of clinically relevant hyperglycemia with metoprolol compared to carvedilol in older adults with heart failure and diabetes","Dave CV, Strom BL, Kobylarz FA, Horton DB, Gerhard T, Tseng CL, Dejanovic I, Nyandege A, Setoguchi S.","Pharmacoepidemiol Drug Saf. 2021 Oct;30(10):1420-1427. doi: 10.1002/pds.5303. Epub 2021 Jun 14.","Dave CV","Pharmacoepidemiol Drug Saf","2021","2021/06/08","PMC8419080","NIHMS1714114","10.1002/pds.5303"
"34096151","No effect modification of influenza virus vaccine effectiveness by age or chronic condition was observed in the 2010/11 to 2017/18 seasons","Machado A, Leite A, Larrauri A, Gomez V, Rodrigues AP, Kislaya I, Nunes B.","Pharmacoepidemiol Drug Saf. 2021 Oct;30(10):1411-1419. doi: 10.1002/pds.5302. Epub 2021 Jun 14.","Machado A","Pharmacoepidemiol Drug Saf","2021","2021/06/07","","","10.1002/pds.5302"
"34092001","A review of the sampling methodology used in studies evaluating the effectiveness of risk minimisation measures in Europe","Jouaville LS, Paul T, Almas MF.","Pharmacoepidemiol Drug Saf. 2021 Sep;30(9):1143-1152. doi: 10.1002/pds.5301. Epub 2021 Jun 24.","Jouaville LS","Pharmacoepidemiol Drug Saf","2021","2021/06/06","PMC8453956","","10.1002/pds.5301"
"34089206","Validation of an ICD-10-based algorithm to identify stillbirth in the Sentinel System","Andrade SE, Shinde M, Moore Simas TA, Bird ST, Bohn J, Haynes K, Taylor LG, Lauring JR, Longley E, McMahill-Walraven CN, Trinacty CM, Saphirak C, Delude C, DeLuccia S, Zhang T, Cole DV, DiNunzio N, Gertz A, Fazio-Eynullayeva E, Stojanovic D.","Pharmacoepidemiol Drug Saf. 2021 Sep;30(9):1175-1183. doi: 10.1002/pds.5300. Epub 2021 Jun 11.","Andrade SE","Pharmacoepidemiol Drug Saf","2021","2021/06/05","","","10.1002/pds.5300"
"34053137","Using administrative healthcare database records to study trends in prescribed medication dispensed during pregnancy in Belgium from 2003 to 2017","Larcin L, Lona M, Karakaya G, Van Espen A, Damase-Michel C, Kirakoya-Samadoulougou F.","Pharmacoepidemiol Drug Saf. 2021 Sep;30(9):1224-1232. doi: 10.1002/pds.5299. Epub 2021 Jun 9.","Larcin L","Pharmacoepidemiol Drug Saf","2021","2021/05/30","","","10.1002/pds.5299"
"34038608","Prevalence and quality of antihypertensive therapy among hypertension patients enrolled in the Ghana National Health Insurance Scheme","Donneyong MM, Chang TJ, Pottegård A, Ankrah D, Asenso-Boadi F, Addo-Cobbiah V, Dsane-Selby L, Hallas J.","Pharmacoepidemiol Drug Saf. 2021 Nov;30(11):1566-1575. doi: 10.1002/pds.5298. Epub 2021 Jun 16.","Donneyong MM","Pharmacoepidemiol Drug Saf","2021","2021/05/26","","","10.1002/pds.5298"
"34031946","Classification and visualization of longitudinal patterns of medication dose: An application to interferon-beta-1a and amitriptyline in patients with multiple sclerosis","Mésidor M, Rousseau MC, Duquette P, Sylvestre MP.","Pharmacoepidemiol Drug Saf. 2021 Sep;30(9):1214-1223. doi: 10.1002/pds.5297. Epub 2021 Jun 4.","Mésidor M","Pharmacoepidemiol Drug Saf","2021","2021/05/25","","","10.1002/pds.5297"
"34021676","Oral anticoagulant therapy and outcome in patients with stroke. A retrospective nation-wide cohort study in Austria 2012-2017","Preinreich J, Sheikh Rezaei S, Mittlböck M, Greisenegger S, Reichardt B, Wolzt M.","Pharmacoepidemiol Drug Saf. 2021 Oct;30(10):1332-1338. doi: 10.1002/pds.5296. Epub 2021 Jun 3.","Preinreich J","Pharmacoepidemiol Drug Saf","2021","2021/05/22","PMC8453954","","10.1002/pds.5296"
"34015159","Use of hydrochlorothiazide and risk of skin cancer in a large nested case-control study in Spain","León-Muñoz LM, Duarte-Salles T, Llorente A, Díaz Y, Puente D, Pottegård A, Montero-Corominas D, Huerta C.","Pharmacoepidemiol Drug Saf. 2021 Sep;30(9):1269-1278. doi: 10.1002/pds.5295. Epub 2021 Jun 8.","León-Muñoz LM","Pharmacoepidemiol Drug Saf","2021","2021/05/20","","","10.1002/pds.5295"
"33993606","Use of negative controls in a prescription sequence symmetry analysis to reduce time-varying bias","Vouri SM, Jiang X, Morris EJ, Brumback BA, Winterstein AG.","Pharmacoepidemiol Drug Saf. 2021 Sep;30(9):1192-1199. doi: 10.1002/pds.5293. Epub 2021 Jun 7.","Vouri SM","Pharmacoepidemiol Drug Saf","2021","2021/05/16","","","10.1002/pds.5293"
"33991132","Identifying frequent drug combinations associated with delirium in older adults: Application of association rules method to a case-time-control design","Chyou TY, Nishtala PS.","Pharmacoepidemiol Drug Saf. 2021 Oct;30(10):1402-1410. doi: 10.1002/pds.5292. Epub 2021 May 31.","Chyou TY","Pharmacoepidemiol Drug Saf","2021","2021/05/15","","","10.1002/pds.5292"
"33988275","Sensitivity analyses of unmeasured and partially-measured confounders using multiple imputation in a vaccine safety study","Xu S, Clarke CL, Newcomer SR, Daley MF, Glanz JM.","Pharmacoepidemiol Drug Saf. 2021 Sep;30(9):1200-1213. doi: 10.1002/pds.5294. Epub 2021 May 31.","Xu S","Pharmacoepidemiol Drug Saf","2021","2021/05/14","","","10.1002/pds.5294"
"33979005","Validating a novel algorithm to identify patients with autoimmune hepatitis in an administrative database","Bittermann T, Mahmud N, Lewis JD, Levy C, Goldberg DS.","Pharmacoepidemiol Drug Saf. 2021 Sep;30(9):1168-1174. doi: 10.1002/pds.5291. Epub 2021 May 21.","Bittermann T","Pharmacoepidemiol Drug Saf","2021","2021/05/12","PMC8717407","NIHMS1764336","10.1002/pds.5291"
"33960586","More extreme duplication in the U.S. FDA FAERS database and a suggested check point for disproportionality analysis","Hauben M, Zou C, Bright S, Hung E.","Pharmacoepidemiol Drug Saf. 2021 Aug;30(8):1140-1141. doi: 10.1002/pds.5265. Epub 2021 May 13.","Hauben M","Pharmacoepidemiol Drug Saf","2021","2021/05/07","","","10.1002/pds.5265"
"33960576","Hydrochlorothiazide and risk of melanoma subtypes","Habel LA, Achacoso N, Fireman B, Pedersen SA, Pottegård A.","Pharmacoepidemiol Drug Saf. 2021 Oct;30(10):1396-1401. doi: 10.1002/pds.5266. Epub 2021 May 26.","Habel LA","Pharmacoepidemiol Drug Saf","2021","2021/05/07","","","10.1002/pds.5266"
"33960542","Validity of claims-based algorithms for selected cancers in Japan: Results from the VALIDATE-J study","de Luise C, Sugiyama N, Morishima T, Higuchi T, Katayama K, Nakamura S, Chen H, Nonnenmacher E, Hase R, Jinno S, Kinjo M, Suzuki D, Tanaka Y, Setoguchi S.","Pharmacoepidemiol Drug Saf. 2021 Sep;30(9):1153-1161. doi: 10.1002/pds.5263. Epub 2021 Jun 1.","de Luise C","Pharmacoepidemiol Drug Saf","2021","2021/05/07","PMC8453514","","10.1002/pds.5263"
"33960541","Validation of coding algorithms for the identification of herpes zoster among children","Rutstein BH, Gmuca S, Gerber JS, Lim T, Argraves M, Ogdie A.","Pharmacoepidemiol Drug Saf. 2021 Sep;30(9):1162-1167. doi: 10.1002/pds.5264. Epub 2021 May 18.","Rutstein BH","Pharmacoepidemiol Drug Saf","2021","2021/05/07","","","10.1002/pds.5264"
"33949722","Statin (mis)use in older people: A cross-sectional study using French health insurance databases","Borne E, Meyer N, Blanchard O, Lombard M, Vogel T, Lang PO, Michel B.","Pharmacoepidemiol Drug Saf. 2021 Aug;30(8):1084-1090. doi: 10.1002/pds.5262. Epub 2021 May 14.","Borne E","Pharmacoepidemiol Drug Saf","2021","2021/05/05","","","10.1002/pds.5262"
"33938603","Impact of adherence to drugs for secondary prevention on mortality and cardiovascular morbidity: A population-based cohort study. IMPACT study","Sotorra-Figuerola G, Ouchi D, Giner-Soriano M, Morros R.","Pharmacoepidemiol Drug Saf. 2021 Sep;30(9):1250-1257. doi: 10.1002/pds.5261. Epub 2021 May 16.","Sotorra-Figuerola G","Pharmacoepidemiol Drug Saf","2021","2021/05/03","","","10.1002/pds.5261"
"33931917","Drug product dispensing and estimates of use in a general population survey as a signal detection problem","Black JC, Forber A, Severtson SG, Rockhill K, May KP, Amioka E, Schwarz J, Iwanicki J, Dart RC.","Pharmacoepidemiol Drug Saf. 2021 Aug;30(8):1132-1139. doi: 10.1002/pds.5260. Epub 2021 May 10.","Black JC","Pharmacoepidemiol Drug Saf","2021","2021/05/01","","","10.1002/pds.5260"
"33913205","Linkage of public health and all payer claims data for population-level opioid research","Hallvik SE, Dameshghi N, El Ibrahimi S, Hendricks MA, Hildebran C, Bishop CJ, Weiner SG.","Pharmacoepidemiol Drug Saf. 2021 Jul;30(7):927-933. doi: 10.1002/pds.5259. Epub 2021 May 10.","Hallvik SE","Pharmacoepidemiol Drug Saf","2021","2021/04/29","PMC8172471","NIHMS1702533","10.1002/pds.5259"
"33901339","Chronic pain patients' willingness to share personal identifiers on the web for the linkage of medico-administrative claims and patient-reported data: The chronic pain treatment cohort","Lacasse A, Gagnon V, Nguena Nguefack HL, Gosselin M, Pagé MG, Blais L, Guénette L.","Pharmacoepidemiol Drug Saf. 2021 Aug;30(8):1012-1026. doi: 10.1002/pds.5255. Epub 2021 May 4.","Lacasse A","Pharmacoepidemiol Drug Saf","2021","2021/04/26","PMC8360172","","10.1002/pds.5255"
"33899314","Development and validation of a predictive model algorithm to identify anaphylaxis in adults with type 2 diabetes in U.S. administrative claims data","Beachler DC, Taylor DH, Anthony MS, Yin R, Li L, Saltus CW, Li L, Shaunik A, Walsh KE, Rothman KJ, Johannes CB, Aroda VR, Carr W, Goldberg P, Accardi A, O'Shura JS, Sharma K, Juhaeri J, Lanes S, Wu C.","Pharmacoepidemiol Drug Saf. 2021 Jul;30(7):918-926. doi: 10.1002/pds.5257. Epub 2021 May 5.","Beachler DC","Pharmacoepidemiol Drug Saf","2021","2021/04/26","","","10.1002/pds.5257"
"33899311","Validation of an electronic algorithm for Hodgkin and non-Hodgkin lymphoma in ICD-10-CM","Epstein MM, Dutcher SK, Maro JC, Saphirak C, DeLuccia S, Ramanathan M, Dhawale T, Harchandani S, Delude C, Hou L, Gertz A, DiNunzio N, McMahill-Walraven CN, Selvan MS, Vigeant J, Cole DV, Leishear K, Gurwitz JH, Andrade S, Cocoros NM.","Pharmacoepidemiol Drug Saf. 2021 Jul;30(7):910-917. doi: 10.1002/pds.5256. Epub 2021 May 5.","Epstein MM","Pharmacoepidemiol Drug Saf","2021","2021/04/26","PMC8205565","NIHMS1707792","10.1002/pds.5256"
"33899305","New-user and prevalent-user designs and the definition of study time origin in pharmacoepidemiology: A review of reporting practices","Luijken K, Spekreijse JJ, van Smeden M, Gardarsdottir H, Groenwold RHH.","Pharmacoepidemiol Drug Saf. 2021 Jul;30(7):960-974. doi: 10.1002/pds.5258. Epub 2021 May 10.","Luijken K","Pharmacoepidemiol Drug Saf","2021","2021/04/26","PMC8252086","","10.1002/pds.5258"
"33886141","Prescription of antibiotics in the medical care of newly arrived refugees and migrants","Kleinert E, Hillermann N, Jablonka A, Happle C, Müller F, Simmenroth A.","Pharmacoepidemiol Drug Saf. 2021 Aug;30(8):1074-1083. doi: 10.1002/pds.5254. Epub 2021 May 4.","Kleinert E","Pharmacoepidemiol Drug Saf","2021","2021/04/22","","","10.1002/pds.5254"
"33885214","Validity of ICD-10-CM diagnoses to identify hospitalizations for serious infections among patients treated with biologic therapies","Lo Re V 3rd, Carbonari DM, Jacob J, Short WR, Leonard CE, Lyons JG, Kennedy A, Damon J, Haug N, Zhou EH, Graham DJ, McMahill-Walraven CN, Parlett LE, Nair V, Selvan M, Zhou Y, Pocobelli G, Maro JC, Nguyen MD.","Pharmacoepidemiol Drug Saf. 2021 Jul;30(7):899-909. doi: 10.1002/pds.5253. Epub 2021 May 3.","Lo Re V 3rd","Pharmacoepidemiol Drug Saf","2021","2021/04/22","","","10.1002/pds.5253"
"33881794","The identification and validity of congenital malformation diagnoses in UK electronic health records: A systematic review","Peppa M, Minassian C, Mangtani P, Thomas SL.","Pharmacoepidemiol Drug Saf. 2021 Jul;30(7):875-898. doi: 10.1002/pds.5251. Epub 2021 May 4.","Peppa M","Pharmacoepidemiol Drug Saf","2021","2021/04/21","","","10.1002/pds.5251"
"33881179","Sodium-glucose cotransporter-2 inhibitors and the risk of gout: A Danish population based cohort study and symmetry analysis","Lund LC, Højlund M, Henriksen DP, Hallas J, Kristensen KB.","Pharmacoepidemiol Drug Saf. 2021 Oct;30(10):1391-1395. doi: 10.1002/pds.5252. Epub 2021 May 13.","Lund LC","Pharmacoepidemiol Drug Saf","2021","2021/04/21","","","10.1002/pds.5252"
"33866622","Prenatal exposure to non-steroidal anti-inflammatory drugs and risk of attention-deficit/hyperactivity disorder: A follow-up study in the Norwegian mother, father and child cohort","Hjorth S, Lupattelli A, Handal M, Spigset O, Ystrom E, Nordeng H.","Pharmacoepidemiol Drug Saf. 2021 Oct;30(10):1380-1390. doi: 10.1002/pds.5250. Epub 2021 May 7.","Hjorth S","Pharmacoepidemiol Drug Saf","2021","2021/04/18","","","10.1002/pds.5250"
"33864401","Pharmacovigilance network as an additional tool for the surveillance of antimicrobial resistance","Habarugira JMV, Figueras A.","Pharmacoepidemiol Drug Saf. 2021 Aug;30(8):1123-1131. doi: 10.1002/pds.5249. Epub 2021 Apr 27.","Habarugira JMV","Pharmacoepidemiol Drug Saf","2021","2021/04/17","","","10.1002/pds.5249"
"33840147","Survival of advanced melanoma patients treated with immunotherapy and targeted therapy: A real-world study","Yu SY, Mckavanagh D, McPherson I, Walpole E, Atkinson V, Hollingworth S.","Pharmacoepidemiol Drug Saf. 2021 Oct;30(10):1371-1379. doi: 10.1002/pds.5248. Epub 2021 Apr 21.","Yu SY","Pharmacoepidemiol Drug Saf","2021","2021/04/11","","","10.1002/pds.5248"
"33840136","Signals from the Dutch national spontaneous reporting system: Characteristics and regulatory actions","van Hunsel F, de Jong E, Gross-Martirosyan L, Hoekman J.","Pharmacoepidemiol Drug Saf. 2021 Aug;30(8):1115-1122. doi: 10.1002/pds.5246. Epub 2021 Apr 21.","van Hunsel F","Pharmacoepidemiol Drug Saf","2021","2021/04/11","","","10.1002/pds.5246"
"33840133","Trends in strong opioid prescribing in Ireland: A repeated cross-sectional analysis of a national pharmacy claims database between 2010 and 2019","Norris BA, Smith A, Doran S, Barry M.","Pharmacoepidemiol Drug Saf. 2021 Aug;30(8):1003-1011. doi: 10.1002/pds.5247. Epub 2021 May 5.","Norris BA","Pharmacoepidemiol Drug Saf","2021","2021/04/11","","","10.1002/pds.5247"
"33835610","Validity of congenital malformation diagnoses in healthcare claims from a university hospital in Japan","Ishikawa T, Oyanagi G, Obara T, Noda A, Morishita K, Takagi S, Inoue R, Kawame H, Mano N.","Pharmacoepidemiol Drug Saf. 2021 Jul;30(7):975-978. doi: 10.1002/pds.5244. Epub 2021 Apr 16.","Ishikawa T","Pharmacoepidemiol Drug Saf","2021","2021/04/09","","","10.1002/pds.5244"
"33834577","Online tool to create publication ready graphical depictions of longitudinal study design implemented in healthcare databases","Lund LC, Hallas J, Wang SV.","Pharmacoepidemiol Drug Saf. 2021 Jul;30(7):982. doi: 10.1002/pds.5241. Epub 2021 Apr 19.","Lund LC","Pharmacoepidemiol Drug Saf","2021","2021/04/09","","","10.1002/pds.5241"
"33834576","A systematic review of how missing data are handled and reported in multi-database pharmacoepidemiologic studies","Hunt NB, Gardarsdottir H, Bazelier MT, Klungel OH, Pajouheshnia R.","Pharmacoepidemiol Drug Saf. 2021 Jul;30(7):819-826. doi: 10.1002/pds.5245. Epub 2021 May 7.","Hunt NB","Pharmacoepidemiol Drug Saf","2021","2021/04/09","PMC8252545","","10.1002/pds.5245"
"33822430","Prescribed drugs in 27 000 individuals after diagnosis of colorectal cancer: A population-based cohort study","Engeland A, Ghaderi S, Dos-Santos-Silva I, Furu K, Hjellvik V, Kvåle R, Bjørge T.","Pharmacoepidemiol Drug Saf. 2021 Aug;30(8):1037-1048. doi: 10.1002/pds.5243. Epub 2021 May 5.","Engeland A","Pharmacoepidemiol Drug Saf","2021","2021/04/06","","","10.1002/pds.5243"
"33822401","Adherence to direct oral anticoagulant treatment for atrial fibrillation in the Netherlands: A surveillance study","Zielinski GD, van Rein N, Teichert M, Klok FA, Rosendaal FR, van der Meer FJM, Huisman MV, Cannegieter SC, Lijfering WM.","Pharmacoepidemiol Drug Saf. 2021 Aug;30(8):1027-1036. doi: 10.1002/pds.5242. Epub 2021 May 4.","Zielinski GD","Pharmacoepidemiol Drug Saf","2021","2021/04/06","PMC8360064","","10.1002/pds.5242"
"33797822","Opioid prescribing and risks among commercially insured women undergoing pelvic organ prolapse repair","Gressler LE, dosReis S, Chughtai B.","Pharmacoepidemiol Drug Saf. 2021 Aug;30(8):993-1002. doi: 10.1002/pds.5239. Epub 2021 Apr 19.","Gressler LE","Pharmacoepidemiol Drug Saf","2021","2021/04/02","","","10.1002/pds.5239"
"33797815","A COVID-19-ready public health surveillance system: The Food and Drug Administration's Sentinel System","Cocoros NM, Fuller CC, Adimadhyam S, Ball R, Brown JS, Dal Pan GJ, Kluberg SA, Lo Re V 3rd, Maro JC, Nguyen M, Orr R, Paraoan D, Perlin J, Poland RE, Driscoll MR, Sands K, Toh S, Yih WK, Platt R; And the FDA-Sentinel COVID-19 Working Group.","Pharmacoepidemiol Drug Saf. 2021 Jul;30(7):827-837. doi: 10.1002/pds.5240. Epub 2021 Apr 18.","Cocoros NM","Pharmacoepidemiol Drug Saf","2021","2021/04/02","PMC8250843","","10.1002/pds.5240"
"33797156","Mandates are not magic bullets: Leveraging context, meaning and relationships to increase meaningful use of prescription monitoring programs","Szymczak JE.","Pharmacoepidemiol Drug Saf. 2021 Jul;30(7):979-981. doi: 10.1002/pds.5238. Epub 2021 Apr 12.","Szymczak JE","Pharmacoepidemiol Drug Saf","2021","2021/04/02","","","10.1002/pds.5238"
"33797137","Corrigendum","","Pharmacoepidemiol Drug Saf. 2021 May;30(5):669. doi: 10.1002/pds.5225. Epub 2021 Mar 15.","","Pharmacoepidemiol Drug Saf","2021","2021/04/02","","","10.1002/pds.5225"
"33783918","Risk of antibiotic treatment failure in premenopausal women with uncomplicated urinary tract infection","Butler AM, Durkin MJ, Keller MR, Ma Y, Dharnidharka VR, Powderly WG, Olsen MA.","Pharmacoepidemiol Drug Saf. 2021 Oct;30(10):1360-1370. doi: 10.1002/pds.5237. Epub 2021 Apr 13.","Butler AM","Pharmacoepidemiol Drug Saf","2021","2021/03/30","PMC8419150","NIHMS1695570","10.1002/pds.5237"
"33772938","Estimation of adverse drug reaction reporting in Iran: Correction for underreporting","Khalili M, Mesgarpour B, Sharifi H, Golozar A, Haghdoost AA.","Pharmacoepidemiol Drug Saf. 2021 Aug;30(8):1101-1114. doi: 10.1002/pds.5235. Epub 2021 May 2.","Khalili M","Pharmacoepidemiol Drug Saf","2021","2021/03/27","","","10.1002/pds.5235"
"33772933","QTc prolongation in COVID-19 patients treated with hydroxychloroquine, chloroquine, azithromycin, or lopinavir/ritonavir: A systematic review and meta-analysis","Diaz-Arocutipa C, Brañez-Condorena A, Hernandez AV.","Pharmacoepidemiol Drug Saf. 2021 Jun;30(6):694-706. doi: 10.1002/pds.5234. Epub 2021 Apr 3.","Diaz-Arocutipa C","Pharmacoepidemiol Drug Saf","2021","2021/03/27","PMC8251490","","10.1002/pds.5234"
"33772928","Association between control of diabetes mellitus and polypharmacy at the Brazilian Longitudinal Study of Adult Health (ELSA-Brasil)","Coutinho DF, de Figueiredo RC, Duncan BB, Schmidt MI, Barreto SM, Diniz MFHS.","Pharmacoepidemiol Drug Saf. 2021 Jun;30(6):749-757. doi: 10.1002/pds.5236. Epub 2021 Apr 3.","Coutinho DF","Pharmacoepidemiol Drug Saf","2021","2021/03/27","","","10.1002/pds.5236"
"33733540","The impact of regulation changes in the spontaneous reporting system for vaccines on reporting trends and signal detection in Japan","Miyazaki M, Sakai T, Obara T, Mano N.","Pharmacoepidemiol Drug Saf. 2021 Aug;30(8):1091-1100. doi: 10.1002/pds.5231. Epub 2021 Mar 27.","Miyazaki M","Pharmacoepidemiol Drug Saf","2021","2021/03/18","","","10.1002/pds.5231"
"33733533","Greedy caliper propensity score matching can yield variable estimates of the treatment-outcome association-A simulation study","Komen JJ, Belitser SV, Wyss R, Schneeweiss S, Taams AC, Pajouheshnia R, Forslund T, Klungel OH.","Pharmacoepidemiol Drug Saf. 2021 Jul;30(7):934-951. doi: 10.1002/pds.5232. Epub 2021 Mar 25.","Komen JJ","Pharmacoepidemiol Drug Saf","2021","2021/03/18","PMC8251845","","10.1002/pds.5232"
"33730412","Risk of interstitial lung disease in patients treated for atrial fibrillation with dronedarone versus other antiarrhythmics","Tave A, Goehring E, Desai V, Wu C, Bohn RL, Tamayo SG, Sicignano N, Juhaeri J, Jones JK, Weiss SR.","Pharmacoepidemiol Drug Saf. 2021 Oct;30(10):1353-1359. doi: 10.1002/pds.5233. Epub 2021 May 4.","Tave A","Pharmacoepidemiol Drug Saf","2021","2021/03/17","PMC8453764","","10.1002/pds.5233"
"33715299","Identifying prescribing cascades in Alzheimer's disease and related dementias: The calcium channel blocker-diuretic prescribing cascade","Singh S, Cocoros NM, Haynes K, Nair VP, Harkins TP, Rochon PA, Platt R, Dashevsky I, Reynolds J, Mazor KM, Bloomstone S, Anzuoni K, Crawford SL, Gurwitz JH.","Pharmacoepidemiol Drug Saf. 2021 Aug;30(8):1066-1073. doi: 10.1002/pds.5230. Epub 2021 Mar 23.","Singh S","Pharmacoepidemiol Drug Saf","2021","2021/03/14","","","10.1002/pds.5230"
"33715291","Effect of concomitant antiplatelet therapy on ischemic and hemorrhagic events in patients taking oral anticoagulants for nonvalvular atrial fibrillation in daily clinical practice","Morimoto T, Uchida K, Sakakibara F, Kinjo N, Ueda S.","Pharmacoepidemiol Drug Saf. 2021 Oct;30(10):1321-1331. doi: 10.1002/pds.5228. Epub 2021 May 3.","Morimoto T","Pharmacoepidemiol Drug Saf","2021","2021/03/14","","","10.1002/pds.5228"
"33715280","Validation of claims-based algorithms to identify patients with psoriasis","Lee H, He M, Cho SK, Bessette L, Tong AY, Merola JF, Wegrzyn LR, Kilpatrick RD, Kim SC.","Pharmacoepidemiol Drug Saf. 2021 Jul;30(7):868-874. doi: 10.1002/pds.5229. Epub 2021 Mar 23.","Lee H","Pharmacoepidemiol Drug Saf","2021","2021/03/14","","","10.1002/pds.5229"
"33715268","Pharmacoepidemiology: A time for a new multidisciplinary approach to precision medicine","Issa AM, Carleton B, Gerhard T, Filipski KK, Freedman AN, Kimmel S, Liu G, Longo C, Maitland-van der Zee AH, Sansbury L, Zhou W, Bartlett G.","Pharmacoepidemiol Drug Saf. 2021 Aug;30(8):985-992. doi: 10.1002/pds.5226. Epub 2021 Apr 7.","Issa AM","Pharmacoepidemiol Drug Saf","2021","2021/03/14","","","10.1002/pds.5226"
"33715267","Control yourself: ISPE-endorsed guidance in the application of self-controlled study designs in pharmacoepidemiology","Cadarette SM, Maclure M, Delaney JAC, Whitaker HJ, Hayes KN, Wang SV, Tadrous M, Gagne JJ, Consiglio GP, Hallas J.","Pharmacoepidemiol Drug Saf. 2021 Jun;30(6):671-684. doi: 10.1002/pds.5227. Epub 2021 Apr 1.","Cadarette SM","Pharmacoepidemiol Drug Saf","2021","2021/03/14","PMC8251635","","10.1002/pds.5227"
"33683783","Effect of 5-HT2C receptor gene polymorphism (HTR2C-759C/T) on metabolic adverse effects in Thai psychiatric patients treated with risperidone","Vanwong N, Puangpetch A, Unaharassamee W, Jiratjintana N, Na Nakorn C, Hongkaew Y, Sukasem C.","Pharmacoepidemiol Drug Saf. 2021 Jun;30(6):806-813. doi: 10.1002/pds.5224. Epub 2021 Mar 23.","Vanwong N","Pharmacoepidemiol Drug Saf","2021","2021/03/08","","","10.1002/pds.5224"
"33675260","Use of preventive drugs during the last year of life in older adults with cancer or chronic progressive diseases","Bosetti C, Santucci C, Pasina L, Fortino I, Merlino L, Corli O, Nobili A.","Pharmacoepidemiol Drug Saf. 2021 Aug;30(8):1057-1065. doi: 10.1002/pds.5223. Epub 2021 Mar 30.","Bosetti C","Pharmacoepidemiol Drug Saf","2021","2021/03/06","","","10.1002/pds.5223"
"33675258","Women are started on a lower daily dose of metoprolol than men irrespective of dose recommendations: A potential source of confounding by contraindication in pharmacoepidemiology","Hendriksen LC, Verhamme KMC, Van der Linden PD, Stricker BH, Visser LE.","Pharmacoepidemiol Drug Saf. 2021 Jul;30(7):952-959. doi: 10.1002/pds.5220. Epub 2021 Mar 29.","Hendriksen LC","Pharmacoepidemiol Drug Saf","2021","2021/03/06","PMC8252087","","10.1002/pds.5220"
"33675248","Real-world evidence to support regulatory decision making: New or expanded medical product indications","Franklin JM, Liaw KL, Iyasu S, Critchlow CW, Dreyer NA.","Pharmacoepidemiol Drug Saf. 2021 Jun;30(6):685-693. doi: 10.1002/pds.5222. Epub 2021 Mar 18.","Franklin JM","Pharmacoepidemiol Drug Saf","2021","2021/03/06","","","10.1002/pds.5222"
"33675245","Validity of bariatric surgery codes in the UK Clinical Practice Research Datalink (CPRD) GOLD compared with Hospital Episodes Statistics","Burkard T, Rauch M, Jick SS, Meier CR.","Pharmacoepidemiol Drug Saf. 2021 Jul;30(7):858-867. doi: 10.1002/pds.5221. Epub 2021 Mar 17.","Burkard T","Pharmacoepidemiol Drug Saf","2021","2021/03/06","","","10.1002/pds.5221"
"33655544","Comparative neurological safety of fluoroquinolones versus therapeutic alternatives","Ellis DE, Hubbard RA, Willis AW, Zuppa AF, Zaoutis TE, Hennessy S.","Pharmacoepidemiol Drug Saf. 2021 Jun;30(6):797-805. doi: 10.1002/pds.5219. Epub 2021 Mar 23.","Ellis DE","Pharmacoepidemiol Drug Saf","2021","2021/03/03","","","10.1002/pds.5219"
"33650210","Global COVID-19 pandemic and reporting behavior - An analysis of the Food and Drug Administration adverse events reporting system","Dörks M, Jobski K, Hoffmann F, Douros A.","Pharmacoepidemiol Drug Saf. 2021 Jun;30(6):707-715. doi: 10.1002/pds.5217. Epub 2021 Mar 17.","Dörks M","Pharmacoepidemiol Drug Saf","2021","2021/03/02","PMC8012989","","10.1002/pds.5217"
"33650133","'Considering the totality of evidence: Combining real-world data with clinical trial results to better inform decision-making","Mamtani R, Lund J, Hubbard RA.","Pharmacoepidemiol Drug Saf. 2021 Jun;30(6):814-816. doi: 10.1002/pds.5218. Epub 2021 Mar 14.","Mamtani R","Pharmacoepidemiol Drug Saf","2021","2021/03/02","","","10.1002/pds.5218"
"33638243","Health outcomes coding trends in the US Food and Drug Administration's Sentinel System during transition to International Classification of Diseases-10 coding system: A brief review","Nam YH, Mendelsohn AB, Panozzo CA, Maro JC, Brown JS.","Pharmacoepidemiol Drug Saf. 2021 Jul;30(7):838-842. doi: 10.1002/pds.5216. Epub 2021 Mar 17.","Nam YH","Pharmacoepidemiol Drug Saf","2021","2021/02/27","PMC8251911","","10.1002/pds.5216"
"33634545","Suitability of databases in the Asia-Pacific for collaborative monitoring of vaccine safety","Duszynski KM, Stark JH, Cohet C, Huang WT, Shin JY, Lai EC, Man KKC, Choi NK, Khromava A, Kimura T, Huang K, Watcharathanakij S, Kochhar S, Chen RT, Pratt NL.","Pharmacoepidemiol Drug Saf. 2021 Jul;30(7):843-857. doi: 10.1002/pds.5214. Epub 2021 Mar 23.","Duszynski KM","Pharmacoepidemiol Drug Saf","2021","2021/02/26","","","10.1002/pds.5214"
"33630347","Emergency hospitalizations for adverse drug events in China: Clinical pharmacists' approach to assessment and categorization","Zhang Y, Jin L, Zhang X, Bai R, Chen D, Ma Y, Zhai X.","Pharmacoepidemiol Drug Saf. 2021 May;30(5):636-643. doi: 10.1002/pds.5215. Epub 2021 Mar 5.","Zhang Y","Pharmacoepidemiol Drug Saf","2021","2021/02/25","","","10.1002/pds.5215"
"33629363","Accuracy of Japanese claims data in identifying diabetes-related complications","Fujihara K, Yamada-Harada M, Matsubayashi Y, Kitazawa M, Yamamoto M, Yaguchi Y, Seida H, Kodama S, Akazawa K, Sone H.","Pharmacoepidemiol Drug Saf. 2021 May;30(5):594-601. doi: 10.1002/pds.5213. Epub 2021 Mar 4.","Fujihara K","Pharmacoepidemiol Drug Saf","2021","2021/02/25","","","10.1002/pds.5213"
"33625786","Outpatient insulin-related adverse events due to mix-up errors: Findings from two national surveillance systems, United States, 2012-2017","Geller AI, Conrad AO, Weidle NJ, Mehta H, Budnitz DS, Shehab N.","Pharmacoepidemiol Drug Saf. 2021 May;30(5):573-581. doi: 10.1002/pds.5212. Epub 2021 Mar 5.","Geller AI","Pharmacoepidemiol Drug Saf","2021","2021/02/24","PMC9540655","NIHMS1838168","10.1002/pds.5212"
"33625778","Evolution of medication consumption in a working environment in France: Results of the four waves of the ""Drugs and Work"" study (1986-2016)","Herin F, Othenin J, Jouanjus E, Rousseau V, Niezborala M, Lapeyre-Mestre M.","Pharmacoepidemiol Drug Saf. 2021 May;30(5):661-668. doi: 10.1002/pds.5211. Epub 2021 Mar 7.","Herin F","Pharmacoepidemiol Drug Saf","2021","2021/02/24","","","10.1002/pds.5211"
"33617072","Self-reported medication intake vs information from other data sources such as pharmacy records or medical records: Identification and description of existing publications, and comparison of agreement results for publications focusing on patients with cancer - a systematic review","Brüne M, Emmel C, Meilands G, Andrich S, Droste S, Claessen H, Jülich F, Icks A.","Pharmacoepidemiol Drug Saf. 2021 May;30(5):531-560. doi: 10.1002/pds.5210. Epub 2021 Mar 5.","Brüne M","Pharmacoepidemiol Drug Saf","2021","2021/02/22","","","10.1002/pds.5210"
"33611812","Chronic opioid use and complication risks in women with endometriosis: A cohort study in US administrative claims","Chiuve SE, Kilpatrick RD, Hornstein MD, Petruski-Ivleva N, Wegrzyn LR, Dabrowski EC, Velentgas P, Snabes MC, Bateman BT.","Pharmacoepidemiol Drug Saf. 2021 Jun;30(6):787-796. doi: 10.1002/pds.5209. Epub 2021 Mar 16.","Chiuve SE","Pharmacoepidemiol Drug Saf","2021","2021/02/21","PMC8251707","","10.1002/pds.5209"
"33611792","The Chang Gung Research Database: Multi-institutional real-world data source for traditional Chinese medicine in Taiwan","Shao SC, Lai EC, Huang TH, Hung MJ, Tsai MS, Yang YH, Chan YY.","Pharmacoepidemiol Drug Saf. 2021 May;30(5):652-660. doi: 10.1002/pds.5208. Epub 2021 Mar 5.","Shao SC","Pharmacoepidemiol Drug Saf","2021","2021/02/21","","","10.1002/pds.5208"
"33608939","Association of baloxavir marboxil prescription with subsequent medical resource utilization among school-aged children with influenza","Takeuchi M, Kawakami K.","Pharmacoepidemiol Drug Saf. 2021 Jun;30(6):779-786. doi: 10.1002/pds.5207. Epub 2021 Mar 1.","Takeuchi M","Pharmacoepidemiol Drug Saf","2021","2021/02/20","","","10.1002/pds.5207"
"33606340","Using machine learning to identify diabetes patients with canagliflozin prescriptions at high-risk of lower extremity amputation using real-world data","Yang L, Gabriel N, Hernandez I, Winterstein AG, Guo J.","Pharmacoepidemiol Drug Saf. 2021 May;30(5):644-651. doi: 10.1002/pds.5206. Epub 2021 Mar 2.","Yang L","Pharmacoepidemiol Drug Saf","2021","2021/02/19","","","10.1002/pds.5206"
"33583126","Statins and risk of diverticular disease: Nested case-control study","Skajaa N, Schønfeldt Troelsen F, Pedersen L, Ekholm O, Strate LL, Erichsen R, Sørensen HT.","Pharmacoepidemiol Drug Saf. 2021 Jun;30(6):770-778. doi: 10.1002/pds.5205. Epub 2021 Feb 21.","Skajaa N","Pharmacoepidemiol Drug Saf","2021","2021/02/14","","","10.1002/pds.5205"
"33580525","Validation of an International Classification of Disease, 10th revision coding adaptation for the Charlson Comorbidity Index in United States healthcare claims data","Beyrer J, Manjelievskaia J, Bonafede M, Lenhart G, Nolot S, Haldane D, Johnston J.","Pharmacoepidemiol Drug Saf. 2021 May;30(5):582-593. doi: 10.1002/pds.5204. Epub 2021 Mar 4.","Beyrer J","Pharmacoepidemiol Drug Saf","2021","2021/02/13","PMC8252530","","10.1002/pds.5204"
"33559352","A comparison of decision and timing of safety related labeling changes for new drugs approved both in Japan and the United States","Hoshino Y, Narukawa M.","Pharmacoepidemiol Drug Saf. 2021 May;30(5):561-572. doi: 10.1002/pds.5203. Epub 2021 Feb 18.","Hoshino Y","Pharmacoepidemiol Drug Saf","2021","2021/02/09","","","10.1002/pds.5203"
"33534188","Trends in Erythropoiesis-stimulating agent use and blood transfusions for chemotherapy-induced anemia throughout FDA's risk evaluation and mitigation strategy lifecycle","Vega A, Zhang R, Wong HL, Wernecke M, Alexander M, Feng Y, Lo AC, Lufkin B, Ryan Q, Izem R, MaCurdy TE, Kelman JA, Graham DJ.","Pharmacoepidemiol Drug Saf. 2021 May;30(5):626-635. doi: 10.1002/pds.5202. Epub 2021 Feb 22.","Vega A","Pharmacoepidemiol Drug Saf","2021","2021/02/03","","","10.1002/pds.5202"
"33534172","Trends in fall-related mortality and fall risk increasing drugs among older individuals in the United States,1999-2017","Shaver AL, Clark CM, Hejna M, Feuerstein S, Wahler RG Jr, Jacobs DM.","Pharmacoepidemiol Drug Saf. 2021 Aug;30(8):1049-1056. doi: 10.1002/pds.5201. Epub 2021 Feb 16.","Shaver AL","Pharmacoepidemiol Drug Saf","2021","2021/02/03","PMC8254780","NIHMS1702543","10.1002/pds.5201"
"33533072","Prediction of post-vaccination Guillain-Barré syndrome using data from a passive surveillance system","Luo C, Jiang Y, Du J, Tong J, Huang J, Lo Re V 3rd, Ellenberg SS, Poland GA, Tao C, Chen Y.","Pharmacoepidemiol Drug Saf. 2021 May;30(5):602-609. doi: 10.1002/pds.5196. Epub 2021 Feb 23.","Luo C","Pharmacoepidemiol Drug Saf","2021","2021/02/03","PMC8014460","","10.1002/pds.5196"
"33480091","Performance assessment of different machine learning approaches in predicting diabetic ketoacidosis in adults with type 1 diabetes using electronic health records data","Li L, Lee CC, Zhou FL, Molony C, Doder Z, Zalmover E, Sharma K, Juhaeri J, Wu C.","Pharmacoepidemiol Drug Saf. 2021 May;30(5):610-618. doi: 10.1002/pds.5199. Epub 2021 Feb 3.","Li L","Pharmacoepidemiol Drug Saf","2021","2021/01/22","PMC8049019","","10.1002/pds.5199"
"33480043","Bottleneck analysis: Simple prediction of the precision of a planned case-control or cohort study based on healthcare registers","Hallas J, Hansen MR, Pottegård A, Støvring H.","Pharmacoepidemiol Drug Saf. 2021 May;30(5):619-625. doi: 10.1002/pds.5200. Epub 2021 Feb 9.","Hallas J","Pharmacoepidemiol Drug Saf","2021","2021/01/22","","","10.1002/pds.5200"
"33458926","Factors associated with the use of the prescription monitoring program by prescribers and pharmacists in Texas","Thornton JD, Varisco TJ, Downs CG.","Pharmacoepidemiol Drug Saf. 2021 Apr;30(4):492-503. doi: 10.1002/pds.5198. Epub 2021 Jan 31.","Thornton JD","Pharmacoepidemiol Drug Saf","2021","2021/01/18","","","10.1002/pds.5198"
"33432654","Detecting deviations from the efficacy and safety results of single-arm trials using real-world data: The case of a CAR-T cell therapy in B-cell lymphoma","Jakobsen LH, Callréus T, Sessa M, Jerkeman M, Andersen M, El-Galaly TC.","Pharmacoepidemiol Drug Saf. 2021 Apr;30(4):514-519. doi: 10.1002/pds.5195. Epub 2021 Jan 20.","Jakobsen LH","Pharmacoepidemiol Drug Saf","2021","2021/01/12","","","10.1002/pds.5195"
"33428309","SGLT-2 inhibitors and the risk of hospitalization for community-acquired pneumonia: A population-based cohort study","Brunetti VC, Reynier P, Azoulay L, Yu OHY, Ernst P, Platt RW, Filion KB.","Pharmacoepidemiol Drug Saf. 2021 Jun;30(6):740-748. doi: 10.1002/pds.5192. Epub 2021 Jan 25.","Brunetti VC","Pharmacoepidemiol Drug Saf","2021","2021/01/11","","","10.1002/pds.5192"
"33428292","Outcomes in patients with lung cancer treated with crizotinib and erlotinib in routine clinical practice: A post-authorization safety cohort study conducted in Europe and in the United States","Ehrenstein V, Huang K, Kahlert J, Bahmanyar S, Karlsson P, Löfling L, Nunes AP, Enger C, Bezemer ID, Kuiper JG, Hoti F, Juuti R, Korhonen P, Mo J, Schachterle SE, Wilner KD, Rørth M, Sørensen HT.","Pharmacoepidemiol Drug Saf. 2021 Jun;30(6):758-769. doi: 10.1002/pds.5193. Epub 2021 Jan 24.","Ehrenstein V","Pharmacoepidemiol Drug Saf","2021","2021/01/11","","","10.1002/pds.5193"
"33428239","Chronic prescription opioid use in pregnancy in the United States","Straub L, Huybrechts KF, Hernandez-Diaz S, Zhu Y, Vine S, Desai RJ, Gray KJ, Bateman BT.","Pharmacoepidemiol Drug Saf. 2021 Apr;30(4):504-513. doi: 10.1002/pds.5194. Epub 2021 Jan 17.","Straub L","Pharmacoepidemiol Drug Saf","2021","2021/01/11","","","10.1002/pds.5194"
"33386650","Impact of EMA regulatory label changes on hydroxyzine initiation, discontinuation and switching to other medicines in Denmark, Scotland, England and the Netherlands: An interrupted time series regression analysis","Morales DR, Macfarlane T, MacDonald TM, Hallas J, Ernst MT, Herings RMC, Smits E, Overbeek JA, Mitchell L, Morant S, Mackenzie I, Doney ASF, Robertson C, Bennie M, Wei L, Nicholson L, Morris C, Flynn RWF.","Pharmacoepidemiol Drug Saf. 2021 Apr;30(4):482-491. doi: 10.1002/pds.5191. Epub 2021 Jan 20.","Morales DR","Pharmacoepidemiol Drug Saf","2021","2021/01/02","","","10.1002/pds.5191"
"33372366","Safety of Andrographis paniculata: A systematic review and meta-analysis","Worakunphanich W, Thavorncharoensap M, Youngkong S, Thadanipon K, Thakkinstian A.","Pharmacoepidemiol Drug Saf. 2021 Jun;30(6):727-739. doi: 10.1002/pds.5190. Epub 2021 Jan 9.","Worakunphanich W","Pharmacoepidemiol Drug Saf","2021","2020/12/29","","","10.1002/pds.5190"
"33372303","Measured and accounted-for confounding in pharmacoepidemiologic studies: Some thoughts for practitioners","Roy J, Mitra N.","Pharmacoepidemiol Drug Saf. 2021 Mar;30(3):277-282. doi: 10.1002/pds.5189. Epub 2021 Jan 6.","Roy J","Pharmacoepidemiol Drug Saf","2021","2020/12/29","PMC8635757","NIHMS1755615","10.1002/pds.5189"
"33368820","Feasibility of using Clinical Practice Research Datalink data to identify patients with chronic obstructive pulmonary disease to enrol into real-world trials","Requena G, Wolf A, Williams R, Dedman D, Quint JK, Murray-Thomas T, Pimenta JM.","Pharmacoepidemiol Drug Saf. 2021 Apr;30(4):472-481. doi: 10.1002/pds.5188. Epub 2021 Jan 9.","Requena G","Pharmacoepidemiol Drug Saf","2021","2020/12/28","PMC7986187","","10.1002/pds.5188"
"33368819","Confirming diagnoses of acute pancreatitis with commonly available electronic data","Nichols GA, Déruaz-Luyet A, Iliev H, Brodovicz KG.","Pharmacoepidemiol Drug Saf. 2021 Mar;30(3):313-319. doi: 10.1002/pds.5185. Epub 2021 Jan 4.","Nichols GA","Pharmacoepidemiol Drug Saf","2021","2020/12/28","","","10.1002/pds.5185"
"33368798","Postoperative inpatient utilization of opioid and opioid-sparing analgesics in the United States hospitals, 2007-2017","Bykov K, Patorno E, Franklin JM, Vine SM, Bateman BT.","Pharmacoepidemiol Drug Saf. 2021 Mar;30(3):390-394. doi: 10.1002/pds.5187. Epub 2021 Jan 5.","Bykov K","Pharmacoepidemiol Drug Saf","2021","2020/12/28","PMC7854478","NIHMS1659683","10.1002/pds.5187"
"33368726","Prescribing of menopausal hormone therapy in Germany: Current status and changes between 2004 and 2016","Heinig M, Braitmaier M, Haug U.","Pharmacoepidemiol Drug Saf. 2021 Apr;30(4):462-471. doi: 10.1002/pds.5186. Epub 2021 Jan 11.","Heinig M","Pharmacoepidemiol Drug Saf","2021","2020/12/28","","","10.1002/pds.5186"
"33314561","Thyroid hormone replacement therapy in pregnancy and motor function, communication skills, and behavior of preschool children: The Norwegian Mother, Father, and Child Cohort Study","van den Broek S, Lupattelli A, Frank AS, Haug LS, Nordeng H.","Pharmacoepidemiol Drug Saf. 2021 Jun;30(6):716-726. doi: 10.1002/pds.5184. Epub 2020 Dec 27.","van den Broek S","Pharmacoepidemiol Drug Saf","2021","2020/12/14","PMC8247290","","10.1002/pds.5184"
"33314542","""I know my body better than you:"" patient focus groups to inform a decision aid on oral corticosteroid use during pregnancy","Palmsten K, Bredesen D, JaKa MM, Kumar PC, Ziegenfuss JY, Kharbanda EO.","Pharmacoepidemiol Drug Saf. 2021 Apr;30(4):451-461. doi: 10.1002/pds.5183. Epub 2020 Dec 22.","Palmsten K","Pharmacoepidemiol Drug Saf","2021","2020/12/14","PMC8686489","NIHMS1757829","10.1002/pds.5183"
"33314441","Ways COVID-19 may impact unrelated pharmacoepidemiologic research using routinely collected data","Webster-Clark M.","Pharmacoepidemiol Drug Saf. 2021 Mar;30(3):400-401. doi: 10.1002/pds.5182. Epub 2020 Dec 16.","Webster-Clark M","Pharmacoepidemiol Drug Saf","2021","2020/12/14","","","10.1002/pds.5182"
"33314401","Comparative effectiveness and safety of direct oral anticoagulants versus warfarin in UK patients with atrial fibrillation and type 2 diabetes: A retrospective cohort study","Rustem Gulluoglu F, Souverein PC, van den Ham HA, de Boer A, Komen J.","Pharmacoepidemiol Drug Saf. 2021 Oct;30(10):1293-1320. doi: 10.1002/pds.5181. Epub 2020 Dec 24.","Rustem Gulluoglu F","Pharmacoepidemiol Drug Saf","2021","2020/12/14","PMC8451809","","10.1002/pds.5181"
"33300138","Initial opioid prescription patterns and the risk of ongoing use and adverse outcomes","Gomes T, Campbell T, Tadrous M, Mamdani MM, Paterson JM, Juurlink DN.","Pharmacoepidemiol Drug Saf. 2021 Mar;30(3):379-389. doi: 10.1002/pds.5180. Epub 2020 Dec 18.","Gomes T","Pharmacoepidemiol Drug Saf","2021","2020/12/10","","","10.1002/pds.5180"
"33295644","Systematic evaluation of the efficacy-effectiveness gap of systemic treatments in extensive disease small cell lung cancer","Cramer-van der Welle CM, Schramel FMNH, Peters BJM, van Putten JWG, Klungel OH, Groen HJM, van de Garde EMW; Santeon SCLC Study Group.","Pharmacoepidemiol Drug Saf. 2021 Apr;30(4):445-450. doi: 10.1002/pds.5179. Epub 2020 Dec 18.","Cramer-van der Welle CM","Pharmacoepidemiol Drug Saf","2021","2020/12/09","","","10.1002/pds.5179"
"33280184","Self-medication practice with antimalarials & the determinants of malaria treatment-seeking behavior among postpartum mothers in a rural community in Nigeria","Iribhogbe OI, Odoya EM.","Pharmacoepidemiol Drug Saf. 2021 Apr;30(4):435-444. doi: 10.1002/pds.5178. Epub 2020 Dec 15.","Iribhogbe OI","Pharmacoepidemiol Drug Saf","2021","2020/12/06","","","10.1002/pds.5178"
"33219601","Using artificial intelligence to identify anti-hypertensives as possible disease modifying agents in Parkinson's disease","Visanji NP, Madan P, Lacoste AMB, Buleje I, Han Y, Spangler S, Kalia LV, Hensley Alford S, Marras C.","Pharmacoepidemiol Drug Saf. 2021 Feb;30(2):201-209. doi: 10.1002/pds.5176. Epub 2020 Nov 30.","Visanji NP","Pharmacoepidemiol Drug Saf","2021","2020/11/21","","","10.1002/pds.5176"
"33219593","Inflammatory bowel disease patients provide reliable self-reported medical information: A multicentre prospective pharmacovigilance monitoring system","Thomas PWA, West RL, Russel MGVM, Jansen JM, Kosse LJ, Jessurun NT, Römkens TEH, Hoentjen F; IBDREAM registry.","Pharmacoepidemiol Drug Saf. 2021 Apr;30(4):520-524. doi: 10.1002/pds.5175. Epub 2020 Dec 1.","Thomas PWA","Pharmacoepidemiol Drug Saf","2021","2020/11/21","PMC7983909","","10.1002/pds.5175"
"33219586","Developing algorithms for identifying major structural birth defects using automated electronic health data","Kharbanda EO, Vazquez-Benitez G, DeSilva MB, Spaulding AB, Daley MF, Naleway AL, Irving SA, Klein NP, Tseng HF, Jackson LA, Hambidge SJ, Olaiya O, Panozzo CA, Myers TR, Romitti PA.","Pharmacoepidemiol Drug Saf. 2021 Feb;30(2):266-274. doi: 10.1002/pds.5177. Epub 2020 Dec 3.","Kharbanda EO","Pharmacoepidemiol Drug Saf","2021","2020/11/21","PMC9116134","NIHMS1670139","10.1002/pds.5177"
"33216434","Effectiveness of risk minimisation measures for valproate: A cross-sectional survey among physicians in Europe","Toussi M, Isabelle B, Tcherny-Lessenot S, de Voogd H, Dimos V, Kaplan S.","Pharmacoepidemiol Drug Saf. 2021 Mar;30(3):283-291. doi: 10.1002/pds.5119. Epub 2020 Nov 20.","Toussi M","Pharmacoepidemiol Drug Saf","2021","2020/11/20","PMC7894483","","10.1002/pds.5119"
"33197106","Does additional monitoring status increase the reporting of adverse drug reactions? An interrupted time series analysis of EudraVigilance data","Segec A, Slattery J, Morales DR, Januskiene J, Kurz X, Arlett P.","Pharmacoepidemiol Drug Saf. 2021 Mar;30(3):350-359. doi: 10.1002/pds.5174. Epub 2020 Dec 8.","Segec A","Pharmacoepidemiol Drug Saf","2021","2020/11/16","PMC7898803","","10.1002/pds.5174"
"33190379","Influence of statin-potency on the risk of kidney disease - A nationwide cohort study using laboratory data","Citarella A, Linder M, Cammarota S, Sundström A, Kieler H.","Pharmacoepidemiol Drug Saf. 2021 Feb;30(2):210-219. doi: 10.1002/pds.5173. Epub 2020 Nov 26.","Citarella A","Pharmacoepidemiol Drug Saf","2021","2020/11/15","","","10.1002/pds.5173"
"33179845","A joint industry-sponsored data monitoring committee model for observational, retrospective drug safety studies in the real-world setting","Major-Pedersen A, McCullen MK, Sabol ME, Adetunji O, Massaro J, Neugut AI, Sosa JA, Hollenberg AN.","Pharmacoepidemiol Drug Saf. 2021 Jan;30(1):9-16. doi: 10.1002/pds.5172. Epub 2020 Nov 24.","Major-Pedersen A","Pharmacoepidemiol Drug Saf","2021","2020/11/12","PMC8247341","","10.1002/pds.5172"
"33174338","Real-world reproducibility study characterizing patients newly diagnosed with multiple myeloma using Clinical Practice Research Datalink, a UK-based electronic health records database","Seesaghur A, Petruski-Ivleva N, Banks V, Wang JR, Mattox P, Hoeben E, Maskell J, Neasham D, Reynolds SL, Kafatos G.","Pharmacoepidemiol Drug Saf. 2021 Feb;30(2):248-256. doi: 10.1002/pds.5171. Epub 2020 Nov 21.","Seesaghur A","Pharmacoepidemiol Drug Saf","2021","2020/11/11","PMC7984077","","10.1002/pds.5171"
"33156565","The evolution of anti-emetic prescriptions in primary care, between 2006 and 2016","De Bandt D, Safsaf S, Bourrion B, Francois M.","Pharmacoepidemiol Drug Saf. 2021 Apr;30(4):418-425. doi: 10.1002/pds.5170. Epub 2020 Dec 3.","De Bandt D","Pharmacoepidemiol Drug Saf","2021","2020/11/06","","","10.1002/pds.5170"
"33146908","Building an active medical product safety surveillance system in Taiwan: Adaptation of the U.S. Sentinel System common data model structure to the National Health Insurance Research Database in Taiwan","Huang K, Lin FJ, Ou HT, Hsu CN, Huang LY, Wang CC, Toh S.","Pharmacoepidemiol Drug Saf. 2021 Jan;30(1):97-101. doi: 10.1002/pds.5168. Epub 2020 Nov 11.","Huang K","Pharmacoepidemiol Drug Saf","2021","2020/11/04","","","10.1002/pds.5168"
"33146901","The utility of real-world evidence for benefit-risk assessment, communication, and evaluation of pharmaceuticals: Case studies","Radawski CA, Hammad TA, Colilla S, Coplan P, Hornbuckle K, Freeman E, Smith MY, Sobel RE, Bahri P, Arias AE, Bennett D.","Pharmacoepidemiol Drug Saf. 2020 Dec;29(12):1532-1539. doi: 10.1002/pds.5167. Epub 2020 Nov 17.","Radawski CA","Pharmacoepidemiol Drug Saf","2020","2020/11/04","","","10.1002/pds.5167"
"33146896","Incorporating patient generated health data into pharmacoepidemiological research","Bourke A, Dixon WG, Roddam A, Lin KJ, Hall GC, Curtis JR, van der Veer SN, Soriano-Gabarró M, Mills JK, Major JM, Verstraeten T, Francis MJ, Bartels DB.","Pharmacoepidemiol Drug Saf. 2020 Dec;29(12):1540-1549. doi: 10.1002/pds.5169. Epub 2020 Nov 13.","Bourke A","Pharmacoepidemiol Drug Saf","2020","2020/11/04","","","10.1002/pds.5169"
"33111396","Mortality and morbidity following postoperative use of short-term, low-dose quetiapine vs risperidone in patients with diabetes: Analysis using a national inpatient database","Sato D, Uda K, Kumazawa R, Matsui H, Yasunaga H.","Pharmacoepidemiol Drug Saf. 2020 Dec;29(12):1703-1709. doi: 10.1002/pds.5164. Epub 2020 Nov 12.","Sato D","Pharmacoepidemiol Drug Saf","2020","2020/10/28","","","10.1002/pds.5164"
"33108674","Effectiveness of risk minimisation measures for valproate: A drug utilisation study in Europe","Toussi M, Shlaen M, Coste F, de Voogd H, Dimos V, Kaplan S.","Pharmacoepidemiol Drug Saf. 2021 Mar;30(3):292-303. doi: 10.1002/pds.5166. Epub 2020 Nov 23.","Toussi M","Pharmacoepidemiol Drug Saf","2021","2020/10/27","PMC7894134","","10.1002/pds.5166"
"33108004","Real world data to identify target population for new CAR-T therapies","Belleudi V, Trotta F, Fortinguerra F, Poggi FR, Olimpieri O, Santelli E, Cozzi I, Michelozzi P, Addis A.","Pharmacoepidemiol Drug Saf. 2021 Jan;30(1):78-85. doi: 10.1002/pds.5165. Epub 2020 Nov 11.","Belleudi V","Pharmacoepidemiol Drug Saf","2021","2020/10/27","","","10.1002/pds.5165"
"33103788","Monitoring real-life utilization of pembrolizumab in advanced melanoma using the Portuguese National Cancer Registry","Borges FC, Ramos C, Ramos A, Mendes GP, Murteira R, Soares P, Furtado C, Miranda AC, Costa FA; RON network.","Pharmacoepidemiol Drug Saf. 2021 Mar;30(3):342-349. doi: 10.1002/pds.5163. Epub 2020 Nov 9.","Borges FC","Pharmacoepidemiol Drug Saf","2021","2020/10/26","","","10.1002/pds.5163"
"33099846","What are the patients' and health care professionals' understanding and behaviors towards adverse drug reaction reporting and additional monitoring?","Januskiene J, Segec A, Slattery J, Genov G, Plueschke K, Kurz X, Arlett P.","Pharmacoepidemiol Drug Saf. 2021 Mar;30(3):334-341. doi: 10.1002/pds.5162. Epub 2020 Nov 8.","Januskiene J","Pharmacoepidemiol Drug Saf","2021","2020/10/25","PMC7894330","","10.1002/pds.5162"
"33099844","Empirical assessment of case-based methods for identification of drugs associated with acute liver injury in the French National Healthcare System database (SNDS)","Thurin NH, Lassalle R, Schuemie M, Pénichon M, Gagne JJ, Rassen JA, Benichou J, Weill A, Blin P, Moore N, Droz-Perroteau C.","Pharmacoepidemiol Drug Saf. 2021 Mar;30(3):320-333. doi: 10.1002/pds.5161. Epub 2020 Nov 19.","Thurin NH","Pharmacoepidemiol Drug Saf","2021","2020/10/25","","","10.1002/pds.5161"
"33098336","New prescription of antihyperglycemic agents among patients with diabetes in Germany: Moderate concordance between health insurance data and self-reports","Brüne M, Andrich S, Haastert B, Kaltheuner M, Icks A.","Pharmacoepidemiol Drug Saf. 2021 Mar;30(3):304-312. doi: 10.1002/pds.5160. Epub 2020 Nov 5.","Brüne M","Pharmacoepidemiol Drug Saf","2021","2020/10/24","","","10.1002/pds.5160"
"33098321","Antidepressant use in Australia and Sweden-A cross-country comparison","Eek E, van Driel M, Falk M, Hollingworth SA, Merlo G.","Pharmacoepidemiol Drug Saf. 2021 Apr;30(4):409-417. doi: 10.1002/pds.5158. Epub 2020 Nov 9.","Eek E","Pharmacoepidemiol Drug Saf","2021","2020/10/24","","","10.1002/pds.5158"
"33098318","Relation between anticholinergic burden and cognitive impairment: Results from the Monzino 80-plus population-based study","Pasina L, Lucca U, Tettamanti M.","Pharmacoepidemiol Drug Saf. 2020 Dec;29(12):1696-1702. doi: 10.1002/pds.5159. Epub 2020 Nov 3.","Pasina L","Pharmacoepidemiol Drug Saf","2020","2020/10/24","","","10.1002/pds.5159"
"33094502","Antibiotic utilization within 18 community hospitals in the United States: A 5-year analysis","Thabit AK, Shea KM, Guzman OE, Garey KW.","Pharmacoepidemiol Drug Saf. 2021 Apr;30(4):403-408. doi: 10.1002/pds.5156. Epub 2020 Nov 20.","Thabit AK","Pharmacoepidemiol Drug Saf","2021","2020/10/23","","","10.1002/pds.5156"
"33091194","Validation of cardiovascular outcomes and risk factors in the Clinical Practice Research Datalink in the United Kingdom","Arana A, Margulis AV, Varas-Lorenzo C, Bui CL, Gilsenan A, McQuay LJ, Reynolds M, Rebordosa C, Franks B, de Vogel S, Appenteng K, Perez-Gutthann S.","Pharmacoepidemiol Drug Saf. 2021 Feb;30(2):237-247. doi: 10.1002/pds.5150. Epub 2020 Oct 28.","Arana A","Pharmacoepidemiol Drug Saf","2021","2020/10/22","PMC7821285","","10.1002/pds.5150"
"33090666","Characteristics associated with time-to-treatment initiation for chronic Hepatitis C with new direct acting antivirals","Karmarkar T, Padula WV, Gaskin DJ, Watson E, Rodriguez CV.","Pharmacoepidemiol Drug Saf. 2021 Jan;30(1):86-96. doi: 10.1002/pds.5138. Epub 2020 Oct 11.","Karmarkar T","Pharmacoepidemiol Drug Saf","2021","2020/10/22","","","10.1002/pds.5138"
"33089918","Accuracy of diagnoses of inflammatory arthritis in administrative hospitalization databases","Ward MM.","Pharmacoepidemiol Drug Saf. 2021 Feb;30(2):257-265. doi: 10.1002/pds.5157. Epub 2020 Nov 30.","Ward MM","Pharmacoepidemiol Drug Saf","2021","2020/10/22","","","10.1002/pds.5157"
"33084196","Allopurinol-induced severe cutaneous adverse drug reactions: Risk minimization measures in Malaysia","Panickar R, Wo WK, Ali NM, Tang MM, Ramanathan GRL, Kamarulzaman A, Aziz Z.","Pharmacoepidemiol Drug Saf. 2020 Oct;29(10):1254-1262. doi: 10.1002/pds.5033.","Panickar R","Pharmacoepidemiol Drug Saf","2020","2020/10/21","","","10.1002/pds.5033"
"33078476","Long-term effect of first-line injectable multiple sclerosis treatments: Input of a time-dependent propensity score","Lefort M, Foucher Y, Lenain R, Vukusic S, Edan G, Leray E.","Pharmacoepidemiol Drug Saf. 2020 Dec;29(12):1680-1688. doi: 10.1002/pds.5154. Epub 2020 Nov 11.","Lefort M","Pharmacoepidemiol Drug Saf","2020","2020/10/20","","","10.1002/pds.5154"
"33078448","Analysis of the US FDA adverse event reporting system to identify adverse cardiac events associated with hydroxychloroquine in older adults","Nishtala PS, Gill S, Chyou TY.","Pharmacoepidemiol Drug Saf. 2020 Dec;29(12):1689-1695. doi: 10.1002/pds.5155. Epub 2020 Nov 5.","Nishtala PS","Pharmacoepidemiol Drug Saf","2020","2020/10/20","","","10.1002/pds.5155"
"33067914","Direct healthcare costs of chronic kidney disease management in Italy: What cost-savings can be achieved with higher biosimilar uptake and more appropriate use of erythropoiesis-stimulating agents?","Ingrasciotta Y, Sultana J, Formica D, Ientile V, Aiello A, Chinellato A, Tari DU, Gini R, Pastorello M, Scondotto S, Cananzi P, Traversa G, Rossi M, Santoro D, Trifirò G; Italian Biosimilars Network (I-BioNetwork).","Pharmacoepidemiol Drug Saf. 2021 Jan;30(1):65-77. doi: 10.1002/pds.5152. Epub 2020 Nov 16.","Ingrasciotta Y","Pharmacoepidemiol Drug Saf","2021","2020/10/17","","","10.1002/pds.5152"
"33067868","Ondansetron use in early pregnancy and the risk of late pregnancy outcomes","Suarez EA, Boggess K, Engel SM, Stürmer T, Lund JL, Funk MJ.","Pharmacoepidemiol Drug Saf. 2021 Feb;30(2):114-125. doi: 10.1002/pds.5151. Epub 2020 Nov 9.","Suarez EA","Pharmacoepidemiol Drug Saf","2021","2020/10/17","","","10.1002/pds.5151"
"33064335","Hepatic adverse drug reactions in Malaysia: An 18-year review of the national centralized reporting system","Lee FY, Wong HS, Chan HK, Mohamed Ali N, Abu Hassan MR, Omar H, Abdul Mutalib NA.","Pharmacoepidemiol Drug Saf. 2020 Dec;29(12):1669-1679. doi: 10.1002/pds.5153. Epub 2020 Nov 2.","Lee FY","Pharmacoepidemiol Drug Saf","2020","2020/10/16","","","10.1002/pds.5153"
"33063370","Use of non-vitamin K antagonist oral anticoagulants in Colombia: A descriptive study using a national administrative healthcare database","Machado-Alba JE, Gaviria-Mendoza A, Machado-Duque ME, Tovar-Yepes C, Ruigómez A, García Rodríguez LA.","Pharmacoepidemiol Drug Saf. 2021 Apr;30(4):426-434. doi: 10.1002/pds.5124. Epub 2020 Oct 15.","Machado-Alba JE","Pharmacoepidemiol Drug Saf","2021","2020/10/16","PMC7983923","","10.1002/pds.5124"
"33058357","Special Issue: Abstracts of the 36th International Conference on Pharmacoepidemiology & Therapeutic Risk Management, Virtual, September 16-17, 2020","","Pharmacoepidemiol Drug Saf. 2020 Oct;29 Suppl 3:3-649. doi: 10.1002/pds.5114.","","Pharmacoepidemiol Drug Saf","2020","2020/10/15","","","10.1002/pds.5114"
"33051958","Prevalence and incidence rate of hospital admissions related to medication between 2008 and 2013 in The Netherlands","Lghoul-Oulad Saïd F, Hek K, Flinterman LE, Herings RM, Warlé-van Herwaarden MF, de Bie S, Valkhoff VE, Alsma J, Mosseveld M, Vanrolleghem AM, Stricker BH, Sturkenboom MC, De Smet PA, van den Bemt PM.","Pharmacoepidemiol Drug Saf. 2020 Dec;29(12):1659-1668. doi: 10.1002/pds.5122. Epub 2020 Oct 13.","Lghoul-Oulad Saïd F","Pharmacoepidemiol Drug Saf","2020","2020/10/14","PMC7756305","","10.1002/pds.5122"
"33047458","Patterns of opioid use in older people diagnosed with cancer in New South Wales, Australia","Tervonen HE, Schaffer AL, Luckett T, Phillips J, Litchfield M, Todd A, Pearson SA.","Pharmacoepidemiol Drug Saf. 2021 Mar;30(3):360-370. doi: 10.1002/pds.5081. Epub 2020 Oct 12.","Tervonen HE","Pharmacoepidemiol Drug Saf","2021","2020/10/13","","","10.1002/pds.5081"
"33026123","Medication-related problems in older people in Catalonia: A real-world data study","Troncoso-Mariño A, López-Jiménez T, Roso-Llorach A, Villén N, Amado-Guirado E, Guisado-Clavero M, Fernández-Bertolin S, Pons Vigues M, Foguet-Boreu Q, Violán C.","Pharmacoepidemiol Drug Saf. 2021 Feb;30(2):220-228. doi: 10.1002/pds.5149. Epub 2020 Nov 26.","Troncoso-Mariño A","Pharmacoepidemiol Drug Saf","2021","2020/10/07","PMC7839740","","10.1002/pds.5149"
"33020970","Phosphodiesterase type 5 inhibitor use among pregnant and reproductive-age women in the United States","Liu W, Menzin TJ, Woods CM, Haug NR, Li J, Mathew JA, Nguyen CP, Chai GP, Moeny DG, Shinde M.","Pharmacoepidemiol Drug Saf. 2021 Feb;30(2):126-134. doi: 10.1002/pds.5112. Epub 2020 Oct 5.","Liu W","Pharmacoepidemiol Drug Saf","2021","2020/10/06","","","10.1002/pds.5112"
"33015899","Are anticholinergic medications used for overactive bladder associated with new onset depression? A population-based matched cohort study","Welk B, McArthur E.","Pharmacoepidemiol Drug Saf. 2020 Dec;29(12):1710-1714. doi: 10.1002/pds.5147. Epub 2020 Oct 15.","Welk B","Pharmacoepidemiol Drug Saf","2020","2020/10/05","","","10.1002/pds.5147"
"33015888","Effectiveness of adjuvant FOLFOX vs 5FU/LV in adults over age 65 with stage II and III colon cancer using a novel hybrid approach","Lund JL, Webster-Clark MA, Hinton SP, Shmuel S, Stürmer T, Sanoff HK.","Pharmacoepidemiol Drug Saf. 2020 Dec;29(12):1579-1587. doi: 10.1002/pds.5148. Epub 2020 Oct 12.","Lund JL","Pharmacoepidemiol Drug Saf","2020","2020/10/05","","","10.1002/pds.5148"
"33012044","Development and validation of coding algorithms to identify patients with incident lung cancer in United States healthcare claims data","Beyrer J, Nelson DR, Sheffield KM, Huang YJ, Ellington T, Hincapie AL.","Pharmacoepidemiol Drug Saf. 2020 Nov;29(11):1465-1479. doi: 10.1002/pds.5137. Epub 2020 Oct 4.","Beyrer J","Pharmacoepidemiol Drug Saf","2020","2020/10/04","","","10.1002/pds.5137"
"33009718","Patterns of anticonvulsant use and adverse drug events in older adults","Moura LMVR, Smith JR, Yan Z, Blacker D, Schwamm LH, Newhouse JP, Hernandez-Diaz S, Hsu J.","Pharmacoepidemiol Drug Saf. 2021 Jan;30(1):28-36. doi: 10.1002/pds.5139. Epub 2020 Oct 2.","Moura LMVR","Pharmacoepidemiol Drug Saf","2021","2020/10/03","PMC7849867","NIHMS1641540","10.1002/pds.5139"
"33009708","Validation of venous thromboembolism diagnoses in patients receiving rivaroxaban or warfarin in The Health Improvement Network","Ruigómez A, Brobert G, Vora P, García Rodríguez LA.","Pharmacoepidemiol Drug Saf. 2021 Feb;30(2):229-236. doi: 10.1002/pds.5146. Epub 2020 Oct 12.","Ruigómez A","Pharmacoepidemiol Drug Saf","2021","2020/10/03","PMC7821274","","10.1002/pds.5146"
"33009703","Risk of age-related macular degeneration in aspirin users and non-aspirin users: A population-based cohort study in Taiwan","Lee WA, Yang YK, Cheng CL.","Pharmacoepidemiol Drug Saf. 2021 Feb;30(2):178-188. doi: 10.1002/pds.5145. Epub 2020 Oct 14.","Lee WA","Pharmacoepidemiol Drug Saf","2021","2020/10/03","","","10.1002/pds.5145"
"33006803","Tenofovir disoproxil fumarate associated nephrotoxicity: a retrospective cohort study at two referral hospitals in Namibia","Kalemeera F, Godman B, Stergachis A, Rennie T.","Pharmacoepidemiol Drug Saf. 2021 Feb;30(2):189-200. doi: 10.1002/pds.5125. Epub 2020 Oct 2.","Kalemeera F","Pharmacoepidemiol Drug Saf","2021","2020/10/02","","","10.1002/pds.5125"
"33006179","High concordance between chart review adjudication and electronic medical record data to identify prevalent and incident diabetes mellitus among persons with and without HIV","McGinnis KA, Justice AC, Bailin S, Wellons M, Freiberg M, Koethe JR.","Pharmacoepidemiol Drug Saf. 2020 Nov;29(11):1432-1439. doi: 10.1002/pds.5111. Epub 2020 Oct 1.","McGinnis KA","Pharmacoepidemiol Drug Saf","2020","2020/10/02","PMC7810212","NIHMS1652097","10.1002/pds.5111"
"33000871","Ondansetron use in early pregnancy and the risk of miscarriage","Suarez EA, Boggess K, Engel SM, Stürmer T, Lund JL, Jonsson Funk M.","Pharmacoepidemiol Drug Saf. 2021 Feb;30(2):103-113. doi: 10.1002/pds.5143. Epub 2020 Oct 12.","Suarez EA","Pharmacoepidemiol Drug Saf","2021","2020/10/01","","","10.1002/pds.5143"
"33000867","Quantifying cumulative anticholinergic and sedative drug load among US Medicare Beneficiaries","Shmuel S, Pate V, Pepin MJ, Bailey JC, Hanson LC, Stürmer T, Naumann RB, Golightly YM, Gnjidic D, Lund JL.","Pharmacoepidemiol Drug Saf. 2021 Feb;30(2):144-156. doi: 10.1002/pds.5144. Epub 2020 Oct 15.","Shmuel S","Pharmacoepidemiol Drug Saf","2021","2020/10/01","PMC8858445","NIHMS1778430","10.1002/pds.5144"
"32986901","CPRD Aurum database: Assessment of data quality and completeness of three important comorbidities","Persson R, Vasilakis-Scaramozza C, Hagberg KW, Sponholtz T, Williams T, Myles P, Jick SS.","Pharmacoepidemiol Drug Saf. 2020 Nov;29(11):1456-1464. doi: 10.1002/pds.5135. Epub 2020 Sep 28.","Persson R","Pharmacoepidemiol Drug Saf","2020","2020/09/28","","","10.1002/pds.5135"
"32978861","Preparing for COVID-19 vaccine safety surveillance: A United States perspective","Haynes K.","Pharmacoepidemiol Drug Saf. 2020 Dec;29(12):1529-1531. doi: 10.1002/pds.5142. Epub 2020 Oct 2.","Haynes K","Pharmacoepidemiol Drug Saf","2020","2020/09/26","PMC7537525","","10.1002/pds.5142"
"32975344","Risk of common infections among individuals with psoriasis in Sweden: A nationwide cohort study comparing secukinumab to ustekinumab","Srinivas C, Odsbu I, Linder M.","Pharmacoepidemiol Drug Saf. 2020 Dec;29(12):1562-1569. doi: 10.1002/pds.5132. Epub 2020 Sep 25.","Srinivas C","Pharmacoepidemiol Drug Saf","2020","2020/09/25","PMC7756328","","10.1002/pds.5132"
"32964695","The controversy around technical standards for similar biotherapeutics: barriers to access and competition?(†)","González CPV, Muñoz CG.","Pharmacoepidemiol Drug Saf. 2020 Nov;29(11):1518-1522. doi: 10.1002/pds.5100. Epub 2020 Sep 22.","González CPV","Pharmacoepidemiol Drug Saf","2020","2020/09/23","","","10.1002/pds.5100"
"32964608","Can we identify allergic rhinitis from administrative data: A validation study","Leth-Møller KB, Skaaby T, Madsen F, Petersen J, Linneberg A.","Pharmacoepidemiol Drug Saf. 2020 Nov;29(11):1423-1431. doi: 10.1002/pds.5120. Epub 2020 Sep 23.","Leth-Møller KB","Pharmacoepidemiol Drug Saf","2020","2020/09/23","","","10.1002/pds.5120"
"32964590","Impact of a drug safety communication on the severity of benzonatate exposures reported to poison centers","Leonard JB, Seung H, Klein-Schwartz W.","Pharmacoepidemiol Drug Saf. 2021 Jan;30(1):45-52. doi: 10.1002/pds.5136. Epub 2020 Sep 23.","Leonard JB","Pharmacoepidemiol Drug Saf","2021","2020/09/23","","","10.1002/pds.5136"
"32964569","Impact of a nationwide prospective drug utilization review program to improve prescribing safety of potentially inappropriate medications in older adults: An interrupted time series with segmented regression analysis","Jang S, Jeong S, Kang E, Jang S.","Pharmacoepidemiol Drug Saf. 2021 Jan;30(1):17-27. doi: 10.1002/pds.5140. Epub 2020 Oct 9.","Jang S","Pharmacoepidemiol Drug Saf","2021","2020/09/23","","","10.1002/pds.5140"
"32964514","Methods for external control groups for single arm trials or long-term uncontrolled extensions to randomized clinical trials","Seeger JD, Davis KJ, Iannacone MR, Zhou W, Dreyer N, Winterstein AG, Santanello N, Gertz B, Berlin JA.","Pharmacoepidemiol Drug Saf. 2020 Nov;29(11):1382-1392. doi: 10.1002/pds.5141. Epub 2020 Oct 4.","Seeger JD","Pharmacoepidemiol Drug Saf","2020","2020/09/23","PMC7756307","","10.1002/pds.5141"
"32955156","Trends in HbA(1c) thresholds for initiation of hypoglycemic agents: Impact of changed recommendations for older and frail patients","Ambrož M, de Vries ST, Hoogenberg K, Denig P.","Pharmacoepidemiol Drug Saf. 2021 Jan;30(1):37-44. doi: 10.1002/pds.5129. Epub 2020 Sep 21.","Ambrož M","Pharmacoepidemiol Drug Saf","2021","2020/09/21","PMC7756585","","10.1002/pds.5129"
"32954579","Not all aspirin products have equivalent antiplatelet efficacy-Aspirin formulated with magnesium stearate is less effective in preventing ischemic stroke","Huang K, Cheng CL, Yang YK.","Pharmacoepidemiol Drug Saf. 2020 Dec;29(12):1570-1578. doi: 10.1002/pds.5134. Epub 2020 Sep 21.","Huang K","Pharmacoepidemiol Drug Saf","2020","2020/09/21","","","10.1002/pds.5134"
"32954565","Navigating stormy waters: 10 years of operation of the European Union Regulatory Network Incident Management Plan for Medicines for Human Use","Santoro A, Caplanusi I, Sweeney F, Cappelli B, Nolan L, Straus S, Arlett P.","Pharmacoepidemiol Drug Saf. 2020 Nov;29(11):1343-1352. doi: 10.1002/pds.5133. Epub 2020 Sep 21.","Santoro A","Pharmacoepidemiol Drug Saf","2020","2020/09/21","PMC7756214","","10.1002/pds.5133"
"32940401","Randomized, observational, interventional, and real-world-What's in a name?","Concato J, Stein P, Dal Pan GJ, Ball R, Corrigan-Curay J.","Pharmacoepidemiol Drug Saf. 2020 Nov;29(11):1514-1517. doi: 10.1002/pds.5123. Epub 2020 Sep 17.","Concato J","Pharmacoepidemiol Drug Saf","2020","2020/09/17","","","10.1002/pds.5123"
"32939919","Factors associated with achieving target serum uric acid level and occurrence of gouty arthritis: A retrospective observational study of Japanese health insurance claims data","Koto R, Nakajima A, Horiuchi H, Yamanaka H.","Pharmacoepidemiol Drug Saf. 2021 Feb;30(2):157-168. doi: 10.1002/pds.5127. Epub 2020 Sep 16.","Koto R","Pharmacoepidemiol Drug Saf","2021","2020/09/17","PMC7821287","","10.1002/pds.5127"
"32939910","Brief discussion on sampling variability in 1:1 propensity score matching without replacement","Ripollone JE, Huybrechts KF, Rothman KJ, Ferguson RE, Franklin JM.","Pharmacoepidemiol Drug Saf. 2020 Sep;29(9):1194-1197. doi: 10.1002/pds.5094. Epub 2020 Aug 10.","Ripollone JE","Pharmacoepidemiol Drug Saf","2020","2020/09/17","","","10.1002/pds.5094"
"32939909","A comparison of trends in opioid dispensing patterns between Medicaid pharmacy claims and prescription drug monitoring program data","El Ibrahimi S, Hallvik S, Johnston K, Leichtling G, Choo E, Hartung DM.","Pharmacoepidemiol Drug Saf. 2020 Sep;29(9):1168-1174. doi: 10.1002/pds.5097. Epub 2020 Aug 10.","El Ibrahimi S","Pharmacoepidemiol Drug Saf","2020","2020/09/17","PMC8015255","NIHMS1684676","10.1002/pds.5097"
"32936997","Gastrointestinal bleeding risk with rivaroxaban vs aspirin in atrial fibrillation: A multinational study","Fanning L, Wong ICK, Li X, Chan EW, Mongkhon P, Man KKC, Wei L, Leung WK, Darzins P, Bell JS, Ilomaki J, Lau WCY.","Pharmacoepidemiol Drug Saf. 2020 Dec;29(12):1550-1561. doi: 10.1002/pds.5130. Epub 2020 Sep 16.","Fanning L","Pharmacoepidemiol Drug Saf","2020","2020/09/16","","","10.1002/pds.5130"
"32935407","Medications used disproportionately during pregnancy: Priorities for research on the risks and benefits of medications when used during pregnancy","Havard A, Barbieri S, Hanly M, Perez-Concha O, Tran DT, Kennedy D, Jorm LR.","Pharmacoepidemiol Drug Saf. 2021 Jan;30(1):53-64. doi: 10.1002/pds.5131. Epub 2020 Sep 16.","Havard A","Pharmacoepidemiol Drug Saf","2021","2020/09/16","","","10.1002/pds.5131"
"32929845","Validity of diagnosis and procedure codes for identifying neural tube defects in infants","Cheetham TC, Dublin S, Pocobelli G, Bobb JF, Andrade S, Hechter RC, Portugal C, Munis M, Albertson-Junkans L, Salgado G, Wong L, Maarup TJ, Carroll K, Griffin MR, Raebel MA, Smith D, Li DK, Pawloski PA, Toh S, Taylor L, Hua W, Dinatale M, Ceresa C, Trinidad JP, Boudreau DM.","Pharmacoepidemiol Drug Saf. 2020 Nov;29(11):1489-1493. doi: 10.1002/pds.5128. Epub 2020 Sep 15.","Cheetham TC","Pharmacoepidemiol Drug Saf","2020","2020/09/15","","","10.1002/pds.5128"
"32929830","Assessing the impact of unmeasured confounders for credible and reliable real-world evidence","Zhang X, Stamey JD, Mathur MB.","Pharmacoepidemiol Drug Saf. 2020 Oct;29(10):1219-1227. doi: 10.1002/pds.5117. Epub 2020 Sep 14.","Zhang X","Pharmacoepidemiol Drug Saf","2020","2020/09/15","","","10.1002/pds.5117"
"32929809","Drug utilization study on immediate release Fentanyl in Spain. Prevalence, incidence, and indication","González-Bermejo D, Rayón-Iglesias P, Rodríguez-Pascual A, Álvarez-Gutiérrez A, Fernández-Dueñas A, Montero-Corominas D, Huerta-Álvarez C.","Pharmacoepidemiol Drug Saf. 2021 Mar;30(3):371-378. doi: 10.1002/pds.5118. Epub 2020 Sep 14.","González-Bermejo D","Pharmacoepidemiol Drug Saf","2021","2020/09/15","","","10.1002/pds.5118"
"32926504","Implementing high-dimensional propensity score principles to improve confounder adjustment in UK electronic health records","Tazare J, Smeeth L, Evans SJW, Williamson E, Douglas IJ.","Pharmacoepidemiol Drug Saf. 2020 Nov;29(11):1373-1381. doi: 10.1002/pds.5121. Epub 2020 Sep 14.","Tazare J","Pharmacoepidemiol Drug Saf","2020","2020/09/14","","","10.1002/pds.5121"
"32924243","Improving transparency to build trust in real-world secondary data studies for hypothesis testing-Why, what, and how: recommendations and a road map from the real-world evidence transparency initiative","Orsini LS, Monz B, Mullins CD, Van Brunt D, Daniel G, Eichler HG, Graff J, Guerino J, Berger M, Lederer NM, Jonsson P, Schneeweiss S, Wang SV, Crown W, Goettsch W, Willke RJ.","Pharmacoepidemiol Drug Saf. 2020 Nov;29(11):1504-1513. doi: 10.1002/pds.5079. Epub 2020 Sep 13.","Orsini LS","Pharmacoepidemiol Drug Saf","2020","2020/09/14","","","10.1002/pds.5079"
"32914920","Assessment of colistimethate sodium (COLOBREATHE) risk minimization measures implemented in the European Union: A cross-sectional study","Kaplan S, Patino O, Rainville C, Madison T.","Pharmacoepidemiol Drug Saf. 2020 Feb;29(2):219-223. doi: 10.1002/pds.4940. Epub 2019 Dec 9.","Kaplan S","Pharmacoepidemiol Drug Saf","2020","2020/09/11","","","10.1002/pds.4940"
"32909348","Validation of algorithms to estimate gestational age at birth in the Medicaid Analytic eXtract-Quantifying the misclassification of maternal drug exposure during pregnancy","Zhu Y, Hampp C, Wang X, Albogami Y, Wei YJ, Brumback BA, Roussos-Ross D, Winterstein AG.","Pharmacoepidemiol Drug Saf. 2020 Nov;29(11):1414-1422. doi: 10.1002/pds.5126. Epub 2020 Sep 9.","Zhu Y","Pharmacoepidemiol Drug Saf","2020","2020/09/10","","","10.1002/pds.5126"
"32909330","Proton pump inhibitors and chronic kidney disease: Reevaluating the evidence from a randomized controlled trial","Gerstman BB.","Pharmacoepidemiol Drug Saf. 2021 Jan;30(1):4-8. doi: 10.1002/pds.5101. Epub 2020 Sep 9.","Gerstman BB","Pharmacoepidemiol Drug Saf","2021","2020/09/10","","","10.1002/pds.5101"
"32902061","Using real-world evidence to support a changing paradigm for cancer screening: A commentary","Leavy MB, Starzyk K, Myers E, Curhan G, Gliklich R.","Pharmacoepidemiol Drug Saf. 2020 Oct;29(10):1312-1315. doi: 10.1002/pds.5104. Epub 2020 Sep 9.","Leavy MB","Pharmacoepidemiol Drug Saf","2020","2020/09/09","","","10.1002/pds.5104"
"32897626","Risk of type 2 diabetes mellitus by antimuscarinic agents among adult females receiving care in the military health system","Selig DJ, Brown AJ, DeLuca JP, Kress AT, Livezey JR, Oliver TG, Por ED, Thelus Jean R.","Pharmacoepidemiol Drug Saf. 2020 Dec;29(12):1605-1615. doi: 10.1002/pds.5090. Epub 2020 Sep 8.","Selig DJ","Pharmacoepidemiol Drug Saf","2020","2020/09/08","","","10.1002/pds.5090"
"32894794","Assessing the incidence of osteosarcoma among teriparatide users based on Medicare Part D and US State Cancer Registry Data","Gilsenan A, Midkiff K, Harris D, McQuay L, Hunter S, Kellier-Steele N, Andrews E.","Pharmacoepidemiol Drug Saf. 2020 Dec;29(12):1616-1626. doi: 10.1002/pds.5103. Epub 2020 Sep 7.","Gilsenan A","Pharmacoepidemiol Drug Saf","2020","2020/09/07","PMC7754479","","10.1002/pds.5103"
"32894792","Using real-world evidence for pharmacovigilance and drug safety-related decision making by a resource-limited health authority: 10 years of experience in Taiwan","Chen WW, Lin CW, Huang WI, Chao PH, Gau CS, Hsiao FY.","Pharmacoepidemiol Drug Saf. 2020 Nov;29(11):1402-1413. doi: 10.1002/pds.5084. Epub 2020 Sep 7.","Chen WW","Pharmacoepidemiol Drug Saf","2020","2020/09/07","","","10.1002/pds.5084"
"32885513","The recording and prevalence of Inflammatory bowel disease in girls' primary care medical Spanish records","Martín-Merino E, Martín-Pérez M, Castillo-Cano B, Montero-Corominas D.","Pharmacoepidemiol Drug Saf. 2020 Nov;29(11):1440-1449. doi: 10.1002/pds.5107. Epub 2020 Sep 3.","Martín-Merino E","Pharmacoepidemiol Drug Saf","2020","2020/09/05","","","10.1002/pds.5107"
"32875686","Attention-deficit/hyperactivity disorder medication and risk of suicide attempt: A meta-analysis of observational studies","Liu WJ, Mao HJ, Hu LL, Song MF, Jiang HY, Zhang L.","Pharmacoepidemiol Drug Saf. 2020 Nov;29(11):1364-1372. doi: 10.1002/pds.5110. Epub 2020 Sep 1.","Liu WJ","Pharmacoepidemiol Drug Saf","2020","2020/09/03","","","10.1002/pds.5110"
"32869941","Analysis of immune-related adverse events caused by immune checkpoint inhibitors using the Japanese Adverse Drug Event Report database","Hasegawa S, Ikesue H, Nakao S, Shimada K, Mukai R, Tanaka M, Matsumoto K, Inoue M, Satake R, Yoshida Y, Goto F, Hashida T, Nakamura M.","Pharmacoepidemiol Drug Saf. 2020 Oct;29(10):1279-1294. doi: 10.1002/pds.5108. Epub 2020 Sep 1.","Hasegawa S","Pharmacoepidemiol Drug Saf","2020","2020/09/02","PMC7692939","","10.1002/pds.5108"
"32869447","Association between domperidone use and adverse cardiovascular events: A nested case-control and case-time-control study","Shin SM, Jeong HE, Lee H, Shin JY.","Pharmacoepidemiol Drug Saf. 2020 Dec;29(12):1636-1649. doi: 10.1002/pds.5106. Epub 2020 Sep 1.","Shin SM","Pharmacoepidemiol Drug Saf","2020","2020/09/02","","","10.1002/pds.5106"
"32860317","Outcome misclassification: Impact, usual practice in pharmacoepidemiology database studies and an online aid to correct biased estimates of risk ratio or cumulative incidence","Hall GC, Lanes S, Bollaerts K, Zhou X, Ferreira G, Gini R.","Pharmacoepidemiol Drug Saf. 2020 Nov;29(11):1450-1455. doi: 10.1002/pds.5109. Epub 2020 Aug 28.","Hall GC","Pharmacoepidemiol Drug Saf","2020","2020/08/30","","","10.1002/pds.5109"
"32854158","Insight in the safety profile of antidiabetic agents glucagon-like peptide-1 agonists and dipeptidyl peptidase-4 inhibitors in daily practice from the patient perspective","van Gorp AM, Rolfes L, Härmark L, van der Horst P, Hendriks J, Vorstenbosch S.","Pharmacoepidemiol Drug Saf. 2020 Dec;29(12):1588-1595. doi: 10.1002/pds.5077. Epub 2020 Aug 27.","van Gorp AM","Pharmacoepidemiol Drug Saf","2020","2020/08/28","","","10.1002/pds.5077"
"32852147","Alzheimer's disease and related dementias risk: Comparing users of non-selective and M3-selective bladder antimuscarinic drugs","Barthold D, Marcum ZA, Gray SL, Zissimopoulos J.","Pharmacoepidemiol Drug Saf. 2020 Dec;29(12):1650-1658. doi: 10.1002/pds.5098. Epub 2020 Aug 27.","Barthold D","Pharmacoepidemiol Drug Saf","2020","2020/08/28","PMC7825274","NIHMS1662204","10.1002/pds.5098"
"32851782","Safety concerns reported by consumers, manufacturers and healthcare professionals: A detailed evaluation of opioid-related adverse drug reactions in the FDA database over 15 years","Andreaggi CA, Novak EA, Mirabile ME, Sampathkumar S, Gray MP, He M, Kane-Gill SL.","Pharmacoepidemiol Drug Saf. 2020 Dec;29(12):1627-1635. doi: 10.1002/pds.5105. Epub 2020 Aug 26.","Andreaggi CA","Pharmacoepidemiol Drug Saf","2020","2020/08/28","","","10.1002/pds.5105"
"32844549","Optimizing identification of resistant hypertension: Computable phenotype development and validation","McDonough CW, Babcock K, Chucri K, Crawford DC, Bian J, Modave F, Cooper-DeHoff RM, Hogan WR.","Pharmacoepidemiol Drug Saf. 2020 Nov;29(11):1393-1401. doi: 10.1002/pds.5095. Epub 2020 Aug 26.","McDonough CW","Pharmacoepidemiol Drug Saf","2020","2020/08/27","PMC7754782","NIHMS1648668","10.1002/pds.5095"
"32844498","Identifying opioid dose reductions and discontinuation among patients with chronic opioid therapy","Hallvik SE, Johnston K, Geddes J, Leichtling G, Korthuis PT, Hartung DM.","Pharmacoepidemiol Drug Saf. 2021 Mar;30(3):395-399. doi: 10.1002/pds.5096. Epub 2020 Aug 26.","Hallvik SE","Pharmacoepidemiol Drug Saf","2021","2020/08/27","PMC8213356","NIHMS1710093","10.1002/pds.5096"
"32844487","Real-world effectiveness of pembrolizumab in previously treated non-small cell lung cancer: A population-based cohort study","Murteira R, Borges FC, Mendes GP, Ramos C, Ramos A, Soares P, Furtado C, Miranda A, da Costa FA; RON Network.","Pharmacoepidemiol Drug Saf. 2020 Oct;29(10):1295-1302. doi: 10.1002/pds.5091. Epub 2020 Aug 25.","Murteira R","Pharmacoepidemiol Drug Saf","2020","2020/08/27","","","10.1002/pds.5091"
"32844466","Comparison of laboratory threshold criteria in drug-induced liver injury detection algorithms for use in pharmacovigilance","Tan EH, Ling ZJ, Ang PS, Sung C, Dan YY, Tai BC.","Pharmacoepidemiol Drug Saf. 2020 Nov;29(11):1480-1488. doi: 10.1002/pds.5099. Epub 2020 Aug 26.","Tan EH","Pharmacoepidemiol Drug Saf","2020","2020/08/27","","","10.1002/pds.5099"
"32838482","Opportunities to improve the electronic reporting system for adverse drug reactions in Mexico: A comparative evaluation with the United States of America and the European Union","Cano-Sandoval MÁ, López-Armas GC, Perfecto-Avalos Y, Vázquez-Alvarez AO, Brennan-Bourdon LM.","Pharmacoepidemiol Drug Saf. 2020 Nov;29(11):1523-1526. doi: 10.1002/pds.5092. Epub 2020 Aug 24.","Cano-Sandoval MÁ","Pharmacoepidemiol Drug Saf","2020","2020/08/25","","","10.1002/pds.5092"
"32819030","Who are we missing? Underrepresentation of data sources used for pharmacoepidemiology research in the United States","Kaviani P, Landi SN, McKethan A, Brookhart MA, McGrath LJ.","Pharmacoepidemiol Drug Saf. 2020 Nov;29(11):1494-1498. doi: 10.1002/pds.5087. Epub 2020 Aug 20.","Kaviani P","Pharmacoepidemiol Drug Saf","2020","2020/08/21","","","10.1002/pds.5087"
"32810917","Sleep medications and sleep disturbances across middle aged pre- or peri-menopausal women of different race and ethnicities: A SWAN pharmacoepidemiology cohort study","Solomon DH, Ruppert K, Kazlauskaite R, Lian P, Kravitz HM.","Pharmacoepidemiol Drug Saf. 2020 Dec;29(12):1715-1721. doi: 10.1002/pds.5102. Epub 2020 Aug 18.","Solomon DH","Pharmacoepidemiol Drug Saf","2020","2020/08/19","","","10.1002/pds.5102"
"32798299","Understanding when real world data can be used to replicate a clinical trial: A cross-sectional study of medications approved in 2011","Fralick M, Bartsch E, Darrow JJ, Kesselheim AS.","Pharmacoepidemiol Drug Saf. 2020 Oct;29(10):1273-1278. doi: 10.1002/pds.5086. Epub 2020 Aug 14.","Fralick M","Pharmacoepidemiol Drug Saf","2020","2020/08/17","","","10.1002/pds.5086"
"32790031","FDA postmarketing safety labeling changes: What have we learned since 2010 about impacts on prescribing rates, drug utilization, and treatment outcomes","Rosenberg M, Sheehan S, Zhou E, Pinnow E, Burnell J, Romine M, Dal Pan G.","Pharmacoepidemiol Drug Saf. 2020 Sep;29(9):1022-1029. doi: 10.1002/pds.5073. Epub 2020 Aug 12.","Rosenberg M","Pharmacoepidemiol Drug Saf","2020","2020/08/14","","","10.1002/pds.5073"
"32783283","Time-related biases in pharmacoepidemiology","Suissa S, Dell'Aniello S.","Pharmacoepidemiol Drug Saf. 2020 Sep;29(9):1101-1110. doi: 10.1002/pds.5083. Epub 2020 Aug 11.","Suissa S","Pharmacoepidemiol Drug Saf","2020","2020/08/13","","","10.1002/pds.5083"
"32779806","A national study on prescribed medicine use in Australia on a typical day","Wylie CE, Daniels B, Brett J, Pearson SA, Buckley NA.","Pharmacoepidemiol Drug Saf. 2020 Sep;29(9):1046-1053. doi: 10.1002/pds.5093. Epub 2020 Aug 11.","Wylie CE","Pharmacoepidemiol Drug Saf","2020","2020/08/12","","","10.1002/pds.5093"
"32770586","Tuberculosis drug safety and pharmacovigilance in health system of Kosova: A cross-sectional analysis","Krasniqi S, Neziri B, Jakupi A, Shurdhaj I, Daci A, Jupolli-Krasniqi N, Pira M.","Pharmacoepidemiol Drug Saf. 2020 Sep;29(9):1037-1045. doi: 10.1002/pds.5076. Epub 2020 Aug 7.","Krasniqi S","Pharmacoepidemiol Drug Saf","2020","2020/08/10","","","10.1002/pds.5076"
"32767610","In utero opioid exposure and risk of infections in childhood: A multinational Nordic cohort study","Mahic M, Hernandez-Diaz S, Wood M, Kieler H, Odsbu I, Nørgaard M, Öztürk B, Bateman BT, Hjellvik V, Skurtveit S, Handal M.","Pharmacoepidemiol Drug Saf. 2020 Dec;29(12):1596-1604. doi: 10.1002/pds.5088. Epub 2020 Aug 7.","Mahic M","Pharmacoepidemiol Drug Saf","2020","2020/08/09","","","10.1002/pds.5088"
"32767421","Treatment resistant depression incidence and prevalence using the French nationwide claims database","Bosco-Lévy P, Grelaud A, Blin P, Astruc B, Falissard B, Llorca PM, Bernard MA, Lassalle R, Moore N, Droz-Perroteau C.","Pharmacoepidemiol Drug Saf. 2021 Feb;30(2):169-177. doi: 10.1002/pds.5082. Epub 2020 Aug 6.","Bosco-Lévy P","Pharmacoepidemiol Drug Saf","2021","2020/08/09","","","10.1002/pds.5082"
"32757254","Baseline anticholinergic burden from medications predicts poorer baseline and long-term health-related quality of life in 16 675 men and women of EPIC-Norfolk prospective population-based cohort study","Yrjana KR, Neal SR, Soiza RL, Keevil V, Luben RN, Wareham NJ, Khaw KT, Myint PK.","Pharmacoepidemiol Drug Saf. 2021 Feb;30(2):135-143. doi: 10.1002/pds.5085. Epub 2020 Aug 5.","Yrjana KR","Pharmacoepidemiol Drug Saf","2021","2020/08/07","","","10.1002/pds.5085"
"32748540","Modeling exposures of medications used episodically during pregnancy: Triptans as a motivating example","Harris GE, Wood M, Nordeng H.","Pharmacoepidemiol Drug Saf. 2020 Sep;29(9):1111-1119. doi: 10.1002/pds.5089. Epub 2020 Aug 3.","Harris GE","Pharmacoepidemiol Drug Saf","2020","2020/08/05","","","10.1002/pds.5089"
"32743911","Pharmacoepidemiology of testosterone: Impact of reimbursement policy on curbing off-label prescribing","Handelsman DJ.","Pharmacoepidemiol Drug Saf. 2020 Sep;29(9):1030-1036. doi: 10.1002/pds.5080. Epub 2020 Aug 2.","Handelsman DJ","Pharmacoepidemiol Drug Saf","2020","2020/08/04","","","10.1002/pds.5080"
"32725962","Opioid prescribing on discharge to skilled nursing facilities","Hubsky AR, Noble BN, Hartung DM, Tjia J, Lapane KL, Furuno JP.","Pharmacoepidemiol Drug Saf. 2020 Sep;29(9):1183-1188. doi: 10.1002/pds.5075. Epub 2020 Jul 29.","Hubsky AR","Pharmacoepidemiol Drug Saf","2020","2020/07/30","","","10.1002/pds.5075"
"32716126","Machine learning outcome regression improves doubly robust estimation of average causal effects","Choi BY, Wang CP, Gelfond J.","Pharmacoepidemiol Drug Saf. 2020 Sep;29(9):1120-1133. doi: 10.1002/pds.5074. Epub 2020 Jul 27.","Choi BY","Pharmacoepidemiol Drug Saf","2020","2020/07/28","PMC8098857","NIHMS1641752","10.1002/pds.5074"
"32715560","Suicide-related over-the-counter analgesic exposures reported to United States poison control centers, 2000-2018","Hopkins AG, Spiller HA, Kistamgari S, Zhu M, Michaels NL, Funk AR, Smith GA.","Pharmacoepidemiol Drug Saf. 2020 Sep;29(9):1011-1021. doi: 10.1002/pds.4997. Epub 2020 Jul 26.","Hopkins AG","Pharmacoepidemiol Drug Saf","2020","2020/07/28","","","10.1002/pds.4997"
"32696556","A descriptive analysis of medicines safety advisories issued by national medicines regulators in Australia, Canada, the United Kingdom and the United States - 2007 to 2016","Perry LT, Bhasale A, Fabbri A, Lexchin J, Puil L, Joarder M, Mintzes B.","Pharmacoepidemiol Drug Saf. 2020 Sep;29(9):1054-1063. doi: 10.1002/pds.5072. Epub 2020 Jul 21.","Perry LT","Pharmacoepidemiol Drug Saf","2020","2020/07/23","","","10.1002/pds.5072"
"32666678","Real-world on-treatment and initial treatment absolute risk differences for dabigatran vs warfarin in older US adults","Webster-Clark M, Stürmer T, Edwards JK, Poole C, Simpson RJ Jr, Lund JL.","Pharmacoepidemiol Drug Saf. 2020 Aug;29(8):832-841. doi: 10.1002/pds.5069. Epub 2020 Jul 15.","Webster-Clark M","Pharmacoepidemiol Drug Saf","2020","2020/07/16","PMC8356559","NIHMS1727195","10.1002/pds.5069"
"32662222","Reporting and variability of constructing medication treatment episodes in pharmacoepidemiology studies: A methodologic systematic review using the case study of DPP-4 inhibitors and cardiovascular outcomes","Weisman A, King LK, Mamdani M.","Pharmacoepidemiol Drug Saf. 2020 Aug;29(8):939-950. doi: 10.1002/pds.5071. Epub 2020 Jul 13.","Weisman A","Pharmacoepidemiol Drug Saf","2020","2020/07/15","","","10.1002/pds.5071"
"32648636","Incidence rates of and risk factors for opioid overdose in new users of prescription opioids among US Medicaid enrollees: A cohort study","Nam YH, Bilker WB, DeMayo FJ, Neuman MD, Hennessy S.","Pharmacoepidemiol Drug Saf. 2020 Aug;29(8):931-938. doi: 10.1002/pds.5067. Epub 2020 Jul 10.","Nam YH","Pharmacoepidemiol Drug Saf","2020","2020/07/11","","","10.1002/pds.5067"
"32648308","Impact of variable look-back periods on the incidence rates of chronic diseases using real world data","Rosenlund M, Ekström N, Törnblom M, Wintzell V, Stark JH, Titievsky L.","Pharmacoepidemiol Drug Saf. 2020 Sep;29(9):1086-1092. doi: 10.1002/pds.5066. Epub 2020 Jul 9.","Rosenlund M","Pharmacoepidemiol Drug Saf","2020","2020/07/11","","","10.1002/pds.5066"
"32602152","Memantine misuse and social networks: A content analysis of Internet self-reports","Natter J, Michel B.","Pharmacoepidemiol Drug Saf. 2020 Sep;29(9):1189-1193. doi: 10.1002/pds.5070. Epub 2020 Jun 29.","Natter J","Pharmacoepidemiol Drug Saf","2020","2020/07/01","","","10.1002/pds.5070"
"32602137","Leveraging neuropathological data in pharmacoepidemiology: A promising approach for dementia prevention?","Marcum ZA, Keene CD, Larson EB.","Pharmacoepidemiol Drug Saf. 2021 Jan;30(1):1-3. doi: 10.1002/pds.5068. Epub 2020 Jun 29.","Marcum ZA","Pharmacoepidemiol Drug Saf","2021","2020/07/01","PMC7818889","NIHMS1662205","10.1002/pds.5068"
"32583515","Meta-analysis of the risk of autoimmune thyroiditis, Guillain-Barré syndrome, and inflammatory bowel disease following vaccination with AS04-adjuvanted human papillomavirus 16/18 vaccine","Rosillon D, Willame C, Tavares Da Silva F, Guignard A, Caterina S, Welby S, Struyf F.","Pharmacoepidemiol Drug Saf. 2020 Sep;29(9):1159-1167. doi: 10.1002/pds.5063. Epub 2020 Jun 24.","Rosillon D","Pharmacoepidemiol Drug Saf","2020","2020/06/26","PMC7539912","","10.1002/pds.5063"
"32558177","Spillover effects of state medicaid antipsychotic prior authorization policies in US commercially insured youth","Spence O, Reeves G, dosReis S.","Pharmacoepidemiol Drug Saf. 2020 Sep;29(9):1064-1071. doi: 10.1002/pds.5032. Epub 2020 Jun 18.","Spence O","Pharmacoepidemiol Drug Saf","2020","2020/06/20","","","10.1002/pds.5032"
"32558036","Opioid, gabapentinoid, and nonsteroidal anti-inflammatory medication use and the risks of atrial fibrillation and supraventricular ectopy in the Multi-Ethnic Study of Atherosclerosis","Harding BN, Wiggins KL, Jensen PN, McKnight B, Psaty BM, Heckbert SR, Floyd JS.","Pharmacoepidemiol Drug Saf. 2020 Sep;29(9):1175-1182. doi: 10.1002/pds.5036. Epub 2020 Jun 17.","Harding BN","Pharmacoepidemiol Drug Saf","2020","2020/06/20","PMC7933496","NIHMS1669676","10.1002/pds.5036"
"32548875","Bias in case-crossover studies of medications due to persistent use: A simulation study","Bykov K, Wang SV, Hallas J, Pottegård A, Maclure M, Gagne JJ.","Pharmacoepidemiol Drug Saf. 2020 Sep;29(9):1079-1085. doi: 10.1002/pds.5031. Epub 2020 Jun 16.","Bykov K","Pharmacoepidemiol Drug Saf","2020","2020/06/18","PMC7501161","NIHMS1605319","10.1002/pds.5031"
"32537897","Rivaroxaban was found to be noninferior to warfarin in routine clinical care: A retrospective noninferiority cohort replication study","Althunian TA, de Boer A, Groenwold RHH, Rengerink KO, Souverein PC, Klungel OH.","Pharmacoepidemiol Drug Saf. 2020 Oct;29(10):1263-1272. doi: 10.1002/pds.5065. Epub 2020 Jun 14.","Althunian TA","Pharmacoepidemiol Drug Saf","2020","2020/06/16","PMC7687233","","10.1002/pds.5065"
"32537883","Using negative control outcomes to assess the comparability of treatment groups among women with osteoporosis in the United States","McGrath LJ, Spangler L, Curtis JR, Ehrenstein V, Sørensen HT, Saul B, Levintow SN, Reams D, Bradbury BD, Brookhart MA.","Pharmacoepidemiol Drug Saf. 2020 Aug;29(8):854-863. doi: 10.1002/pds.5037. Epub 2020 Jun 14.","McGrath LJ","Pharmacoepidemiol Drug Saf","2020","2020/06/16","","","10.1002/pds.5037"
"32524701","Empirical assessment of case-based methods for identification of drugs associated with upper gastrointestinal bleeding in the French National Healthcare System database (SNDS)","Thurin NH, Lassalle R, Schuemie M, Pénichon M, Gagne JJ, Rassen JA, Benichou J, Weill A, Blin P, Moore N, Droz-Perroteau C.","Pharmacoepidemiol Drug Saf. 2020 Aug;29(8):890-903. doi: 10.1002/pds.5038. Epub 2020 Jun 10.","Thurin NH","Pharmacoepidemiol Drug Saf","2020","2020/06/12","","","10.1002/pds.5038"
"32515047","Potentially inappropriate medications among elderly patients in community healthcare institutions in Beijing, China","Fu M, Wushouer H, Nie X, Shi L, Guan X, Ross-Degnan D.","Pharmacoepidemiol Drug Saf. 2020 Aug;29(8):923-930. doi: 10.1002/pds.5064. Epub 2020 Jun 8.","Fu M","Pharmacoepidemiol Drug Saf","2020","2020/06/10","","","10.1002/pds.5064"
"32501653","Drug discontinuation in pregnant women with psoriasis: The PSO-MOTHER cohort study","Belleudi V, Poggi FR, Perna S, Naldi L, Bortolus R, Rosa AC, Kirchmayer U, Davoli M, Addis A.","Pharmacoepidemiol Drug Saf. 2020 Aug;29(8):904-912. doi: 10.1002/pds.5030. Epub 2020 Jun 5.","Belleudi V","Pharmacoepidemiol Drug Saf","2020","2020/06/06","","","10.1002/pds.5030"
"32492755","Prevalence trends and individual patterns of antiepileptic drug use in pregnancy 2006-2016: A study in the five Nordic countries, United States, and Australia","Cohen JM, Cesta CE, Furu K, Einarsdóttir K, Gissler M, Havard A, Hernandez-Diaz S, Huybrechts KF, Kieler H, Leinonen MK, Li J, Reutfors J, Schaffer A, Selmer R, Yu Y, Zoega H, Karlstad Ø.","Pharmacoepidemiol Drug Saf. 2020 Aug;29(8):913-922. doi: 10.1002/pds.5035. Epub 2020 Jun 3.","Cohen JM","Pharmacoepidemiol Drug Saf","2020","2020/06/04","","","10.1002/pds.5035"
"32483856","Risk of severe hypoglycemic events from amiodarone-sulfonylureas interactions: A population-based nested case-control study","Lai JH, Wang MT, Wu CC, Huang YL, Lu CH, Liou JT.","Pharmacoepidemiol Drug Saf. 2020 Aug;29(8):842-853. doi: 10.1002/pds.5034. Epub 2020 Jun 1.","Lai JH","Pharmacoepidemiol Drug Saf","2020","2020/06/03","","","10.1002/pds.5034"
"32483401","Changes in emergency department visits for zolpidem-attributed adverse drug reactions after FDA Drug Safety Communications","Geller AI, Zhou EH, Budnitz DS, Lovegrove MC, Dal Pan GJ.","Pharmacoepidemiol Drug Saf. 2020 Mar;29(3):352-356. doi: 10.1002/pds.4952. Epub 2020 Jan 9.","Geller AI","Pharmacoepidemiol Drug Saf","2020","2020/06/03","PMC7263461","NIHMS1067626","10.1002/pds.4952"
"32476226","Ethnic inequality in non-steroidal anti-inflammatory drug-associated harm in New Zealand: A national population-based cohort study","Tomlin A, Woods DJ, Lambie A, Eskildsen L, Ng J, Tilyard M.","Pharmacoepidemiol Drug Saf. 2020 Aug;29(8):881-889. doi: 10.1002/pds.5028. Epub 2020 May 31.","Tomlin A","Pharmacoepidemiol Drug Saf","2020","2020/06/02","","","10.1002/pds.5028"
"32463156","Rapid monitoring of health services utilization following a shift in coverage from brand name to biosimilar drugs in British Columbia-An interim report","Fisher A, Kim JD, Dormuth CR.","Pharmacoepidemiol Drug Saf. 2020 Jul;29(7):803-810. doi: 10.1002/pds.5008. Epub 2020 May 28.","Fisher A","Pharmacoepidemiol Drug Saf","2020","2020/05/29","","","10.1002/pds.5008"
"32458499","Real-world data in Saudi Arabia: Current situation and challenges for regulatory decision-making","Alnofal FA, Alrwisan AA, Alshammari TM.","Pharmacoepidemiol Drug Saf. 2020 Oct;29(10):1303-1306. doi: 10.1002/pds.5025. Epub 2020 May 27.","Alnofal FA","Pharmacoepidemiol Drug Saf","2020","2020/05/28","","","10.1002/pds.5025"
"32449261","Conducting prospective sequential surveillance in real-world dynamic distributed databases","Maro JC, Eworuke E, Hou L, Welch EC, Goulding MR, Izem R, Lee JY, Toh S, Fireman B, Nguyen MD.","Pharmacoepidemiol Drug Saf. 2020 Oct;29(10):1331-1335. doi: 10.1002/pds.5002. Epub 2020 May 25.","Maro JC","Pharmacoepidemiol Drug Saf","2020","2020/05/26","","","10.1002/pds.5002"
"32436295","Using the waiting time distribution with random index dates to estimate prescription durations in the presence of seasonal stockpiling","Bødkergaard K, Selmer RM, Hallas J, Kjerpeseth LJ, Pottegård A, Skovlund E, Støvring H.","Pharmacoepidemiol Drug Saf. 2020 Sep;29(9):1072-1078. doi: 10.1002/pds.5026. Epub 2020 May 21.","Bødkergaard K","Pharmacoepidemiol Drug Saf","2020","2020/05/22","","","10.1002/pds.5026"
"32431069","Interventions to improve adverse drug reaction reporting: A scoping review","Khalili M, Mesgarpour B, Sharifi H, Daneshvar Dehnavi S, Haghdoost AA.","Pharmacoepidemiol Drug Saf. 2020 Sep;29(9):965-992. doi: 10.1002/pds.4966. Epub 2020 May 19.","Khalili M","Pharmacoepidemiol Drug Saf","2020","2020/05/21","","","10.1002/pds.4966"
"32419226","Challenges facing drug utilization research in the Latin American region","Salas M, Lopes LC, Godman B, Truter I, Hartzema AG, Wettermark B, Fadare J, Burger JR, Appenteng K, Donneyong M, Arias A, Ankrah D, Ogunleye OO, Lubbe M, Horne L, Bernet J, Gómez-Galicia DL, Del Carmen Garcia Estrada M, Oluka MN, Massele A, Alesso L, Herrera Comoglio R, da Costa Lima E, Vilaseca C, Bergman U.","Pharmacoepidemiol Drug Saf. 2020 Nov;29(11):1353-1363. doi: 10.1002/pds.4989. Epub 2020 May 17.","Salas M","Pharmacoepidemiol Drug Saf","2020","2020/05/19","","","10.1002/pds.4989"
"32410339","Nonsteroidal anti-inflammatory drugs use in patients with chronic kidney disease are often prescribed from different clinicians than those who diagnosed them","Imai S, Momo K, Kashiwagi H, Miyai T, Sugawara M, Takekuma Y.","Pharmacoepidemiol Drug Saf. 2020 Aug;29(8):873-880. doi: 10.1002/pds.5027. Epub 2020 May 14.","Imai S","Pharmacoepidemiol Drug Saf","2020","2020/05/16","","","10.1002/pds.5027"
"32410265","Identifying drugs with disease-modifying potential in Parkinson's disease using artificial intelligence and pharmacoepidemiology","Maclagan LC, Visanji NP, Cheng Y, Tadrous M, Lacoste AMB, Kalia LV, Bronskill SE, Marras C.","Pharmacoepidemiol Drug Saf. 2020 Aug;29(8):864-872. doi: 10.1002/pds.5015. Epub 2020 May 14.","Maclagan LC","Pharmacoepidemiol Drug Saf","2020","2020/05/16","","","10.1002/pds.5015"
"32406104","A quantitative bias analysis of the confounding effects due to smoking on the association between fluoroquinolones and risk of aortic aneurysm","Zhang M, Falconer M, Taylor L.","Pharmacoepidemiol Drug Saf. 2020 Aug;29(8):958-961. doi: 10.1002/pds.5019. Epub 2020 May 13.","Zhang M","Pharmacoepidemiol Drug Saf","2020","2020/05/15","","","10.1002/pds.5019"
"32399991","Nintedanib and ischemic colitis: Signal assessment with the integrated use of two types of real-world evidence, spontaneous reports of suspected adverse drug reactions, and observational data from large health-care databases","Chandler RE.","Pharmacoepidemiol Drug Saf. 2020 Aug;29(8):951-957. doi: 10.1002/pds.5022. Epub 2020 May 12.","Chandler RE","Pharmacoepidemiol Drug Saf","2020","2020/05/14","PMC7496543","","10.1002/pds.5022"
"32394589","Quality of reporting of drug exposure in pharmacoepidemiological studies","Hempenius M, Luijken K, de Boer A, Klungel O, Groenwold R, Gardarsdottir H.","Pharmacoepidemiol Drug Saf. 2020 Sep;29(9):1141-1150. doi: 10.1002/pds.5020. Epub 2020 May 11.","Hempenius M","Pharmacoepidemiol Drug Saf","2020","2020/05/13","PMC7539966","","10.1002/pds.5020"
"32394495","The impact of statin discontinuation and restarting rates on the optimal time to initiate statins and on the number of cardiovascular events prevented","Pate A, Elliott RA, Gkountouras G, Thompson A, Emsley R, van Staa T.","Pharmacoepidemiol Drug Saf. 2020 Jun;29(6):644-652. doi: 10.1002/pds.5023. Epub 2020 May 11.","Pate A","Pharmacoepidemiol Drug Saf","2020","2020/05/13","","","10.1002/pds.5023"
"32394485","Linking process indicators and clinical/safety outcomes to assess the effectiveness of abatacept (ORENCIA) patient alert cards in patients with rheumatoid arthritis","Artime E, Kahlon R, Méndez I, Kou T, Garrido-Estepa M, Qizilbash N.","Pharmacoepidemiol Drug Saf. 2020 Jun;29(6):664-674. doi: 10.1002/pds.5012. Epub 2020 May 12.","Artime E","Pharmacoepidemiol Drug Saf","2020","2020/05/13","","","10.1002/pds.5012"
"32390266","Outpatient fluoroquinolone prescribing patterns before and after US FDA boxed warning","Bratsman A, Mathias K, Laubscher R, Grigoryan L, Rose S.","Pharmacoepidemiol Drug Saf. 2020 Jun;29(6):701-707. doi: 10.1002/pds.5018. Epub 2020 May 11.","Bratsman A","Pharmacoepidemiol Drug Saf","2020","2020/05/12","","","10.1002/pds.5018"
"32383248","In utero exposure to analgesic opioids and language development in 5-year old children","Skovlund E, Selmer R, Skurtveit S, Brandlistuen RE, Handal M.","Pharmacoepidemiol Drug Saf. 2020 Jun;29(6):736-744. doi: 10.1002/pds.5009. Epub 2020 May 8.","Skovlund E","Pharmacoepidemiol Drug Saf","2020","2020/05/09","","","10.1002/pds.5009"
"32383226","Sulphonylureas monotherapy and risk of hospitalization for heart failure in patients with type 2 diabetes mellitus: A population-based cohort study in China","Xu Y, Wang T, Yang Z, Lin H, Shen P, Zhan S.","Pharmacoepidemiol Drug Saf. 2020 Jun;29(6):635-643. doi: 10.1002/pds.5024. Epub 2020 May 8.","Xu Y","Pharmacoepidemiol Drug Saf","2020","2020/05/09","","","10.1002/pds.5024"
"32378285","Safety of clozapine use during pregnancy: Analysis of international pharmacovigilance data","Beex-Oosterhuis MM, Samb A, Heerdink ER, Souverein PC, Van Gool AR, Meyboom RHB, van Marum RJ.","Pharmacoepidemiol Drug Saf. 2020 Jun;29(6):725-735. doi: 10.1002/pds.5016. Epub 2020 May 6.","Beex-Oosterhuis MM","Pharmacoepidemiol Drug Saf","2020","2020/05/08","","","10.1002/pds.5016"
"32374042","Considerations when evaluating real-world data quality in the context of fitness for purpose","Reynolds MW, Bourke A, Dreyer NA.","Pharmacoepidemiol Drug Saf. 2020 Oct;29(10):1316-1318. doi: 10.1002/pds.5010. Epub 2020 May 6.","Reynolds MW","Pharmacoepidemiol Drug Saf","2020","2020/05/07","PMC7687257","","10.1002/pds.5010"
"32369865","Considerations for pharmacoepidemiological analyses in the SARS-CoV-2 pandemic","Pottegård A, Kurz X, Moore N, Christiansen CF, Klungel O.","Pharmacoepidemiol Drug Saf. 2020 Aug;29(8):825-831. doi: 10.1002/pds.5029. Epub 2020 May 21.","Pottegård A","Pharmacoepidemiol Drug Saf","2020","2020/05/06","","","10.1002/pds.5029"
"32364664","Medication persistence of targeted immunomodulators for plaque psoriasis: A retrospective analysis using a U.S. claims database","Hendrix N, Marcum ZA, Veenstra DL.","Pharmacoepidemiol Drug Saf. 2020 Jun;29(6):675-683. doi: 10.1002/pds.5021. Epub 2020 May 4.","Hendrix N","Pharmacoepidemiol Drug Saf","2020","2020/05/05","","","10.1002/pds.5021"
"32363681","Risk of incident dementia following metformin initiation compared with noninitiation or delay of antidiabetic medication therapy","Salas J, Morley JE, Scherrer JF, Floyd JS, Farr SA, Zubatsky M, Barthold D, Dublin S.","Pharmacoepidemiol Drug Saf. 2020 Jun;29(6):623-634. doi: 10.1002/pds.5014. Epub 2020 May 3.","Salas J","Pharmacoepidemiol Drug Saf","2020","2020/05/05","PMC8457517","NIHMS1740568","10.1002/pds.5014"
"32347619","Risk of pregnancy loss in patients exposed to mycophenolate compared to azathioprine: A retrospective cohort study","Thai TN, Sarayani A, Wang X, Albogami Y, Rasmussen SA, Winterstein AG.","Pharmacoepidemiol Drug Saf. 2020 Jun;29(6):716-724. doi: 10.1002/pds.5017. Epub 2020 Apr 29.","Thai TN","Pharmacoepidemiol Drug Saf","2020","2020/04/30","","","10.1002/pds.5017"
"32337840","Base de Datos para la Investigación Farmacoepidemiológica en Atención Primaria (BIFAP): A data resource for pharmacoepidemiology in Spain","Maciá-Martínez MA, Gil M, Huerta C, Martín-Merino E, Álvarez A, Bryant V, Montero D; BIFAP Team.","Pharmacoepidemiol Drug Saf. 2020 Oct;29(10):1236-1245. doi: 10.1002/pds.5006. Epub 2020 Apr 26.","Maciá-Martínez MA","Pharmacoepidemiol Drug Saf","2020","2020/04/28","","","10.1002/pds.5006"
"32323442","Association of eszopiclone, zaleplon, or zolpidem with complex sleep behaviors resulting in serious injuries, including death","Harbourt K, Nevo ON, Zhang R, Chan V, Croteau D.","Pharmacoepidemiol Drug Saf. 2020 Jun;29(6):684-691. doi: 10.1002/pds.5004. Epub 2020 Apr 22.","Harbourt K","Pharmacoepidemiol Drug Saf","2020","2020/04/24","","","10.1002/pds.5004"
"32319139","A review of the United States' naming convention for biological products","Saunders J, Proctor C, Shermock KM.","Pharmacoepidemiol Drug Saf. 2020 Jun;29(6):750-753. doi: 10.1002/pds.5003. Epub 2020 Apr 21.","Saunders J","Pharmacoepidemiol Drug Saf","2020","2020/04/23","","","10.1002/pds.5003"
"32316077","Use of record linkage to evaluate treatment outcomes and trial eligibility in a real-world metastatic prostate cancer population in Scotland","Baillie K, Mueller T, Pan J, Laskey J, Bennie M, Crearie C, Kavanagh K, Alvarez-Madrazo S, Morrison D, Clarke J, Keel A, Cameron D, Wu O, Kurdi A, Jones RJ.","Pharmacoepidemiol Drug Saf. 2020 Jun;29(6):653-663. doi: 10.1002/pds.4998. Epub 2020 Apr 21.","Baillie K","Pharmacoepidemiol Drug Saf","2020","2020/04/22","PMC8246935","","10.1002/pds.4998"
"32316074","The effect of an intervention program on the knowledge and attitudes among medical staff regarding adverse drug reaction reporting","Shchory MP, Goldstein LH, Arcavi L, Shihmanter R, Berkovitch M, Levy A.","Pharmacoepidemiol Drug Saf. 2020 Oct;29(10):1246-1253. doi: 10.1002/pds.5013. Epub 2020 Apr 21.","Shchory MP","Pharmacoepidemiol Drug Saf","2020","2020/04/22","","","10.1002/pds.5013"
"32311192","The association between aspirin use and depression: a systematic review and meta-analysis of observational studies","Kim HB, Kim JS, Jung JG.","Pharmacoepidemiol Drug Saf. 2020 Jun;29(6):613-622. doi: 10.1002/pds.5011. Epub 2020 Apr 20.","Kim HB","Pharmacoepidemiol Drug Saf","2020","2020/04/21","","","10.1002/pds.5011"
"32301237","Comparative risk of Parkinsonism associated with olanzapine, risperidone and quetiapine in older adults-a propensity score matched cohort study","Chyou TY, Nishtala R, Nishtala PS.","Pharmacoepidemiol Drug Saf. 2020 Jun;29(6):692-700. doi: 10.1002/pds.5007. Epub 2020 Apr 16.","Chyou TY","Pharmacoepidemiol Drug Saf","2020","2020/04/18","","","10.1002/pds.5007"
"32301230","Assessing strength of evidence for regulatory decision making in licensing: What proof do we need for observational studies of effectiveness?","Slattery J, Kurz X.","Pharmacoepidemiol Drug Saf. 2020 Oct;29(10):1336-1340. doi: 10.1002/pds.5005. Epub 2020 Apr 16.","Slattery J","Pharmacoepidemiol Drug Saf","2020","2020/04/18","PMC7687174","","10.1002/pds.5005"
"32283564","Validity of administrative claims-based algorithms for ventricular arrhythmia and cardiac arrest in the pediatric population","Czaja AS, Collins K, Valuck RJ, Anderson HD, Ghosh D, Davidson JA.","Pharmacoepidemiol Drug Saf. 2020 Nov;29(11):1499-1503. doi: 10.1002/pds.5001. Epub 2020 Apr 13.","Czaja AS","Pharmacoepidemiol Drug Saf","2020","2020/04/14","","","10.1002/pds.5001"
"32281186","Translational hurdles with cannabis medicines","Graham M, Lucas CJ, Schneider J, Martin JH, Hall W.","Pharmacoepidemiol Drug Saf. 2020 Oct;29(10):1325-1330. doi: 10.1002/pds.4999. Epub 2020 Apr 12.","Graham M","Pharmacoepidemiol Drug Saf","2020","2020/04/14","","","10.1002/pds.4999"
"32267029","No association between use of phosphodiesterase 5 inhibitors and colorectal cancer in men with erectile dysfunction","Cea Soriano L, García Rodríguez LA.","Pharmacoepidemiol Drug Saf. 2020 May;29(5):605-608. doi: 10.1002/pds.5000. Epub 2020 Apr 8.","Cea Soriano L","Pharmacoepidemiol Drug Saf","2020","2020/04/09","","","10.1002/pds.5000"
"32237005","A behavioral economics-based telehealth intervention to improve aspirin adherence following hospitalization for acute coronary syndrome","Riegel B, Stephens-Shields A, Jaskowiak-Barr A, Daus M, Kimmel SE.","Pharmacoepidemiol Drug Saf. 2020 May;29(5):513-517. doi: 10.1002/pds.4988. Epub 2020 Mar 31.","Riegel B","Pharmacoepidemiol Drug Saf","2020","2020/04/03","PMC7217735","NIHMS1580519","10.1002/pds.4988"
"32222005","Quality and completeness of diagnoses recorded in the new CPRD Aurum Database: evaluation of pulmonary embolism","Jick SS, Hagberg KW, Persson R, Vasilakis-Scaramozza C, Williams T, Crellin E, Myles P.","Pharmacoepidemiol Drug Saf. 2020 Sep;29(9):1134-1140. doi: 10.1002/pds.4996. Epub 2020 Mar 28.","Jick SS","Pharmacoepidemiol Drug Saf","2020","2020/03/30","","","10.1002/pds.4996"
"32219905","Prescribing and Research in Medicines Management - PRIMM (UK & Ireland) 31st Annual Scientific Meeting, Manchester, UK, January 17th, 2020: 'Medication Without Harm - WHO is Responsible?'","","Pharmacoepidemiol Drug Saf. 2020 Mar;29 Suppl 2:3-28. doi: 10.1002/pds.4977.","","Pharmacoepidemiol Drug Saf","2020","2020/03/29","","","10.1002/pds.4977"
"32212282","What types of real-world evidence studies do U.S. commercial health plans cite in their specialty drug coverage decisions?","Panzer AD, Margaretos NM, Lai RC, Enright DE, Chambers JD.","Pharmacoepidemiol Drug Saf. 2020 Oct;29(10):1307-1311. doi: 10.1002/pds.4992. Epub 2020 Mar 25.","Panzer AD","Pharmacoepidemiol Drug Saf","2020","2020/03/27","","","10.1002/pds.4992"
"32196839","The impact of generic aromatase inhibitors on initiation, adherence, and persistence among women with breast cancer: Applying multi-state models to understand the dynamics of adherence","Winn AN, Fergestrom NM, Pezzin LE, Laud PW, Neuner JM.","Pharmacoepidemiol Drug Saf. 2020 May;29(5):550-557. doi: 10.1002/pds.4995. Epub 2020 Mar 20.","Winn AN","Pharmacoepidemiol Drug Saf","2020","2020/03/21","","","10.1002/pds.4995"
"32196836","Assessing the effects of beta-blockers on pancreatic cancer risk: A nested case-control study","Saad A, Goldstein J, Margalit O, Shacham-Shmueli E, Lawrence YR, Yang YX, Reiss KA, Golan T, Mamtani R, Halpern N, Aderka D, Mouallem M, Goldstein A, Giantonio B, Boursi B.","Pharmacoepidemiol Drug Saf. 2020 May;29(5):599-604. doi: 10.1002/pds.4993. Epub 2020 Mar 20.","Saad A","Pharmacoepidemiol Drug Saf","2020","2020/03/21","","","10.1002/pds.4993"
"32190948","Impact of medication nonadherence on stroke recurrence and mortality in patients after first-ever ischemic stroke: Insights from registry data in Singapore","Yeo SH, Toh MPHS, Lee SH, Seet RCS, Wong LY, Yau WP.","Pharmacoepidemiol Drug Saf. 2020 May;29(5):538-549. doi: 10.1002/pds.4981. Epub 2020 Mar 19.","Yeo SH","Pharmacoepidemiol Drug Saf","2020","2020/03/20","","","10.1002/pds.4981"
"32189390","Using real-world safety data in regulatory approval decisions: Sotagliflozin and the risk of diabetic ketoacidosis","Fralick M, Kesselheim AS.","Pharmacoepidemiol Drug Saf. 2020 Oct;29(10):1322-1324. doi: 10.1002/pds.4994. Epub 2020 Mar 18.","Fralick M","Pharmacoepidemiol Drug Saf","2020","2020/03/20","","","10.1002/pds.4994"
"32181540","National pharmacovigilance programs in Arab countries: A quantitative assessment study","Alshammari TM, Alenzi KA, Ata SI.","Pharmacoepidemiol Drug Saf. 2020 Sep;29(9):1001-1010. doi: 10.1002/pds.4991. Epub 2020 Mar 17.","Alshammari TM","Pharmacoepidemiol Drug Saf","2020","2020/03/18","","","10.1002/pds.4991"
"32173955","Rise and regional disparities in buprenorphine utilization in the United States","Pashmineh Azar AR, Cruz-Mullane A, Podd JC, Lam WS, Kaleem SH, Lockard LB, Mandel MR, Chung DY, Simoyan OM, Davis CS, Nichols SD, McCall KL, Piper BJ.","Pharmacoepidemiol Drug Saf. 2020 Jun;29(6):708-715. doi: 10.1002/pds.4984. Epub 2020 Mar 16.","Pashmineh Azar AR","Pharmacoepidemiol Drug Saf","2020","2020/03/17","","","10.1002/pds.4984"
"32162407","Dual renin-angiotensin-aldosterone blockade: Implementation of published research and Dear Doctor letters in ambulatory care: A retrospective observational study using prescription data","Angelow A, Ploner T, Grimmsmann T, Walker J, Chenot JF.","Pharmacoepidemiol Drug Saf. 2020 May;29(5):530-537. doi: 10.1002/pds.4965. Epub 2020 Mar 11.","Angelow A","Pharmacoepidemiol Drug Saf","2020","2020/03/13","","","10.1002/pds.4965"
"32162381","Real-world evidence to support regulatory decision-making for medicines: Considerations for external control arms","Burcu M, Dreyer NA, Franklin JM, Blum MD, Critchlow CW, Perfetto EM, Zhou W.","Pharmacoepidemiol Drug Saf. 2020 Oct;29(10):1228-1235. doi: 10.1002/pds.4975. Epub 2020 Mar 11.","Burcu M","Pharmacoepidemiol Drug Saf","2020","2020/03/13","PMC7687199","","10.1002/pds.4975"
"32153056","Comparison of long-term use of prolonged-release ropinirole and immediate-release dopamine agonists in an observational study in patients with Parkinson's disease","Gungabissoon U, Kirichek O, El Baou C, Galwey N.","Pharmacoepidemiol Drug Saf. 2020 May;29(5):591-598. doi: 10.1002/pds.4986. Epub 2020 Mar 9.","Gungabissoon U","Pharmacoepidemiol Drug Saf","2020","2020/03/11","PMC7317950","","10.1002/pds.4986"
"32134549","Medication burden and frailty in older adults with intellectual disability: An observational cross-sectional study","O'Connell J, Henman MC, McMahon N, Burke É, McCallion P, McCarron M, O'Dwyer M.","Pharmacoepidemiol Drug Saf. 2020 Apr;29(4):482-492. doi: 10.1002/pds.4987. Epub 2020 Mar 5.","O'Connell J","Pharmacoepidemiol Drug Saf","2020","2020/03/06","","","10.1002/pds.4987"
"32134162","Assessment of risk of variant creutzfeldt-Jakob disease (vCJD) from use of bovine heparin","Huang Y, Forshee RA, Keire D, Lee S, Gregori L, Asher DM, Bett C, Niland B, Brubaker SA, Anderson SA, Yang H.","Pharmacoepidemiol Drug Saf. 2020 May;29(5):575-581. doi: 10.1002/pds.4982. Epub 2020 Mar 5.","Huang Y","Pharmacoepidemiol Drug Saf","2020","2020/03/06","","","10.1002/pds.4982"
"32134161","Genetic and clinical risk factors associated with phenytoin-induced cutaneous adverse drug reactions in Thai population","Sukasem C, Sririttha S, Tempark T, Klaewsongkram J, Rerkpattanapipat T, Puangpetch A, Boongird A, Chulavatnatol S.","Pharmacoepidemiol Drug Saf. 2020 May;29(5):565-574. doi: 10.1002/pds.4979. Epub 2020 Mar 5.","Sukasem C","Pharmacoepidemiol Drug Saf","2020","2020/03/06","","","10.1002/pds.4979"
"32133717","Empirical assessment of case-based methods for drug safety alert identification in the French National Healthcare System database (SNDS): Methodology of the ALCAPONE project","Thurin NH, Lassalle R, Schuemie M, Pénichon M, Gagne JJ, Rassen JA, Benichou J, Weill A, Blin P, Moore N, Droz-Perroteau C.","Pharmacoepidemiol Drug Saf. 2020 Sep;29(9):993-1000. doi: 10.1002/pds.4983. Epub 2020 Mar 4.","Thurin NH","Pharmacoepidemiol Drug Saf","2020","2020/03/06","","","10.1002/pds.4983"
"32128936","Medical device active surveillance of spontaneous reports: A literature review of signal detection methods","Chung G, Etter K, Yoo A.","Pharmacoepidemiol Drug Saf. 2020 Apr;29(4):369-379. doi: 10.1002/pds.4980. Epub 2020 Mar 3.","Chung G","Pharmacoepidemiol Drug Saf","2020","2020/03/05","","","10.1002/pds.4980"
"32128913","Descriptive analysis of postmarket surveillance data for hip implants","Pane J, Verhamme KMC, Rebollo I, Sturkenboom MCJM.","Pharmacoepidemiol Drug Saf. 2020 Apr;29(4):380-387. doi: 10.1002/pds.4971. Epub 2020 Mar 3.","Pane J","Pharmacoepidemiol Drug Saf","2020","2020/03/05","PMC7216945","","10.1002/pds.4971"
"32128905","Interrupted time series analysis to assess changes in prescription filling around conception and implications for exposure misclassification","Cohen JM, Selmer R, Furu K, Karlstad Ø.","Pharmacoepidemiol Drug Saf. 2020 Jun;29(6):745-749. doi: 10.1002/pds.4974. Epub 2020 Mar 3.","Cohen JM","Pharmacoepidemiol Drug Saf","2020","2020/03/05","","","10.1002/pds.4974"
"32124527","Effects of sodium glucose cotransporter 2 inhibitors on risk of dyslipidemia among patients with type 2 diabetes: A systematic review and meta-analysis of randomized controlled trials","Li D, Wu T, Wang T, Wei H, Wang A, Tang H, Song Y.","Pharmacoepidemiol Drug Saf. 2020 May;29(5):582-590. doi: 10.1002/pds.4985. Epub 2020 Mar 2.","Li D","Pharmacoepidemiol Drug Saf","2020","2020/03/04","","","10.1002/pds.4985"
"32124511","Validation of algorithms to identify adverse perinatal outcomes in the Medicaid Analytic Extract database","He M, Huybrechts KF, Dejene SZ, Straub L, Bartels D, Burns S, Combs DJ, Cottral J, Gray KJ, Manning-Geist BL, Mogun H, Reimers RM, Hernandez-Diaz S, Bateman BT.","Pharmacoepidemiol Drug Saf. 2020 Apr;29(4):419-426. doi: 10.1002/pds.4967. Epub 2020 Mar 2.","He M","Pharmacoepidemiol Drug Saf","2020","2020/03/04","","","10.1002/pds.4967"
"32102118","Off-label use of prescription analgesics among hospitalized children in the United States","Carmack M, Berde C, Monuteaux MC, Manzi S, Bourgeois FT.","Pharmacoepidemiol Drug Saf. 2020 Apr;29(4):474-481. doi: 10.1002/pds.4978. Epub 2020 Feb 26.","Carmack M","Pharmacoepidemiol Drug Saf","2020","2020/02/27","","","10.1002/pds.4978"
"32102109","Chronic opioid use in women following hysterectomy: Patterns and predictors","Wen X, Kogut S, Aroke H, Taylor L, Matteson KA.","Pharmacoepidemiol Drug Saf. 2020 Apr;29(4):493-503. doi: 10.1002/pds.4972. Epub 2020 Feb 26.","Wen X","Pharmacoepidemiol Drug Saf","2020","2020/02/27","","","10.1002/pds.4972"
"32092786","Adverse drug reaction or innocent bystander? A systematic comparison of statistical discovery methods for spontaneous reporting systems","Dijkstra L, Garling M, Foraita R, Pigeot I.","Pharmacoepidemiol Drug Saf. 2020 Apr;29(4):396-403. doi: 10.1002/pds.4970. Epub 2020 Feb 24.","Dijkstra L","Pharmacoepidemiol Drug Saf","2020","2020/02/25","","","10.1002/pds.4970"
"32086848","Pregabalin and injury: A nested case-control and case-crossover study","Miyamoto Y, Iwagami M, Aso S, Matsui H, Doi K, Yasunaga H.","Pharmacoepidemiol Drug Saf. 2020 May;29(5):558-564. doi: 10.1002/pds.4976. Epub 2020 Feb 21.","Miyamoto Y","Pharmacoepidemiol Drug Saf","2020","2020/02/23","","","10.1002/pds.4976"
"32080933","Identifying drug combinations associated with acute kidney injury using association rules method","Nishtala PS, Chyou TY.","Pharmacoepidemiol Drug Saf. 2020 Apr;29(4):467-473. doi: 10.1002/pds.4960. Epub 2020 Feb 20.","Nishtala PS","Pharmacoepidemiol Drug Saf","2020","2020/02/22","","","10.1002/pds.4960"
"32067291","Determinants of antidementia drug prescription in patients older than 65: A latent class analysis","François M, Sicsic J, Pelletier-Fleury N.","Pharmacoepidemiol Drug Saf. 2020 Apr;29(4):444-452. doi: 10.1002/pds.4921. Epub 2020 Feb 17.","François M","Pharmacoepidemiol Drug Saf","2020","2020/02/19","","","10.1002/pds.4921"
"32067286","Translating claims-based CHA(2) DS(2) -VaSc and HAS-BLED to ICD-10-CM: Impacts of mapping strategies","Webster-Clark M, Huang TY, Hou L, Toh S.","Pharmacoepidemiol Drug Saf. 2020 Apr;29(4):409-418. doi: 10.1002/pds.4973. Epub 2020 Feb 17.","Webster-Clark M","Pharmacoepidemiol Drug Saf","2020","2020/02/19","","","10.1002/pds.4973"
"32067283","Effectiveness by gender and age of renin-angiotensin system blockade in heart failure-A national register-based cohort study","Ohlsson A, Lindahl B, Pingel R, Hanning M, Westerling R.","Pharmacoepidemiol Drug Saf. 2020 May;29(5):518-529. doi: 10.1002/pds.4958. Epub 2020 Feb 17.","Ohlsson A","Pharmacoepidemiol Drug Saf","2020","2020/02/19","PMC7318275","","10.1002/pds.4958"
"32056336","Age and postoperative opioid prescriptions: a population-based cohort study of opioid-naïve adults","Bethell J, Neuman MD, Bateman BT, Hill AD, Ladha KS, Wijeysundera DN, Wunsch H.","Pharmacoepidemiol Drug Saf. 2020 Apr;29(4):504-509. doi: 10.1002/pds.4964. Epub 2020 Feb 13.","Bethell J","Pharmacoepidemiol Drug Saf","2020","2020/02/15","PMC7188586","NIHMS1574580","10.1002/pds.4964"
"32048414","Characteristics of finasteride users in comparison with nonusers: A Nordic nationwide study based on individual-level data from Denmark, Finland, and Sweden","Kjaerulff TM, Ersbøll AK, Pukkala E, Bolin K, Green A, Emneus M, Brasso K, Iversen P, Thygesen LC.","Pharmacoepidemiol Drug Saf. 2020 Apr;29(4):453-460. doi: 10.1002/pds.4947. Epub 2020 Feb 11.","Kjaerulff TM","Pharmacoepidemiol Drug Saf","2020","2020/02/13","","","10.1002/pds.4947"
"32045502","Do drug-related safety warnings have the expected impact on drug therapy? A systematic review","Georgi U, Lämmel J, Datzmann T, Schmitt J, Deckert S.","Pharmacoepidemiol Drug Saf. 2020 Mar;29(3):229-251. doi: 10.1002/pds.4968. Epub 2020 Feb 11.","Georgi U","Pharmacoepidemiol Drug Saf","2020","2020/02/12","","","10.1002/pds.4968"
"32043303","Polypharmacy in a semirural community in Chile: Results from Maule Cohort","Oyarzún-González X, Ferreccio C, Abner EL, Vargas C, Huidobro A, Toro P.","Pharmacoepidemiol Drug Saf. 2020 Mar;29(3):306-315. doi: 10.1002/pds.4941. Epub 2020 Feb 10.","Oyarzún-González X","Pharmacoepidemiol Drug Saf","2020","2020/02/12","","","10.1002/pds.4941"
"32020767","Anti-TNF treatment during pregnancy and birth outcomes: A population-based study from Denmark, Finland, and Sweden","Bröms G, Kieler H, Ekbom A, Gissler M, Hellgren K, Lahesmaa-Korpinen AM, Pedersen L, Schmitt-Egenolf M, Sørensen HT, Granath F.","Pharmacoepidemiol Drug Saf. 2020 Mar;29(3):316-327. doi: 10.1002/pds.4930. Epub 2020 Feb 4.","Bröms G","Pharmacoepidemiol Drug Saf","2020","2020/02/06","","","10.1002/pds.4930"
"32017292","Pancreatic safety of sodium-glucose cotransporter 2 inhibitors in patients with type 2 diabetes mellitus: A systematic review and meta-analysis","Tang H, Yang K, Li X, Song Y, Han J.","Pharmacoepidemiol Drug Saf. 2020 Feb;29(2):161-172. doi: 10.1002/pds.4943.","Tang H","Pharmacoepidemiol Drug Saf","2020","2020/02/05","","","10.1002/pds.4943"
"32004396","Extreme polypharmacy: The need to mint a new term","Machado-Alba JE, Machado-Duque ME, Gaviria-Mendoza A.","Pharmacoepidemiol Drug Saf. 2020 Feb;29(2):224-225. doi: 10.1002/pds.4942. Epub 2020 Jan 31.","Machado-Alba JE","Pharmacoepidemiol Drug Saf","2020","2020/02/01","","","10.1002/pds.4942"
"32003065","Use of real-world evidence in regulatory decisions for rare diseases in the United States-Current status and future directions","Wu J, Wang C, Toh S, Pisa FE, Bauer L.","Pharmacoepidemiol Drug Saf. 2020 Oct;29(10):1213-1218. doi: 10.1002/pds.4962. Epub 2020 Jan 30.","Wu J","Pharmacoepidemiol Drug Saf","2020","2020/02/01","","","10.1002/pds.4962"
"32000300","Use of methylphenidate and risk for valvular heart disease: A case-control study nested in the BIFAP cohort","Saiz LC, Gil M, Alonso A, Erviti J, Garjón J, Martínez M.","Pharmacoepidemiol Drug Saf. 2020 Mar;29(3):288-295. doi: 10.1002/pds.4954. Epub 2020 Jan 30.","Saiz LC","Pharmacoepidemiol Drug Saf","2020","2020/01/31","","","10.1002/pds.4954"
"31990131","Overuse of proton pump inhibitors in nursing homes: An Italian multicenter observational study","Pasina L, Novella A, Elli C, Nobili A, Ianes A.","Pharmacoepidemiol Drug Saf. 2020 Apr;29(4):461-466. doi: 10.1002/pds.4963. Epub 2020 Jan 27.","Pasina L","Pharmacoepidemiol Drug Saf","2020","2020/01/29","","","10.1002/pds.4963"
"31972062","Improving measurement of binary covariates in claims data: A simulation study","Connolly JG, Glynn RJ, Schneeweiss S, Gagne JJ.","Pharmacoepidemiol Drug Saf. 2020 Sep;29(9):1093-1100. doi: 10.1002/pds.4961. Epub 2020 Jan 23.","Connolly JG","Pharmacoepidemiol Drug Saf","2020","2020/01/24","","","10.1002/pds.4961"
"31958191","Comparison of medication adherence measures derived from linked administrative data and associations with mortality using restricted cubic splines in heart failure patients","Qin X, Hung J, Knuiman MW, Briffa TG, Teng TK, Sanfilippo FM.","Pharmacoepidemiol Drug Saf. 2020 Feb;29(2):208-218. doi: 10.1002/pds.4939. Epub 2020 Jan 20.","Qin X","Pharmacoepidemiol Drug Saf","2020","2020/01/21","","","10.1002/pds.4939"
"31950565","Linking electronic health data in pharmacoepidemiology: Appropriateness and feasibility","Rivera DR, Gokhale MN, Reynolds MW, Andrews EB, Chun D, Haynes K, Jonsson-Funk ML, Lynch KE, Lund JL, Strongman H, Bhullar H, Raman SR.","Pharmacoepidemiol Drug Saf. 2020 Jan;29(1):18-29. doi: 10.1002/pds.4918.","Rivera DR","Pharmacoepidemiol Drug Saf","2020","2020/01/18","","","10.1002/pds.4918"
"31950545","Comedication prescription patterns and potential for drug-drug interactions with antiretroviral therapy in people living with human immunodeficiency virus type 1 infection in Germany","Lopes S, O'Day K, Meyer K, Van Stiphout J, Punekar Y, Radford M, Haas JS.","Pharmacoepidemiol Drug Saf. 2020 Mar;29(3):270-278. doi: 10.1002/pds.4928. Epub 2020 Jan 16.","Lopes S","Pharmacoepidemiol Drug Saf","2020","2020/01/18","","","10.1002/pds.4928"
"31923351","Impact of pre-exposure time bias in self-controlled case series when the event conditions the exposure: Hip/femur fracture and use of benzodiazepines as a case study","Requena G, Douglas IJ, Huerta C, de Abajo F.","Pharmacoepidemiol Drug Saf. 2020 Apr;29(4):388-395. doi: 10.1002/pds.4959. Epub 2020 Jan 10.","Requena G","Pharmacoepidemiol Drug Saf","2020","2020/01/11","","","10.1002/pds.4959"
"31914214","A rapid monitoring plan following a shift in coverage from brand name to biosimilar drugs for rheumatoid arthritis in British Columbia","Dormuth CR, Fisher A, Carney G.","Pharmacoepidemiol Drug Saf. 2020 Jul;29(7):796-802. doi: 10.1002/pds.4957. Epub 2020 Jan 8.","Dormuth CR","Pharmacoepidemiol Drug Saf","2020","2020/01/09","","","10.1002/pds.4957"
"31908111","Evolution of polypharmacy in a spanish population (2005-2015): A database study","Hernández-Rodríguez MÁ, Sempere-Verdú E, Vicens-Caldentey C, González-Rubio F, Miguel-García F, Palop-Larrea V, Orueta-Sánchez R, Esteban-Jiménez Ó, Sempere-Manuel M, Arroyo-Aniés MP, Fernández-San José B.","Pharmacoepidemiol Drug Saf. 2020 Apr;29(4):433-443. doi: 10.1002/pds.4956. Epub 2020 Jan 6.","Hernández-Rodríguez MÁ","Pharmacoepidemiol Drug Saf","2020","2020/01/08","","","10.1002/pds.4956"
"31908100","Bayesian hierarchical methods in the detection of potentially teratogenic first-trimester medications","Cavadino A, Prieto-Merino D, Morris JK.","Pharmacoepidemiol Drug Saf. 2020 Mar;29(3):337-346. doi: 10.1002/pds.4948. Epub 2020 Jan 6.","Cavadino A","Pharmacoepidemiol Drug Saf","2020","2020/01/08","","","10.1002/pds.4948"
"31899936","Impact of EMA regulatory label changes on systemic diclofenac initiation, discontinuation, and switching to other pain medicines in Scotland, England, Denmark, and The Netherlands","Morales DR, Morant SV, MacDonald TM, Mackenzie IS, Doney ASF, Mitchell L, Bennie M, Robertson C, Hallas J, Pottegard A, Ernst MT, Wei L, Nicholson L, Morris C, Herings RMC, Overbeek JA, Smits E, Flynn RWV.","Pharmacoepidemiol Drug Saf. 2020 Mar;29(3):296-305. doi: 10.1002/pds.4955. Epub 2020 Jan 3.","Morales DR","Pharmacoepidemiol Drug Saf","2020","2020/01/04","PMC7079064","","10.1002/pds.4955"
"31876044","A survey of clarithromycin monotherapy and long-term administration of ethambutol for patients with MAC lung disease in Japan: A retrospective cohort study using the database of health insurance claims","Iwao T, Kato G, Ito I, Aramaki E, Kuroda T.","Pharmacoepidemiol Drug Saf. 2020 Apr;29(4):427-432. doi: 10.1002/pds.4951. Epub 2019 Dec 25.","Iwao T","Pharmacoepidemiol Drug Saf","2020","2019/12/27","","","10.1002/pds.4951"
"31863536","Using nationally representative survey data for external adjustment of unmeasured confounders: An example using the NHANES data","Hernández-Díaz S, Bateman BT, Palmsten K, Schneeweiss S, Huybrechts KF.","Pharmacoepidemiol Drug Saf. 2020 Sep;29(9):1151-1158. doi: 10.1002/pds.4946. Epub 2019 Dec 20.","Hernández-Díaz S","Pharmacoepidemiol Drug Saf","2020","2019/12/22","PMC8900668","NIHMS1757942","10.1002/pds.4946"
"31854053","Mapping from the International Classification of Diseases (ICD) 9th to 10th Revision for Research in Biologics and Biosimilars Using Administrative Healthcare Data","He M, Santiago Ortiz AJ, Marshall J, Mendelsohn AB, Curtis JR, Barr CE, Lockhart CM, Kim SC.","Pharmacoepidemiol Drug Saf. 2020 Jul;29(7):770-777. doi: 10.1002/pds.4933. Epub 2019 Dec 18.","He M","Pharmacoepidemiol Drug Saf","2020","2019/12/20","","","10.1002/pds.4933"
"31851773","Long-term opioid therapy definitions and predictors: A systematic review","Karmali RN, Bush C, Raman SR, Campbell CI, Skinner AC, Roberts AW.","Pharmacoepidemiol Drug Saf. 2020 Mar;29(3):252-269. doi: 10.1002/pds.4929. Epub 2019 Dec 18.","Karmali RN","Pharmacoepidemiol Drug Saf","2020","2019/12/19","PMC7058495","NIHMS1561241","10.1002/pds.4929"
"31849154","Validation of claims-based algorithms for psoriatic arthritis","Lee H, Ford JA, Jin Y, Cho SK, Santiago Ortiz AJ, Tong AY, Kim SC.","Pharmacoepidemiol Drug Saf. 2020 Apr;29(4):404-408. doi: 10.1002/pds.4950. Epub 2019 Dec 17.","Lee H","Pharmacoepidemiol Drug Saf","2020","2019/12/19","","","10.1002/pds.4950"
"31833141","Consumer understanding of the scope of FDA's prescription drug regulatory oversight: A nationally representative survey","Sullivan HW, Aikin KJ, David KT, Berktold J, Stein KL, Hoverman VJ.","Pharmacoepidemiol Drug Saf. 2020 Feb;29(2):134-140. doi: 10.1002/pds.4914. Epub 2019 Dec 12.","Sullivan HW","Pharmacoepidemiol Drug Saf","2020","2019/12/14","PMC7325631","NIHMS1595654","10.1002/pds.4914"
"31828887","Understanding utilization patterns of biologics and biosimilars in the United States to support postmarketing studies of safety and effectiveness","Dutcher SK, Fazio-Eynullayeva E, Eworuke E, Carruth A, Dee EC, Blum MD, Nguyen MD, Toh S, Panozzo CA, Lyons JG.","Pharmacoepidemiol Drug Saf. 2020 Jul;29(7):786-795. doi: 10.1002/pds.4908. Epub 2019 Dec 11.","Dutcher SK","Pharmacoepidemiol Drug Saf","2020","2019/12/13","","","10.1002/pds.4908"
"31828875","Pharmaceutically treated comorbidities and associated healthcare costs among triptan users in Switzerland: A pharmacoepidemiological study from a nationwide health insurance database","Huber CA, Agosti R, Näpflin M, Blozik E.","Pharmacoepidemiol Drug Saf. 2020 Mar;29(3):279-287. doi: 10.1002/pds.4938. Epub 2019 Dec 11.","Huber CA","Pharmacoepidemiol Drug Saf","2020","2019/12/13","","","10.1002/pds.4938"
"31823506","Quality evaluation of the Japanese Adverse Drug Event Report database (JADER)","Tsuchiya M, Obara T, Sakai T, Nomura K, Takamura C, Mano N.","Pharmacoepidemiol Drug Saf. 2020 Feb;29(2):173-181. doi: 10.1002/pds.4944. Epub 2019 Dec 10.","Tsuchiya M","Pharmacoepidemiol Drug Saf","2020","2019/12/12","","","10.1002/pds.4944"
"31823482","Trial designs using real-world data: The changing landscape of the regulatory approval process","Baumfeld Andre E, Reynolds R, Caubel P, Azoulay L, Dreyer NA.","Pharmacoepidemiol Drug Saf. 2020 Oct;29(10):1201-1212. doi: 10.1002/pds.4932. Epub 2019 Dec 10.","Baumfeld Andre E","Pharmacoepidemiol Drug Saf","2020","2019/12/12","PMC7687110","","10.1002/pds.4932"
"31820497","Potentially inappropriate medication prescribed among older patients in a primary care setting in Malaysia","Kua KP, Hamzah NN, Lee SWH.","Pharmacoepidemiol Drug Saf. 2020 Mar;29(3):363-364. doi: 10.1002/pds.4945. Epub 2019 Dec 9.","Kua KP","Pharmacoepidemiol Drug Saf","2020","2019/12/11","","","10.1002/pds.4945"
"31814201","The Canadian Network for Observational Drug Effect Studies (CNODES): Reflections on the first eight years, and a look to the future","Platt RW, Henry DA, Suissa S.","Pharmacoepidemiol Drug Saf. 2020 Jan;29 Suppl 1:103-107. doi: 10.1002/pds.4936. Epub 2019 Dec 8.","Platt RW","Pharmacoepidemiol Drug Saf","2020","2019/12/10","","","10.1002/pds.4936"
"31811680","Comparison of electronic self-reported prescription medication use during pregnancy with the national prescription register in Denmark","Laursen M, Hallgreen CE, Dreyer N, Bourke A, Mt-Isa S, Blackburn S.","Pharmacoepidemiol Drug Saf. 2020 Mar;29(3):328-336. doi: 10.1002/pds.4937. Epub 2019 Dec 6.","Laursen M","Pharmacoepidemiol Drug Saf","2020","2019/12/08","","","10.1002/pds.4937"
"31808271","The role of prescription drugs in female overactive bladder syndrome-A population-wide cohort study","Umek W, Gleiss A, Bodner-Adler B, Reichardt B, Rinner C, Heinze G.","Pharmacoepidemiol Drug Saf. 2020 Feb;29(2):189-198. doi: 10.1002/pds.4920. Epub 2019 Dec 5.","Umek W","Pharmacoepidemiol Drug Saf","2020","2019/12/07","PMC7027558","","10.1002/pds.4920"
"31802581","Opening the black box of the group-based trajectory modeling process to analyze medication adherence patterns: An example using real-world statin adherence data","Hickson RP, Annis IE, Killeya-Jones LA, Fang G.","Pharmacoepidemiol Drug Saf. 2020 Mar;29(3):357-362. doi: 10.1002/pds.4917. Epub 2019 Dec 4.","Hickson RP","Pharmacoepidemiol Drug Saf","2020","2019/12/06","PMC7058496","NIHMS1055747","10.1002/pds.4917"
"31802568","Capture of biologic and biosimilar dispensings in a consortium of U.S.-based claims databases: Utilization of national drug codes and Healthcare Common Procedure Coding System modifiers in medical claims","Zhang J, Haynes K, Mendelsohn AB, Marshall J, Barr CE, McDermott C, Brown J, Kline A, Kenney J, King KJ, Holmes C, Yeung K, Barron J, Yun H, Lockhart CM.","Pharmacoepidemiol Drug Saf. 2020 Jul;29(7):778-785. doi: 10.1002/pds.4934. Epub 2019 Dec 4.","Zhang J","Pharmacoepidemiol Drug Saf","2020","2019/12/06","","","10.1002/pds.4934"
"31802557","Medical device postmarket clinical follow-up in Europe: Getting priorities right","Braillon A, Bewley S.","Pharmacoepidemiol Drug Saf. 2020 Feb;29(2):226-227. doi: 10.1002/pds.4935. Epub 2019 Dec 4.","Braillon A","Pharmacoepidemiol Drug Saf","2020","2019/12/06","","","10.1002/pds.4935"
"31797484","Exposure to guideline-recommended drugs after a first acute myocardial infarction in older adults: does deprivation matter?","Akator AE, Blais C, Gamache P, Lunghi C, Guénette L.","Pharmacoepidemiol Drug Saf. 2020 Feb;29(2):141-149. doi: 10.1002/pds.4915. Epub 2019 Dec 3.","Akator AE","Pharmacoepidemiol Drug Saf","2020","2019/12/05","","","10.1002/pds.4915"
"31797475","The use of natural language processing to identify vaccine-related anaphylaxis at five health care systems in the Vaccine Safety Datalink","Yu W, Zheng C, Xie F, Chen W, Mercado C, Sy LS, Qian L, Glenn S, Tseng HF, Lee G, Duffy J, McNeil MM, Daley MF, Crane B, McLean HQ, Jackson LA, Jacobsen SJ.","Pharmacoepidemiol Drug Saf. 2020 Feb;29(2):182-188. doi: 10.1002/pds.4919. Epub 2019 Dec 3.","Yu W","Pharmacoepidemiol Drug Saf","2020","2019/12/05","PMC7528887","NIHMS1627119","10.1002/pds.4919"
"31793135","Identifying sequential episodes of pharmacotherapy as a method for assessing treatment failure in comparative effectiveness research","Carney G, Maclure M, Bassett K, Taylor S, Dormuth CR.","Pharmacoepidemiol Drug Saf. 2020 Feb;29(2):199-207. doi: 10.1002/pds.4926. Epub 2019 Dec 2.","Carney G","Pharmacoepidemiol Drug Saf","2020","2019/12/04","","","10.1002/pds.4926"
"31788909","Using cancer registries to supplement clinical trial data and inform regulatory decision","da Costa FA, da Costa Miranda A.","Pharmacoepidemiol Drug Saf. 2020 Oct;29(10):1319-1321. doi: 10.1002/pds.4931. Epub 2019 Dec 1.","da Costa FA","Pharmacoepidemiol Drug Saf","2020","2019/12/03","","","10.1002/pds.4931"
"31788906","Interrupted time series analysis on first cardiovascular disease hospitalization for adherence to lipid-lowering therapy","Hu F, Warren J, Exeter DJ.","Pharmacoepidemiol Drug Saf. 2020 Feb;29(2):150-160. doi: 10.1002/pds.4916. Epub 2019 Dec 1.","Hu F","Pharmacoepidemiol Drug Saf","2020","2019/12/03","","","10.1002/pds.4916"
"31749191","An algorithm to identify pregnancies in BIFAP Primary Care database in Spain: Results from a cohort of 155 419 pregnancies","Sanchez Ortiz S, Llorente García A, Astasio P, Huerta C, Cea Soriano L.","Pharmacoepidemiol Drug Saf. 2020 Jan;29(1):57-68. doi: 10.1002/pds.4910. Epub 2019 Nov 20.","Sanchez Ortiz S","Pharmacoepidemiol Drug Saf","2020","2019/11/22","","","10.1002/pds.4910"
"31737976","Usability of encounter data for Medicaid comprehensive managed care vs traditional Medicaid fee-for-service claims among pregnant women","Choi Y, Park H, Hampp C, Brumback B, Meissner HC, Li Y, Roussos-Ross D, Zhu Y, Henriksen C, Winterstein AG.","Pharmacoepidemiol Drug Saf. 2020 Jan;29(1):30-38. doi: 10.1002/pds.4923. Epub 2019 Nov 18.","Choi Y","Pharmacoepidemiol Drug Saf","2020","2019/11/19","","","10.1002/pds.4923"
"31736248","Data linkage in pharmacoepidemiology: A call for rigorous evaluation and reporting","Pratt NL, Mack CD, Meyer AM, Davis KJ, Hammill BG, Hampp C, Setoguchi S, Raman SR, Chun DS, Stürmer T, Lund JL.","Pharmacoepidemiol Drug Saf. 2020 Jan;29(1):9-17. doi: 10.1002/pds.4924. Epub 2019 Nov 17.","Pratt NL","Pharmacoepidemiol Drug Saf","2020","2019/11/19","","","10.1002/pds.4924"
"31736190","A retrospective analysis of reporting of adverse drug reactions over 4 years in a primary care health clinic in Malaysia","Kua KP, Jamil MFB, Liew MH, Si JY, Lee SWH.","Pharmacoepidemiol Drug Saf. 2019 Dec;28(12):1560-1561. doi: 10.1002/pds.4913. Epub 2019 Nov 17.","Kua KP","Pharmacoepidemiol Drug Saf","2019","2019/11/19","","","10.1002/pds.4913"
"31736189","Identifying monoclonal gammopathy of undetermined significance in electronic health data","Epstein MM, Saphirak C, Zhou Y, LeBlanc C, Rosmarin AG, Ash A, Singh S, Fisher K, Birmann BM, Gurwitz JH.","Pharmacoepidemiol Drug Saf. 2020 Jan;29(1):69-76. doi: 10.1002/pds.4912. Epub 2019 Nov 17.","Epstein MM","Pharmacoepidemiol Drug Saf","2020","2019/11/19","PMC7365702","NIHMS1064429","10.1002/pds.4912"
"31736149","Quantifying how small variations in design elements affect risk in an incident cohort study in claims","Izem R, Huang TY, Hou L, Pestine E, Nguyen M, Maro JC.","Pharmacoepidemiol Drug Saf. 2020 Jan;29(1):84-93. doi: 10.1002/pds.4892. Epub 2019 Nov 17.","Izem R","Pharmacoepidemiol Drug Saf","2020","2019/11/19","","","10.1002/pds.4892"
"31730289","Factors of importance for discontinuation of thiazides associated with hyponatremia in Sweden: A population-based register study","Fahlén Bergh C, Toivanen S, Johnell K, Calissendorff J, Skov J, Falhammar H, Nathanson D, Lindh JD, Mannheimer B.","Pharmacoepidemiol Drug Saf. 2020 Jan;29(1):77-83. doi: 10.1002/pds.4922. Epub 2019 Nov 15.","Fahlén Bergh C","Pharmacoepidemiol Drug Saf","2020","2019/11/16","","","10.1002/pds.4922"
"31730266","Run-in periods and clinical outcomes of antipsychotics in dementia: A meta-epidemiological study of placebo-controlled trials","Hulshof TA, Zuidema SU, Gispen-de Wied CC, Luijendijk HJ.","Pharmacoepidemiol Drug Saf. 2020 Feb;29(2):125-133. doi: 10.1002/pds.4903. Epub 2019 Nov 15.","Hulshof TA","Pharmacoepidemiol Drug Saf","2020","2019/11/16","PMC7027584","","10.1002/pds.4903"
"31730260","Epidemiology of multimorbidity in Iran: An investigation of a large pharmacy claims database","Ebrahimoghli R, Janati A, Sadeghi-Bazargani H, Hamishehkar H, Ghaffari S, Sanaat Z, Farahbakhsh M, Farhoudi M, Khalili-Azimi A.","Pharmacoepidemiol Drug Saf. 2020 Jan;29(1):39-47. doi: 10.1002/pds.4925. Epub 2019 Nov 15.","Ebrahimoghli R","Pharmacoepidemiol Drug Saf","2020","2019/11/16","","","10.1002/pds.4925"
"31724270","Effectiveness of interventions to improve adverse drug reaction reporting by healthcare professionals over the last decade: A systematic review","Li R, Zaidi STR, Chen T, Castelino R.","Pharmacoepidemiol Drug Saf. 2020 Jan;29(1):1-8. doi: 10.1002/pds.4906. Epub 2019 Nov 14.","Li R","Pharmacoepidemiol Drug Saf","2020","2019/11/15","","","10.1002/pds.4906"
"31714644","Pharmacy-led pharmacovigilance: Ready for use or missed opportunity?","Leufkens HG.","Pharmacoepidemiol Drug Saf. 2019 Dec;28(12):1562. doi: 10.1002/pds.4901. Epub 2019 Nov 12.","Leufkens HG","Pharmacoepidemiol Drug Saf","2019","2019/11/13","","","10.1002/pds.4901"
"31713940","The role of 5α-reductase inhibitors in gastro-oesophageal cancer risk: A nested case-control study","Busby J, Karasneh R, Murchie P, McMenamin Ú, Gadalla SM, Camargo MC, Iversen L, Lee AJ, Spence AD, Cardwell CR.","Pharmacoepidemiol Drug Saf. 2020 Jan;29(1):48-56. doi: 10.1002/pds.4909. Epub 2019 Nov 12.","Busby J","Pharmacoepidemiol Drug Saf","2020","2019/11/13","PMC8520491","NIHMS1742304","10.1002/pds.4909"
"31713302","Risk of adverse birth outcomes after maternal varenicline use: A population-based observational study in Denmark and Sweden","Pedersen L, Petronis KR, Nørgaard M, Mo J, Frøslev T, Stephansson O, Granath F, Kieler H, Sørensen HT.","Pharmacoepidemiol Drug Saf. 2020 Jan;29(1):94-102. doi: 10.1002/pds.4894. Epub 2019 Nov 11.","Pedersen L","Pharmacoepidemiol Drug Saf","2020","2019/11/13","","","10.1002/pds.4894"
"31693269","Comparative effectiveness of metformin versus insulin for gestational diabetes in New Zealand","Landi SN, Radke S, Boggess K, Engel SM, Stürmer T, Howe AS, Jonsson Funk M.","Pharmacoepidemiol Drug Saf. 2019 Dec;28(12):1609-1619. doi: 10.1002/pds.4907. Epub 2019 Nov 6.","Landi SN","Pharmacoepidemiol Drug Saf","2019","2019/11/07","","","10.1002/pds.4907"
"31692182","Predictors of adverse drug reactions associated with ribavirin in direct-acting antiviral therapies for chronic hepatitis C","Cursino CN, Monteiro PGO, Duarte GDS, Vieira TBQ, Crisante VC, Giordani F, Xavier AR, de Almeida RMVR, Calil-Elias S.","Pharmacoepidemiol Drug Saf. 2019 Dec;28(12):1601-1608. doi: 10.1002/pds.4904. Epub 2019 Nov 6.","Cursino CN","Pharmacoepidemiol Drug Saf","2019","2019/11/07","","","10.1002/pds.4904"
"31692176","Using real-world data to evaluate biosimilar switching","Dutcher SK, Eworuke E, Blum MD, Ball R.","Pharmacoepidemiol Drug Saf. 2020 Jul;29(7):814-816. doi: 10.1002/pds.4899. Epub 2019 Nov 6.","Dutcher SK","Pharmacoepidemiol Drug Saf","2020","2019/11/07","","","10.1002/pds.4899"
"31692168","Features of anticholinergic prescriptions and predictors of high use in the elderly: Population-based study","Joung KI, Shin JY, Cho SI.","Pharmacoepidemiol Drug Saf. 2019 Dec;28(12):1591-1600. doi: 10.1002/pds.4902. Epub 2019 Nov 6.","Joung KI","Pharmacoepidemiol Drug Saf","2019","2019/11/07","","","10.1002/pds.4902"
"31667955","Pre/post effectiveness evaluation of updated additional risk minimisation measures for an orphan disease: Myozyme (alglucosidase alfa) Safety Information Packet","Artime E, Shui I, Mendez I, Tcherny-Lessenot S, D'Arbigny P, Alfaro N, Qizilbash N.","Pharmacoepidemiol Drug Saf. 2020 Jan;29(1):103-110. doi: 10.1002/pds.4905. Epub 2019 Oct 31.","Artime E","Pharmacoepidemiol Drug Saf","2020","2019/11/01","","","10.1002/pds.4905"
"31646732","Sodium-glucose co-transporter 2 inhibitors and the risk of fractures: A propensity score-matched cohort study","Adimadhyam S, Lee TA, Calip GS, Smith Marsh DE, Layden BT, Schumock GT.","Pharmacoepidemiol Drug Saf. 2019 Dec;28(12):1629-1639. doi: 10.1002/pds.4900. Epub 2019 Oct 24.","Adimadhyam S","Pharmacoepidemiol Drug Saf","2019","2019/10/25","","","10.1002/pds.4900"
"31642154","The International Society for Pharmacoepidemiology's Comments on the Core Recommendations in the Summary of the Heads of Medicines Agencies (HMA) - EMA Joint Big Data Task Force","Pottegård A, Klungel O, Winterstein A, Huybrechts K, Hallas J, Schneeweiss S, Evans S, Bate A, Pont L, Trifirò G, Smith M, Bourke A.","Pharmacoepidemiol Drug Saf. 2019 Dec;28(12):1640-1641. doi: 10.1002/pds.4911. Epub 2019 Oct 22.","Pottegård A","Pharmacoepidemiol Drug Saf","2019","2019/10/24","","","10.1002/pds.4911"
"31571347","Estimation of high-dimensional propensity scores with multiple exposure levels","Eberg M, Platt RW, Reynier P, Filion KB.","Pharmacoepidemiol Drug Saf. 2020 Jan;29 Suppl 1:53-60. doi: 10.1002/pds.4890. Epub 2019 Sep 30.","Eberg M","Pharmacoepidemiol Drug Saf","2020","2019/10/02","","","10.1002/pds.4890"
"31517431","Statins for primary prevention of cardiovascular disease and the risk of acute kidney injury","Coste J, Karras A, Rudnichi A, Dray-Spira R, Pouchot J, Giral P, Zureik M.","Pharmacoepidemiol Drug Saf. 2019 Dec;28(12):1583-1590. doi: 10.1002/pds.4898. Epub 2019 Sep 13.","Coste J","Pharmacoepidemiol Drug Saf","2019","2019/09/14","PMC6916201","","10.1002/pds.4898"
"31517430","Prescription of antiepileptic medicines including valproate in pregnant women: A study in three European countries","Hurault-Delarue C, Morris JK, Charlton R, Gini R, Loane M, Pierini A, Puccini A, Neville A, Snowball J, Damase-Michel C; EUROmediSAFE consortium.","Pharmacoepidemiol Drug Saf. 2019 Nov;28(11):1510-1518. doi: 10.1002/pds.4897. Epub 2019 Sep 13.","Hurault-Delarue C","Pharmacoepidemiol Drug Saf","2019","2019/09/14","","","10.1002/pds.4897"
"31517414","Poor concordance among drug compendia for proposed interactions between enzyme-inducing antiepileptic drugs and direct oral anticoagulants","Acton EK, Willis AW, Gelfand MA, Kasner SE.","Pharmacoepidemiol Drug Saf. 2019 Nov;28(11):1534-1538. doi: 10.1002/pds.4896. Epub 2019 Sep 13.","Acton EK","Pharmacoepidemiol Drug Saf","2019","2019/09/14","","","10.1002/pds.4896"
"31509302","L-TRUST: Long-term risk of cancer in patients under statins therapy. A systematic review and meta-analysis","Craveiro NS, Silva Lopes B, Tomás L, Fraga Almeida S, Palma H, Afreixo V, Costa Matos L.","Pharmacoepidemiol Drug Saf. 2019 Nov;28(11):1431-1439. doi: 10.1002/pds.4895. Epub 2019 Sep 11.","Craveiro NS","Pharmacoepidemiol Drug Saf","2019","2019/09/12","","","10.1002/pds.4895"
"31507029","Data variability across Canadian administrative health databases: Differences in content, coding, and completeness","Doyle CM, Lix LM, Hemmelgarn BR, Paterson JM, Renoux C.","Pharmacoepidemiol Drug Saf. 2020 Jan;29 Suppl 1:68-77. doi: 10.1002/pds.4889. Epub 2019 Sep 10.","Doyle CM","Pharmacoepidemiol Drug Saf","2020","2019/09/12","","","10.1002/pds.4889"
"31507005","Initiation of generic imatinib may improve medication adherence for patients with chronic myeloid leukemia","Cole AL, Jazowski SA, Dusetzina SB.","Pharmacoepidemiol Drug Saf. 2019 Nov;28(11):1529-1533. doi: 10.1002/pds.4893. Epub 2019 Sep 11.","Cole AL","Pharmacoepidemiol Drug Saf","2019","2019/09/12","","","10.1002/pds.4893"
"31486217","CORRIGENDUM","","Pharmacoepidemiol Drug Saf. 2019 Sep;28(9):1278-1279. doi: 10.1002/pds.4856.","","Pharmacoepidemiol Drug Saf","2019","2019/09/06","PMC6885944","","10.1002/pds.4856"
"31486198","Ivabradine drug utilization study in five European countries: A multinational, retrospective, observational study to assess effectiveness of risk-minimization measures","Salem L, Malouvier A, Blatchford J, Rivero-Ferrer E, Deltour N, Jacquot E.","Pharmacoepidemiol Drug Saf. 2019 Nov;28(11):1470-1479. doi: 10.1002/pds.4880. Epub 2019 Sep 4.","Salem L","Pharmacoepidemiol Drug Saf","2019","2019/09/06","PMC6899761","","10.1002/pds.4880"
"31486165","Multiple imputation for systematically missing confounders within a distributed data drug safety network: A simulation study and real-world example","Secrest MH, Platt RW, Reynier P, Dormuth CR, Benedetti A, Filion KB.","Pharmacoepidemiol Drug Saf. 2020 Jan;29 Suppl 1:35-44. doi: 10.1002/pds.4876. Epub 2019 Sep 4.","Secrest MH","Pharmacoepidemiol Drug Saf","2020","2019/09/06","","","10.1002/pds.4876"
"31483548","Validation of an administrative claims coding algorithm for serious opioid overdose: A medical chart review","Mountcastle SB, Joyce AR, Sasinowski M, Costello N, Doshi S, Zedler BK.","Pharmacoepidemiol Drug Saf. 2019 Oct;28(10):1422-1428. doi: 10.1002/pds.4886. Epub 2019 Sep 4.","Mountcastle SB","Pharmacoepidemiol Drug Saf","2019","2019/09/05","PMC6810754","NIHMS1043873","10.1002/pds.4886"
"31483085","Identification of potential drug name confusion errors in the Sentinel System","Cocoros NM, Haynes K, Her Q, Cosgrove A, Dee E, Lin ND, Tu CM, Ding Y, Nguyen M, Toh S.","Pharmacoepidemiol Drug Saf. 2019 Oct;28(10):1405-1410. doi: 10.1002/pds.4891. Epub 2019 Sep 4.","Cocoros NM","Pharmacoepidemiol Drug Saf","2019","2019/09/05","","","10.1002/pds.4891"
"31482621","Effectiveness of two-drug therapy versus monotherapy as initial regimen in hypertension: A propensity score-matched cohort study in the UK Clinical Practice Research Datalink","Marinier K, Macouillard P, de Champvallins M, Deltour N, Poulter N, Mancia G.","Pharmacoepidemiol Drug Saf. 2019 Dec;28(12):1572-1582. doi: 10.1002/pds.4884. Epub 2019 Sep 3.","Marinier K","Pharmacoepidemiol Drug Saf","2019","2019/09/05","PMC6916605","","10.1002/pds.4884"
"31464069","A population-based analysis of antidiabetic medications in four Canadian provinces: Secular trends and prescribing patterns","Secrest MH, Azoulay L, Dahl M, Clemens KK, Durand M, Hu N, Targownik L, Turin TC, Dormuth CR, Filion KB.","Pharmacoepidemiol Drug Saf. 2020 Jan;29 Suppl 1:86-92. doi: 10.1002/pds.4878. Epub 2019 Aug 28.","Secrest MH","Pharmacoepidemiol Drug Saf","2020","2019/08/30","","","10.1002/pds.4878"
"31464008","Establishment of the MID-NET(®) medical information database network as a reliable and valuable database for drug safety assessments in Japan","Yamaguchi M, Inomata S, Harada S, Matsuzaki Y, Kawaguchi M, Ujibe M, Kishiba M, Fujimura Y, Kimura M, Murata K, Nakashima N, Nakayama M, Ohe K, Orii T, Sueoka E, Suzuki T, Yokoi H, Takahashi F, Uyama Y.","Pharmacoepidemiol Drug Saf. 2019 Oct;28(10):1395-1404. doi: 10.1002/pds.4879. Epub 2019 Aug 29.","Yamaguchi M","Pharmacoepidemiol Drug Saf","2019","2019/08/30","PMC6851601","","10.1002/pds.4879"
"31456304","Diabetic ketoacidosis in patients with type 2 diabetes treated with sodium glucose co-transporter 2 inhibitors versus other antihyperglycemic agents: An observational study of four US administrative claims databases","Wang L, Voss EA, Weaver J, Hester L, Yuan Z, DeFalco F, Schuemie MJ, Ryan PB, Sun D, Freedman A, Alba M, Lind J, Meininger G, Berlin JA, Rosenthal N.","Pharmacoepidemiol Drug Saf. 2019 Dec;28(12):1620-1628. doi: 10.1002/pds.4887. Epub 2019 Aug 27.","Wang L","Pharmacoepidemiol Drug Saf","2019","2019/08/29","PMC6916409","","10.1002/pds.4887"
"31452307","Did advice on the prescription of sodium valproate reduce prescriptions to women? An observational study in three European countries between 2007 and 2016","Charlton R, Damase-Michel C, Hurault-Delarue C, Gini R, Loane M, Pierini A, Puccini A, Neville A, Snowball J, Morris JK; EUROmediSAFE consortium.","Pharmacoepidemiol Drug Saf. 2019 Nov;28(11):1519-1528. doi: 10.1002/pds.4881. Epub 2019 Aug 26.","Charlton R","Pharmacoepidemiol Drug Saf","2019","2019/08/28","","","10.1002/pds.4881"
"31441188","Positive predictive value of ICD-10 codes to detect anaphylaxis due to vaccination: A validation study","Mesfin YM, Cheng AC, Tran AHL, Buttery J.","Pharmacoepidemiol Drug Saf. 2019 Oct;28(10):1353-1360. doi: 10.1002/pds.4877. Epub 2019 Aug 23.","Mesfin YM","Pharmacoepidemiol Drug Saf","2019","2019/08/24","","","10.1002/pds.4877"
"31432599","An empirical assessment of immeasurable time bias in the setting of nested case-control studies: Statins and all-cause mortality among patients with heart failure","Oh IS, Filion KB, Jeong HE, Shin JY.","Pharmacoepidemiol Drug Saf. 2019 Oct;28(10):1318-1327. doi: 10.1002/pds.4888. Epub 2019 Aug 20.","Oh IS","Pharmacoepidemiol Drug Saf","2019","2019/08/22","","","10.1002/pds.4888"
"31429168","Abstracts of the 35th International Conference on Pharmacoepidemiology & Therapeutic Risk Management, Pennsylvania Convention Center, Philadelphia, PA, USA, August 24-28, 2019","","Pharmacoepidemiol Drug Saf. 2019 Aug;28 Suppl 2:5-586. doi: 10.1002/pds.4864.","","Pharmacoepidemiol Drug Saf","2019","2019/08/21","","","10.1002/pds.4864"
"31423694","Cardiovascular safety of macrolide and fluoroquinolone antibiotics: An analysis of the WHO database of adverse drug reactions","Bonaldo G, Andriani LA, D'Annibali O, Motola D, Vaccheri A.","Pharmacoepidemiol Drug Saf. 2019 Nov;28(11):1457-1463. doi: 10.1002/pds.4873. Epub 2019 Aug 18.","Bonaldo G","Pharmacoepidemiol Drug Saf","2019","2019/08/20","","","10.1002/pds.4873"
"31418512","Individual short-acting opioids and the risk of opioid-related adverse events in adolescents","Chung CP, Callahan ST, Cooper WO, Dupont WD, Murray KT, Franklin AD, Hall K, Dudley JA, Stein CM, Ray WA.","Pharmacoepidemiol Drug Saf. 2019 Nov;28(11):1448-1456. doi: 10.1002/pds.4872. Epub 2019 Aug 16.","Chung CP","Pharmacoepidemiol Drug Saf","2019","2019/08/17","PMC6956399","NIHMS1049722","10.1002/pds.4872"
"31418506","Postmarket surveillance of arthroplasty device components using machine learning methods","Cafri G, Graves SE, Sedrakyan A, Fan J, Calhoun P, de Steiger RN, Cuthbert A, Lorimer M, Paxton EW.","Pharmacoepidemiol Drug Saf. 2019 Nov;28(11):1440-1447. doi: 10.1002/pds.4882. Epub 2019 Aug 16.","Cafri G","Pharmacoepidemiol Drug Saf","2019","2019/08/17","","","10.1002/pds.4882"
"31410963","Analyzing patient-reported outcome data when completion differs between arms in open-label trials: an application of principal stratification","Roydhouse JK, Gutman R, Bhatnagar V, Kluetz PG, Sridhara R, Mishra-Kalyani PS.","Pharmacoepidemiol Drug Saf. 2019 Oct;28(10):1386-1394. doi: 10.1002/pds.4875. Epub 2019 Aug 13.","Roydhouse JK","Pharmacoepidemiol Drug Saf","2019","2019/08/15","","","10.1002/pds.4875"
"31410932","Development of an algorithm to detect methotrexate wrong frequency error using computerized health care data","Herrinton LJ, Woodworth TS, Eworuke E, Amsden LB, Liu L, Wyeth J, Petrone A, Menzin TJ, Williams J, Goldfien R, Nguyen M.","Pharmacoepidemiol Drug Saf. 2019 Oct;28(10):1361-1368. doi: 10.1002/pds.4858. Epub 2019 Aug 13.","Herrinton LJ","Pharmacoepidemiol Drug Saf","2019","2019/08/15","","","10.1002/pds.4858"
"31407838","Agreement between self-reported and registry-based use of sleep medications and tranquilizers","Evandt J, Skurtveit S, Oftedal B, Krog NH, Nafstad P, Skovlund E, Schwarze PE, Aasvang GM.","Pharmacoepidemiol Drug Saf. 2019 Oct;28(10):1336-1343. doi: 10.1002/pds.4854. Epub 2019 Aug 13.","Evandt J","Pharmacoepidemiol Drug Saf","2019","2019/08/14","","","10.1002/pds.4854"
"31402548","A comparison of opioid-involved fatalities captured in the National Poison Data System to data derived from US death certificate literal text","Mallama CA, Trinidad JP, Swain RS, Zhao Y, Woods C, McAninch JK.","Pharmacoepidemiol Drug Saf. 2019 Oct;28(10):1377-1385. doi: 10.1002/pds.4869. Epub 2019 Aug 11.","Mallama CA","Pharmacoepidemiol Drug Saf","2019","2019/08/13","PMC6945507","NIHMS1062523","10.1002/pds.4869"
"31402533","Barriers and facilitators to conduct high-quality, large-scale safety and comparative effectiveness research: The Biologics and Biosimilars Collective Intelligence Consortium experience","Lockhart CM, McDermott CL, Felix T, Lin ND, Cziraky MJ, Mendelsohn AB, Brown JS.","Pharmacoepidemiol Drug Saf. 2020 Jul;29(7):811-813. doi: 10.1002/pds.4885. Epub 2019 Aug 11.","Lockhart CM","Pharmacoepidemiol Drug Saf","2020","2019/08/13","","","10.1002/pds.4885"
"31397051","Treatment patterns of prostate cancer with bone metastasis in Beijing: A real-world study using data from an administrative claims database","Cheng Y, Zhuo L, Pan Y, Wang S, Zong J, Sun W, Gao S, Lu J, Zhan S.","Pharmacoepidemiol Drug Saf. 2019 Nov;28(11):1501-1509. doi: 10.1002/pds.4874. Epub 2019 Aug 8.","Cheng Y","Pharmacoepidemiol Drug Saf","2019","2019/08/10","PMC6900185","","10.1002/pds.4874"
"31392844","Comparison of text processing methods in social media-based signal detection","Gavrielov-Yusim N, Kürzinger ML, Nishikawa C, Pan C, Pouget J, Epstein LB, Golant Y, Tcherny-Lessenot S, Lin S, Hamelin B, Juhaeri J.","Pharmacoepidemiol Drug Saf. 2019 Oct;28(10):1309-1317. doi: 10.1002/pds.4857. Epub 2019 Aug 7.","Gavrielov-Yusim N","Pharmacoepidemiol Drug Saf","2019","2019/08/09","","","10.1002/pds.4857"
"31390681","A comparison of two algorithms to identify sudden cardiac deaths in computerized databases","Min JY, Grijalva CG, Morrow JA, Whitmore CC, Hawley RE, Singh S, Swain RS, Griffin MR.","Pharmacoepidemiol Drug Saf. 2019 Oct;28(10):1411-1416. doi: 10.1002/pds.4845. Epub 2019 Aug 7.","Min JY","Pharmacoepidemiol Drug Saf","2019","2019/08/08","PMC6810726","NIHMS1034917","10.1002/pds.4845"
"31389118","NSAID use among residents in 68 residential aged care facilities 2014 to 2017: An analysis of duration, concomitant medication use, and high-risk conditions","Lind KE, Raban MZ, Georgiou A, Westbrook JI.","Pharmacoepidemiol Drug Saf. 2019 Nov;28(11):1480-1488. doi: 10.1002/pds.4866. Epub 2019 Aug 6.","Lind KE","Pharmacoepidemiol Drug Saf","2019","2019/08/08","","","10.1002/pds.4866"
"31385428","Chronic obstructive pulmonary disease exacerbation episodes derived from electronic health record data validated using clinical trial data","Sperrin M, Webb DJ, Patel P, Davis KJ, Collier S, Pate A, Leather DA, Pimenta JM.","Pharmacoepidemiol Drug Saf. 2019 Oct;28(10):1369-1376. doi: 10.1002/pds.4883. Epub 2019 Aug 5.","Sperrin M","Pharmacoepidemiol Drug Saf","2019","2019/08/07","PMC7028141","","10.1002/pds.4883"
"31385394","Comparison of alternative approaches to trim subjects in the tails of the propensity score distribution","Glynn RJ, Lunt M, Rothman KJ, Poole C, Schneeweiss S, Stürmer T.","Pharmacoepidemiol Drug Saf. 2019 Oct;28(10):1290-1298. doi: 10.1002/pds.4846. Epub 2019 Aug 5.","Glynn RJ","Pharmacoepidemiol Drug Saf","2019","2019/08/07","","","10.1002/pds.4846"
"31373736","Amiodarone use and the risk of acute pancreatitis: Influence of different exposure definitions","Hempenius M, Groenwold RHH, de Boer A, Klungel OH, Gardarsdottir H.","Pharmacoepidemiol Drug Saf. 2019 Dec;28(12):1563-1571. doi: 10.1002/pds.4851. Epub 2019 Aug 2.","Hempenius M","Pharmacoepidemiol Drug Saf","2019","2019/08/03","PMC6916315","","10.1002/pds.4851"
"31373423","Developing public health tools for combating the opioid epidemic","Green CA, Hazlehurst B.","Pharmacoepidemiol Drug Saf. 2019 Aug;28(8):1125-1126. doi: 10.1002/pds.4871.","Green CA","Pharmacoepidemiol Drug Saf","2019","2019/08/03","","","10.1002/pds.4871"
"31373422","Corrigendum","","Pharmacoepidemiol Drug Saf. 2019 Aug;28(8):1152-1153. doi: 10.1002/pds.4852.","","Pharmacoepidemiol Drug Saf","2019","2019/08/03","","","10.1002/pds.4852"
"31373108","Validity of hospital ICD-10-GM codes to identify acute liver injury in Germany","Timmer A, de Sordi D, Kappen S, Kohse KP, Schink T, Perez-Gutthann S, Jacquot E, Deltour N, Pladevall M.","Pharmacoepidemiol Drug Saf. 2019 Oct;28(10):1344-1352. doi: 10.1002/pds.4855. Epub 2019 Aug 1.","Timmer A","Pharmacoepidemiol Drug Saf","2019","2019/08/03","","","10.1002/pds.4855"
"31359557","Antidepressant use during pregnancy and risk of congenital heart defects: A case-time-control study","Sun Y, Pedersen LH, Wu CS, Petersen I, Sørensen HT, Olsen J.","Pharmacoepidemiol Drug Saf. 2019 Sep;28(9):1180-1193. doi: 10.1002/pds.4844. Epub 2019 Jul 29.","Sun Y","Pharmacoepidemiol Drug Saf","2019","2019/07/31","","","10.1002/pds.4844"
"31348593","Validation of drug prescription records for senior patients in Alberta's Tomorrow Project: Assessing agreement between two population-level administrative pharmaceutical databases in Alberta, Canada","Ye M, Vena JE, Johnson JA, Xu JY, Eurich DT.","Pharmacoepidemiol Drug Saf. 2019 Oct;28(10):1417-1421. doi: 10.1002/pds.4861. Epub 2019 Jul 26.","Ye M","Pharmacoepidemiol Drug Saf","2019","2019/07/27","","","10.1002/pds.4861"
"31348585","Nitrosatable drug exposure during pregnancy and risk of stillbirth","Thomsen AML, Liew Z, Riis AH, Stayner LT, Ramlau-Hansen CH, Sigsgaard T, Olsen J.","Pharmacoepidemiol Drug Saf. 2019 Sep;28(9):1204-1210. doi: 10.1002/pds.4867. Epub 2019 Jul 26.","Thomsen AML","Pharmacoepidemiol Drug Saf","2019","2019/07/27","","","10.1002/pds.4867"
"31342605","Health products' and substance use among pregnant women visiting a tertiary hospital in Belgium: A cross-sectional study","Ceulemans M, Van Calsteren K, Allegaert K, Foulon V.","Pharmacoepidemiol Drug Saf. 2019 Sep;28(9):1231-1238. doi: 10.1002/pds.4862. Epub 2019 Jul 25.","Ceulemans M","Pharmacoepidemiol Drug Saf","2019","2019/07/26","","","10.1002/pds.4862"
"31339629","Adherence to ESC guideline-recommended medications over a 36-month follow-up period after hospitalization for heart failure: Results from the EPICAL2 cohort study","Bitar S, Agrinier N, Alla F, Rossignol P, Mebazaa A, Thilly N.","Pharmacoepidemiol Drug Saf. 2019 Nov;28(11):1489-1500. doi: 10.1002/pds.4868. Epub 2019 Jul 24.","Bitar S","Pharmacoepidemiol Drug Saf","2019","2019/07/25","","","10.1002/pds.4868"
"31338935","Cardiovascular risks associated with dipeptidyl peptidase-4 inhibitors monotherapy compared with other antidiabetes drugs in the Japanese population: A nationwide cohort study","Komamine M, Kajiyama K, Ishiguro C, Uyama Y.","Pharmacoepidemiol Drug Saf. 2019 Sep;28(9):1166-1174. doi: 10.1002/pds.4847. Epub 2019 Jul 23.","Komamine M","Pharmacoepidemiol Drug Saf","2019","2019/07/25","","","10.1002/pds.4847"
"31338909","Do the 2015 Beers Criteria predict medication-related harm in older adults? Analysis from a multicentre prospective study in the United Kingdom","Parekh N, Ali K, Davies JG, Rajkumar C.","Pharmacoepidemiol Drug Saf. 2019 Nov;28(11):1464-1469. doi: 10.1002/pds.4849. Epub 2019 Jul 23.","Parekh N","Pharmacoepidemiol Drug Saf","2019","2019/07/25","","","10.1002/pds.4849"
"31338901","Reduced risk of cancer among low-dose aspirin users: Data from French health care databases","Ajrouche A, De Rycke Y, Dalichampt M, Messika Zeitoun D, Hulot JS, Estellat C, Tubach F.","Pharmacoepidemiol Drug Saf. 2019 Sep;28(9):1258-1266. doi: 10.1002/pds.4870. Epub 2019 Jul 23.","Ajrouche A","Pharmacoepidemiol Drug Saf","2019","2019/07/25","","","10.1002/pds.4870"
"31328369","National trends in hydroxyurea and opioid prescribing for sickle cell disease by office-based physicians in the United States, 1997-2017","Su ZT, Segal JB, Lanzkron S, Ogunsile FJ.","Pharmacoepidemiol Drug Saf. 2019 Sep;28(9):1246-1250. doi: 10.1002/pds.4860. Epub 2019 Jul 22.","Su ZT","Pharmacoepidemiol Drug Saf","2019","2019/07/23","","","10.1002/pds.4860"
"31328342","Concordance of hospitalizations between Clinical Practice Research Datalink and linked Hospital Episode Statistics among patients treated with oral antidiabetic therapies","Saine ME, Carbonari DM, Newcomb CW, Gallagher AM, Blak BT, Roy JA, Wood J, Cardillo S, Hennessy S, Strom BL, Lo Re V 3rd.","Pharmacoepidemiol Drug Saf. 2019 Oct;28(10):1328-1335. doi: 10.1002/pds.4853. Epub 2019 Jul 22.","Saine ME","Pharmacoepidemiol Drug Saf","2019","2019/07/23","","","10.1002/pds.4853"
"31328328","Identifying pregnancies in insurance claims data: Methods and application to retinoid teratogenic surveillance","MacDonald SC, Cohen JM, Panchaud A, McElrath TF, Huybrechts KF, Hernández-Díaz S.","Pharmacoepidemiol Drug Saf. 2019 Sep;28(9):1211-1221. doi: 10.1002/pds.4794. Epub 2019 Jul 22.","MacDonald SC","Pharmacoepidemiol Drug Saf","2019","2019/07/23","PMC6830505","NIHMS1056545","10.1002/pds.4794"
"31318470","EU postmarket surveillance plans for medical devices","Pane J, Francisca RDC, Verhamme KMC, Orozco M, Viroux H, Rebollo I, Sturkenboom MCJM.","Pharmacoepidemiol Drug Saf. 2019 Sep;28(9):1155-1165. doi: 10.1002/pds.4859. Epub 2019 Jul 18.","Pane J","Pharmacoepidemiol Drug Saf","2019","2019/07/19","PMC6771951","","10.1002/pds.4859"
"31313427","A concept-wide association study to identify potential risk factors for nonadherence among prevalent users of antihypertensives","Singh K, Choudhry NK, Krumme AA, McKay C, McElwee NE, Kimura J, Franklin JM.","Pharmacoepidemiol Drug Saf. 2019 Oct;28(10):1299-1308. doi: 10.1002/pds.4850. Epub 2019 Jul 16.","Singh K","Pharmacoepidemiol Drug Saf","2019","2019/07/18","","","10.1002/pds.4850"
"31313390","The comparative effectiveness of fourth-line drugs in resistant hypertension: An application in electronic health record data","Sinnott SJ, Smeeth L, Williamson E, Perel P, Nitsch D, Tomlinson LA, Douglas IJ.","Pharmacoepidemiol Drug Saf. 2019 Sep;28(9):1267-1277. doi: 10.1002/pds.4808. Epub 2019 Jul 16.","Sinnott SJ","Pharmacoepidemiol Drug Saf","2019","2019/07/18","PMC6771826","","10.1002/pds.4808"
"31298463","Methodologic considerations for noninterventional studies of switching from reference biologic to biosimilars","Desai RJ, Kim SC, Curtis JR, Bosco JLF, Eichelberger B, Barr CE, Lockhart CM, Bradbury BD, Clewell J, Cohen HP, Gagne JJ; Biologics and Biosimilars Collective Intelligence Consortium (BBCIC) Switching Workgroup.","Pharmacoepidemiol Drug Saf. 2020 Jul;29(7):757-769. doi: 10.1002/pds.4809. Epub 2019 Jul 12.","Desai RJ","Pharmacoepidemiol Drug Saf","2020","2019/07/13","","","10.1002/pds.4809"
"31298445","Antidepressant continuation in pregnancy and risk of gestational diabetes","Wartko PD, Weiss NS, Enquobahrie DA, Chan KCG, Stephenson-Famy A, Mueller BA, Dublin S.","Pharmacoepidemiol Drug Saf. 2019 Sep;28(9):1194-1203. doi: 10.1002/pds.4799. Epub 2019 Jul 12.","Wartko PD","Pharmacoepidemiol Drug Saf","2019","2019/07/13","PMC6728166","NIHMS1025903","10.1002/pds.4799"
"31286636","Implementation fidelity of patient-centered prescription label to promote opioid safe use","McCarthy DM, Russell AM, Eifler MR, Opsasnick LA, Lyden AE, Gravenor SJ, Montague E, Hur SI, Cameron KA, Curtis LM, Wolf MS.","Pharmacoepidemiol Drug Saf. 2019 Sep;28(9):1251-1257. doi: 10.1002/pds.4795. Epub 2019 Jul 9.","McCarthy DM","Pharmacoepidemiol Drug Saf","2019","2019/07/10","","","10.1002/pds.4795"
"31286617","Use of opioids during pregnancy and effects of pregnancy outcomes","Fältmarch S, Perttilä I, Tuomi U, Kautiainen H, Gissler M, Pennanen P, Eriksson JG, Laine MK.","Pharmacoepidemiol Drug Saf. 2019 Sep;28(9):1239-1245. doi: 10.1002/pds.4848. Epub 2019 Jul 9.","Fältmarch S","Pharmacoepidemiol Drug Saf","2019","2019/07/10","","","10.1002/pds.4848"
"31286606","Validation of mother-infant linkage using Medicaid Case ID variable within the Medicaid Analytic eXtract (MAX) database","Knox CA, Hampp C, Palmsten K, Zhu Y, Setoguchi S, Brumback B, Segal R, Winterstein AG.","Pharmacoepidemiol Drug Saf. 2019 Sep;28(9):1222-1230. doi: 10.1002/pds.4843. Epub 2019 Jul 9.","Knox CA","Pharmacoepidemiol Drug Saf","2019","2019/07/10","PMC8756527","NIHMS1756761","10.1002/pds.4843"
"31271484","Sibship and dispensing patterns of asthma medication in young children-a population-based study","Dahlén E, Ekberg S, Lundholm C, Jonsson EW, Kull I, Wettermark B, Almqvist C.","Pharmacoepidemiol Drug Saf. 2019 Aug;28(8):1109-1116. doi: 10.1002/pds.4802. Epub 2019 Jul 4.","Dahlén E","Pharmacoepidemiol Drug Saf","2019","2019/07/05","","","10.1002/pds.4802"
"31267629","Policy-induced selection bias in pharmacoepidemiology: The example of coverage for Alzheimer's medications in British Columbia","Fisher A, Carney G, Bassett K, Maclure KM, Dormuth CR.","Pharmacoepidemiol Drug Saf. 2019 Aug;28(8):1067-1076. doi: 10.1002/pds.4804. Epub 2019 Jul 3.","Fisher A","Pharmacoepidemiol Drug Saf","2019","2019/07/04","PMC6771502","","10.1002/pds.4804"
"31237054","Impact of a population-based asthma management program in France (Sophia Asthme): A matched controlled before-and-after quasi-experimental study using the French health insurance database (SNDS)","Dib F, de Rycke Y, Guillo S, Lafourcade A, Raherison C, Taillé C, Tubach F.","Pharmacoepidemiol Drug Saf. 2019 Aug;28(8):1097-1108. doi: 10.1002/pds.4842. Epub 2019 Jun 24.","Dib F","Pharmacoepidemiol Drug Saf","2019","2019/06/26","","","10.1002/pds.4842"
"31222967","A simulation study of the statistical power and signaling characteristics of an early season sequential test for influenza vaccine safety","Forshee RA, Hu M, Arya D, Perez-Vilar S, Anderson SA, Lo AC, Swarr M, Wernecke M, MaCurdy T, Chu S, Kelman J.","Pharmacoepidemiol Drug Saf. 2019 Aug;28(8):1077-1085. doi: 10.1002/pds.4807. Epub 2019 Jun 20.","Forshee RA","Pharmacoepidemiol Drug Saf","2019","2019/06/22","","","10.1002/pds.4807"
"31219227","A European multicentre drug utilisation study of the impact of regulatory measures on prescribing of codeine for pain in children","Hedenmalm K, Blake K, Donegan K, Macia MA, Gil M, Williams J, Montero D, Candore G, Morales D, Kurz X, Arlett P.","Pharmacoepidemiol Drug Saf. 2019 Aug;28(8):1086-1096. doi: 10.1002/pds.4836. Epub 2019 Jun 20.","Hedenmalm K","Pharmacoepidemiol Drug Saf","2019","2019/06/21","PMC6771637","","10.1002/pds.4836"
"31218780","Using natural language processing of clinical text to enhance identification of opioid-related overdoses in electronic health records data","Hazlehurst B, Green CA, Perrin NA, Brandes J, Carrell DS, Baer A, DeVeaugh-Geiss A, Coplan PM.","Pharmacoepidemiol Drug Saf. 2019 Aug;28(8):1143-1151. doi: 10.1002/pds.4810. Epub 2019 Jun 19.","Hazlehurst B","Pharmacoepidemiol Drug Saf","2019","2019/06/21","PMC6772185","","10.1002/pds.4810"
"31209934","Adverse drug event patterns experienced by patients with diabetes: A diary study in primary care","Denig P, van Puijenbroek EP, Soliman N, Mol PGM, de Vries ST.","Pharmacoepidemiol Drug Saf. 2019 Sep;28(9):1175-1179. doi: 10.1002/pds.4839. Epub 2019 Jun 17.","Denig P","Pharmacoepidemiol Drug Saf","2019","2019/06/19","PMC6771843","","10.1002/pds.4839"
"31197928","Methods to generate and validate a Pregnancy Register in the UK Clinical Practice Research Datalink primary care database","Minassian C, Williams R, Meeraus WH, Smeeth L, Campbell OMR, Thomas SL.","Pharmacoepidemiol Drug Saf. 2019 Jul;28(7):923-933. doi: 10.1002/pds.4811. Epub 2019 Jun 13.","Minassian C","Pharmacoepidemiol Drug Saf","2019","2019/06/15","PMC6618019","","10.1002/pds.4811"
"31197912","Development and preliminary validation of an instrument to enable laypersons to assess suspected side effects from medicines","O'Donovan B, Rodgers RM, Cox AR, Krska J.","Pharmacoepidemiol Drug Saf. 2019 Jul;28(7):1023-1031. doi: 10.1002/pds.4841. Epub 2019 Jun 13.","O'Donovan B","Pharmacoepidemiol Drug Saf","2019","2019/06/15","","","10.1002/pds.4841"
"31197887","Identification of gastrointestinal perforation based on ICD-10 code in a Japanese administrative medical information database and associated drug exposure risk factors","Tanigawa M, Kataoka Y, Kishino T, Kohama M, Uyama Y, Suzuki Y, Yokoi H.","Pharmacoepidemiol Drug Saf. 2019 Jul;28(7):976-984. doi: 10.1002/pds.4837. Epub 2019 Jun 13.","Tanigawa M","Pharmacoepidemiol Drug Saf","2019","2019/06/15","","","10.1002/pds.4837"
"31189217","Time to onset in statistical signal detection revisited: A follow-up study in long-term onset adverse drug reactions","Scholl JHG, van Hunsel FPAM, Hak E, van Puijenbroek EP.","Pharmacoepidemiol Drug Saf. 2019 Oct;28(10):1283-1289. doi: 10.1002/pds.4790. Epub 2019 Jun 12.","Scholl JHG","Pharmacoepidemiol Drug Saf","2019","2019/06/13","PMC6852418","","10.1002/pds.4790"
"31179613","Patient-reported factors associated with the desire to continue taking sleep-inducing drugs after hospital discharge: A survey of older adults","Heinemann S, Neukirchen F, Nau R, Hummers E, Himmel W.","Pharmacoepidemiol Drug Saf. 2019 Jul;28(7):1014-1022. doi: 10.1002/pds.4806. Epub 2019 Jun 10.","Heinemann S","Pharmacoepidemiol Drug Saf","2019","2019/06/11","PMC6618328","","10.1002/pds.4806"
"31179606","Determination of good pharmacovigilance reporting practices in Quebec hospital pharmacies using a modified Delphi method","Rault P, Mégrourèche É, Labarre JS, Pettersen-Coulombe F, Lebel D, Bussières JF.","Pharmacoepidemiol Drug Saf. 2019 Jul;28(7):985-992. doi: 10.1002/pds.4840. Epub 2019 Jun 10.","Rault P","Pharmacoepidemiol Drug Saf","2019","2019/06/11","","","10.1002/pds.4840"
"31172633","Validity of ICD-9 and ICD-10 codes used to identify acute liver injury: A study in three European data sources","Forns J, Cainzos-Achirica M, Hellfritzsch M, Morros R, Poblador-Plou B, Hallas J, Giner-Soriano M, Prados-Torres A, Pottegård A, Cortés J, Castellsagué J, Jacquot E, Deltour N, Perez-Gutthann S, Pladevall M.","Pharmacoepidemiol Drug Saf. 2019 Jul;28(7):965-975. doi: 10.1002/pds.4803. Epub 2019 Jun 6.","Forns J","Pharmacoepidemiol Drug Saf","2019","2019/06/08","PMC6618105","","10.1002/pds.4803"
"31168897","Zostavax vaccine effectiveness among US elderly using real-world evidence: Addressing unmeasured confounders by using multiple imputation after linking beneficiary surveys with Medicare claims","Izurieta HS, Wu X, Lu Y, Chillarige Y, Wernecke M, Lindaas A, Pratt D, MaCurdy TE, Chu S, Kelman J, Forshee R.","Pharmacoepidemiol Drug Saf. 2019 Jul;28(7):993-1001. doi: 10.1002/pds.4801. Epub 2019 Jun 5.","Izurieta HS","Pharmacoepidemiol Drug Saf","2019","2019/06/07","","","10.1002/pds.4801"
"31168860","Doctor hopping and doctor shopping for prescription opioids associated with increased odds of high-risk use","Young SG, Hayes CJ, Aram J, Tait MA.","Pharmacoepidemiol Drug Saf. 2019 Aug;28(8):1117-1124. doi: 10.1002/pds.4838. Epub 2019 Jun 5.","Young SG","Pharmacoepidemiol Drug Saf","2019","2019/06/07","PMC6679752","NIHMS1029830","10.1002/pds.4838"
"31148344","Safety of medicines-Pharmacists' knowledge, practice, and attitudes toward pharmacovigilance and adverse drug reactions reporting process","Kopciuch D, Zaprutko T, Paczkowska A, Ratajczak P, Zielińska-Tomczak Ł, Kus K, Nowakowska E.","Pharmacoepidemiol Drug Saf. 2019 Dec;28(12):1543-1551. doi: 10.1002/pds.4792. Epub 2019 May 30.","Kopciuch D","Pharmacoepidemiol Drug Saf","2019","2019/06/01","","","10.1002/pds.4792"
"31148288","Barriers towards effective pharmacovigilance systems of biosimilars in rheumatology: A Latin American survey","Castañeda-Hernández G, Sandoval H, Coindreau J, Rodriguez-Davison LF, Pineda C.","Pharmacoepidemiol Drug Saf. 2019 Aug;28(8):1035-1044. doi: 10.1002/pds.4785. Epub 2019 May 30.","Castañeda-Hernández G","Pharmacoepidemiol Drug Saf","2019","2019/06/01","PMC6771580","","10.1002/pds.4785"
"31144403","Assessment of ICD-10-CM code assignment validity for case finding of outpatient anticoagulant-related bleeding among Medicare beneficiaries","Shehab N, Ziemba R, Campbell KN, Geller AI, Moro RN, Gage BF, Budnitz DS, Yang TH.","Pharmacoepidemiol Drug Saf. 2019 Jul;28(7):951-964. doi: 10.1002/pds.4783. Epub 2019 May 29.","Shehab N","Pharmacoepidemiol Drug Saf","2019","2019/05/31","","","10.1002/pds.4783"
"31134701","Nature and frequency of dosing instructions on prescription labels in primary care","Borgsteede SD, Heringa M.","Pharmacoepidemiol Drug Saf. 2019 Aug;28(8):1060-1066. doi: 10.1002/pds.4796. Epub 2019 May 28.","Borgsteede SD","Pharmacoepidemiol Drug Saf","2019","2019/05/29","","","10.1002/pds.4796"
"31131966","Adverse drug reaction reporting by community pharmacists-The barriers and facilitators","Hughes ML, Weiss M.","Pharmacoepidemiol Drug Saf. 2019 Dec;28(12):1552-1559. doi: 10.1002/pds.4800. Epub 2019 May 27.","Hughes ML","Pharmacoepidemiol Drug Saf","2019","2019/05/28","","","10.1002/pds.4800"
"31131965","A tool for empirical equipoise assessment in multigroup comparative effectiveness research","Yoshida K, Solomon DH, Haneuse S, Kim SC, Patorno E, Tedeschi SK, Lyu H, Hernández-Díaz S, Glynn RJ.","Pharmacoepidemiol Drug Saf. 2019 Jul;28(7):934-941. doi: 10.1002/pds.4767. Epub 2019 May 27.","Yoshida K","Pharmacoepidemiol Drug Saf","2019","2019/05/28","PMC7057252","NIHMS1062393","10.1002/pds.4767"
"31131950","Safety profile of traditional Chinese herbal injection: An analysis of a spontaneous reporting system in China","Li H, Deng J, Deng L, Ren X, Xia J.","Pharmacoepidemiol Drug Saf. 2019 Jul;28(7):1002-1013. doi: 10.1002/pds.4805. Epub 2019 May 27.","Li H","Pharmacoepidemiol Drug Saf","2019","2019/05/28","","","10.1002/pds.4805"
"31112361","Short lookback periods causing exaggerated stroke risk estimates in atrial fibrillation may expose patients to unnecessary anticoagulant treatment","Friberg L.","Pharmacoepidemiol Drug Saf. 2019 Aug;28(8):1054-1059. doi: 10.1002/pds.4793. Epub 2019 May 21.","Friberg L","Pharmacoepidemiol Drug Saf","2019","2019/05/22","","","10.1002/pds.4793"
"31095831","Development of an algorithm to identify inpatient opioid-related overdoses and oversedation using electronic data","Green CA, Hazlehurst B, Brandes J, Sapp DS, Janoff SL, Coplan PM, DeVeaugh-Geiss A.","Pharmacoepidemiol Drug Saf. 2019 Aug;28(8):1138-1142. doi: 10.1002/pds.4797. Epub 2019 May 16.","Green CA","Pharmacoepidemiol Drug Saf","2019","2019/05/17","PMC6767384","","10.1002/pds.4797"
"31094048","A theoretical exploration of therapeutic monomania as a physician-based instrumental variable","Potter BJ, Dormuth C, Le Lorier J.","Pharmacoepidemiol Drug Saf. 2020 Jan;29 Suppl 1(Suppl 1):45-52. doi: 10.1002/pds.4757. Epub 2019 May 15.","Potter BJ","Pharmacoepidemiol Drug Saf","2020","2019/05/17","PMC6973254","","10.1002/pds.4757"
"31074570","Use of real-world evidence from healthcare utilization data to evaluate drug safety during pregnancy","Huybrechts KF, Bateman BT, Hernández-Díaz S.","Pharmacoepidemiol Drug Saf. 2019 Jul;28(7):906-922. doi: 10.1002/pds.4789. Epub 2019 May 10.","Huybrechts KF","Pharmacoepidemiol Drug Saf","2019","2019/05/11","PMC6823105","NIHMS1056425","10.1002/pds.4789"
"31066490","Incidence, risk factors, and outcomes of warfarin-associated major bleeding in Thai population","Priksri W, Rattanavipanon W, Saejear W, Tanyasaensook K, Phrommintikul A, Chulavatnatol S, Nathisuwan S.","Pharmacoepidemiol Drug Saf. 2019 Jul;28(7):942-950. doi: 10.1002/pds.4781. Epub 2019 May 8.","Priksri W","Pharmacoepidemiol Drug Saf","2019","2019/05/09","","","10.1002/pds.4781"
"31066478","Comment on ""How pharmacoepidemiology networks can manage distributed analyses to improve replicability and transparency and minimize bias""","Schuemie MJ, Madigan D, Ryan PB, Reich C, Suchard MA, Berlin JA, Hripcsak G.","Pharmacoepidemiol Drug Saf. 2019 Jul;28(7):1032-1033. doi: 10.1002/pds.4798. Epub 2019 May 8.","Schuemie MJ","Pharmacoepidemiol Drug Saf","2019","2019/05/09","","","10.1002/pds.4798"
"31062446","Identification and mapping of worldwide sources of generic real-world data","Wang X, Lahoz R, Jawla S, Przybysz R, Kahler KH, Burdukova L, Venkata SK, Nassim M, Jalapu A, Justo N.","Pharmacoepidemiol Drug Saf. 2019 Jul;28(7):899-905. doi: 10.1002/pds.4782. Epub 2019 May 6.","Wang X","Pharmacoepidemiol Drug Saf","2019","2019/05/08","","","10.1002/pds.4782"
"31062443","Change in risk for narcolepsy over time and impact of definition of onset date following vaccination with AS03 adjuvanted pandemic A/H1N1 influenza vaccine (Pandemrix) during the 2009 H1N1 influenza pandemic","Granath F, Gedeborg R, Smedje H, Feltelius N.","Pharmacoepidemiol Drug Saf. 2019 Aug;28(8):1045-1053. doi: 10.1002/pds.4788. Epub 2019 May 6.","Granath F","Pharmacoepidemiol Drug Saf","2019","2019/05/08","","","10.1002/pds.4788"
"31050092","Engaging stakeholders in pharmacoepidemiology research: Current state and recommendations","Camelo Castillo W, Heath N, Kim J, Yang K, Ritchey ME, dosReis S, Santanello N, West SL.","Pharmacoepidemiol Drug Saf. 2019 Jun;28(6):766-776. doi: 10.1002/pds.4786. Epub 2019 May 2.","Camelo Castillo W","Pharmacoepidemiol Drug Saf","2019","2019/05/04","","","10.1002/pds.4786"
"31050078","Impact of antibiotic treatment duration on outcomes in older men with suspected urinary tract infection: Retrospective cohort study","Ahmed H, Farewell D, Francis NA, Paranjothy S, Butler CC.","Pharmacoepidemiol Drug Saf. 2019 Jun;28(6):857-866. doi: 10.1002/pds.4791. Epub 2019 May 2.","Ahmed H","Pharmacoepidemiol Drug Saf","2019","2019/05/04","","","10.1002/pds.4791"
"31044478","Variation of clinical manifestations according to culprit drugs in DRESS syndrome","Sim DW, Yu JE, Jeong J, Jung JW, Kang HR, Kang DY, Ye YM, Jee YK, Kim S, Park JW, Kang MG, Kim SH, Park HK, Yang MS, Hur GY, Lee JK, Choi JH, Kwon YE, Koh YI; Korean Severe Cutaneous Adverse Reactions Consortium.","Pharmacoepidemiol Drug Saf. 2019 Jun;28(6):840-848. doi: 10.1002/pds.4774. Epub 2019 May 1.","Sim DW","Pharmacoepidemiol Drug Saf","2019","2019/05/03","","","10.1002/pds.4774"
"31038268","Effects of pharmacist participation in chronic kidney disease (CKD) network and CKD manual distribution on drug-related kidney injury","Yamamoto T, Nakayama I, Kawakatsu Y, Yamamoto T, Ishigami N, Watanuki K, Okabe T, Yokoyama H.","Pharmacoepidemiol Drug Saf. 2019 Jun;28(6):887-896. doi: 10.1002/pds.4787. Epub 2019 Apr 30.","Yamamoto T","Pharmacoepidemiol Drug Saf","2019","2019/05/01","","","10.1002/pds.4787"
"31020755","Identifying and classifying opioid-related overdoses: A validation study","Green CA, Perrin NA, Hazlehurst B, Janoff SL, DeVeaugh-Geiss A, Carrell DS, Grijalva CG, Liang C, Enger CL, Coplan PM.","Pharmacoepidemiol Drug Saf. 2019 Aug;28(8):1127-1137. doi: 10.1002/pds.4772. Epub 2019 Apr 24.","Green CA","Pharmacoepidemiol Drug Saf","2019","2019/04/26","PMC6767606","","10.1002/pds.4772"
"31020732","Evaluating the use of bootstrapping in cohort studies conducted with 1:1 propensity score matching-A plasmode simulation study","Desai RJ, Wyss R, Abdia Y, Toh S, Johnson M, Lee H, Karami S, Major JM, Nguyen M, Wang SV, Franklin JM, Gagne JJ.","Pharmacoepidemiol Drug Saf. 2019 Jun;28(6):879-886. doi: 10.1002/pds.4784. Epub 2019 Apr 24.","Desai RJ","Pharmacoepidemiol Drug Saf","2019","2019/04/26","","","10.1002/pds.4784"
"30993835","All-cause pneumonia in children after the introduction of pneumococcal vaccines in the United Kingdom: A population-based study","Lau WCY, Bielicki J, Tersigni C, Saxena S, Wong ICK, Sharland M, Hsia Y.","Pharmacoepidemiol Drug Saf. 2019 Jun;28(6):821-829. doi: 10.1002/pds.4770. Epub 2019 Apr 16.","Lau WCY","Pharmacoepidemiol Drug Saf","2019","2019/04/18","","","10.1002/pds.4770"
"30993825","Classification and characteristics of on-label and off-label apixaban use in Denmark and Sweden","Vinter N, Linder M, Andersen M, Pedersen AB, Madsen M, Schachterle SE, Ataher Q, Mo J, Johnsen SP, Ehrenstein V.","Pharmacoepidemiol Drug Saf. 2019 Jun;28(6):867-878. doi: 10.1002/pds.4778. Epub 2019 Apr 16.","Vinter N","Pharmacoepidemiol Drug Saf","2019","2019/04/18","","","10.1002/pds.4778"
"30993808","Limitations for health research with restricted data collection from UK primary care","Strongman H, Williams R, Meeraus W, Murray-Thomas T, Campbell J, Carty L, Dedman D, Gallagher AM, Oyinlola J, Kousoulis A, Valentine J.","Pharmacoepidemiol Drug Saf. 2019 Jun;28(6):777-787. doi: 10.1002/pds.4765. Epub 2019 Apr 16.","Strongman H","Pharmacoepidemiol Drug Saf","2019","2019/04/18","PMC6618795","","10.1002/pds.4765"
"30945387","The utilization and challenges of Japan's MID-NET(®) medical information database network in postmarketing drug safety assessments: A summary of pilot pharmacoepidemiological studies","Yamada K, Itoh M, Fujimura Y, Kimura M, Murata K, Nakashima N, Nakayama M, Ohe K, Orii T, Sueoka E, Suzuki T, Yokoi H, Ishiguro C, Uyama Y; MID-NET® project group.","Pharmacoepidemiol Drug Saf. 2019 May;28(5):601-608. doi: 10.1002/pds.4777. Epub 2019 Apr 3.","Yamada K","Pharmacoepidemiol Drug Saf","2019","2019/04/05","","","10.1002/pds.4777"
"30945381","Risk of second breast cancer events with chronic opioid use in breast cancer survivors","Boudreau DM, Chen L, Yu O, Bowles EJA, Chubak J.","Pharmacoepidemiol Drug Saf. 2019 May;28(5):740-753. doi: 10.1002/pds.4779. Epub 2019 Apr 3.","Boudreau DM","Pharmacoepidemiol Drug Saf","2019","2019/04/05","PMC6553619","NIHMS1016503","10.1002/pds.4779"
"30920085","The relation between falls and medication use among elderly in assisted living facilities","Hamza SA, Adly NN, Abdelrahman EE, Fouad IM.","Pharmacoepidemiol Drug Saf. 2019 Jun;28(6):849-856. doi: 10.1002/pds.4775. Epub 2019 Mar 28.","Hamza SA","Pharmacoepidemiol Drug Saf","2019","2019/03/29","","","10.1002/pds.4775"
"30920070","The association between proton pump inhibitor use and the risk of tuberculosis: A case-control study","Song HJ, Park H, Park S, Kwon JW.","Pharmacoepidemiol Drug Saf. 2019 Jun;28(6):830-839. doi: 10.1002/pds.4773. Epub 2019 Mar 28.","Song HJ","Pharmacoepidemiol Drug Saf","2019","2019/03/29","","","10.1002/pds.4773"
"30920062","Impact of a prescription drug monitoring program use mandate on potentially problematic patterns of opioid analgesic prescriptions in New York City","Bachhuber MA, Tuazon E, Nolan ML, Kunins HV, Paone D.","Pharmacoepidemiol Drug Saf. 2019 May;28(5):734-739. doi: 10.1002/pds.4766. Epub 2019 Mar 28.","Bachhuber MA","Pharmacoepidemiol Drug Saf","2019","2019/03/29","PMC6689227","NIHMS1039590","10.1002/pds.4766"
"30919516","Effectiveness of drug allergy card to prevent repeated prescribing of allergenic medications in a Malaysian public hospital","Lee FY, Chan HK, Wong HS.","Pharmacoepidemiol Drug Saf. 2019 May;28(5):760-761. doi: 10.1002/pds.4780. Epub 2019 Mar 28.","Lee FY","Pharmacoepidemiol Drug Saf","2019","2019/03/29","","","10.1002/pds.4780"
"30916840","Ascertaining vaccine exposure at the brand level using real-world data","Lasky T.","Pharmacoepidemiol Drug Saf. 2019 Jun;28(6):763-765. doi: 10.1002/pds.4776. Epub 2019 Mar 27.","Lasky T","Pharmacoepidemiol Drug Saf","2019","2019/03/28","","","10.1002/pds.4776"
"30916833","Heterogeneity in the treatment of bloodstream infections identified from antibiotic exposure mapping","Caffrey AR, Babcock ZR, Lopes VV, Timbrook TT, LaPlante KL.","Pharmacoepidemiol Drug Saf. 2019 May;28(5):707-715. doi: 10.1002/pds.4761. Epub 2019 Mar 27.","Caffrey AR","Pharmacoepidemiol Drug Saf","2019","2019/03/28","PMC6593441","","10.1002/pds.4761"
"30909323","The diversion of nonscheduled psychoactive prescription medications in the United States, 2002 to 2017","Kurtz SP, Buttram ME, Margolin ZR, Wogenstahl K.","Pharmacoepidemiol Drug Saf. 2019 May;28(5):700-706. doi: 10.1002/pds.4771. Epub 2019 Mar 25.","Kurtz SP","Pharmacoepidemiol Drug Saf","2019","2019/03/26","","","10.1002/pds.4771"
"30908785","The accuracy of date of death recording in the Clinical Practice Research Datalink GOLD database in England compared with the Office for National Statistics death registrations","Gallagher AM, Dedman D, Padmanabhan S, Leufkens HGM, de Vries F.","Pharmacoepidemiol Drug Saf. 2019 May;28(5):563-569. doi: 10.1002/pds.4747. Epub 2019 Mar 25.","Gallagher AM","Pharmacoepidemiol Drug Saf","2019","2019/03/26","PMC6593793","","10.1002/pds.4747"
"30891850","Development and validation of a 5-year mortality prediction model using regularized regression and Medicare data","Lund JL, Kuo TM, Brookhart MA, Meyer AM, Dalton AF, Kistler CE, Wheeler SB, Lewis CL.","Pharmacoepidemiol Drug Saf. 2019 May;28(5):584-592. doi: 10.1002/pds.4769. Epub 2019 Mar 19.","Lund JL","Pharmacoepidemiol Drug Saf","2019","2019/03/21","PMC6519458","NIHMS1014037","10.1002/pds.4769"
"30873729","An evaluation of the impact of missing deaths on overall survival analyses of advanced non-small cell lung cancer patients conducted in an electronic health records database","Carrigan G, Whipple S, Taylor MD, Torres AZ, Gossai A, Arnieri B, Tucker M, Hofmeister PP, Lambert P, Griffith SD, Capra WB.","Pharmacoepidemiol Drug Saf. 2019 May;28(5):572-581. doi: 10.1002/pds.4758. Epub 2019 Mar 14.","Carrigan G","Pharmacoepidemiol Drug Saf","2019","2019/03/16","PMC6594237","","10.1002/pds.4758"
"30873707","Impact of delisting high-strength opioid formulations from a public drug benefit formulary on opioid utilization in Ontario, Canada","Martins D, Khuu W, Tadrous M, Juurlink DN, Mamdani MM, Paterson JM, Gomes T; Ontario Drug Policy Research Network.","Pharmacoepidemiol Drug Saf. 2019 May;28(5):726-733. doi: 10.1002/pds.4764. Epub 2019 Mar 14.","Martins D","Pharmacoepidemiol Drug Saf","2019","2019/03/16","PMC6518867","","10.1002/pds.4764"
"30873670","Commentary in response to Carrigan et al: ""An Evaluation of the Impact of Missing Deaths on Overall Survival Analyses of Advanced Non-small Cell Lung Cancer Patients Conducted in an Electronic Health Records Database""","Wang SV.","Pharmacoepidemiol Drug Saf. 2019 May;28(5):582-583. doi: 10.1002/pds.4768. Epub 2019 Mar 14.","Wang SV","Pharmacoepidemiol Drug Saf","2019","2019/03/16","","","10.1002/pds.4768"
"30861622","Utilization of transdermal fentanyl in German nursing home residents from 2010 to 2014","Jobski K, Bantel C, Hoffmann F.","Pharmacoepidemiol Drug Saf. 2019 May;28(5):754-759. doi: 10.1002/pds.4753. Epub 2019 Mar 12.","Jobski K","Pharmacoepidemiol Drug Saf","2019","2019/03/13","","","10.1002/pds.4753"
"30861596","Patterns of endocrine therapy in a national cohort of early stage HER2-positive breast cancer patients","Tervonen HE, Daniels B, Tang M, Preen DB, Pearson SA.","Pharmacoepidemiol Drug Saf. 2019 Jun;28(6):812-820. doi: 10.1002/pds.4751. Epub 2019 Mar 12.","Tervonen HE","Pharmacoepidemiol Drug Saf","2019","2019/03/13","","","10.1002/pds.4751"
"30854762","Examination of the prescription of antiepileptic drugs to prenatal and postpartum women in Japan from a health administrative database","Ishikawa T, Obara T, Jin K, Nishigori H, Miyakoda K, Suzuka M, Ikeda-Sakai Y, Akazawa M, Nakasato N, Yaegashi N, Kuriyama S, Mano N.","Pharmacoepidemiol Drug Saf. 2019 Jun;28(6):804-811. doi: 10.1002/pds.4749. Epub 2019 Mar 10.","Ishikawa T","Pharmacoepidemiol Drug Saf","2019","2019/03/12","","","10.1002/pds.4749"
"30848536","Proton-pump inhibitors and the risk of Clostridium difficile-associated diarrhea in high-risk antibiotics users: A population-based case-crossover study","Hong SH, Lee EK, Shin JY.","Pharmacoepidemiol Drug Saf. 2019 Apr;28(4):479-488. doi: 10.1002/pds.4745. Epub 2019 Mar 8.","Hong SH","Pharmacoepidemiol Drug Saf","2019","2019/03/09","","","10.1002/pds.4745"
"30848013","Clinical outcomes and risk factors of thromboprophylaxis with rivaroxaban versus aspirin in patients undergoing hip arthroplasty in low-incidence population: A nationwide study in Korea","Kim HA, Lee JY, Park SH, Kang J, Choi KS, Rhie SJ.","Pharmacoepidemiol Drug Saf. 2019 Apr;28(4):507-514. doi: 10.1002/pds.4737. Epub 2019 Mar 7.","Kim HA","Pharmacoepidemiol Drug Saf","2019","2019/03/09","","","10.1002/pds.4737"
"30848010","Personalized benefit-risk assessments combining clinical trial and real-world data provide further insights into which patients may benefit most from therapy: Demonstration for a new oral antiplatelet therapy","Pinto CA, Tervonen T, Marsh K, Lambrelli D, Schultze A, Tershakovec A, Hyacinthe J, Prawitz T, Hammad TA.","Pharmacoepidemiol Drug Saf. 2019 Apr;28(4):443-451. doi: 10.1002/pds.4752. Epub 2019 Mar 7.","Pinto CA","Pharmacoepidemiol Drug Saf","2019","2019/03/09","","","10.1002/pds.4752"
"30848006","Availability of drug at convenient stores is not associated with an increased incidence of their poisoning","Jung KY, Kim T, Hwang SY, Yoon H, Shin TG, Sim MS, Jo IJ, Cha WC.","Pharmacoepidemiol Drug Saf. 2019 Apr;28(4):536-543. doi: 10.1002/pds.4760. Epub 2019 Mar 7.","Jung KY","Pharmacoepidemiol Drug Saf","2019","2019/03/09","","","10.1002/pds.4760"
"30847998","Perinatal deaths after sildenafil treatment of fetal growth restriction raise the issue of safety in randomised clinical trials","Lombardi N, Crescioli G, Bettiol A, Ravaldi C, Vannacci A.","Pharmacoepidemiol Drug Saf. 2019 Apr;28(4):437-438. doi: 10.1002/pds.4740. Epub 2019 Mar 7.","Lombardi N","Pharmacoepidemiol Drug Saf","2019","2019/03/09","","","10.1002/pds.4740"
"30843332","Accuracy of a composite event definition for hypoglycemia","Min JY, Presley CA, Wharton J, Griffin MR, Greevy RA Jr, Hung AM, Chipman J, Grijalva CG, Hackstadt AJ, Roumie CL.","Pharmacoepidemiol Drug Saf. 2019 May;28(5):625-631. doi: 10.1002/pds.4712. Epub 2019 Mar 6.","Min JY","Pharmacoepidemiol Drug Saf","2019","2019/03/08","PMC6497537","NIHMS998752","10.1002/pds.4712"
"30843303","The Devil's in the details: Reports on reproducibility in pharmacoepidemiologic studies","Petrone AB, DuCott A, Gagne JJ, Toh S, Maro JC.","Pharmacoepidemiol Drug Saf. 2019 May;28(5):671-679. doi: 10.1002/pds.4730. Epub 2019 Mar 6.","Petrone AB","Pharmacoepidemiol Drug Saf","2019","2019/03/08","","","10.1002/pds.4730"
"30840349","Secret safety warnings on medicines: A case study of information access requests","Torka M, Mintzes B, Bhasale A, Fabbri A, Perry L, Lexchin J.","Pharmacoepidemiol Drug Saf. 2019 Apr;28(4):551-555. doi: 10.1002/pds.4762. Epub 2019 Mar 6.","Torka M","Pharmacoepidemiol Drug Saf","2019","2019/03/07","","","10.1002/pds.4762"
"30839139","Population-based estimate of the use of intermittent androgen deprivation therapy in prostate cancer patients in Catalonia, Spain","Cordero JA, Sancho G, Bonfill X.","Pharmacoepidemiol Drug Saf. 2019 Jun;28(6):796-803. doi: 10.1002/pds.4744. Epub 2019 Mar 6.","Cordero JA","Pharmacoepidemiol Drug Saf","2019","2019/03/07","","","10.1002/pds.4744"
"30838712","Prenatal exposure to non-steroidal anti-inflammatory drugs (NSAIDs) and neurodevelopmental outcomes in children","Markovic M, Swanson SA, Stricker BH, Jaddoe VWV, Verhulst FC, Tiemeier H, El Marroun H.","Pharmacoepidemiol Drug Saf. 2019 Apr;28(4):452-459. doi: 10.1002/pds.4625. Epub 2019 Mar 5.","Markovic M","Pharmacoepidemiol Drug Saf","2019","2019/03/07","","","10.1002/pds.4625"
"30838708","The ENCePP Code of Conduct: A best practise for scientific independence and transparency in noninterventional postauthorisation studies","Gini R, Fournie X, Dolk H, Kurz X, Verpillat P, Simondon F, Strassmann V, Apostolidis K, Goedecke T.","Pharmacoepidemiol Drug Saf. 2019 Apr;28(4):422-433. doi: 10.1002/pds.4763. Epub 2019 Mar 5.","Gini R","Pharmacoepidemiol Drug Saf","2019","2019/03/07","PMC6594014","","10.1002/pds.4763"
"30838704","Safety of a quadrivalent meningococcal conjugate vaccine in healthy subjects aged 9 months to 55 years in Vietnam","Phan CH, Nguyen TPT, Doan UY, Nguyen TA, Thollot Y, Nievera MC.","Pharmacoepidemiol Drug Saf. 2019 Apr;28(4):515-520. doi: 10.1002/pds.4754. Epub 2019 Mar 5.","Phan CH","Pharmacoepidemiol Drug Saf","2019","2019/03/07","","","10.1002/pds.4754"
"30834654","Use and safety of disease-modifying therapy in pregnant women with multiple sclerosis","MacDonald SC, McElrath TF, Hernández-Díaz S.","Pharmacoepidemiol Drug Saf. 2019 Apr;28(4):556-560. doi: 10.1002/pds.4735. Epub 2019 Mar 4.","MacDonald SC","Pharmacoepidemiol Drug Saf","2019","2019/03/06","","","10.1002/pds.4735"
"30834626","Oseltamivir phosphate-Lifting the restriction on its use to treat teenagers with influenza in Japan","Takeuchi S, Tetsuhashi M, Sato D.","Pharmacoepidemiol Drug Saf. 2019 Apr;28(4):434-436. doi: 10.1002/pds.4721. Epub 2019 Mar 4.","Takeuchi S","Pharmacoepidemiol Drug Saf","2019","2019/03/06","","","10.1002/pds.4721"
"30834618","Corrigendum","","Pharmacoepidemiol Drug Saf. 2019 Mar;28(3):401. doi: 10.1002/pds.4748.","","Pharmacoepidemiol Drug Saf","2019","2019/03/06","","","10.1002/pds.4748"
"30828912","Multistate methodology improves risk assessment under time-varying drug intake-a new view on pregnancy outcomes following coumarin exposure","Bluhmki T, Fietz AK, Stegherr R, Beck E, Padberg S, Beyersmann J, Schaefer C, Meister R.","Pharmacoepidemiol Drug Saf. 2019 May;28(5):616-624. doi: 10.1002/pds.4710. Epub 2019 Mar 3.","Bluhmki T","Pharmacoepidemiol Drug Saf","2019","2019/03/05","","","10.1002/pds.4710"
"30793813","Exposure to phthalate-containing prescription drugs and the risk of colorectal adenocarcinoma: A Danish nationwide case-control study","Ennis ZN, Pottegård A, Ahern TP, Hallas J, Damkier P.","Pharmacoepidemiol Drug Saf. 2019 Apr;28(4):528-535. doi: 10.1002/pds.4759. Epub 2019 Feb 22.","Ennis ZN","Pharmacoepidemiol Drug Saf","2019","2019/02/23","PMC7444013","NIHMS1617125","10.1002/pds.4759"
"30790376","Anticipating the effects of restricting high-dose preparations of strong opioids in Australia: A population-based analysis to inform the current policy debate","Zheng D, Narayan SW, Zoega H, Litchfield M, Buckley NA, Pearson SA, Schaffer AL.","Pharmacoepidemiol Drug Saf. 2019 Apr;28(4):521-527. doi: 10.1002/pds.4755. Epub 2019 Feb 20.","Zheng D","Pharmacoepidemiol Drug Saf","2019","2019/02/22","","","10.1002/pds.4755"
"30788900","Building a framework for the evaluation of knowledge translation for the Canadian Network for Observational Drug Effect Studies","Sketris IS, Carter N, Traynor RL, Watts D, Kelly K; following contributing members of the CNODES Knowledge Translation Team: Pierre Ernst, JM Gamble, Brenda Hemmelgarn, Colleen Metge, Michael Paterson, Robert Platt W. and Gary Teare.","Pharmacoepidemiol Drug Saf. 2020 Jan;29 Suppl 1(Suppl 1):8-25. doi: 10.1002/pds.4738. Epub 2019 Feb 20.","Sketris IS","Pharmacoepidemiol Drug Saf","2020","2019/02/22","PMC6972643","","10.1002/pds.4738"
"30788887","Informative censoring by health plan disenrollment among commercially insured adults","Butler AM, Todd JV, Sahrmann JM, Lesko CR, Brookhart MA.","Pharmacoepidemiol Drug Saf. 2019 May;28(5):640-648. doi: 10.1002/pds.4750. Epub 2019 Feb 20.","Butler AM","Pharmacoepidemiol Drug Saf","2019","2019/02/22","PMC6497556","NIHMS1008246","10.1002/pds.4750"
"30786103","Quantifying bias reduction with fixed-duration versus all-available covariate assessment periods","Connolly JG, Schneeweiss S, Glynn RJ, Gagne JJ.","Pharmacoepidemiol Drug Saf. 2019 May;28(5):665-670. doi: 10.1002/pds.4729. Epub 2019 Feb 20.","Connolly JG","Pharmacoepidemiol Drug Saf","2019","2019/02/21","","","10.1002/pds.4729"
"30784140","Long-term persistence and adherence to blood pressure lowering agents among older Australians","Si S, Ofori-Asenso R, Briffa T, Sanfilippo FM, Ilomaki J, Qin X, Tacey M, Reid CM, Liew D.","Pharmacoepidemiol Drug Saf. 2019 Jun;28(6):788-795. doi: 10.1002/pds.4742. Epub 2019 Feb 19.","Si S","Pharmacoepidemiol Drug Saf","2019","2019/02/21","","","10.1002/pds.4742"
"30784132","Propensity score methods and regression adjustment for analysis of nonrandomized studies with health-related quality of life outcomes","Cottone F, Anota A, Bonnetain F, Collins GS, Efficace F.","Pharmacoepidemiol Drug Saf. 2019 May;28(5):690-699. doi: 10.1002/pds.4756. Epub 2019 Feb 19.","Cottone F","Pharmacoepidemiol Drug Saf","2019","2019/02/21","","","10.1002/pds.4756"
"30779395","Validating registry data on statins prescriptions by blood measurements","Riis AH, Erichsen R, Ostenfeld EB, Højskov CS, Thorlacius-Ussing O, Stender MT, Lash TL, Møller HJ.","Pharmacoepidemiol Drug Saf. 2019 May;28(5):609-615. doi: 10.1002/pds.4700. Epub 2019 Feb 19.","Riis AH","Pharmacoepidemiol Drug Saf","2019","2019/02/20","","","10.1002/pds.4700"
"30779266","Does the use of incretin-based medications increase the risk of cancer in patients with type-2 diabetes mellitus?","Karp I, Sivaswamy A, Booth C.","Pharmacoepidemiol Drug Saf. 2019 Apr;28(4):489-499. doi: 10.1002/pds.4746. Epub 2019 Feb 18.","Karp I","Pharmacoepidemiol Drug Saf","2019","2019/02/20","","","10.1002/pds.4746"
"30767342","Paediatric safety signals identified in VigiBase: Methods and results from Uppsala Monitoring Centre","Star K, Sandberg L, Bergvall T, Choonara I, Caduff-Janosa P, Edwards IR.","Pharmacoepidemiol Drug Saf. 2019 May;28(5):680-689. doi: 10.1002/pds.4734. Epub 2019 Feb 15.","Star K","Pharmacoepidemiol Drug Saf","2019","2019/02/16","PMC6594230","","10.1002/pds.4734"
"30761662","A systematic review of methods for determining cross-sectional active medications using pharmacy databases","Anderson TS, Xu E, Whitaker E, Steinman MA.","Pharmacoepidemiol Drug Saf. 2019 Apr;28(4):403-421. doi: 10.1002/pds.4706. Epub 2019 Feb 13.","Anderson TS","Pharmacoepidemiol Drug Saf","2019","2019/02/15","PMC7050409","NIHMS1557800","10.1002/pds.4706"
"30747477","Anticholinergic and sedative medication use in older community-dwelling people: A national population study in the Netherlands","van der Meer HG, Taxis K, Teichert M, Griens F, Pont LG, Wouters H.","Pharmacoepidemiol Drug Saf. 2019 Mar;28(3):315-321. doi: 10.1002/pds.4698. Epub 2019 Feb 12.","van der Meer HG","Pharmacoepidemiol Drug Saf","2019","2019/02/13","PMC6593836","","10.1002/pds.4698"
"30747473","A new analytic tool developed to assess safe use recommendations","Cocoros NM, Wagner A, Haynes K, Petrone AB, Fazio-Eynullayeva E, Ding Y, Izem R, Lee JY, Major JM, Nguyen M, Ju J.","Pharmacoepidemiol Drug Saf. 2019 May;28(5):649-656. doi: 10.1002/pds.4724. Epub 2019 Feb 12.","Cocoros NM","Pharmacoepidemiol Drug Saf","2019","2019/02/13","","","10.1002/pds.4724"
"30747466","Prevalence of drug use among adults with intellectual disabilities compared with drug use in the general population","Hove O, Biringer E, Havik OE, Assmus J, Braatveit KJ, Holm SEH, Hermann M.","Pharmacoepidemiol Drug Saf. 2019 Mar;28(3):337-344. doi: 10.1002/pds.4741. Epub 2019 Feb 12.","Hove O","Pharmacoepidemiol Drug Saf","2019","2019/02/13","","","10.1002/pds.4741"
"30746841","Conditional validation sampling for consistent risk estimation with binary outcome data subject to misclassification","Gravel CA, Farrell PJ, Krewski D.","Pharmacoepidemiol Drug Saf. 2019 Feb;28(2):227-233. doi: 10.1002/pds.4701.","Gravel CA","Pharmacoepidemiol Drug Saf","2019","2019/02/13","","","10.1002/pds.4701"
"30740819","Prescribing and Research in Medicines Management (UK & Ireland) Annual Conference 2018, NCVO, Society Building, London, UK, 14th December 2018: 'Person-centred Care in the Digital Age: Nudge, Nudge, Tweet, Tweet'","","Pharmacoepidemiol Drug Saf. 2019 Feb;28 Suppl 1:3-16. doi: 10.1002/pds.4732.","","Pharmacoepidemiol Drug Saf","2019","2019/02/12","","","10.1002/pds.4732"
"30740818","A mixed methods analysis of clozapine errors reported to the National Reporting and Learning System","Dabba K, Elswood M, Ameer A, Gerrett D, Maidment I.","Pharmacoepidemiol Drug Saf. 2019 May;28(5):657-664. doi: 10.1002/pds.4727. Epub 2019 Feb 10.","Dabba K","Pharmacoepidemiol Drug Saf","2019","2019/02/12","","","10.1002/pds.4727"
"30724414","Variation of the prevalence of pediatric polypharmacy: A scoping review","Baker C, Feinstein JA, Ma X, Bolen S, Dawson NV, Golchin N, Horace A, Kleinman LC, Meropol SB, Pestana Knight EM, Winterstein AG, Bakaki PM.","Pharmacoepidemiol Drug Saf. 2019 Mar;28(3):275-287. doi: 10.1002/pds.4719. Epub 2019 Feb 6.","Baker C","Pharmacoepidemiol Drug Saf","2019","2019/02/07","PMC6461742","NIHMS1022122","10.1002/pds.4719"
"30724413","Use of dipeptidyl peptidase-4 inhibitors and the risk of arthralgia: Population-based cohort and nested case-control studies","Wang CY, Fu SH, Yang RS, Hsiao FY.","Pharmacoepidemiol Drug Saf. 2019 Apr;28(4):500-506. doi: 10.1002/pds.4733. Epub 2019 Feb 6.","Wang CY","Pharmacoepidemiol Drug Saf","2019","2019/02/07","","","10.1002/pds.4733"
"30723973","Misuse of prescribed opioids in the United States","Mojtabai R, Amin-Esmaeili M, Nejat E, Olfson M.","Pharmacoepidemiol Drug Saf. 2019 Mar;28(3):345-353. doi: 10.1002/pds.4743. Epub 2019 Feb 5.","Mojtabai R","Pharmacoepidemiol Drug Saf","2019","2019/02/07","","","10.1002/pds.4743"
"30719785","Validating an algorithm for multiple myeloma based on administrative data using a SEER tumor registry and medical record review","Brandenburg NA, Phillips S, Wells KE, Woodcroft KJ, Amend KL, Enger C, Oliveria SA.","Pharmacoepidemiol Drug Saf. 2019 Feb;28(2):256-263. doi: 10.1002/pds.4711. Epub 2019 Feb 4.","Brandenburg NA","Pharmacoepidemiol Drug Saf","2019","2019/02/06","","","10.1002/pds.4711"
"30714240","Pharmacoepidemiology and Drug Safety's special issue on validation studies","Chun DS, Lund JL, Stürmer T.","Pharmacoepidemiol Drug Saf. 2019 Feb;28(2):123-125. doi: 10.1002/pds.4694. Epub 2019 Feb 3.","Chun DS","Pharmacoepidemiol Drug Saf","2019","2019/02/05","","","10.1002/pds.4694"
"30714239","Causal inference for evaluating prescription opioid abuse using trend-in-trend design","Dasgupta N, Schwarz J, Hennessy S, Ertefaie A, Dart RC.","Pharmacoepidemiol Drug Saf. 2019 May;28(5):716-725. doi: 10.1002/pds.4736. Epub 2019 Feb 3.","Dasgupta N","Pharmacoepidemiol Drug Saf","2019","2019/02/05","","","10.1002/pds.4736"
"30706619","Drug-induced anaphylactic reactions in children: A retrospective analysis of 159 validated spontaneous reports","Sachs B, Dubrall D, Fischer-Barth W, Schmid M, Stingl J.","Pharmacoepidemiol Drug Saf. 2019 Mar;28(3):377-388. doi: 10.1002/pds.4726. Epub 2019 Jan 31.","Sachs B","Pharmacoepidemiol Drug Saf","2019","2019/02/02","PMC6590409","","10.1002/pds.4726"
"30701619","Patterns of initial migraine treatment in Denmark: A population-based study","Thomsen RW, Szépligeti SK, Xue F, Pedersen L, Sørensen HT, Ehrenstein V.","Pharmacoepidemiol Drug Saf. 2019 Mar;28(3):322-329. doi: 10.1002/pds.4723. Epub 2019 Jan 31.","Thomsen RW","Pharmacoepidemiol Drug Saf","2019","2019/02/01","","","10.1002/pds.4723"
"30701612","Mortality: The final outcome","Haynes K.","Pharmacoepidemiol Drug Saf. 2019 May;28(5):570-571. doi: 10.1002/pds.4715. Epub 2019 Jan 31.","Haynes K","Pharmacoepidemiol Drug Saf","2019","2019/02/01","","","10.1002/pds.4715"
"30680859","Identifying patients using antidepressants for the treatment of depression: A predictive algorithm for use in pharmaceutical and medical claims data","Havard A, Straka P, Sara G, Lujic S, Tran DT, Jorm LR.","Pharmacoepidemiol Drug Saf. 2019 Mar;28(3):354-361. doi: 10.1002/pds.4739. Epub 2019 Jan 25.","Havard A","Pharmacoepidemiol Drug Saf","2019","2019/01/26","","","10.1002/pds.4739"
"30680840","Performance of a computable phenotype for identification of patients with diabetes within PCORnet: The Patient-Centered Clinical Research Network","Wiese AD, Roumie CL, Buse JB, Guzman H, Bradford R, Zalimeni E, Knoepp P, Morris HL, Donahoo WT, Fanous N, Epstein BF, Katalenich BL, Ayala SG, Cook MM, Worley KJ, Bachmann KN, Grijalva CG, Rothman RL, Chakkalakal RJ.","Pharmacoepidemiol Drug Saf. 2019 May;28(5):632-639. doi: 10.1002/pds.4718. Epub 2019 Jan 24.","Wiese AD","Pharmacoepidemiol Drug Saf","2019","2019/01/26","PMC6615719","NIHMS1030466","10.1002/pds.4718"
"30677205","Development and validation of algorithms to identify newly diagnosed type 1 and type 2 diabetes in pediatric population using electronic medical records and claims data","Teltsch DY, Fazeli Farsani S, Swain RS, Kaspers S, Huse S, Cristaldi C, Nordstrom BL, Brodovicz KG.","Pharmacoepidemiol Drug Saf. 2019 Feb;28(2):234-243. doi: 10.1002/pds.4728. Epub 2019 Jan 24.","Teltsch DY","Pharmacoepidemiol Drug Saf","2019","2019/01/25","","","10.1002/pds.4728"
"30667114","The validity of dementia diagnoses in routinely collected electronic health records in the United Kingdom: A systematic review","McGuinness LA, Warren-Gash C, Moorhouse LR, Thomas SL.","Pharmacoepidemiol Drug Saf. 2019 Feb;28(2):244-255. doi: 10.1002/pds.4669. Epub 2019 Jan 22.","McGuinness LA","Pharmacoepidemiol Drug Saf","2019","2019/01/23","PMC6519035","","10.1002/pds.4669"
"30656799","The double opioid crisis: A call for balance","Vranken MJM, Schutjens MDB, Mantel-Teeuwisse AK.","Pharmacoepidemiol Drug Saf. 2019 Jan;28(1):1-3. doi: 10.1002/pds.4720.","Vranken MJM","Pharmacoepidemiol Drug Saf","2019","2019/01/19","PMC6590408","","10.1002/pds.4720"
"30648314","The Chang Gung Research Database-A multi-institutional electronic medical records database for real-world epidemiological studies in Taiwan","Shao SC, Chan YY, Kao Yang YH, Lin SJ, Hung MJ, Chien RN, Lai CC, Lai EC.","Pharmacoepidemiol Drug Saf. 2019 May;28(5):593-600. doi: 10.1002/pds.4713. Epub 2019 Jan 16.","Shao SC","Pharmacoepidemiol Drug Saf","2019","2019/01/17","","","10.1002/pds.4713"
"30648307","How pharmacoepidemiology networks can manage distributed analyses to improve replicability and transparency and minimize bias","Platt RW, Platt R, Brown JS, Henry DA, Klungel OH, Suissa S.","Pharmacoepidemiol Drug Saf. 2019 Jan 15. doi: 10.1002/pds.4722. Online ahead of print.","Platt RW","Pharmacoepidemiol Drug Saf","2019","2019/01/17","","","10.1002/pds.4722"
"30648304","Current status of pharmacovigilance regulatory structures, processes, and outcomes in the Asia-Pacific region: Survey results from 15 countries","Shin JY, Shin E, Jeong HE, Kim JH, Lee EK.","Pharmacoepidemiol Drug Saf. 2019 Mar;28(3):362-369. doi: 10.1002/pds.4717. Epub 2019 Jan 16.","Shin JY","Pharmacoepidemiol Drug Saf","2019","2019/01/17","","","10.1002/pds.4717"
"30628152","Extreme restriction design as a method for reducing confounding by indication in pharmacoepidemiologic research","Secrest MH, Platt RW, Dormuth CR, Chateau D, Targownik L, Nie R, Doyle CM, Dell'Aniello S, Filion KB.","Pharmacoepidemiol Drug Saf. 2020 Jan;29 Suppl 1:26-34. doi: 10.1002/pds.4708. Epub 2019 Jan 9.","Secrest MH","Pharmacoepidemiol Drug Saf","2020","2019/01/11","","","10.1002/pds.4708"
"30628139","Pharmacologically pertinent period of effect (PPPE)","Suissa M, LeLorier J.","Pharmacoepidemiol Drug Saf. 2020 Jan;29 Suppl 1(Suppl 1):61-67. doi: 10.1002/pds.4714. Epub 2019 Jan 9.","Suissa M","Pharmacoepidemiol Drug Saf","2020","2019/01/11","PMC6972608","","10.1002/pds.4714"
"30623512","Rates of reported codeine-related poisonings and codeine prescribing following new national guidance in Ireland","Kennedy C, Duggan E, Bennett K, Williams DJ.","Pharmacoepidemiol Drug Saf. 2019 Jan;28(1):106-111. doi: 10.1002/pds.4725. Epub 2019 Jan 9.","Kennedy C","Pharmacoepidemiol Drug Saf","2019","2019/01/10","","","10.1002/pds.4725"
"30585374","Maternal and neonatal outcomes after exposure to ADHD medication during pregnancy: A systematic review and meta-analysis","Jiang HY, Zhang X, Jiang CM, Fu HB.","Pharmacoepidemiol Drug Saf. 2019 Mar;28(3):288-295. doi: 10.1002/pds.4716. Epub 2018 Dec 26.","Jiang HY","Pharmacoepidemiol Drug Saf","2019","2018/12/27","","","10.1002/pds.4716"
"30565786","Proton pump inhibitor use and risk of breast cancer, prostate cancer, and malignant melanoma: An Icelandic population-based case-control study","Hálfdánarson ÓÖ, Fall K, Ogmundsdottir MH, Lund SH, Steingrímsson E, Ogmundsdottir HM, Zoega H.","Pharmacoepidemiol Drug Saf. 2019 Apr;28(4):471-478. doi: 10.1002/pds.4702. Epub 2018 Dec 19.","Hálfdánarson ÓÖ","Pharmacoepidemiol Drug Saf","2019","2018/12/20","","","10.1002/pds.4702"
"30565779","Changing predictors of statin initiation in US women over two decades","Kinsey TL, Stürmer T, Poole C, Rothman KJ, Glynn RJ.","Pharmacoepidemiol Drug Saf. 2019 Mar;28(3):305-314. doi: 10.1002/pds.4704. Epub 2018 Dec 19.","Kinsey TL","Pharmacoepidemiol Drug Saf","2019","2018/12/20","PMC7147936","NIHMS1574962","10.1002/pds.4704"
"30556617","Increased risk for aseptic meningitis after amoxicillin or amoxicillin-clavulanic acid in males: A signal revealed by subset disproportionality analysis within a global database of suspected adverse drug reactions","Chandler RE.","Pharmacoepidemiol Drug Saf. 2019 Mar;28(3):389-395. doi: 10.1002/pds.4707. Epub 2018 Dec 17.","Chandler RE","Pharmacoepidemiol Drug Saf","2019","2018/12/18","PMC6590467","","10.1002/pds.4707"
"30548462","Validation study of colorectal cancer diagnosis in the Spanish primary care database, BIFAP","Gil M, Rodríguez-Miguel A, Montoya-Catalá H, González-González R, Álvarez-Gutiérrez A, Rodríguez-Martín S, García-Rodríguez LA, de Abajo FJ.","Pharmacoepidemiol Drug Saf. 2019 Feb;28(2):209-216. doi: 10.1002/pds.4686. Epub 2018 Dec 12.","Gil M","Pharmacoepidemiol Drug Saf","2019","2018/12/15","","","10.1002/pds.4686"
"30548353","Tramadol dispensing patterns and trends in Canada, 2007-2016","Fischer B, Kurdyak P, Jones W.","Pharmacoepidemiol Drug Saf. 2019 Mar;28(3):396-400. doi: 10.1002/pds.4679. Epub 2018 Dec 12.","Fischer B","Pharmacoepidemiol Drug Saf","2019","2018/12/15","","","10.1002/pds.4679"
"30507019","Corrigendum","","Pharmacoepidemiol Drug Saf. 2018 Dec;27(12):1434. doi: 10.1002/pds.4705.","","Pharmacoepidemiol Drug Saf","2018","2018/12/04","","","10.1002/pds.4705"
"30507018",".Corrigendum","","Pharmacoepidemiol Drug Saf. 2018 Dec;27(12):1430-1433. doi: 10.1002/pds.4691.","","Pharmacoepidemiol Drug Saf","2018","2018/12/04","","","10.1002/pds.4691"
"30515910","Considerations in characterizing real-world data relevance and quality for regulatory purposes: A commentary","Girman CJ, Ritchey ME, Zhou W, Dreyer NA.","Pharmacoepidemiol Drug Saf. 2019 Apr;28(4):439-442. doi: 10.1002/pds.4697. Epub 2018 Dec 5.","Girman CJ","Pharmacoepidemiol Drug Saf","2019","2018/12/06","PMC6718007","","10.1002/pds.4697"
"30515908","Comparing external and internal validation methods in correcting outcome misclassification bias in logistic regression: A simulation study and application to the case of postsurgical venous thromboembolism following total hip and knee arthroplasty","Ni J, Dasgupta K, Kahn SR, Talbot D, Lefebvre G, Lix LM, Berry G, Burman M, Dimentberg R, Laflamme Y, Cirkovic A, Rahme E.","Pharmacoepidemiol Drug Saf. 2019 Feb;28(2):217-226. doi: 10.1002/pds.4693. Epub 2018 Dec 4.","Ni J","Pharmacoepidemiol Drug Saf","2019","2018/12/06","","","10.1002/pds.4693"
"30488571","Validity of maternal recall of gestational age and weight at birth: Comparison of structured interview and medical records","Petersen JM, Mitchell AA, Van Bennekom C, Werler MM.","Pharmacoepidemiol Drug Saf. 2019 Feb;28(2):269-273. doi: 10.1002/pds.4699. Epub 2018 Nov 29.","Petersen JM","Pharmacoepidemiol Drug Saf","2019","2018/11/30","","","10.1002/pds.4699"
"30488510","The recording of human papillomavirus (HPV) vaccination in BIFAP primary care database: A validation study","Martín-Merino E, Llorente-García A, Montero-Corominas D, Huerta C.","Pharmacoepidemiol Drug Saf. 2019 Feb;28(2):201-208. doi: 10.1002/pds.4674. Epub 2018 Nov 29.","Martín-Merino E","Pharmacoepidemiol Drug Saf","2019","2018/11/30","","","10.1002/pds.4674"
"30467909","A descriptive epidemiological study on the treatment options for head and neck cancer: Transition before and after approval of cetuximab","Yamada S, Sato I, Kawakami K.","Pharmacoepidemiol Drug Saf. 2019 Mar;28(3):330-336. doi: 10.1002/pds.4703. Epub 2018 Nov 23.","Yamada S","Pharmacoepidemiol Drug Saf","2019","2018/11/24","","","10.1002/pds.4703"
"30456916","Statin use and survival in patients with gastric cancer in two independent population-based cohorts","Spence AD, Busby J, Hughes CM, Johnston BT, Coleman HG, Cardwell CR.","Pharmacoepidemiol Drug Saf. 2019 Apr;28(4):460-470. doi: 10.1002/pds.4688. Epub 2018 Nov 20.","Spence AD","Pharmacoepidemiol Drug Saf","2019","2018/11/21","","","10.1002/pds.4688"
"30443944","Direct oral anticoagulant use and subsequent start of proton pump inhibitors as proxy for gastric complaints","Zielinski GD, Teichert M, Klok FA, Rosendaal FR, Huisman MV, Cannegieter SC, Lijfering WM.","Pharmacoepidemiol Drug Saf. 2018 Dec;27(12):1371-1378. doi: 10.1002/pds.4684. Epub 2018 Nov 15.","Zielinski GD","Pharmacoepidemiol Drug Saf","2018","2018/11/17","","","10.1002/pds.4684"
"30430682","Use of tumor necrosis factor-alpha inhibitors during pregnancy among women who delivered live born infants","Eworuke E, Panucci G, Goulding M, Neuner R, Toh S.","Pharmacoepidemiol Drug Saf. 2019 Mar;28(3):296-304. doi: 10.1002/pds.4695. Epub 2018 Nov 14.","Eworuke E","Pharmacoepidemiol Drug Saf","2019","2018/11/16","","","10.1002/pds.4695"
"30421839","Overall and cause-specific mortality in the Sentinel system: A power analysis","Swain RS, Taylor LG, Woodworth TS, Fuller CC, Petrone AB, Menzin TJ, Haug NR, Toh S, Mosholder AD.","Pharmacoepidemiol Drug Saf. 2018 Dec;27(12):1416-1421. doi: 10.1002/pds.4692. Epub 2018 Nov 13.","Swain RS","Pharmacoepidemiol Drug Saf","2018","2018/11/14","","","10.1002/pds.4692"
"30421838","Increases in controlled-release oxycodone utilisation following the subsidy of oxycodone with naloxone formulations: An Australian population-based study","Schaffer AL, Karanges EA, Buckley NA, Wilson A, Degenhardt L, Larance B, Pearson SA.","Pharmacoepidemiol Drug Saf. 2019 Jan;28(1):97-105. doi: 10.1002/pds.4683. Epub 2018 Nov 13.","Schaffer AL","Pharmacoepidemiol Drug Saf","2019","2018/11/14","PMC6687879","NIHMS1037302","10.1002/pds.4683"
"30421828","""Methotrexate and NSAIDs in rheumatoid arthritis-Confirmation of a known NSAIDs adverse effect rather than a dangerous combination""","Al-Khalili O, Mikuls TR, O'Dell JR, England BR.","Pharmacoepidemiol Drug Saf. 2018 Dec;27(12):1429. doi: 10.1002/pds.4670. Epub 2018 Nov 13.","Al-Khalili O","Pharmacoepidemiol Drug Saf","2018","2018/11/14","","","10.1002/pds.4670"
"30411819","Understanding multi-pill ingestion of prescription opioids: Prevalence, characteristics, and motivation","Ellis MS, Cicero TJ, Dart RC, Green JL.","Pharmacoepidemiol Drug Saf. 2019 Jan;28(1):117-121. doi: 10.1002/pds.4687. Epub 2018 Nov 9.","Ellis MS","Pharmacoepidemiol Drug Saf","2019","2018/11/10","","","10.1002/pds.4687"
"30411431","Predictive model algorithms identifying early and advanced stage ER+/HER2- breast cancer in claims data","Beachler DC, de Luise C, Yin R, Gangemi K, Cochetti PT, Lanes S.","Pharmacoepidemiol Drug Saf. 2019 Feb;28(2):171-178. doi: 10.1002/pds.4681. Epub 2018 Nov 9.","Beachler DC","Pharmacoepidemiol Drug Saf","2019","2018/11/10","","","10.1002/pds.4681"
"30395375","Diagnostic accuracy of the International Classification of Diseases, Tenth Revision, codes of heart failure in an administrative database","Bosco-Lévy P, Duret S, Picard F, Dos Santos P, Puymirat E, Gilleron V, Blin P, Chatellier G, Looten V, Moore N.","Pharmacoepidemiol Drug Saf. 2019 Feb;28(2):194-200. doi: 10.1002/pds.4690. Epub 2018 Nov 5.","Bosco-Lévy P","Pharmacoepidemiol Drug Saf","2019","2018/11/06","","","10.1002/pds.4690"
"30394649","Generation of a pregnancy cohort for medicine utilisation and medicine safety studies in New Zealand","Donald S, Barson D, Horsburgh S, Sharples K, Parkin L.","Pharmacoepidemiol Drug Saf. 2018 Dec;27(12):1335-1343. doi: 10.1002/pds.4671. Epub 2018 Nov 5.","Donald S","Pharmacoepidemiol Drug Saf","2018","2018/11/06","","","10.1002/pds.4671"
"30379379","Assessment of prior opioid tolerance among new users of fentanyl transdermal system in FDA's Sentinel System","Cocoros NM, Larochelle MR, Popovic J, Petrone AB, Kornegay C, Ju J, Racoosin JA.","Pharmacoepidemiol Drug Saf. 2019 Jan;28(1):112-116. doi: 10.1002/pds.4677. Epub 2018 Oct 31.","Cocoros NM","Pharmacoepidemiol Drug Saf","2019","2018/11/01","","","10.1002/pds.4677"
"30379378","Pregnancy outcomes in women exposed to cancer chemotherapy","Danet C, Araujo M, Bos-Thompson MA, Portolan G, Gautier S, Vanlemmens L, Bonenfant S, Jonville-Béra AP, Cottin J, Vial T, Bavoux F, Montastruc JL, Damase-Michel C, Benevent J, Bourgeois-Mondon I, Lacroix I.","Pharmacoepidemiol Drug Saf. 2018 Dec;27(12):1302-1308. doi: 10.1002/pds.4689. Epub 2018 Oct 31.","Danet C","Pharmacoepidemiol Drug Saf","2018","2018/11/01","","","10.1002/pds.4689"
"30379373","Impact of the ""French Levothyrox crisis"" on signal detection in the World Health Organization pharmacovigilance database","Khouri C, Revol B, Lepelley M, Mallaret M, Cracowski JL.","Pharmacoepidemiol Drug Saf. 2018 Dec;27(12):1427-1428. doi: 10.1002/pds.4682. Epub 2018 Oct 31.","Khouri C","Pharmacoepidemiol Drug Saf","2018","2018/11/01","","","10.1002/pds.4682"
"30379372","Comparative effectiveness and safety of antiplatelet drugs in patients with diabetes mellitus and acute coronary syndrome","Spoendlin J, Gagne JJ, Lewey JJ, Patorno E, Schneeweiss S, Desai RJ.","Pharmacoepidemiol Drug Saf. 2018 Dec;27(12):1361-1370. doi: 10.1002/pds.4668. Epub 2018 Oct 31.","Spoendlin J","Pharmacoepidemiol Drug Saf","2018","2018/11/01","","","10.1002/pds.4668"
"30379371","Comparing drug effectiveness in children: A systematic review","Dukanovic J, Osokogu OU, Patel K, Ferrajolo C, Sturkenboom MCJM; Global Research in Pediatrics project.","Pharmacoepidemiol Drug Saf. 2018 Dec;27(12):1295-1301. doi: 10.1002/pds.4676. Epub 2018 Oct 31.","Dukanovic J","Pharmacoepidemiol Drug Saf","2018","2018/11/01","","","10.1002/pds.4676"
"30379369","Who diagnosed and prescribed what? Using provider details to inform observational research","Bushnell GA, Stürmer T, Mack C, Pate V, Miller M.","Pharmacoepidemiol Drug Saf. 2018 Dec;27(12):1422-1426. doi: 10.1002/pds.4685. Epub 2018 Oct 31.","Bushnell GA","Pharmacoepidemiol Drug Saf","2018","2018/11/01","PMC6407693","NIHMS1014956","10.1002/pds.4685"
"30379361","Evaluation of the effectiveness of risk minimization measures for trimetazidine: A cross sectional joint PASS survey among physicians in selected European countries","von Bredow D, Toussi M, Samad A, Kaplan S, Domahidy M, de Voogd H, Böhmert S, Ramos RS, Arora D.","Pharmacoepidemiol Drug Saf. 2018 Dec;27(12):1385-1392. doi: 10.1002/pds.4675. Epub 2018 Oct 31.","von Bredow D","Pharmacoepidemiol Drug Saf","2018","2018/11/01","","","10.1002/pds.4675"
"30375122","Inflation of type I error rates due to differential misclassification in EHR-derived outcomes: Empirical illustration using breast cancer recurrence","Chen Y, Wang J, Chubak J, Hubbard RA.","Pharmacoepidemiol Drug Saf. 2019 Feb;28(2):264-268. doi: 10.1002/pds.4680. Epub 2018 Oct 30.","Chen Y","Pharmacoepidemiol Drug Saf","2019","2018/10/31","PMC6716793","NIHMS1046518","10.1002/pds.4680"
"30375121","Impact of initiatives to reduce prescription opioid risks on medically attended injuries in people using chronic opioid therapy","Dublin S, Walker RL, Shortreed SM, Ludman EJ, Sherman KJ, Hansen RN, Thakral M, Saunders K, Parchman ML, Von Korff M.","Pharmacoepidemiol Drug Saf. 2019 Jan;28(1):90-96. doi: 10.1002/pds.4678. Epub 2018 Oct 30.","Dublin S","Pharmacoepidemiol Drug Saf","2019","2018/10/31","","","10.1002/pds.4678"
"30375101","Validation of hip osteoarthritis diagnosis recording in the UK Clinical Practice Research Datalink","Ferguson RJ, Prieto-Alhambra D, Walker C, Yu D, Valderas JM, Judge A, Griffiths J, Jordan KP, Peat G, Glyn-Jones S, Silman AJ.","Pharmacoepidemiol Drug Saf. 2019 Feb;28(2):187-193. doi: 10.1002/pds.4673. Epub 2018 Oct 30.","Ferguson RJ","Pharmacoepidemiol Drug Saf","2019","2018/10/31","","","10.1002/pds.4673"
"30324671","Significance of data mining in routine signal detection: Analysis based on the safety signals identified by the FDA","Fukazawa C, Hinomura Y, Kaneko M, Narukawa M.","Pharmacoepidemiol Drug Saf. 2018 Dec;27(12):1402-1408. doi: 10.1002/pds.4672. Epub 2018 Oct 15.","Fukazawa C","Pharmacoepidemiol Drug Saf","2018","2018/10/17","","","10.1002/pds.4672"
"30289578","Medication history assessment in research: A randomized controlled trial comparing tablet-based (eMedHAT) versus structured interview (MedHAT)","Green JL, Anderson V, Dart RC, Heard K.","Pharmacoepidemiol Drug Saf. 2018 Dec;27(12):1356-1360. doi: 10.1002/pds.4665. Epub 2018 Oct 5.","Green JL","Pharmacoepidemiol Drug Saf","2018","2018/10/06","","","10.1002/pds.4665"
"30288856","Identification of incident pancreatic cancer in Ontario administrative health data: A validation study","Wu JW, Azoulay L, Huang A, Paterson M, Wu F, Secrest MH, Filion KB.","Pharmacoepidemiol Drug Saf. 2020 Jan;29 Suppl 1:78-85. doi: 10.1002/pds.4641. Epub 2018 Oct 4.","Wu JW","Pharmacoepidemiol Drug Saf","2020","2018/10/06","","","10.1002/pds.4641"
"30264901","Blood eosinophilia, use of inhaled corticosteroids, and risk of COPD exacerbations and mortality","Oshagbemi OA, Franssen FME, Braeken DCW, Henskens Y, Wouters EFM, Maitland-van der Zee AH, Burden AM, de Vries F.","Pharmacoepidemiol Drug Saf. 2018 Nov;27(11):1191-1199. doi: 10.1002/pds.4655. Epub 2018 Sep 28.","Oshagbemi OA","Pharmacoepidemiol Drug Saf","2018","2018/09/29","PMC6282838","","10.1002/pds.4655"
"30264894","Comparing outpatient oral antibiotic use in Germany and the Netherlands from 2012 to 2016","Gradl G, Teichert M, Kieble M, Werning J, Schulz M.","Pharmacoepidemiol Drug Saf. 2018 Dec;27(12):1344-1355. doi: 10.1002/pds.4643. Epub 2018 Sep 28.","Gradl G","Pharmacoepidemiol Drug Saf","2018","2018/09/29","PMC6585743","","10.1002/pds.4643"
"30264875","Exposure measurement error when assessing current glucocorticoid use using UK primary care electronic prescription data","Joseph RM, van Staa TP, Lunt M, Abrahamowicz M, Dixon WG.","Pharmacoepidemiol Drug Saf. 2019 Feb;28(2):179-186. doi: 10.1002/pds.4649. Epub 2018 Sep 28.","Joseph RM","Pharmacoepidemiol Drug Saf","2019","2018/09/29","PMC6492099","","10.1002/pds.4649"
"30264874","Disclosing accelerated approval on direct-to-consumer prescription drug websites","Sullivan HW, O'Donoghue AC, David KT, Patel NJ.","Pharmacoepidemiol Drug Saf. 2018 Nov;27(11):1277-1280. doi: 10.1002/pds.4664. Epub 2018 Sep 28.","Sullivan HW","Pharmacoepidemiol Drug Saf","2018","2018/09/29","PMC7291603","NIHMS1595682","10.1002/pds.4664"
"30264866","Prospective identification versus administrative coding of adverse drug reaction-related hospitalizations in the elderly: A comparative analysis","Parameswaran Nair N, Chalmers L, Peterson GM, Bereznicki BJ, Curtain CM, Bereznicki LR.","Pharmacoepidemiol Drug Saf. 2018 Nov;27(11):1281-1285. doi: 10.1002/pds.4667. Epub 2018 Sep 28.","Parameswaran Nair N","Pharmacoepidemiol Drug Saf","2018","2018/09/29","","","10.1002/pds.4667"
"30256490","In utero beta-2-adrenergic agonists exposure and risk of epilepsy: A Danish nationwide population-based cohort study","Chen J, Liang H, Miao M, Su X, Yang F, Thomsen RW, Yuan W, Li J.","Pharmacoepidemiol Drug Saf. 2018 Nov;27(11):1200-1208. doi: 10.1002/pds.4648. Epub 2018 Sep 7.","Chen J","Pharmacoepidemiol Drug Saf","2018","2018/09/27","","","10.1002/pds.4648"
"30255606","Differential prescription behavior in benign prostatic syndrome may explain relationship found between tamsulosin and dementia","Ulrich S.","Pharmacoepidemiol Drug Saf. 2018 Nov;27(11):1157-1158. doi: 10.1002/pds.4666. Epub 2018 Sep 26.","Ulrich S","Pharmacoepidemiol Drug Saf","2018","2018/09/27","","","10.1002/pds.4666"
"30255533","Detecting the diverted use of psychoactive drugs by adolescents and young adults: A pilot study","Jouanjus E, Falcou A, Deheul S, Roussin A, Lapeyre-Mestre M.","Pharmacoepidemiol Drug Saf. 2018 Nov;27(11):1286-1292. doi: 10.1002/pds.4624. Epub 2018 Sep 25.","Jouanjus E","Pharmacoepidemiol Drug Saf","2018","2018/09/27","","","10.1002/pds.4624"
"30252199","The association between concerns toward adverse reactions during pre-approval drug reviews and the post-approval addition of clinically significant adverse reactions to package inserts: A retrospective analysis of pre-approval drug review reports and safety updates","Watanabe K, Murakami M, Masuyama K, Ishiguro C, Matsuda T.","Pharmacoepidemiol Drug Saf. 2018 Nov;27(11):1265-1276. doi: 10.1002/pds.4662. Epub 2018 Sep 25.","Watanabe K","Pharmacoepidemiol Drug Saf","2018","2018/09/26","","","10.1002/pds.4662"
"30252182","Antihypertensives prescribed for pregnant women in Japan: Prevalence and timing determined from a database of health insurance claims","Ishikawa T, Obara T, Nishigori H, Miyakoda K, Ishikuro M, Metoki H, Ohkubo T, Sugawara J, Yaegashi N, Akazawa M, Kuriyama S, Mano N.","Pharmacoepidemiol Drug Saf. 2018 Dec;27(12):1325-1334. doi: 10.1002/pds.4654. Epub 2018 Sep 25.","Ishikawa T","Pharmacoepidemiol Drug Saf","2018","2018/09/26","","","10.1002/pds.4654"
"30251424","Risk of hospitalisation and death related to baclofen for alcohol use disorders: Comparison with nalmefene, acamprosate, and naltrexone in a cohort study of 165 334 patients between 2009 and 2015 in France","Chaignot C, Zureik M, Rey G, Dray-Spira R, Coste J, Weill A.","Pharmacoepidemiol Drug Saf. 2018 Nov;27(11):1239-1248. doi: 10.1002/pds.4635. Epub 2018 Sep 25.","Chaignot C","Pharmacoepidemiol Drug Saf","2018","2018/09/26","PMC6282718","","10.1002/pds.4635"
"30246898","Changes in renal function with long-term exposure to antiretroviral therapy in HIV-infected adults in Asia","Joshi K, Boettiger D, Kerr S, Nishijima T, Van Nguyen K, Ly PS, Lee MP, Kumarasamy N, Wong W, Kantipong P, Cuong DD, Kamarulzaman A, Choi JY, Zhang F, Chaiwarith R, Ng OT, Kiertiburanakul S, Sim BLH, Merati TP, Yunihastuti E, Ditangco R, Ross J, Pujari S.","Pharmacoepidemiol Drug Saf. 2018 Nov;27(11):1209-1216. doi: 10.1002/pds.4657. Epub 2018 Sep 24.","Joshi K","Pharmacoepidemiol Drug Saf","2018","2018/09/25","PMC6218305","NIHMS986835","10.1002/pds.4657"
"30240072","Use of existing electronic health care databases to evaluate medication safety in pregnancy: Triptan exposure in pregnancy as a case study","Yusuf A, Chia V, Xue F, Mikol DD, Bollinger L, Cangialose C.","Pharmacoepidemiol Drug Saf. 2018 Dec;27(12):1309-1315. doi: 10.1002/pds.4658. Epub 2018 Sep 21.","Yusuf A","Pharmacoepidemiol Drug Saf","2018","2018/09/22","PMC6586074","","10.1002/pds.4658"
"30232832","Comparative safety of NSAIDs for gastrointestinal events in Asia-Pacific populations: A multi-database, international cohort study","Lai EC, Shin JY, Kubota K, Man KKC, Park BJ, Pratt N, Roughead EE, Wong ICK, Kao Yang YH, Setoguchi S.","Pharmacoepidemiol Drug Saf. 2018 Nov;27(11):1223-1230. doi: 10.1002/pds.4663. Epub 2018 Sep 19.","Lai EC","Pharmacoepidemiol Drug Saf","2018","2018/09/21","","","10.1002/pds.4663"
"30232825","Principles and considerations for effective academia-industry collaboration in pharmacoepidemiology","Ephross SA, Mitchell AA, Sacks S, Straus W, Stürmer T.","Pharmacoepidemiol Drug Saf. 2018 Nov;27(11):1153-1156. doi: 10.1002/pds.4644. Epub 2018 Sep 19.","Ephross SA","Pharmacoepidemiol Drug Saf","2018","2018/09/21","","","10.1002/pds.4644"
"30232823","Application of biclustering algorithm in adverse drug reaction monitoring system of China","Zhu T, Zhang Y, Ye X, Hou Y, Liu J, Shi W, Xu J, Guo X, He J.","Pharmacoepidemiol Drug Saf. 2018 Nov;27(11):1257-1264. doi: 10.1002/pds.4661. Epub 2018 Sep 19.","Zhu T","Pharmacoepidemiol Drug Saf","2018","2018/09/21","","","10.1002/pds.4661"
"30221424","Development and pharmacist-mediated use of tools for monitoring atypical antipsychotic-induced side effects related to blood glucose levels","Ishida S, Takechi K, Bando H, Imanishi M, Zamami Y, Chuma M, Yanagawa H, Kirino Y, Nakamura T, Teraoka K, Ishizawa K.","Pharmacoepidemiol Drug Saf. 2018 Dec;27(12):1379-1384. doi: 10.1002/pds.4656. Epub 2018 Sep 17.","Ishida S","Pharmacoepidemiol Drug Saf","2018","2018/09/18","","","10.1002/pds.4656"
"30221421","Differential uptake of herpes zoster vaccination associated with socioeconomic status: A population-based study in Stockholm County, Sweden","Fogelberg S, Lamb F, Grönlund O, Eriksson I, Sundström K, Clements M, Arnheim-Dahlström L.","Pharmacoepidemiol Drug Saf. 2018 Nov;27(11):1159-1165. doi: 10.1002/pds.4653. Epub 2018 Sep 17.","Fogelberg S","Pharmacoepidemiol Drug Saf","2018","2018/09/18","","","10.1002/pds.4653"
"30221420","Commentary on ""Methodologic limitations of prescription opioid safety research and recommendations for improving the evidence base""","Staffa J, Meyer T, Secora A, McAninch J.","Pharmacoepidemiol Drug Saf. 2019 Jan;28(1):13-15. doi: 10.1002/pds.4650. Epub 2018 Sep 17.","Staffa J","Pharmacoepidemiol Drug Saf","2019","2018/09/18","","","10.1002/pds.4650"
"30209862","Psychiatric adverse events in oseltamivir prophylaxis trials: Novel comparative analysis using data obtained from clinical study reports","Jones M, Tett SE, Del Mar C.","Pharmacoepidemiol Drug Saf. 2018 Nov;27(11):1217-1222. doi: 10.1002/pds.4651. Epub 2018 Sep 12.","Jones M","Pharmacoepidemiol Drug Saf","2018","2018/09/14","","","10.1002/pds.4651"
"30192041","Adherence trajectories of buprenorphine therapy among pregnant women in a large state Medicaid program in the United States","Lo-Ciganic WH, Donohue JM, Kim JY, Krans EE, Jones BL, Kelley D, James AE, Jarlenski MP.","Pharmacoepidemiol Drug Saf. 2019 Jan;28(1):80-89. doi: 10.1002/pds.4647. Epub 2018 Sep 7.","Lo-Ciganic WH","Pharmacoepidemiol Drug Saf","2019","2018/09/08","PMC6557135","NIHMS1027937","10.1002/pds.4647"
"30187590","Factors distinguishing important identified risks from important potential risks in orphan and nonorphan drugs: An analysis of safety specifications of Japan and European Union risk management plans","Hirota S, Yamaguchi T.","Pharmacoepidemiol Drug Saf. 2018 Nov;27(11):1231-1238. doi: 10.1002/pds.4646. Epub 2018 Sep 5.","Hirota S","Pharmacoepidemiol Drug Saf","2018","2018/09/07","","","10.1002/pds.4646"
"30187574","Using trajectory models to assess the effect of hydrocodone upscheduling among chronic hydrocodone users","Murimi IB, Chang HY, Bicket M, Jones CM, Alexander GC.","Pharmacoepidemiol Drug Saf. 2019 Jan;28(1):70-79. doi: 10.1002/pds.4639. Epub 2018 Sep 5.","Murimi IB","Pharmacoepidemiol Drug Saf","2019","2018/09/07","","","10.1002/pds.4639"
"30168222","A tailor-made approach for causality assessment for ADR reports on drugs and vaccines","Oosterhuis I, Zweers P, Rümke H, Muller-Hansma A, van Puijenbroek EP.","Pharmacoepidemiol Drug Saf. 2019 Apr;28(4):544-550. doi: 10.1002/pds.4637. Epub 2018 Aug 30.","Oosterhuis I","Pharmacoepidemiol Drug Saf","2019","2018/09/01","","","10.1002/pds.4637"
"30152575","Evaluating automated approaches to anaphylaxis case classification using unstructured data from the FDA Sentinel System","Ball R, Toh S, Nolan J, Haynes K, Forshee R, Botsis T.","Pharmacoepidemiol Drug Saf. 2018 Oct;27(10):1077-1084. doi: 10.1002/pds.4645. Epub 2018 Aug 28.","Ball R","Pharmacoepidemiol Drug Saf","2018","2018/08/29","","","10.1002/pds.4645"
"30136330","Treatment with montelukast and antidepressive medication-a symmetry analysis","Winkel JS, Damkier P, Hallas J, Henriksen DP.","Pharmacoepidemiol Drug Saf. 2018 Dec;27(12):1409-1415. doi: 10.1002/pds.4638. Epub 2018 Aug 23.","Winkel JS","Pharmacoepidemiol Drug Saf","2018","2018/08/24","","","10.1002/pds.4638"
"30112779","Risk of hospital admission for liver injury in users of NSAIDs and nonoverdose paracetamol: Preliminary results from the EPIHAM study","Gulmez SE, Unal US, Lassalle R, Chartier A, Grolleau A, Moore N.","Pharmacoepidemiol Drug Saf. 2018 Nov;27(11):1174-1181. doi: 10.1002/pds.4640. Epub 2018 Aug 16.","Gulmez SE","Pharmacoepidemiol Drug Saf","2018","2018/08/17","","","10.1002/pds.4640"
"30106194","Modafinil and the risk of cardiovascular events: Findings from three US claims databases","Kaplan S, Goehring EL Jr, Melamed-Gal S, Nguyen-Khoa BA, Knebel H, Jones JK.","Pharmacoepidemiol Drug Saf. 2018 Nov;27(11):1182-1190. doi: 10.1002/pds.4642. Epub 2018 Aug 14.","Kaplan S","Pharmacoepidemiol Drug Saf","2018","2018/08/15","","","10.1002/pds.4642"
"30106193","Domperidone for insufficient lactation in England 2002-2015: A drug utilization study with interrupted time series analysis","Mehrabadi A, Reynier P, Platt RW, Filion KB.","Pharmacoepidemiol Drug Saf. 2018 Dec;27(12):1316-1324. doi: 10.1002/pds.4621. Epub 2018 Aug 14.","Mehrabadi A","Pharmacoepidemiol Drug Saf","2018","2018/08/15","","","10.1002/pds.4621"
"30095199","Thiazide but not loop diuretics is associated with hypomagnesaemia in the general population","Kieboom BCT, Zietse R, Ikram MA, Hoorn EJ, Stricker BH.","Pharmacoepidemiol Drug Saf. 2018 Nov;27(11):1166-1173. doi: 10.1002/pds.4636. Epub 2018 Aug 10.","Kieboom BCT","Pharmacoepidemiol Drug Saf","2018","2018/08/11","","","10.1002/pds.4636"
"30094880","Analysis of factors related to the occurrence of important drug-specific postmarketing safety-related regulatory actions: A cohort study focused on first-in-class drugs","Ikeda J, Kaneko M, Narukawa M.","Pharmacoepidemiol Drug Saf. 2018 Dec;27(12):1393-1401. doi: 10.1002/pds.4634. Epub 2018 Aug 10.","Ikeda J","Pharmacoepidemiol Drug Saf","2018","2018/08/11","","","10.1002/pds.4634"
"30073735","Tramadol use in Norway: A register-based population study","Birke H, Ekholm O, Sjøgren P, Fredheim O, Clausen T, Skurtveit S.","Pharmacoepidemiol Drug Saf. 2019 Jan;28(1):54-61. doi: 10.1002/pds.4626. Epub 2018 Aug 2.","Birke H","Pharmacoepidemiol Drug Saf","2019","2018/08/04","","","10.1002/pds.4626"
"30066460","Masking by vaccines in pediatric drug safety signal detection in the EudraVigilance database","Dodd C, Pacurariu A, Osokogu OU, Weibel D, Ferrajolo C, Vo DH, Becker B, Kors JA, Sturkenboom M.","Pharmacoepidemiol Drug Saf. 2018 Nov;27(11):1249-1256. doi: 10.1002/pds.4623. Epub 2018 Jul 31.","Dodd C","Pharmacoepidemiol Drug Saf","2018","2018/08/02","","","10.1002/pds.4623"
"30051945","Active surveillance of severe cutaneous adverse reactions: A case-population approach using a registry and a health care database","Rodríguez-Martín S, Martín-Merino E, Lerma V, Rodríguez-Miguel A, González O, González-Herrada C, Ramírez E, Bellón T, de Abajo FJ.","Pharmacoepidemiol Drug Saf. 2018 Sep;27(9):1042-1050. doi: 10.1002/pds.4622. Epub 2018 Jul 27.","Rodríguez-Martín S","Pharmacoepidemiol Drug Saf","2018","2018/07/28","","","10.1002/pds.4622"
"30051944","Medication-related anaphylaxis treated in hospital: Agents implicated, patient outcomes, and management lessons","Graudins LV, Trubiano JA, Zubrinich CM, Elliott AS, Aung AK.","Pharmacoepidemiol Drug Saf. 2018 Sep;27(9):1029-1033. doi: 10.1002/pds.4587. Epub 2018 Jul 27.","Graudins LV","Pharmacoepidemiol Drug Saf","2018","2018/07/28","","","10.1002/pds.4587"
"30043552","Effectiveness of risk minimization measures for the use of cilostazol in United Kingdom, Spain, Sweden, and Germany","Castellsague J, Poblador-Plou B, Giner-Soriano M, Linder M, Scholle O, Calingaert B, Bui C, Arana A, Laguna C, Gonzalez-Rubio F, Roso-Llorach A, Prados-Torres A, Perez-Gutthann S.","Pharmacoepidemiol Drug Saf. 2018 Sep;27(9):953-961. doi: 10.1002/pds.4584. Epub 2018 Jul 25.","Castellsague J","Pharmacoepidemiol Drug Saf","2018","2018/07/26","PMC6175151","","10.1002/pds.4584"
"30022561","Comparison of privacy-protecting analytic and data-sharing methods: A simulation study","Yoshida K, Gruber S, Fireman BH, Toh S.","Pharmacoepidemiol Drug Saf. 2018 Sep;27(9):1034-1041. doi: 10.1002/pds.4615. Epub 2018 Jul 18.","Yoshida K","Pharmacoepidemiol Drug Saf","2018","2018/07/20","PMC6135666","NIHMS976859","10.1002/pds.4615"
"30022560","Validation studies of claims data in the Asia-Pacific region: A comprehensive review","Koram N, Delgado M, Stark JH, Setoguchi S, de Luise C.","Pharmacoepidemiol Drug Saf. 2019 Feb;28(2):156-170. doi: 10.1002/pds.4616. Epub 2018 Jul 18.","Koram N","Pharmacoepidemiol Drug Saf","2019","2018/07/20","","","10.1002/pds.4616"
"30022557","Optimizing an algorithm for the identification and classification of pregnancy outcomes in German claims data","Wentzell N, Schink T, Haug U, Ulrich S, Niemeyer M, Mikolajczyk R.","Pharmacoepidemiol Drug Saf. 2018 Sep;27(9):1005-1010. doi: 10.1002/pds.4588. Epub 2018 Jul 18.","Wentzell N","Pharmacoepidemiol Drug Saf","2018","2018/07/20","","","10.1002/pds.4588"
"30003617","Validation of body mass index (BMI)-related ICD-9-CM and ICD-10-CM administrative diagnosis codes recorded in US claims data","Ammann EM, Kalsekar I, Yoo A, Johnston SS.","Pharmacoepidemiol Drug Saf. 2018 Oct;27(10):1092-1100. doi: 10.1002/pds.4617. Epub 2018 Jul 12.","Ammann EM","Pharmacoepidemiol Drug Saf","2018","2018/07/14","","","10.1002/pds.4617"
"30003613","Comparative out-of-hospital mortality of long-acting opioids prescribed for non-cancer pain: A retrospective cohort study","Chung CP, Dupont WD, Murray KT, Hall K, Stein CM, Ray WA.","Pharmacoepidemiol Drug Saf. 2019 Jan;28(1):48-53. doi: 10.1002/pds.4619. Epub 2018 Jul 12.","Chung CP","Pharmacoepidemiol Drug Saf","2019","2018/07/14","PMC6330158","NIHMS980602","10.1002/pds.4619"
"30003610","What is the quality of drug safety information for patients: An analysis of REMS educational materials","Chan HW, Russell AM, Smith MY.","Pharmacoepidemiol Drug Saf. 2018 Sep;27(9):969-978. doi: 10.1002/pds.4614. Epub 2018 Jul 13.","Chan HW","Pharmacoepidemiol Drug Saf","2018","2018/07/14","PMC6646909","","10.1002/pds.4614"
"29992780","Effect of European Medicines Agency's restrictions on trimetazidine utilization in Portugal","Pinto D, Silva A, Heleno B, Rodrigues DS, Santos I, Caetano PA.","Pharmacoepidemiol Drug Saf. 2018 Sep;27(9):962-968. doi: 10.1002/pds.4585. Epub 2018 Jul 10.","Pinto D","Pharmacoepidemiol Drug Saf","2018","2018/07/12","","","10.1002/pds.4585"
"29992679","Benefits of combining change-point analysis with disproportionality analysis in pharmacovigilance signal detection","Trinh NTH, Solé E, Benkebil M.","Pharmacoepidemiol Drug Saf. 2019 Mar;28(3):370-376. doi: 10.1002/pds.4613. Epub 2018 Jul 10.","Trinh NTH","Pharmacoepidemiol Drug Saf","2019","2018/07/12","","","10.1002/pds.4613"
"29992656","Understanding medicines with a propensity to increase the risk of heart failure: Combining existing knowledge with targeted population assessment","Tomlin AM, Woods DJ, Lloyd HS, Stewart RAH, Tilyard MW.","Pharmacoepidemiol Drug Saf. 2018 Sep;27(9):1019-1028. doi: 10.1002/pds.4586. Epub 2018 Jul 10.","Tomlin AM","Pharmacoepidemiol Drug Saf","2018","2018/07/12","","","10.1002/pds.4586"
"29952049","Empirical validation of the reverse parametric waiting time distribution and standard methods to estimate prescription durations for warfarin","Thrane JM, Støvring H, Hellfritzsch M, Hallas J, Pottegård A.","Pharmacoepidemiol Drug Saf. 2018 Sep;27(9):1011-1018. doi: 10.1002/pds.4581. Epub 2018 Jun 28.","Thrane JM","Pharmacoepidemiol Drug Saf","2018","2018/06/29","","","10.1002/pds.4581"
"29952045","Using the ""proportion of patients covered"" and the Kaplan-Meier survival analysis to describe treatment persistence","Rasmussen L, Pratt N, Hansen MR, Hallas J, Pottegård A.","Pharmacoepidemiol Drug Saf. 2018 Aug;27(8):867-871. doi: 10.1002/pds.4582. Epub 2018 Jun 27.","Rasmussen L","Pharmacoepidemiol Drug Saf","2018","2018/06/29","","","10.1002/pds.4582"
"29947124","Ascertainment and validation of major bleeding events in a primary care database","Ruigómez A, Brobert G, Suzart-Woischnik K, García-Rodríguez LA.","Pharmacoepidemiol Drug Saf. 2019 Feb;28(2):148-155. doi: 10.1002/pds.4580. Epub 2018 Jun 27.","Ruigómez A","Pharmacoepidemiol Drug Saf","2019","2018/06/28","","","10.1002/pds.4580"
"29947045","Assessing the impact of the new ICD-10-CM coding system on pharmacoepidemiologic studies-An application to the known association between angiotensin-converting enzyme inhibitors and angioedema","Panozzo CA, Welch EC, Woodworth TS, Huang TY, Her QL, Gagne JJ, Sun JW, Rogers C, Menzin TJ, Ehrmann M, Freitas KE, Haug NR, Toh S.","Pharmacoepidemiol Drug Saf. 2018 Aug;27(8):829-838. doi: 10.1002/pds.4550. Epub 2018 Jun 26.","Panozzo CA","Pharmacoepidemiol Drug Saf","2018","2018/06/28","","","10.1002/pds.4550"
"29947033","Early impact of the ICD-10-CM transition on selected health outcomes in 13 electronic health care databases in the United States","Panozzo CA, Woodworth TS, Welch EC, Huang TY, Her QL, Haynes K, Rogers C, Menzin TJ, Ehrmann M, Freitas KE, Haug NR, Toh S.","Pharmacoepidemiol Drug Saf. 2018 Aug;27(8):839-847. doi: 10.1002/pds.4563. Epub 2018 Jun 26.","Panozzo CA","Pharmacoepidemiol Drug Saf","2018","2018/06/28","","","10.1002/pds.4563"
"29943442","Calendar time as an instrumental variable in assessing the risk of heart failure with antihyperglycemic drugs","Gokhale M, Buse JB, DeFilippo Mack C, Jonsson Funk M, Lund J, Simpson RJ, Stürmer T.","Pharmacoepidemiol Drug Saf. 2018 Aug;27(8):857-866. doi: 10.1002/pds.4578. Epub 2018 Jun 26.","Gokhale M","Pharmacoepidemiol Drug Saf","2018","2018/06/27","","","10.1002/pds.4578"
"29932281","Diagnosis-based cohort augmentation using laboratory results data: The case of chronic kidney disease","Smith DH, Shetterly S, Flory J, Haynes K, Lu CY, Gagne JJ, Herrinton L, Nyirenda C, Patorno E, Shoaibi A, Raebel MA.","Pharmacoepidemiol Drug Saf. 2018 Aug;27(8):872-877. doi: 10.1002/pds.4583. Epub 2018 Jun 22.","Smith DH","Pharmacoepidemiol Drug Saf","2018","2018/06/23","","","10.1002/pds.4583"
"29926998","Prescription of pain medication in prisons: A comparative analysis of younger and older male prisoners","Annaheim B, Bretschneider W, Handtke V, Belardi A, Elger BS.","Pharmacoepidemiol Drug Saf. 2018 Sep;27(9):987-994. doi: 10.1002/pds.4573. Epub 2018 Jun 21.","Annaheim B","Pharmacoepidemiol Drug Saf","2018","2018/06/22","","","10.1002/pds.4573"
"29923258","Accuracy of electronic health record data for the diagnosis of chronic obstructive pulmonary disease in persons living with HIV and uninfected persons","Crothers K, Rodriguez CV, Nance RM, Akgun K, Shahrir S, Kim J, W Soo Hoo G, Sharafkhaneh A, Crane HM, Justice AC.","Pharmacoepidemiol Drug Saf. 2019 Feb;28(2):140-147. doi: 10.1002/pds.4567. Epub 2018 Jun 20.","Crothers K","Pharmacoepidemiol Drug Saf","2019","2018/06/21","PMC6309326","NIHMS975522","10.1002/pds.4567"
"29923251","Use of proton pump inhibitors and risk of pancreatic cancer","Hicks B, Friis S, Pottegård A.","Pharmacoepidemiol Drug Saf. 2018 Aug;27(8):926-930. doi: 10.1002/pds.4576. Epub 2018 Jun 20.","Hicks B","Pharmacoepidemiol Drug Saf","2018","2018/06/21","","","10.1002/pds.4576"
"29920843","Assessing the possible association of anti-TNF use with new malignancies: A neglected methodological consideration","Ozguler Y, Yazici Y, Hatemi G, Tascilar K, Yazici H.","Pharmacoepidemiol Drug Saf. 2018 Aug;27(8):894-901. doi: 10.1002/pds.4579. Epub 2018 Jun 19.","Ozguler Y","Pharmacoepidemiol Drug Saf","2018","2018/06/20","","","10.1002/pds.4579"
"29920833","Trends in prescription drug use during pregnancy and postpartum in Norway, 2005 to 2015","Engeland A, Bjørge T, Klungsøyr K, Hjellvik V, Skurtveit S, Furu K.","Pharmacoepidemiol Drug Saf. 2018 Sep;27(9):995-1004. doi: 10.1002/pds.4577. Epub 2018 Jun 19.","Engeland A","Pharmacoepidemiol Drug Saf","2018","2018/06/20","","","10.1002/pds.4577"
"29896933","Anticholinergic and sedative medications and the risk of vertigo or dizziness in the German primary care setting-A matched case-control study from the CONTENT registry","Phillips A, Strobl R, Grill E, Laux G.","Pharmacoepidemiol Drug Saf. 2018 Aug;27(8):912-920. doi: 10.1002/pds.4575. Epub 2018 Jun 13.","Phillips A","Pharmacoepidemiol Drug Saf","2018","2018/06/14","","","10.1002/pds.4575"
"29896873","Quantifying the utilization of medical devices necessary to detect postmarket safety differences: A case study of implantable cardioverter defibrillators","Bates J, Parzynski CS, Dhruva SS, Coppi A, Kuntz R, Li SX, Marinac-Dabic D, Masoudi FA, Shaw RE, Warner F, Krumholz HM, Ross JS.","Pharmacoepidemiol Drug Saf. 2018 Aug;27(8):848-856. doi: 10.1002/pds.4565. Epub 2018 Jun 12.","Bates J","Pharmacoepidemiol Drug Saf","2018","2018/06/14","PMC6436550","NIHMS1018879","10.1002/pds.4565"
"29888409","Opioid tolerance and clinically recognized opioid poisoning among patients prescribed extended-release long-acting opioids","Young JC, Lund JL, Dasgupta N, Jonsson Funk M.","Pharmacoepidemiol Drug Saf. 2019 Jan;28(1):39-47. doi: 10.1002/pds.4572. Epub 2018 Jun 11.","Young JC","Pharmacoepidemiol Drug Saf","2019","2018/06/12","","","10.1002/pds.4572"
"29878643","Prescribing and Research in Medicines Management (UK & Ireland), Annual Conference 2018, National Council for Voluntary Organisations, London, January 26, 2018: ""Optimising Medicines: Factoring in Frailty""","","Pharmacoepidemiol Drug Saf. 2018 May;27 Suppl 1:3-14. doi: 10.1002/pds.4439.","","Pharmacoepidemiol Drug Saf","2018","2018/06/08","","","10.1002/pds.4439"
"29869446","Trimethoprim: The overlooked component of trimethoprim-sulfamethoxazole idiosyncratic adverse drug reactions","Goldman JL, van Haandel L.","Pharmacoepidemiol Drug Saf. 2018 Aug;27(8):949-951. doi: 10.1002/pds.4574. Epub 2018 Jun 4.","Goldman JL","Pharmacoepidemiol Drug Saf","2018","2018/06/06","","","10.1002/pds.4574"
"29869441","Long-acting opioid initiation in US nursing homes","Hunnicutt JN, Hume AL, Ulbricht CM, Tjia J, Lapane KL.","Pharmacoepidemiol Drug Saf. 2019 Jan;28(1):31-38. doi: 10.1002/pds.4568. Epub 2018 Jun 4.","Hunnicutt JN","Pharmacoepidemiol Drug Saf","2019","2018/06/06","PMC6279625","NIHMS983760","10.1002/pds.4568"
"29869382","Methodological challenges in assessment of current use of warfarin among patients with atrial fibrillation using dispensation data from administrative health care databases","Sinyavskaya L, Matteau A, Johnson S, Durand M.","Pharmacoepidemiol Drug Saf. 2018 Sep;27(9):979-986. doi: 10.1002/pds.4570. Epub 2018 Jun 5.","Sinyavskaya L","Pharmacoepidemiol Drug Saf","2018","2018/06/06","","","10.1002/pds.4570"
"29862608","Agreement between asthma questionnaire and health care register data","Hedman AM, Gong T, Lundholm C, Dahlén E, Ullemar V, Brew BK, Almqvist C.","Pharmacoepidemiol Drug Saf. 2018 Oct;27(10):1139-1146. doi: 10.1002/pds.4566. Epub 2018 Jun 3.","Hedman AM","Pharmacoepidemiol Drug Saf","2018","2018/06/05","","","10.1002/pds.4566"
"29862604","Safety of repeated doses of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine in adults and adolescents","Jackson ML, Yu O, Nelson JC, Nordin JD, Tartof SY, Klein NP, Donahue JG, Irving SA, Glanz JM, McNeil MM, Jackson LA.","Pharmacoepidemiol Drug Saf. 2018 Aug;27(8):921-925. doi: 10.1002/pds.4569. Epub 2018 Jun 3.","Jackson ML","Pharmacoepidemiol Drug Saf","2018","2018/06/05","PMC6541919","NIHMS1030767","10.1002/pds.4569"
"29862602","Methodologic limitations of prescription opioid safety research and recommendations for improving the evidence base","Ranapurwala SI, Naumann RB, Austin AE, Dasgupta N, Marshall SW.","Pharmacoepidemiol Drug Saf. 2019 Jan;28(1):4-12. doi: 10.1002/pds.4564. Epub 2018 Jun 3.","Ranapurwala SI","Pharmacoepidemiol Drug Saf","2019","2018/06/05","","","10.1002/pds.4564"
"29851174","Association between dipeptidyl peptidase-4 inhibitors and urinary tract infection in elderly patients: A retrospective cohort study","Imatoh T, Nishi T, Yasui M, Maeda T, Sai K, Saito Y, Une H, Babazono A.","Pharmacoepidemiol Drug Saf. 2018 Aug;27(8):931-939. doi: 10.1002/pds.4560. Epub 2018 May 30.","Imatoh T","Pharmacoepidemiol Drug Saf","2018","2018/06/01","","","10.1002/pds.4560"
"29808503","Effect of statins in preventing hospitalizations for infections: A population study","Policardo L, Seghieri G, Gualdani E, Franconi F.","Pharmacoepidemiol Drug Saf. 2018 Aug;27(8):878-884. doi: 10.1002/pds.4557. Epub 2018 May 28.","Policardo L","Pharmacoepidemiol Drug Saf","2018","2018/05/30","","","10.1002/pds.4557"
"29806185","Electronic health record (EHR) based postmarketing surveillance of adverse events associated with pediatric off-label medication use: A case study of short-acting beta-2 agonists and arrhythmias","Czaja AS, Ross ME, Liu W, Fiks AG, Localio R, Wasserman RC, Grundmeier RW, Adams WG; Comparative Effectiveness Research through Collaborative Electronic Reporting (CER2) Consortium.","Pharmacoepidemiol Drug Saf. 2018 Jul;27(7):815-822. doi: 10.1002/pds.4562. Epub 2018 May 27.","Czaja AS","Pharmacoepidemiol Drug Saf","2018","2018/05/29","","","10.1002/pds.4562"
"29806168","The importance of validating intracranial bleeding diagnoses in The Health Improvement Network, United Kingdom: Misclassification of onset and its impact on the risk associated with low-dose aspirin therapy","Cea Soriano L, Gaist D, Soriano-Gabarró M, García Rodríguez LA.","Pharmacoepidemiol Drug Saf. 2019 Feb;28(2):134-139. doi: 10.1002/pds.4561. Epub 2018 May 27.","Cea Soriano L","Pharmacoepidemiol Drug Saf","2019","2018/05/29","","","10.1002/pds.4561"
"29797447","Concomitant use of low-dose methotrexate and NSAIDs and the risk of serious adverse events among patients with rheumatoid arthritis","Svanström H, Lund M, Melbye M, Pasternak B.","Pharmacoepidemiol Drug Saf. 2018 Aug;27(8):885-893. doi: 10.1002/pds.4555. Epub 2018 May 24.","Svanström H","Pharmacoepidemiol Drug Saf","2018","2018/05/26","","","10.1002/pds.4555"
"29797381","Characteristics of drugs safety signals that predict safety related product information update","Insani WN, Pacurariu AC, Mantel-Teeuwisse AK, Gross-Martirosyan L.","Pharmacoepidemiol Drug Saf. 2018 Jul;27(7):789-796. doi: 10.1002/pds.4446. Epub 2018 May 24.","Insani WN","Pharmacoepidemiol Drug Saf","2018","2018/05/26","PMC6055643","","10.1002/pds.4446"
"29797371","Neuropathic pain is not adequately treated in the older general population: Results from the KORA F4 survey","Meisinger C, Bongaerts BWC, Heier M, Amann U, Kowall B, Herder C, Rückert-Eheberg IM, Rathmann W, Ziegler D.","Pharmacoepidemiol Drug Saf. 2018 Jul;27(7):806-814. doi: 10.1002/pds.4559. Epub 2018 May 24.","Meisinger C","Pharmacoepidemiol Drug Saf","2018","2018/05/26","","","10.1002/pds.4559"
"29766592","Scoring the best deal: Quantity discounts and street price variation of diverted oxycodone and oxymorphone","Lebin JA, Murphy DL, Severtson SG, Bau GE, Dasgupta N, Dart RC.","Pharmacoepidemiol Drug Saf. 2019 Jan;28(1):25-30. doi: 10.1002/pds.4558. Epub 2018 May 15.","Lebin JA","Pharmacoepidemiol Drug Saf","2019","2018/05/17","","","10.1002/pds.4558"
"29763992","Development of an algorithm to identify pregnancy episodes and related outcomes in health care claims databases: An application to antiepileptic drug use in 4.9 million pregnant women in France","Blotière PO, Weill A, Dalichampt M, Billionnet C, Mezzarobba M, Raguideau F, Dray-Spira R, Zureik M, Coste J, Alla F.","Pharmacoepidemiol Drug Saf. 2018 Jul;27(7):763-770. doi: 10.1002/pds.4556. Epub 2018 May 15.","Blotière PO","Pharmacoepidemiol Drug Saf","2018","2018/05/16","PMC6055607","","10.1002/pds.4556"
"29749668","Signal detection on a patient cohort: A disproportionality analysis of the ANRS CO22 HEPATHER cohort to identify associations between direct acting antivirals and adverse events in patients with hepatitis C virus chronic infection","Feldman SF, Lapidus N, Dorival C, Diallo A, Amri I, Fontaine H, Pol S, Carrat F; ANRS/AFEF HEPATHER study group.","Pharmacoepidemiol Drug Saf. 2018 Jul;27(7):797-805. doi: 10.1002/pds.4552. Epub 2018 May 11.","Feldman SF","Pharmacoepidemiol Drug Saf","2018","2018/05/12","","","10.1002/pds.4552"
"29749124","Development of algorithms to determine the onset of pregnancy and delivery date using health care administrative data in a university hospital in Japan","Ishikawa T, Obara T, Nishigori H, Miyakoda K, Inoue R, Hoshiai T, Saito M, Yaegashi N, Mano N.","Pharmacoepidemiol Drug Saf. 2018 Jul;27(7):751-762. doi: 10.1002/pds.4444. Epub 2018 May 11.","Ishikawa T","Pharmacoepidemiol Drug Saf","2018","2018/05/12","","","10.1002/pds.4444"
"29749086","Imposed registries within the European postmarketing surveillance system: Extended analysis and lessons learned for regulators","Pacurariu A, Plueschke K, Olmo CA, Kurz X.","Pharmacoepidemiol Drug Saf. 2018 Jul;27(7):823-826. doi: 10.1002/pds.4449. Epub 2018 May 11.","Pacurariu A","Pharmacoepidemiol Drug Saf","2018","2018/05/12","","","10.1002/pds.4449"
"29740916","Real world management of pregestational diabetes not achieving glycemic control for many patients in the UK","Cea-Soriano L, García-Rodríguez LA, Brodovicz KG, Masso-Gonzalez E, Bartels DB, Hernández-Díaz S.","Pharmacoepidemiol Drug Saf. 2018 Aug;27(8):940-948. doi: 10.1002/pds.4553. Epub 2018 May 8.","Cea-Soriano L","Pharmacoepidemiol Drug Saf","2018","2018/05/10","","","10.1002/pds.4553"
"29740912","Antidepressant and antipsychotic medication errors reported to United States poison control centers","Kamboj A, Spiller HA, Casavant MJ, Chounthirath T, Hodges NL, Smith GA.","Pharmacoepidemiol Drug Saf. 2018 Aug;27(8):902-911. doi: 10.1002/pds.4554. Epub 2018 May 8.","Kamboj A","Pharmacoepidemiol Drug Saf","2018","2018/05/10","","","10.1002/pds.4554"
"29740896","GOLD assessment of COPD severity in the Clinical Practice Research Datalink (CPRD)","Rebordosa C, Plana E, Aguado J, Thomas S, García-Gil E, Perez-Gutthann S, Castellsague J.","Pharmacoepidemiol Drug Saf. 2019 Feb;28(2):126-133. doi: 10.1002/pds.4448. Epub 2018 May 8.","Rebordosa C","Pharmacoepidemiol Drug Saf","2019","2018/05/10","","","10.1002/pds.4448"
"29726630","Trends in the long-term use of benzodiazepine anxiolytics and hypnotics: A national register study for 2006 to 2014","Kurko T, Saastamoinen LK, Tuulio-Henriksson A, Taiminen T, Tiihonen J, Airaksinen M, Hietala J.","Pharmacoepidemiol Drug Saf. 2018 Jun;27(6):674-682. doi: 10.1002/pds.4551. Epub 2018 May 4.","Kurko T","Pharmacoepidemiol Drug Saf","2018","2018/05/05","","","10.1002/pds.4551"
"29726056","Evaluation of compliance with isotretinoin PPP recommendations and exploration of reasons for non-compliance: Survey among French-speaking health care professionals and patients in Belgium","Lelubre M, Hamdani J, Senterre C, Amighi K, Peres M, Schneider MP, Bugnon O, De Vriese C.","Pharmacoepidemiol Drug Saf. 2018 Jun;27(6):668-673. doi: 10.1002/pds.4441. Epub 2018 May 3.","Lelubre M","Pharmacoepidemiol Drug Saf","2018","2018/05/05","","","10.1002/pds.4441"
"29701279","Reuse of data sources to evaluate drug safety signals: When is it appropriate?","Wang SV, Kulldorff M, Glynn RJ, Gagne JJ, Pottegård A, Rothman KJ, Schneeweiss S, Walker AM.","Pharmacoepidemiol Drug Saf. 2018 Jun;27(6):567-569. doi: 10.1002/pds.4442. Epub 2018 Apr 27.","Wang SV","Pharmacoepidemiol Drug Saf","2018","2018/04/28","","","10.1002/pds.4442"
"29700904","Trajectories of dispensed prescription opioids among beneficiaries enrolled in a Medicaid controlled substance ""lock-in"" program","Naumann RB, Marshall SW, Gottfredson NC, Lund JL, Ringwalt CL, Skinner AC.","Pharmacoepidemiol Drug Saf. 2019 Jan;28(1):16-24. doi: 10.1002/pds.4445. Epub 2018 Apr 26.","Naumann RB","Pharmacoepidemiol Drug Saf","2019","2018/04/28","PMC7482140","NIHMS1622737","10.1002/pds.4445"
"29691919","Impact of different assumptions on estimates of childhood diseases obtained from health care data: A retrospective cohort study","Osokogu OU, Pacurariu A, Mosseveld M, Rijnbeek P, Weibel D, Verhamme K, Sturkenboom MCJM.","Pharmacoepidemiol Drug Saf. 2018 Jun;27(6):612-620. doi: 10.1002/pds.4413. Epub 2018 Apr 24.","Osokogu OU","Pharmacoepidemiol Drug Saf","2018","2018/04/26","PMC6001570","","10.1002/pds.4413"
"29687539","Using prescription claims to detect aberrant behaviors with opioids: comparison and validation of 5 algorithms","Rough K, Huybrechts KF, Hernandez-Diaz S, Desai RJ, Patorno E, Bateman BT.","Pharmacoepidemiol Drug Saf. 2019 Jan;28(1):62-69. doi: 10.1002/pds.4443. Epub 2018 Apr 24.","Rough K","Pharmacoepidemiol Drug Saf","2019","2018/04/25","PMC6200661","NIHMS959066","10.1002/pds.4443"
"29687504","Assessing the accuracy of using diagnostic codes from administrative data to infer antidepressant treatment indications: a validation study","Wong J, Abrahamowicz M, Buckeridge DL, Tamblyn R.","Pharmacoepidemiol Drug Saf. 2018 Oct;27(10):1101-1111. doi: 10.1002/pds.4436. Epub 2018 Apr 23.","Wong J","Pharmacoepidemiol Drug Saf","2018","2018/04/25","PMC6220980","","10.1002/pds.4436"
"29667263","Assumptions made when preparing drug exposure data for analysis have an impact on results: An unreported step in pharmacoepidemiology studies","Pye SR, Sheppard T, Joseph RM, Lunt M, Girard N, Haas JS, Bates DW, Buckeridge DL, van Staa TP, Tamblyn R, Dixon WG.","Pharmacoepidemiol Drug Saf. 2018 Jul;27(7):781-788. doi: 10.1002/pds.4440. Epub 2018 Apr 17.","Pye SR","Pharmacoepidemiol Drug Saf","2018","2018/04/19","PMC6055712","","10.1002/pds.4440"
"29664233","Positive predictive value of a register-based algorithm using the Danish National Registries to identify suicidal events","Gasse C, Danielsen AA, Pedersen MG, Pedersen CB, Mors O, Christensen J.","Pharmacoepidemiol Drug Saf. 2018 Oct;27(10):1131-1138. doi: 10.1002/pds.4433. Epub 2018 Apr 17.","Gasse C","Pharmacoepidemiol Drug Saf","2018","2018/04/18","","","10.1002/pds.4433"
"29663572","A review of studies evaluating the effectiveness of risk minimisation measures in Europe using the European Union electronic Register of Post-Authorization Studies","Vora P, Artime E, Soriano-Gabarró M, Qizilbash N, Singh V, Asiimwe A.","Pharmacoepidemiol Drug Saf. 2018 Jul;27(7):695-706. doi: 10.1002/pds.4434. Epub 2018 Apr 16.","Vora P","Pharmacoepidemiol Drug Saf","2018","2018/04/18","PMC6055865","","10.1002/pds.4434"
"29659118","Risk of stroke associated with use of nonsteroidal anti-inflammatory drugs during acute respiratory infection episode","Wen YC, Hsiao FY, Lin ZF, Fang CC, Shen LJ.","Pharmacoepidemiol Drug Saf. 2018 Jun;27(6):645-651. doi: 10.1002/pds.4428. Epub 2018 Apr 16.","Wen YC","Pharmacoepidemiol Drug Saf","2018","2018/04/17","","","10.1002/pds.4428"
"29659109","A tool for assessment of heart failure prescribing quality: A systematic review and meta-analysis","El Hadidi S, Darweesh E, Byrne S, Bermingham M.","Pharmacoepidemiol Drug Saf. 2018 Jul;27(7):685-694. doi: 10.1002/pds.4430. Epub 2018 Apr 16.","El Hadidi S","Pharmacoepidemiol Drug Saf","2018","2018/04/17","","","10.1002/pds.4430"
"29655296","Short-term effects of heat and cold on respiratory drug use. A time-series epidemiological study in A Coruña, Spain","Royé D, Figueiras A, Taracido M.","Pharmacoepidemiol Drug Saf. 2018 Jun;27(6):638-644. doi: 10.1002/pds.4427. Epub 2018 Apr 14.","Royé D","Pharmacoepidemiol Drug Saf","2018","2018/04/15","","","10.1002/pds.4427"
"29655237","Cardiovascular safety signals with dipeptidyl peptidase-4 inhibitors: A disproportionality analysis among high-risk patients","Baksh SN, McAdams-DeMarco M, Segal JB, Alexander GC.","Pharmacoepidemiol Drug Saf. 2018 Jun;27(6):660-667. doi: 10.1002/pds.4437. Epub 2018 Apr 14.","Baksh SN","Pharmacoepidemiol Drug Saf","2018","2018/04/15","PMC6727842","NIHMS1047658","10.1002/pds.4437"
"29655187","Classifying medical histories in US Medicare beneficiaries using fixed vs all-available look-back approaches","Conover MM, Stürmer T, Poole C, Glynn RJ, Simpson RJ Jr, Pate V, Jonsson Funk M.","Pharmacoepidemiol Drug Saf. 2018 Jul;27(7):771-780. doi: 10.1002/pds.4435. Epub 2018 Apr 14.","Conover MM","Pharmacoepidemiol Drug Saf","2018","2018/04/15","PMC6417795","NIHMS962839","10.1002/pds.4435"
"29611249","Association rules method and big data: Evaluating frequent medication combinations associated with fractures in older adults","Nishtala PS, Chyou TY, Held F, Le Couteur DG, Gnjidic D.","Pharmacoepidemiol Drug Saf. 2018 Oct;27(10):1123-1130. doi: 10.1002/pds.4432. Epub 2018 Apr 2.","Nishtala PS","Pharmacoepidemiol Drug Saf","2018","2018/04/04","","","10.1002/pds.4432"
"29602246","Effect of European Medicines Agency's regulatory measures on nimesulide utilization in Portugal","Pinto D, Silva A, Heleno B, Rodrigues DS, Santos I, Caetano PA.","Pharmacoepidemiol Drug Saf. 2018 Jun;27(6):630-637. doi: 10.1002/pds.4424. Epub 2018 Mar 30.","Pinto D","Pharmacoepidemiol Drug Saf","2018","2018/03/31","","","10.1002/pds.4424"
"29582499","Knowledge and behaviors in relation to antibiotic use among rural residents in Anhui, China","Cheng J, Coope C, Chai J, Oliver I, Kessel A, Wang D, Sun Y.","Pharmacoepidemiol Drug Saf. 2018 Jun;27(6):652-659. doi: 10.1002/pds.4429. Epub 2018 Mar 26.","Cheng J","Pharmacoepidemiol Drug Saf","2018","2018/03/28","","","10.1002/pds.4429"
"29575351","Measuring the impact of pharmacoepidemiologic research using altmetrics: A case study of a CNODES drug-safety article","Gamble JM, Traynor RL, Gruzd A, Mai P, Dormuth CR, Sketris IS.","Pharmacoepidemiol Drug Saf. 2020 Jan;29 Suppl 1(Suppl 1):93-102. doi: 10.1002/pds.4401. Epub 2018 Mar 24.","Gamble JM","Pharmacoepidemiol Drug Saf","2020","2018/03/26","PMC7004200","","10.1002/pds.4401"
"29575242","Methodology for computing the burden of disease of adverse events following immunization","McDonald SA, Nijsten D, Bollaerts K, Bauwens J, Praet N, van der Sande M, Bauchau V, de Smedt T, Sturkenboom M, Hahné S.","Pharmacoepidemiol Drug Saf. 2018 Jul;27(7):724-730. doi: 10.1002/pds.4419. Epub 2018 Mar 24.","McDonald SA","Pharmacoepidemiol Drug Saf","2018","2018/03/26","PMC6055877","","10.1002/pds.4419"
"29575226","Discontinuation and dose adjustment of metoprolol after metoprolol-paroxetine/fluoxetine co-prescription in Dutch elderly","Bahar MA, Wang Y, Bos JHJ, Wilffert B, Hak E.","Pharmacoepidemiol Drug Saf. 2018 Jun;27(6):621-629. doi: 10.1002/pds.4422. Epub 2018 Mar 24.","Bahar MA","Pharmacoepidemiol Drug Saf","2018","2018/03/26","PMC6001522","","10.1002/pds.4422"
"29573031","A systematic review of adverse events of rifapentine and isoniazid compared to other treatments for latent tuberculosis infection","Pease C, Hutton B, Yazdi F, Wolfe D, Hamel C, Barbeau P, Skidmore B, Alvarez GG.","Pharmacoepidemiol Drug Saf. 2018 Jun;27(6):557-566. doi: 10.1002/pds.4423. Epub 2018 Mar 23.","Pease C","Pharmacoepidemiol Drug Saf","2018","2018/03/25","","","10.1002/pds.4423"
"29570897","Methodological challenges when evaluating potential off-label prescribing of drugs using electronic health care databases: A case study of dabigatran etexilate in Europe","Cainzos-Achirica M, Varas-Lorenzo C, Pottegård A, Asmar J, Plana E, Rasmussen L, Bizouard G, Forns J, Hellfritzsch M, Zint K, Perez-Gutthann S, Pladevall-Vila M.","Pharmacoepidemiol Drug Saf. 2018 Jul;27(7):713-723. doi: 10.1002/pds.4416. Epub 2018 Mar 23.","Cainzos-Achirica M","Pharmacoepidemiol Drug Saf","2018","2018/03/24","","","10.1002/pds.4416"
"29570893","Comparison of dispensed medications and forensic-toxicological findings to assess pharmacotherapy in the Swedish population 2006 to 2013","Forsman J, Taipale H, Masterman T, Tiihonen J, Tanskanen A.","Pharmacoepidemiol Drug Saf. 2018 Oct;27(10):1112-1122. doi: 10.1002/pds.4426. Epub 2018 Mar 23.","Forsman J","Pharmacoepidemiol Drug Saf","2018","2018/03/24","","","10.1002/pds.4426"
"29537120","Development of algorithms for identifying fatal cardiovascular disease in Medicare claims","Xie F, Colantonio LD, Curtis JR, Kilgore ML, Levitan EB, Monda KL, Safford MM, Taylor B, Woodward M, Muntner P.","Pharmacoepidemiol Drug Saf. 2018 Jul;27(7):740-750. doi: 10.1002/pds.4421. Epub 2018 Mar 14.","Xie F","Pharmacoepidemiol Drug Saf","2018","2018/03/15","PMC7050209","NIHMS962837","10.1002/pds.4421"
"29537112","Polydrug epidemiology: Benzodiazepine prescribing and the drug overdose epidemic in the United States","Zoorob MJ.","Pharmacoepidemiol Drug Saf. 2018 May;27(5):541-549. doi: 10.1002/pds.4417. Epub 2018 Mar 14.","Zoorob MJ","Pharmacoepidemiol Drug Saf","2018","2018/03/15","","","10.1002/pds.4417"
"29532543","Evaluation of the US Food and Drug Administration sentinel analysis tools in confirming previously observed drug-outcome associations: The case of clindamycin and Clostridium difficile infection","Carnahan RM, Kuntz JL, Wang SV, Fuller C, Gagne JJ, Leonard CE, Hennessy S, Meyer T, Archdeacon P, Chen CY, Panozzo CA, Toh S, Katcoff H, Woodworth T, Iyer A, Axtman S, Chrischilles EA.","Pharmacoepidemiol Drug Saf. 2018 Jul;27(7):731-739. doi: 10.1002/pds.4420. Epub 2018 Mar 13.","Carnahan RM","Pharmacoepidemiol Drug Saf","2018","2018/03/14","","","10.1002/pds.4420"
"29516585","Utilization of drugs with pregnancy exposure registries during pregnancy","Illoh OA, Toh S, Andrade SE, Hampp C, Sahin L, Gelperin K, Taylor L, Bird ST.","Pharmacoepidemiol Drug Saf. 2018 Jun;27(6):604-611. doi: 10.1002/pds.4409. Epub 2018 Mar 8.","Illoh OA","Pharmacoepidemiol Drug Saf","2018","2018/03/09","","","10.1002/pds.4409"
"29512263","Risk of sudden sensorineural hearing loss in adults using phosphodiesterase type 5 inhibitors: Population-based cohort study","Liu W, Antonelli PJ, Dahm P, Gerhard T, Delaney JAC, Segal R, Crystal S, Winterstein AG.","Pharmacoepidemiol Drug Saf. 2018 Jun;27(6):587-595. doi: 10.1002/pds.4405. Epub 2018 Mar 7.","Liu W","Pharmacoepidemiol Drug Saf","2018","2018/03/08","","","10.1002/pds.4405"
"29508514","Erratum","","Pharmacoepidemiol Drug Saf. 2018 Mar;27(3):356. doi: 10.1002/pds.4414.","","Pharmacoepidemiol Drug Saf","2018","2018/03/07","PMC6885961","","10.1002/pds.4414"
"29504168","Sequential surveillance for drug safety in a regulatory environment","Martin D, Gagne JJ, Gruber S, Izem R, Nelson JC, Nguyen MD, Ouellet-Hellstrom R, Schneeweiss S, Toh S, Walker AM.","Pharmacoepidemiol Drug Saf. 2018 Jul;27(7):707-712. doi: 10.1002/pds.4407. Epub 2018 Mar 5.","Martin D","Pharmacoepidemiol Drug Saf","2018","2018/03/06","","","10.1002/pds.4407"
"29493050","The impact of permissive and restrictive pharmaceutical policies on quetiapine dispensing: Evaluating a policy pendulum using interrupted time series analysis","Brett J, Schaffer A, Dobbins T, Buckley NA, Pearson SA.","Pharmacoepidemiol Drug Saf. 2018 Apr;27(4):439-446. doi: 10.1002/pds.4408. Epub 2018 Feb 28.","Brett J","Pharmacoepidemiol Drug Saf","2018","2018/03/02","","","10.1002/pds.4408"
"29493043","Proton pump inhibitor use and the risk of fractures among an older adult cohort","Harding BN, Weiss NS, Walker RL, Larson EB, Dublin S.","Pharmacoepidemiol Drug Saf. 2018 Jun;27(6):596-603. doi: 10.1002/pds.4406. Epub 2018 Feb 28.","Harding BN","Pharmacoepidemiol Drug Saf","2018","2018/03/02","PMC5984154","NIHMS953197","10.1002/pds.4406"
"29490427","Icodextrin reduces the risk of congestive heart failure in peritoneal dialysis patients","Wang IK, Lin CL, Yen TH, Lin SY, Yao-Lung L, Sung FC.","Pharmacoepidemiol Drug Saf. 2018 Apr;27(4):447-452. doi: 10.1002/pds.4412. Epub 2018 Feb 28.","Wang IK","Pharmacoepidemiol Drug Saf","2018","2018/03/01","","","10.1002/pds.4412"
"29488663","Impact of Florida's prescription drug monitoring program and pill mill law on high-risk patients: A comparative interrupted time series analysis","Chang HY, Murimi I, Faul M, Rutkow L, Alexander GC.","Pharmacoepidemiol Drug Saf. 2018 Apr;27(4):422-429. doi: 10.1002/pds.4404. Epub 2018 Feb 28.","Chang HY","Pharmacoepidemiol Drug Saf","2018","2018/03/01","PMC6664298","NIHMS976323","10.1002/pds.4404"
"29488294","Agreement between paternal self-reported medication use and records from a national prescription database","Cohen JM, Wood ME, Hernandez-Diaz S, Nordeng H.","Pharmacoepidemiol Drug Saf. 2018 Apr;27(4):413-421. doi: 10.1002/pds.4411. Epub 2018 Feb 28.","Cohen JM","Pharmacoepidemiol Drug Saf","2018","2018/03/01","","","10.1002/pds.4411"
"29488292","Patterns of prednisone use during pregnancy in women with rheumatoid arthritis: Daily and cumulative dose","Palmsten K, Rolland M, Hebert MF, Clowse MEB, Schatz M, Xu R, Chambers CD.","Pharmacoepidemiol Drug Saf. 2018 Apr;27(4):430-438. doi: 10.1002/pds.4410. Epub 2018 Feb 28.","Palmsten K","Pharmacoepidemiol Drug Saf","2018","2018/03/01","PMC6039094","NIHMS962836","10.1002/pds.4410"
"29488288","Changes in consumption of opioid analgesics in Israel 2009 to 2016: An update focusing on oxycodone and fentanyl formulations","Ponizovsky AM, Marom E, Weizman A, Schwartzberg E.","Pharmacoepidemiol Drug Saf. 2018 May;27(5):535-540. doi: 10.1002/pds.4415. Epub 2018 Feb 28.","Ponizovsky AM","Pharmacoepidemiol Drug Saf","2018","2018/03/01","","","10.1002/pds.4415"
"29460385","Primary non-adherence and the new-user design","Li X, Cole SR, Westreich D, Brookhart MA.","Pharmacoepidemiol Drug Saf. 2018 Apr;27(4):361-364. doi: 10.1002/pds.4403. Epub 2018 Feb 19.","Li X","Pharmacoepidemiol Drug Saf","2018","2018/02/21","PMC6013420","NIHMS972752","10.1002/pds.4403"
"29457309","Severe intestinal malabsorption associated with ACE inhibitor or angiotensin receptor blocker treatment. An observational cohort study in Germany and Italy","Malfertheiner P, Ripellino C, Cataldo N.","Pharmacoepidemiol Drug Saf. 2018 Jun;27(6):581-586. doi: 10.1002/pds.4402. Epub 2018 Feb 19.","Malfertheiner P","Pharmacoepidemiol Drug Saf","2018","2018/02/20","PMC6001476","","10.1002/pds.4402"
"29446185","Chart validation of inpatient ICD-9-CM administrative diagnosis codes for acute myocardial infarction (AMI) among intravenous immune globulin (IGIV) users in the Sentinel Distributed Database","Ammann EM, Schweizer ML, Robinson JG, Eschol JO, Kafa R, Girotra S, Winiecki SK, Fuller CC, Carnahan RM, Leonard CE, Haskins C, Garcia C, Chrischilles EA.","Pharmacoepidemiol Drug Saf. 2018 Apr;27(4):398-404. doi: 10.1002/pds.4398. Epub 2018 Feb 15.","Ammann EM","Pharmacoepidemiol Drug Saf","2018","2018/02/16","PMC6410350","NIHMS1004020","10.1002/pds.4398"
"29446176","Meningococcal conjugate vaccine safety surveillance in the Vaccine Safety Datalink using a tree-temporal scan data mining method","Li R, Weintraub E, McNeil MM, Kulldorff M, Lewis EM, Nelson J, Xu S, Qian L, Klein NP, Destefano F.","Pharmacoepidemiol Drug Saf. 2018 Apr;27(4):391-397. doi: 10.1002/pds.4397. Epub 2018 Feb 15.","Li R","Pharmacoepidemiol Drug Saf","2018","2018/02/16","","","10.1002/pds.4397"
"29441647","Methods for addressing ""innocent bystanders"" when evaluating safety of concomitant vaccines","Wang SV, Abdurrob A, Spoendlin J, Lewis E, Newcomer SR, Fireman B, Daley MF, Glanz JM, Duffy J, Weintraub ES, Kulldorff M.","Pharmacoepidemiol Drug Saf. 2018 Apr;27(4):405-412. doi: 10.1002/pds.4399. Epub 2018 Feb 13.","Wang SV","Pharmacoepidemiol Drug Saf","2018","2018/02/15","PMC5937260","NIHMS962835","10.1002/pds.4399"
"29405516","Assessment of Risk Evaluation and Mitigation Strategies (REMS) for varenicline (Chantix): A multistage patient survey","Amend KL, Younus M, Petronis KR, Mo J, Seeger JD, Gately R, Gu X, Enger C.","Pharmacoepidemiol Drug Saf. 2018 Mar;27(3):253-262. doi: 10.1002/pds.4373. Epub 2018 Feb 6.","Amend KL","Pharmacoepidemiol Drug Saf","2018","2018/02/07","","","10.1002/pds.4373"
"29405501","Importance of the lipid-related pathways in the association between statins, mortality, and cardiovascular disease risk: The Multi-Ethnic Study of Atherosclerosis","Talbot D, Delaney JAC, Sandfort V, Herrington DM, McClelland RL.","Pharmacoepidemiol Drug Saf. 2018 Apr;27(4):365-372. doi: 10.1002/pds.4393. Epub 2018 Feb 6.","Talbot D","Pharmacoepidemiol Drug Saf","2018","2018/02/07","PMC5937846","NIHMS962833","10.1002/pds.4393"
"29405474","Position matters: Validation of medicare hospital claims for myocardial infarction against medical record review in the atherosclerosis risk in communities study","Bush M, Stürmer T, Stearns SC, Simpson RJ Jr, Brookhart MA, Rosamond W, Kucharska-Newton AM.","Pharmacoepidemiol Drug Saf. 2018 Oct;27(10):1085-1091. doi: 10.1002/pds.4396. Epub 2018 Feb 6.","Bush M","Pharmacoepidemiol Drug Saf","2018","2018/02/07","PMC6233317","NIHMS960621","10.1002/pds.4396"
"29399959","Re: Quality of warfarin therapy and risk of stroke, bleeding, and mortality among patients with atrial fibrillation","van Miert JHA, Meijer K.","Pharmacoepidemiol Drug Saf. 2018 Feb;27(2):243. doi: 10.1002/pds.4378.","van Miert JHA","Pharmacoepidemiol Drug Saf","2018","2018/02/06","","","10.1002/pds.4378"
"29392851","Do FDA label changes work? Assessment of the 2010 class label change for proton pump inhibitors using the Sentinel System's analytic tools","Sobel RE, Bate A, Marshall J, Haynes K, Selvam N, Nair V, Daniel G, Brown JS, Reynolds RF.","Pharmacoepidemiol Drug Saf. 2018 Mar;27(3):332-339. doi: 10.1002/pds.4392. Epub 2018 Feb 2.","Sobel RE","Pharmacoepidemiol Drug Saf","2018","2018/02/03","","","10.1002/pds.4392"
"29383858","Generalized boosted modeling to identify subgroups where effect of dabigatran versus warfarin may differ: An observational cohort study of patients with atrial fibrillation","Wang SV, Huybrechts KF, Fischer MA, Franklin JM, Glynn RJ, Schneeweiss S, Gagne JJ.","Pharmacoepidemiol Drug Saf. 2018 Apr;27(4):383-390. doi: 10.1002/pds.4395. Epub 2018 Jan 30.","Wang SV","Pharmacoepidemiol Drug Saf","2018","2018/02/01","","","10.1002/pds.4395"
"29383840","Addressing unmeasured confounding in comparative observational research","Zhang X, Faries DE, Li H, Stamey JD, Imbens GW.","Pharmacoepidemiol Drug Saf. 2018 Apr;27(4):373-382. doi: 10.1002/pds.4394. Epub 2018 Jan 30.","Zhang X","Pharmacoepidemiol Drug Saf","2018","2018/02/01","","","10.1002/pds.4394"
"29380457","New statin use and left ventricular structure: Estimating long-term associations in the Multi-Ethnic Study of Atherosclerosis (MESA)","Strand LN, Young RL, Bertoni AG, Bluemke DA, Burke GL, Lima JA, Sotoodehnia N, Psaty BM, McClelland RL, Heckbert SR, Delaney JA.","Pharmacoepidemiol Drug Saf. 2018 Jun;27(6):570-580. doi: 10.1002/pds.4389. Epub 2018 Jan 30.","Strand LN","Pharmacoepidemiol Drug Saf","2018","2018/01/31","PMC5984180","NIHMS962840","10.1002/pds.4389"
"29372579","Exceeding the daily dosing limit of nonsteroidal anti-inflammatory drugs among ibuprofen users","Kaufman DW, Kelly JP, Battista DR, Malone MK, Weinstein RB, Shiffman S.","Pharmacoepidemiol Drug Saf. 2018 Mar;27(3):322-331. doi: 10.1002/pds.4391. Epub 2018 Jan 26.","Kaufman DW","Pharmacoepidemiol Drug Saf","2018","2018/01/27","","","10.1002/pds.4391"
"29368380","Risk of rhabdomyolysis from 5-α reductase inhibitors","Welk B, McArthur E, Ordon M, Dirk J, Dixon S, Garg AX.","Pharmacoepidemiol Drug Saf. 2018 Mar;27(3):351-355. doi: 10.1002/pds.4383. Epub 2018 Jan 25.","Welk B","Pharmacoepidemiol Drug Saf","2018","2018/01/26","","","10.1002/pds.4383"
"29359446","Trends and uptake of new formulations of controlled-release oxycodone in Canada","Gomes T, Jain S, Paterson JM, Sketris I, Caetano P, Henry D; Canadian Network for Observational Drug Effect Studies (CNODES) Investigators.","Pharmacoepidemiol Drug Saf. 2018 May;27(5):520-525. doi: 10.1002/pds.4390. Epub 2018 Jan 23.","Gomes T","Pharmacoepidemiol Drug Saf","2018","2018/01/24","PMC5947657","","10.1002/pds.4390"
"29349834","Drug adherence in treatment resistant and in controlled hypertension-Results from the Swedish Primary Care Cardiovascular Database (SPCCD)","Holmqvist L, Boström KB, Kahan T, Schiöler L, Qvarnström M, Wettermark B, Hjerpe P, Hasselström J, Manhem K.","Pharmacoepidemiol Drug Saf. 2018 Mar;27(3):315-321. doi: 10.1002/pds.4388. Epub 2018 Jan 19.","Holmqvist L","Pharmacoepidemiol Drug Saf","2018","2018/01/20","","","10.1002/pds.4388"
"29349833","A systematic assessment of key design and performance characteristics of drug exposure registries requested by the U.S. Food and Drug Administration","Zhao Y, Pinnow E, Major JM.","Pharmacoepidemiol Drug Saf. 2018 Mar;27(3):299-306. doi: 10.1002/pds.4386. Epub 2018 Jan 19.","Zhao Y","Pharmacoepidemiol Drug Saf","2018","2018/01/20","","","10.1002/pds.4386"
"29341340","Bias from restricting to live births when estimating effects of prescription drug use on pregnancy complications: A simulation","Suarez EA, Landi SN, Conover MM, Jonsson Funk M.","Pharmacoepidemiol Drug Saf. 2018 Mar;27(3):307-314. doi: 10.1002/pds.4387. Epub 2018 Jan 17.","Suarez EA","Pharmacoepidemiol Drug Saf","2018","2018/01/18","","","10.1002/pds.4387"
"29341324","Beta testing the potential link between the alpha antagonist tamsulosin and dementia","Gill SS, Bai AD.","Pharmacoepidemiol Drug Saf. 2018 Mar;27(3):349-350. doi: 10.1002/pds.4382. Epub 2018 Jan 17.","Gill SS","Pharmacoepidemiol Drug Saf","2018","2018/01/18","","","10.1002/pds.4382"
"29327451","Strengthening standards, transparency, and collaboration to support medicine evaluation: Ten years of the European Network of Centres for Pharmacoepidemiology and Pharmacovigilance (ENCePP)","Kurz X, Perez-Gutthann S; ENCePP Steering Group.","Pharmacoepidemiol Drug Saf. 2018 Mar;27(3):245-252. doi: 10.1002/pds.4381. Epub 2018 Jan 11.","Kurz X","Pharmacoepidemiol Drug Saf","2018","2018/01/13","PMC5873428","","10.1002/pds.4381"
"29318705","Relevance of frailty to mortality associated with the use of antipsychotics among community-residing older adults with impaired cognition","Maxwell CJ, Campitelli MA, Hogan DB, Diong C, Austin PC, Amuah JE, Lapane K, Seitz DP, Gill SS, Gruneir A, Wodchis WP, Bronskill SE.","Pharmacoepidemiol Drug Saf. 2018 Mar;27(3):289-298. doi: 10.1002/pds.4385. Epub 2018 Jan 10.","Maxwell CJ","Pharmacoepidemiol Drug Saf","2018","2018/01/11","","","10.1002/pds.4385"
"29318704","Use of antihypertensive drugs and risk of keratinocyte carcinoma: A meta-analysis of observational studies","Tang H, Fu S, Zhai S, Song Y, Asgari MM, Han J.","Pharmacoepidemiol Drug Saf. 2018 Mar;27(3):279-288. doi: 10.1002/pds.4384. Epub 2018 Jan 10.","Tang H","Pharmacoepidemiol Drug Saf","2018","2018/01/11","","","10.1002/pds.4384"
"29318695","Risk factors for medication errors at admission in preoperatively screened patients","Ebbens MM, Gombert-Handoko KB, Al-Dulaimy M, van den Bemt PMLA, Wesselink EJ.","Pharmacoepidemiol Drug Saf. 2018 Mar;27(3):272-278. doi: 10.1002/pds.4380. Epub 2018 Jan 10.","Ebbens MM","Pharmacoepidemiol Drug Saf","2018","2018/01/11","","","10.1002/pds.4380"
"29318683","Prospective surveillance pilot of rivaroxaban safety within the US Food and Drug Administration Sentinel System","Chrischilles EA, Gagne JJ, Fireman B, Nelson J, Toh S, Shoaibi A, Reichman ME, Wang S, Nguyen M, Zhang R, Izem R, Goulding MR, Southworth MR, Graham DJ, Fuller C, Katcoff H, Woodworth T, Rogers C, Saliga R, Lin ND, McMahill-Walraven CN, Nair VP, Haynes K, Carnahan RM.","Pharmacoepidemiol Drug Saf. 2018 Mar;27(3):263-271. doi: 10.1002/pds.4375. Epub 2018 Jan 10.","Chrischilles EA","Pharmacoepidemiol Drug Saf","2018","2018/01/11","","","10.1002/pds.4375"
"29316026","Treatment dynamics of bone-targeting agents among men with bone metastases from prostate cancer in the United States","Butler AM, Cetin K, Hernandez RK, Diane Reams B, Overman RA, I Kim J, Hirsch BR, Abernethy AP, Liede A, Alan Brookhart M.","Pharmacoepidemiol Drug Saf. 2018 Feb;27(2):229-238. doi: 10.1002/pds.4360. Epub 2018 Jan 7.","Butler AM","Pharmacoepidemiol Drug Saf","2018","2018/01/10","","","10.1002/pds.4360"
"29316005","Tamsulosin and the risk of dementia in older men with benign prostatic hyperplasia","Duan Y, Grady JJ, Albertsen PC, Helen Wu Z.","Pharmacoepidemiol Drug Saf. 2018 Mar;27(3):340-348. doi: 10.1002/pds.4361. Epub 2018 Jan 9.","Duan Y","Pharmacoepidemiol Drug Saf","2018","2018/01/10","","","10.1002/pds.4361"
"29292555","Validation of an algorithm for identifying type 1 diabetes in adults based on electronic health record data","Schroeder EB, Donahoo WT, Goodrich GK, Raebel MA.","Pharmacoepidemiol Drug Saf. 2018 Oct;27(10):1053-1059. doi: 10.1002/pds.4377. Epub 2018 Jan 2.","Schroeder EB","Pharmacoepidemiol Drug Saf","2018","2018/01/03","PMC6028322","NIHMS932153","10.1002/pds.4377"
"29292551","Bias from outcome misclassification in immunization schedule safety research","Newcomer SR, Kulldorff M, Xu S, Daley MF, Fireman B, Lewis E, Glanz JM.","Pharmacoepidemiol Drug Saf. 2018 Feb;27(2):221-228. doi: 10.1002/pds.4374. Epub 2018 Jan 2.","Newcomer SR","Pharmacoepidemiol Drug Saf","2018","2018/01/03","PMC5800415","NIHMS932151","10.1002/pds.4374"
"29285840","Methods for time-varying exposure related problems in pharmacoepidemiology: An overview","Pazzagli L, Linder M, Zhang M, Vago E, Stang P, Myers D, Andersen M, Bahmanyar S.","Pharmacoepidemiol Drug Saf. 2018 Feb;27(2):148-160. doi: 10.1002/pds.4372. Epub 2017 Dec 28.","Pazzagli L","Pharmacoepidemiol Drug Saf","2018","2017/12/30","PMC5814826","","10.1002/pds.4372"
"29280228","An update on medication guides","Park LM, Jones PR, Pearsall BM, Araojo RT.","Pharmacoepidemiol Drug Saf. 2018 Feb;27(2):129-132. doi: 10.1002/pds.4370. Epub 2017 Dec 27.","Park LM","Pharmacoepidemiol Drug Saf","2018","2017/12/28","","","10.1002/pds.4370"
"29280224","Trends in opioid utilisation in Australia, 2006-2015: Insights from multiple metrics","Karanges EA, Buckley NA, Brett J, Blanch B, Litchfield M, Degenhardt L, Pearson SA.","Pharmacoepidemiol Drug Saf. 2018 May;27(5):504-512. doi: 10.1002/pds.4369. Epub 2017 Dec 27.","Karanges EA","Pharmacoepidemiol Drug Saf","2018","2017/12/28","","","10.1002/pds.4369"
"29278866","Is patient exposure preapproval and postapproval a determinant of the timing and frequency of occurrence of safety issues?","Pacurariu AC, Hoeve CE, Arlett P, Genov G, Slattery J, Sturkenboom MCJM, Straus SMJM.","Pharmacoepidemiol Drug Saf. 2018 Feb;27(2):168-173. doi: 10.1002/pds.4359. Epub 2017 Dec 26.","Pacurariu AC","Pharmacoepidemiol Drug Saf","2018","2017/12/27","","","10.1002/pds.4359"
"29271049","Decline in opioid prescribing after federal rescheduling of hydrocodone products","Raji MA, Kuo YF, Adhikari D, Baillargeon J, Goodwin JS.","Pharmacoepidemiol Drug Saf. 2018 May;27(5):513-519. doi: 10.1002/pds.4376. Epub 2017 Dec 21.","Raji MA","Pharmacoepidemiol Drug Saf","2018","2017/12/23","PMC5934339","NIHMS932152","10.1002/pds.4376"
"29271017","A prediction model-based algorithm for computer-assisted database screening of adverse drug reactions in the Netherlands","Scholl JHG, van Hunsel FPAM, Hak E, van Puijenbroek EP.","Pharmacoepidemiol Drug Saf. 2018 Feb;27(2):199-205. doi: 10.1002/pds.4364. Epub 2017 Dec 21.","Scholl JHG","Pharmacoepidemiol Drug Saf","2018","2017/12/23","PMC5814895","","10.1002/pds.4364"
"29250905","Validity of diagnostic codes to identify hospitalizations for infections among patients treated with oral anti-diabetic drugs","Saine ME, Gizaw M, Carbonari DM, Newcomb CW, Roy JA, Cardillo S, Esposito DB, Bhullar H, Gallagher AM, Strom BL, Lo Re V 3rd.","Pharmacoepidemiol Drug Saf. 2018 Oct;27(10):1147-1150. doi: 10.1002/pds.4368. Epub 2017 Dec 18.","Saine ME","Pharmacoepidemiol Drug Saf","2018","2017/12/19","","","10.1002/pds.4368"
"29250904","Assessing a composite end point for new tocolytics in clinical trials: Data from 4 US integrated delivery networks","Pimenta JM, Brinkley E, Montague TH, Beach KJ, Mack C.","Pharmacoepidemiol Drug Saf. 2018 Feb;27(2):213-220. doi: 10.1002/pds.4371. Epub 2017 Dec 18.","Pimenta JM","Pharmacoepidemiol Drug Saf","2018","2017/12/19","","","10.1002/pds.4371"
"29243305","Opioid analgesic dose and the risk of misuse, overdose, and death: A narrative review","Coyle DT, Pratt CY, Ocran-Appiah J, Secora A, Kornegay C, Staffa J.","Pharmacoepidemiol Drug Saf. 2018 May;27(5):464-472. doi: 10.1002/pds.4366. Epub 2017 Dec 15.","Coyle DT","Pharmacoepidemiol Drug Saf","2018","2017/12/16","","","10.1002/pds.4366"
"29230891","Linking individual-level data on diagnoses and dispensing for research on antibiotic use: Evaluation of a novel data source from English secondary care","Rockenschaub P, Ansell D, Shallcross L.","Pharmacoepidemiol Drug Saf. 2018 Feb;27(2):206-212. doi: 10.1002/pds.4367. Epub 2017 Dec 12.","Rockenschaub P","Pharmacoepidemiol Drug Saf","2018","2017/12/13","","","10.1002/pds.4367"
"29230890","Effects of analgesics on bone mineral density: A longitudinal analysis of the prospective SWAN cohort with three-group matching weights","Yoshida K, Yu Z, Greendale GA, Ruppert K, Lian Y, Tedeschi SK, Lin TC, Haneuse S, Glynn RJ, Hernández-Díaz S, Solomon DH.","Pharmacoepidemiol Drug Saf. 2018 Feb;27(2):182-190. doi: 10.1002/pds.4362. Epub 2017 Dec 12.","Yoshida K","Pharmacoepidemiol Drug Saf","2018","2017/12/13","PMC5799005","NIHMS932150","10.1002/pds.4362"
"29210149","Retinal vascular complications associated with interferon-ribavirin therapy for chronic hepatitis C: A population-based study","Lai CH, Yang YH, Chen PC, King YC, Liu CY.","Pharmacoepidemiol Drug Saf. 2018 Feb;27(2):191-198. doi: 10.1002/pds.4363. Epub 2017 Dec 6.","Lai CH","Pharmacoepidemiol Drug Saf","2018","2017/12/07","","","10.1002/pds.4363"
"29210147","Drug exposure and the risk of multiple sclerosis: A systematic review","Yong HY, McKay KA, Daley CGJ, Tremlett H.","Pharmacoepidemiol Drug Saf. 2018 Feb;27(2):133-139. doi: 10.1002/pds.4357. Epub 2017 Dec 6.","Yong HY","Pharmacoepidemiol Drug Saf","2018","2017/12/07","","","10.1002/pds.4357"
"29210142","Internal validation of Medicaid Analytic eXtract (MAX) data capture for comprehensive managed care plan enrollees from 2007 to 2010","Li Y, Zhu Y, Chen C, Wang X, Choi Y, Henriksen C, Winterstein AG.","Pharmacoepidemiol Drug Saf. 2018 Oct;27(10):1067-1076. doi: 10.1002/pds.4365. Epub 2017 Dec 6.","Li Y","Pharmacoepidemiol Drug Saf","2018","2017/12/07","","","10.1002/pds.4365"
"29205684","Erratum","","Pharmacoepidemiol Drug Saf. 2017 Dec;26(12):1570. doi: 10.1002/pds.4353.","","Pharmacoepidemiol Drug Saf","2017","2017/12/06","PMC6886090","","10.1002/pds.4353"
"29205683","Corrigendum","","Pharmacoepidemiol Drug Saf. 2017 Dec;26(12):1571-1573. doi: 10.1002/pds.4348.","","Pharmacoepidemiol Drug Saf","2017","2017/12/06","","","10.1002/pds.4348"
"29205633","A combined connectivity mapping and pharmacoepidemiology approach to identify existing medications with breast cancer causing or preventing properties","Busby J, Murray L, Mills K, Zhang SD, Liberante F, Cardwell CR.","Pharmacoepidemiol Drug Saf. 2018 Jan;27(1):78-86. doi: 10.1002/pds.4345. Epub 2017 Dec 4.","Busby J","Pharmacoepidemiol Drug Saf","2018","2017/12/06","","","10.1002/pds.4345"
"29193554","Do delays in data availability limit the implementation of near real-time vaccine safety surveillance using the Clinical Practice Research Datalink?","Leite A, Thomas SL, Andrews NJ.","Pharmacoepidemiol Drug Saf. 2018 Jan;27(1):25-29. doi: 10.1002/pds.4356. Epub 2017 Nov 28.","Leite A","Pharmacoepidemiol Drug Saf","2018","2017/12/02","PMC5767762","","10.1002/pds.4356"
"29171114","Prescription drug use in pregnancy and variations according to prior psychiatric history","Ingstrup KG, Liu X, Gasse C, Debost JP, Munk-Olsen T.","Pharmacoepidemiol Drug Saf. 2018 Jan;27(1):105-113. doi: 10.1002/pds.4355. Epub 2017 Nov 24.","Ingstrup KG","Pharmacoepidemiol Drug Saf","2018","2017/11/25","","","10.1002/pds.4355"
"29171096","Risk of acute myocardial infarction with real-world NSAIDs depends on dose and timing of exposure","Bally M, Beauchamp ME, Abrahamowicz M, Nadeau L, Brophy JM.","Pharmacoepidemiol Drug Saf. 2018 Jan;27(1):69-77. doi: 10.1002/pds.4358. Epub 2017 Nov 24.","Bally M","Pharmacoepidemiol Drug Saf","2018","2017/11/25","","","10.1002/pds.4358"
"29168261","""Impact of drug-reimbursement policies on prescribing: A case-study of a newly marketed long-acting injectable antipsychotic among relapsed schizophrenia patients""","Jackson JW, Fulchino L, Rogers J, Mogun H, Polinski J, Henderson DC, Schneeweiss S, Fischer MA.","Pharmacoepidemiol Drug Saf. 2018 Jan;27(1):95-104. doi: 10.1002/pds.4354. Epub 2017 Nov 23.","Jackson JW","Pharmacoepidemiol Drug Saf","2018","2017/11/24","","","10.1002/pds.4354"
"29152808","Observational safety study of specific outcomes after trivalent cell culture seasonal influenza vaccination (Optaflu(®) ) among adults in THIN database of electronic UK primary healthcare records","Hall GC, Davies PTG, Karim MY, Haag MDM, O'Leary C.","Pharmacoepidemiol Drug Saf. 2018 Jan;27(1):52-58. doi: 10.1002/pds.4347. Epub 2017 Nov 20.","Hall GC","Pharmacoepidemiol Drug Saf","2018","2017/11/21","","","10.1002/pds.4347"
"29148124","The safety of live attenuated influenza vaccine in children and adolescents 2 through 17 years of age: A Vaccine Safety Datalink study","Daley MF, Clarke CL, Glanz JM, Xu S, Hambidge SJ, Donahue JG, Nordin JD, Klein NP, Jacobsen SJ, Naleway AL, Jackson ML, Lee G, Duffy J, Weintraub E.","Pharmacoepidemiol Drug Saf. 2018 Jan;27(1):59-68. doi: 10.1002/pds.4349. Epub 2017 Nov 17.","Daley MF","Pharmacoepidemiol Drug Saf","2018","2017/11/18","PMC6437673","NIHMS1019371","10.1002/pds.4349"
"29148111","Being overweight or obese as a risk factor for acute liver injury secondary to acute acetaminophen overdose","Chomchai S, Chomchai C.","Pharmacoepidemiol Drug Saf. 2018 Jan;27(1):19-24. doi: 10.1002/pds.4339. Epub 2017 Nov 17.","Chomchai S","Pharmacoepidemiol Drug Saf","2018","2017/11/18","","","10.1002/pds.4339"
"29148107","Pediatric drug information available at the time of new drug approvals: A cross-sectional analysis","Hudgins JD, Bacho MA, Olsen KL, Bourgeois FT.","Pharmacoepidemiol Drug Saf. 2018 Feb;27(2):161-167. doi: 10.1002/pds.4351. Epub 2017 Nov 17.","Hudgins JD","Pharmacoepidemiol Drug Saf","2018","2017/11/18","","","10.1002/pds.4351"
"29143393","An algorithm to detect unexpected increases in frequency of reports of adverse events in EudraVigilance","Pinheiro LC, Candore G, Zaccaria C, Slattery J, Arlett P.","Pharmacoepidemiol Drug Saf. 2018 Jan;27(1):38-45. doi: 10.1002/pds.4344. Epub 2017 Nov 16.","Pinheiro LC","Pharmacoepidemiol Drug Saf","2018","2017/11/17","PMC5765515","","10.1002/pds.4344"
"29141274","Use of direct oral anticoagulants in the first year after market entry of edoxaban: A Danish nationwide drug utilization study","Pottegård A, Grove EL, Hellfritzsch M.","Pharmacoepidemiol Drug Saf. 2018 Feb;27(2):174-181. doi: 10.1002/pds.4350. Epub 2017 Nov 15.","Pottegård A","Pharmacoepidemiol Drug Saf","2018","2017/11/16","","","10.1002/pds.4350"
"29141273","Antidepressant use during pregnancy and childhood cancer in the offspring","Momen NC, Munk-Olsen T, Li J, Ingstrup KG, Olsen J, Bergink V, Liu X.","Pharmacoepidemiol Drug Saf. 2018 Jan;27(1):114-118. doi: 10.1002/pds.4352. Epub 2017 Nov 15.","Momen NC","Pharmacoepidemiol Drug Saf","2018","2017/11/16","","","10.1002/pds.4352"
"29108136","Application and optimisation of the Comparison on Extreme Laboratory Tests (CERT) algorithm for detection of adverse drug reactions: Transferability across national boundaries","Tham MY, Ye Q, Ang PS, Fan LY, Yoon D, Park RW, Ling ZJ, Yip JW, Tai BC, Evans SJ, Sung C.","Pharmacoepidemiol Drug Saf. 2018 Jan;27(1):87-94. doi: 10.1002/pds.4340. Epub 2017 Nov 6.","Tham MY","Pharmacoepidemiol Drug Saf","2018","2017/11/07","","","10.1002/pds.4340"
"29108130","Comparative risk of serious hypoglycemia with oral antidiabetic monotherapy: A retrospective cohort study","Leonard CE, Han X, Brensinger CM, Bilker WB, Cardillo S, Flory JH, Hennessy S.","Pharmacoepidemiol Drug Saf. 2018 Jan;27(1):9-18. doi: 10.1002/pds.4337. Epub 2017 Nov 6.","Leonard CE","Pharmacoepidemiol Drug Saf","2018","2017/11/07","PMC5770147","NIHMS932149","10.1002/pds.4337"
"29108128","Safety assessment of niacin in the US Food and Drug Administration's mini-sentinel system","Gagne JJ, Houstoun M, Reichman ME, Hampp C, Marshall JH, Toh S.","Pharmacoepidemiol Drug Saf. 2018 Jan;27(1):30-37. doi: 10.1002/pds.4343. Epub 2017 Nov 6.","Gagne JJ","Pharmacoepidemiol Drug Saf","2018","2017/11/07","","","10.1002/pds.4343"
"29108127","Multi-dose drug dispensing as a tool to improve medication adherence: A study in patients using vitamin K antagonists","van Rein N, de Geus KS, Cannegieter SC, Reitsma PH, van der Meer FJM, Lijfering WM.","Pharmacoepidemiol Drug Saf. 2018 Jan;27(1):46-51. doi: 10.1002/pds.4346. Epub 2017 Nov 6.","van Rein N","Pharmacoepidemiol Drug Saf","2018","2017/11/07","","","10.1002/pds.4346"
"29067759","Who benefits from fixed-dose combinations? Two-year statin adherence trajectories in initiators of combined amlodipine/atorvastatin therapy","Schaffer AL, Buckley NA, Pearson SA.","Pharmacoepidemiol Drug Saf. 2017 Dec;26(12):1465-1473. doi: 10.1002/pds.4342. Epub 2017 Oct 25.","Schaffer AL","Pharmacoepidemiol Drug Saf","2017","2017/10/26","","","10.1002/pds.4342"
"29047196","To what extent do data from pharmaceutical claims under-estimate opioid analgesic utilisation in Australia?","Gisev N, Pearson SA, Karanges EA, Larance B, Buckley NA, Larney S, Dobbins T, Blanch B, Degenhardt L.","Pharmacoepidemiol Drug Saf. 2018 May;27(5):550-555. doi: 10.1002/pds.4329. Epub 2017 Oct 19.","Gisev N","Pharmacoepidemiol Drug Saf","2018","2017/10/20","","","10.1002/pds.4329"
"29047193","Unlicensed pharmaceutical preparations for clinical patient care: Ensuring safety","de Wilde S, de Jong MGH, Le Brun PPH, Guchelaar HJ, Schimmel KJM.","Pharmacoepidemiol Drug Saf. 2018 Jan;27(1):3-8. doi: 10.1002/pds.4335. Epub 2017 Oct 19.","de Wilde S","Pharmacoepidemiol Drug Saf","2018","2017/10/20","","","10.1002/pds.4335"
"29044735","Making fair comparisons in pregnancy medication safety studies: An overview of advanced methods for confounding control","Wood ME, Lapane KL, van Gelder MMHJ, Rai D, Nordeng HME.","Pharmacoepidemiol Drug Saf. 2018 Feb;27(2):140-147. doi: 10.1002/pds.4336. Epub 2017 Oct 17.","Wood ME","Pharmacoepidemiol Drug Saf","2018","2017/10/19","PMC6646901","","10.1002/pds.4336"
"29027336","Trends in utilization of benzodiazepine and Z-drugs in Israel","Berman E, Eyal S, Marom E.","Pharmacoepidemiol Drug Saf. 2017 Dec;26(12):1555-1560. doi: 10.1002/pds.4338. Epub 2017 Oct 13.","Berman E","Pharmacoepidemiol Drug Saf","2017","2017/10/14","","","10.1002/pds.4338"
"29027301","Challenges of post-authorization safety studies: Lessons learned and results of a French study of fentanyl buccal tablet","Gavrielov-Yusim N, Bidollari I, Kaplan S, Bartov N.","Pharmacoepidemiol Drug Saf. 2018 May;27(5):457-463. doi: 10.1002/pds.4331. Epub 2017 Oct 13.","Gavrielov-Yusim N","Pharmacoepidemiol Drug Saf","2018","2017/10/14","","","10.1002/pds.4331"
"29027300","Pattern of in-hospital changes in drug use in the older people from 2010 to 2016","Franchi C, Ardoino I, Nobili A, Pasina L, Mannucci PM, Marengoni A, Perticone F; REPOSI investigators.","Pharmacoepidemiol Drug Saf. 2017 Dec;26(12):1534-1539. doi: 10.1002/pds.4330. Epub 2017 Oct 13.","Franchi C","Pharmacoepidemiol Drug Saf","2017","2017/10/14","","","10.1002/pds.4330"
"29024286","Modelling cumulative exposure for inference about drug effects in observational studies","Farran B, McGurnaghan S, Looker HC, Livingstone S, Lahnsteiner E, Colhoun HM, McKeigue PM.","Pharmacoepidemiol Drug Saf. 2017 Dec;26(12):1527-1533. doi: 10.1002/pds.4327. Epub 2017 Oct 12.","Farran B","Pharmacoepidemiol Drug Saf","2017","2017/10/13","","","10.1002/pds.4327"
"29024218","Using probability of drug use as independent variable in a register-based pharmacoepidemiological cause-effect study-An application of the reverse waiting time distribution","Hallas J, Pottegård A, Støvring H.","Pharmacoepidemiol Drug Saf. 2017 Dec;26(12):1520-1526. doi: 10.1002/pds.4326. Epub 2017 Oct 12.","Hallas J","Pharmacoepidemiol Drug Saf","2017","2017/10/13","","","10.1002/pds.4326"
"28994158","The myths of medication adherence","Gellad WF, Thorpe CT, Steiner JF, Voils CI.","Pharmacoepidemiol Drug Saf. 2017 Dec;26(12):1437-1441. doi: 10.1002/pds.4334. Epub 2017 Oct 10.","Gellad WF","Pharmacoepidemiol Drug Saf","2017","2017/10/11","","","10.1002/pds.4334"
"28984052","Patterns of long-term use of non-vitamin K antagonist oral anticoagulants for non-valvular atrial fibrillation: Quebec observational study","Douros A, Renoux C, Coulombe J, Suissa S.","Pharmacoepidemiol Drug Saf. 2017 Dec;26(12):1546-1554. doi: 10.1002/pds.4333. Epub 2017 Oct 6.","Douros A","Pharmacoepidemiol Drug Saf","2017","2017/10/07","","","10.1002/pds.4333"
"28984050","Comparison of the ability of double-robust estimators to correct bias in propensity score matching analysis. A Monte Carlo simulation study","Nguyen TL, Collins GS, Spence J, Devereaux PJ, Daurès JP, Landais P, Le Manach Y.","Pharmacoepidemiol Drug Saf. 2017 Dec;26(12):1513-1519. doi: 10.1002/pds.4325. Epub 2017 Oct 6.","Nguyen TL","Pharmacoepidemiol Drug Saf","2017","2017/10/07","","","10.1002/pds.4325"
"28984001","A review of the performance of different methods for propensity score matched subgroup analyses and a summary of their application in peer-reviewed research studies","Wang SV, He M, Jin Y, Wyss R, Shin H, Ma Y, Keeton S, Fireman B, Karami S, Major JM, Schneeweiss S, Gagne JJ.","Pharmacoepidemiol Drug Saf. 2017 Dec;26(12):1507-1512. doi: 10.1002/pds.4328. Epub 2017 Oct 6.","Wang SV","Pharmacoepidemiol Drug Saf","2017","2017/10/07","","","10.1002/pds.4328"
"28983992","Registries supporting new drug applications","Jonker CJ, van den Berg HM, Kwa MSG, Hoes AW, Mol PGM.","Pharmacoepidemiol Drug Saf. 2017 Dec;26(12):1451-1457. doi: 10.1002/pds.4332. Epub 2017 Oct 6.","Jonker CJ","Pharmacoepidemiol Drug Saf","2017","2017/10/07","PMC5725674","","10.1002/pds.4332"
"28971545","Patterns of opioid initiation at first visits for pain in United States primary care settings","Mundkur ML, Rough K, Huybrechts KF, Levin R, Gagne JJ, Desai RJ, Patorno E, Choudhry NK, Bateman BT.","Pharmacoepidemiol Drug Saf. 2018 May;27(5):495-503. doi: 10.1002/pds.4322. Epub 2017 Oct 2.","Mundkur ML","Pharmacoepidemiol Drug Saf","2018","2017/10/04","PMC5880749","NIHMS939470","10.1002/pds.4322"
"28967200","Statins and diabetes: is there any difference between the different statins?","Montastruc F, Benevent J, Rousseau V, Chebane L, Bondon-Guitton E, Durrieu G, Montastruc JL, Sommet A.","Pharmacoepidemiol Drug Saf. 2017 Oct;26(10):1296-1297. doi: 10.1002/pds.4296.","Montastruc F","Pharmacoepidemiol Drug Saf","2017","2017/10/03","","","10.1002/pds.4296"
"28952198","Thrombotic risk minimization for Diane-35 and generics","Bezemer ID, Smits E, Penning-van Beest FJA, Asiimwe A, Herings RMC.","Pharmacoepidemiol Drug Saf. 2017 Nov;26(11):1411-1417. doi: 10.1002/pds.4319. Epub 2017 Sep 26.","Bezemer ID","Pharmacoepidemiol Drug Saf","2017","2017/09/28","","","10.1002/pds.4319"
"28944519","A 15-year overview of increasing tramadol utilisation and associated mortality and the impact of tramadol classification in the United Kingdom","Chen TC, Chen LC, Knaggs RD.","Pharmacoepidemiol Drug Saf. 2018 May;27(5):487-494. doi: 10.1002/pds.4320. Epub 2017 Sep 24.","Chen TC","Pharmacoepidemiol Drug Saf","2018","2017/09/26","","","10.1002/pds.4320"
"28924994","Workshop on evaluation of pediatric long-term neurocognitive development and medical products","McMahon AW, Kapcala LP, Sheridan PH.","Pharmacoepidemiol Drug Saf. 2017 Nov;26(11):1428-1430. doi: 10.1002/pds.4306. Epub 2017 Sep 19.","McMahon AW","Pharmacoepidemiol Drug Saf","2017","2017/09/20","PMC5753999","NIHMS924641","10.1002/pds.4306"
"28924989","Media attention regarding sudden cardiac death associated with domperidone use does not affect in hospital ECG recording","Berger F, Saâïd S, van Gelder T, Stricker B, Becker M, van den Bemt P.","Pharmacoepidemiol Drug Saf. 2017 Nov;26(11):1418-1424. doi: 10.1002/pds.4321. Epub 2017 Sep 19.","Berger F","Pharmacoepidemiol Drug Saf","2017","2017/09/20","","","10.1002/pds.4321"
"28924986","Supplementing electronic health records through sample collection and patient diaries: A study set within a primary care research database","Joseph RM, Soames J, Wright M, Sultana K, van Staa TP, Dixon WG.","Pharmacoepidemiol Drug Saf. 2018 Feb;27(2):239-242. doi: 10.1002/pds.4323. Epub 2017 Sep 19.","Joseph RM","Pharmacoepidemiol Drug Saf","2018","2017/09/20","PMC5846885","","10.1002/pds.4323"
"28913966","Good practices for real-world data studies of treatment and/or comparative effectiveness: Recommendations from the joint ISPOR-ISPE Special Task Force on real-world evidence in health care decision making","Berger ML, Sox H, Willke RJ, Brixner DL, Eichler HG, Goettsch W, Madigan D, Makady A, Schneeweiss S, Tarricone R, Wang SV, Watkins J, Daniel Mullins C.","Pharmacoepidemiol Drug Saf. 2017 Sep;26(9):1033-1039. doi: 10.1002/pds.4297.","Berger ML","Pharmacoepidemiol Drug Saf","2017","2017/09/16","PMC5639372","","10.1002/pds.4297"
"28913965","Guidance to reinforce the credibility of health care database studies and ensure their appropriate impact","Bate A.","Pharmacoepidemiol Drug Saf. 2017 Sep;26(9):1013-1017. doi: 10.1002/pds.4305.","Bate A","Pharmacoepidemiol Drug Saf","2017","2017/09/16","","","10.1002/pds.4305"
"28913964","Post-marketing surveillance in Japan: Potential best way forward","Hiroi S, Kubota K, Mishiro I, Fernandez JL.","Pharmacoepidemiol Drug Saf. 2017 Sep;26(9):1138-1139. doi: 10.1002/pds.4290.","Hiroi S","Pharmacoepidemiol Drug Saf","2017","2017/09/16","","","10.1002/pds.4290"
"28913963","Reporting to Improve Reproducibility and Facilitate Validity Assessment for Healthcare Database Studies V1.0","Wang SV, Schneeweiss S, Berger ML, Brown J, de Vries F, Douglas I, Gagne JJ, Gini R, Klungel O, Mullins CD, Nguyen MD, Rassen JA, Smeeth L, Sturkenboom M; joint ISPE-ISPOR Special Task Force on Real World Evidence in Health Care Decision Making.","Pharmacoepidemiol Drug Saf. 2017 Sep;26(9):1018-1032. doi: 10.1002/pds.4295.","Wang SV","Pharmacoepidemiol Drug Saf","2017","2017/09/16","PMC5639362","","10.1002/pds.4295"
"28913962","Refining estimates of prescription durations by using observed covariates in pharmacoepidemiologic databases: Necessary refinements to stimulate alternative approaches","Meid AD, Haefeli WE.","Pharmacoepidemiol Drug Saf. 2017 Sep;26(9):1135-1137. doi: 10.1002/pds.4270.","Meid AD","Pharmacoepidemiol Drug Saf","2017","2017/09/16","","","10.1002/pds.4270"
"28905438","Research to support optimization of prescription drug monitoring programs","Doyle S, Leichtling G, Hildebran C, Reilly C.","Pharmacoepidemiol Drug Saf. 2017 Nov;26(11):1425-1427. doi: 10.1002/pds.4300. Epub 2017 Sep 14.","Doyle S","Pharmacoepidemiol Drug Saf","2017","2017/09/15","","","10.1002/pds.4300"
"28895247","The prevalence of pain and analgesia use in the Australian population: Findings from the 2011 to 2012 Australian National Health Survey","Miller A, Sanderson K, Bruno R, Breslin M, Neil AL.","Pharmacoepidemiol Drug Saf. 2017 Nov;26(11):1403-1410. doi: 10.1002/pds.4301. Epub 2017 Sep 12.","Miller A","Pharmacoepidemiol Drug Saf","2017","2017/09/13","","","10.1002/pds.4301"
"28879660","National trends in long-term use of prescription opioids","Mojtabai R.","Pharmacoepidemiol Drug Saf. 2018 May;27(5):526-534. doi: 10.1002/pds.4278. Epub 2017 Sep 6.","Mojtabai R","Pharmacoepidemiol Drug Saf","2018","2017/09/08","","","10.1002/pds.4278"
"28857419","Bisphosphonate use and the risk of breast cancer: a meta-analysis of observational studies","Ou YJ, Chiu HF, Wong YH, Yang CC, Yang YH.","Pharmacoepidemiol Drug Saf. 2017 Oct;26(10):1286-1295. doi: 10.1002/pds.4302. Epub 2017 Aug 31.","Ou YJ","Pharmacoepidemiol Drug Saf","2017","2017/09/01","","","10.1002/pds.4302"
"28857309","Impact of the black triangle label on prescribing of new drugs in the United Kingdom: lessons for the United States at a time of deregulation","Horton DB, Gerhard T, Davidow A, Strom BL.","Pharmacoepidemiol Drug Saf. 2017 Nov;26(11):1307-1313. doi: 10.1002/pds.4304. Epub 2017 Aug 31.","Horton DB","Pharmacoepidemiol Drug Saf","2017","2017/09/01","PMC5670006","NIHMS900626","10.1002/pds.4304"
"28856767","Risks of newly onset hemorrhagic stroke in patients with neovascular age-related macular degeneration","Lee WA, Cheng CL, Lee CH, Kao Yang YH, Lin SJ, Hsieh CY.","Pharmacoepidemiol Drug Saf. 2017 Oct;26(10):1277-1285. doi: 10.1002/pds.4299. Epub 2017 Aug 30.","Lee WA","Pharmacoepidemiol Drug Saf","2017","2017/09/01","","","10.1002/pds.4299"
"28856756","Validity of the days supply field in pharmacy administrative claims data for the identification of blister packaging of medications","Leong C, Sareen J, Leslie WD, Enns MW, Bolton J, Alessi-Severini S, Katz LY, Logsetty S, Snider C, Berry J, Prior HJ, Chateau D.","Pharmacoepidemiol Drug Saf. 2017 Dec;26(12):1540-1545. doi: 10.1002/pds.4288. Epub 2017 Aug 30.","Leong C","Pharmacoepidemiol Drug Saf","2017","2017/09/01","","","10.1002/pds.4288"
"28840629","Extent and risks of antidepressant off-label use in children and adolescents in Germany between 2004 and 2011","Schröder C, Dörks M, Kollhorst B, Blenk T, Dittmann RW, Garbe E, Riedel O.","Pharmacoepidemiol Drug Saf. 2017 Nov;26(11):1395-1402. doi: 10.1002/pds.4289. Epub 2017 Aug 24.","Schröder C","Pharmacoepidemiol Drug Saf","2017","2017/08/26","","","10.1002/pds.4289"
"28840621","Controlling confounding by frailty when estimating influenza vaccine effectiveness using predictors of dependency in activities of daily living","Zhang HT, McGrath LJ, Wyss R, Ellis AR, Stürmer T.","Pharmacoepidemiol Drug Saf. 2017 Dec;26(12):1500-1506. doi: 10.1002/pds.4298. Epub 2017 Aug 24.","Zhang HT","Pharmacoepidemiol Drug Saf","2017","2017/08/26","PMC5716904","NIHMS900625","10.1002/pds.4298"
"28833803","Important statistical considerations in the evaluation of post-market studies to assess whether opioids with abuse-deterrent properties result in reduced abuse in the community","By K, McAninch JK, Keeton SL, Secora A, Kornegay CJ, Hwang CS, Ly T, Levenson MS.","Pharmacoepidemiol Drug Saf. 2018 May;27(5):473-478. doi: 10.1002/pds.4287. Epub 2017 Aug 23.","By K","Pharmacoepidemiol Drug Saf","2018","2017/08/24","","","10.1002/pds.4287"
"28833745","Pharmacoepidemiology of testosterone: Curbing off-label prescribing","Handelsman DJ.","Pharmacoepidemiol Drug Saf. 2017 Oct;26(10):1248-1255. doi: 10.1002/pds.4284. Epub 2017 Aug 23.","Handelsman DJ","Pharmacoepidemiol Drug Saf","2017","2017/08/24","","","10.1002/pds.4284"
"28815982","Bridge the gap: The need for harmonized regulatory and ethical standards for postmarketing observational studies","Urushihara H, Parmenter L, Tashiro S, Matsui K, Dreyer N.","Pharmacoepidemiol Drug Saf. 2017 Nov;26(11):1299-1306. doi: 10.1002/pds.4269. Epub 2017 Aug 16.","Urushihara H","Pharmacoepidemiol Drug Saf","2017","2017/08/18","","","10.1002/pds.4269"
"28815803","Validity of cancer diagnosis in the National Health Insurance database compared with the linked National Cancer Registry in Taiwan","Kao WH, Hong JH, See LC, Yu HP, Hsu JT, Chou IJ, Chou WC, Chiou MJ, Wang CC, Kuo CF.","Pharmacoepidemiol Drug Saf. 2018 Oct;27(10):1060-1066. doi: 10.1002/pds.4267. Epub 2017 Aug 16.","Kao WH","Pharmacoepidemiol Drug Saf","2018","2017/08/18","","","10.1002/pds.4267"
"28815800","A method for data-driven exploration to pinpoint key features in medical data and facilitate expert review","Juhlin K, Star K, Norén GN.","Pharmacoepidemiol Drug Saf. 2017 Oct;26(10):1256-1265. doi: 10.1002/pds.4285. Epub 2017 Aug 16.","Juhlin K","Pharmacoepidemiol Drug Saf","2017","2017/08/18","PMC5656922","","10.1002/pds.4285"
"28815799","Characterization of opioid use in sickle cell disease","Han J, Zhou J, Saraf SL, Gordeuk VR, Calip GS.","Pharmacoepidemiol Drug Saf. 2018 May;27(5):479-486. doi: 10.1002/pds.4291. Epub 2017 Aug 16.","Han J","Pharmacoepidemiol Drug Saf","2018","2017/08/18","PMC5815963","NIHMS900624","10.1002/pds.4291"
"28815791","Risk of preeclampsia after gestational exposure to selective serotonin reuptake inhibitors and other antidepressants: A study from The Norwegian Mother and Child Cohort Study","Lupattelli A, Wood M, Lapane K, Spigset O, Nordeng H.","Pharmacoepidemiol Drug Saf. 2017 Oct;26(10):1266-1276. doi: 10.1002/pds.4286. Epub 2017 Aug 16.","Lupattelli A","Pharmacoepidemiol Drug Saf","2017","2017/08/18","PMC5659132","","10.1002/pds.4286"
"28812323","A comparison of methods for estimating the temporal change in a continuous variable: Example of HbA1c in patients with diabetes","Sheppard T, Tamblyn R, Abrahamowicz M, Lunt M, Sperrin M, Dixon WG.","Pharmacoepidemiol Drug Saf. 2017 Dec;26(12):1474-1482. doi: 10.1002/pds.4273. Epub 2017 Aug 15.","Sheppard T","Pharmacoepidemiol Drug Saf","2017","2017/08/17","PMC5724699","","10.1002/pds.4273"
"28809087","Spontaneous reporting of suspected narcolepsy after vaccination against pandemic influenza A (H1N1) in Germany","Oberle D, Pavel J, Keller-Stanislawski B.","Pharmacoepidemiol Drug Saf. 2017 Nov;26(11):1321-1327. doi: 10.1002/pds.4292. Epub 2017 Aug 14.","Oberle D","Pharmacoepidemiol Drug Saf","2017","2017/08/16","","","10.1002/pds.4292"
"28809079","Changes in the use of erythropoiesis-stimulating agents (ESAs) and red blood cell transfusion in patients with cancer amidst regulatory and reimbursement changes","Gawade PL, Berlin JA, Henry DH, Tomita D, Brooks BD, Franklin J, Bradbury BD, Critchlow CW.","Pharmacoepidemiol Drug Saf. 2017 Nov;26(11):1357-1366. doi: 10.1002/pds.4293. Epub 2017 Aug 14.","Gawade PL","Pharmacoepidemiol Drug Saf","2017","2017/08/16","","","10.1002/pds.4293"
"28799295","Application of the STOPP/START criteria to a medical record database","Nauta KJ, Groenhof F, Schuling J, Hugtenburg JG, van Hout HPJ, Haaijer-Ruskamp FM, Denig P.","Pharmacoepidemiol Drug Saf. 2017 Oct;26(10):1242-1247. doi: 10.1002/pds.4283. Epub 2017 Aug 11.","Nauta KJ","Pharmacoepidemiol Drug Saf","2017","2017/08/12","","","10.1002/pds.4283"
"28799226","Educational intervention on medication reviews aiming to reduce acute healthcare consumption in elderly patients with potentially inappropriate medicines-A pragmatic open-label cluster-randomized controlled trial in primary care","Schmidt-Mende K, Andersen M, Wettermark B, Hasselström J.","Pharmacoepidemiol Drug Saf. 2017 Nov;26(11):1347-1356. doi: 10.1002/pds.4263. Epub 2017 Aug 11.","Schmidt-Mende K","Pharmacoepidemiol Drug Saf","2017","2017/08/12","","","10.1002/pds.4263"
"28799214","Refill adherence and persistence to lipid-lowering medicines in patients with type 2 diabetes: A nation-wide register-based study","Karlsson SA, Hero C, Eliasson B, Franzén S, Svensson AM, Miftaraj M, Gudbjörnsdottir S, Eeg-Olofsson K, Andersson Sundell K.","Pharmacoepidemiol Drug Saf. 2017 Oct;26(10):1220-1232. doi: 10.1002/pds.4281. Epub 2017 Aug 11.","Karlsson SA","Pharmacoepidemiol Drug Saf","2017","2017/08/12","PMC5656892","","10.1002/pds.4281"
"28799196","Combining evidence from multiple electronic health care databases: performances of one-stage and two-stage meta-analysis in matched case-control studies","La Gamba F, Corrao G, Romio S, Sturkenboom M, Trifirò G, Schink T, de Ridder M.","Pharmacoepidemiol Drug Saf. 2017 Oct;26(10):1213-1219. doi: 10.1002/pds.4280. Epub 2017 Aug 11.","La Gamba F","Pharmacoepidemiol Drug Saf","2017","2017/08/12","","","10.1002/pds.4280"
"28787772","Erratum","","Pharmacoepidemiol Drug Saf. 2017 Aug;26(8):1011. doi: 10.1002/pds.4222.","","Pharmacoepidemiol Drug Saf","2017","2017/08/09","","","10.1002/pds.4222"
"28771942","Patterns of abuse and routes of administration for immediate-release hydrocodone combination products","Cassidy TA, Oyedele N, Mickle TC, Guenther S, Budman SH.","Pharmacoepidemiol Drug Saf. 2017 Sep;26(9):1071-1082. doi: 10.1002/pds.4249. Epub 2017 Aug 3.","Cassidy TA","Pharmacoepidemiol Drug Saf","2017","2017/08/04","PMC5637894","","10.1002/pds.4249"
"28771933","Impact of clinical evidence communications and drug regulation changes concerning rosiglitazone on prescribing patterns of antidiabetic therapies","Noh Y, Kang DR, Kim DJ, Lee KJ, Lee S, Shin S.","Pharmacoepidemiol Drug Saf. 2017 Nov;26(11):1338-1346. doi: 10.1002/pds.4262. Epub 2017 Aug 3.","Noh Y","Pharmacoepidemiol Drug Saf","2017","2017/08/04","","","10.1002/pds.4262"
"28771890","Metamizole use during first trimester-A prospective observational cohort study on pregnancy outcome","Dathe K, Padberg S, Hultzsch S, Meixner K, Tissen-Diabaté T, Meister R, Beck E, Schaefer C.","Pharmacoepidemiol Drug Saf. 2017 Oct;26(10):1197-1204. doi: 10.1002/pds.4277. Epub 2017 Aug 3.","Dathe K","Pharmacoepidemiol Drug Saf","2017","2017/08/04","","","10.1002/pds.4277"
"28771878","National trends in use and costs of oral anticancer drugs in France: An 8-year population-based study","Bosco-Lévy P, de Boissieu P, Gouverneur A, Noize P, Molimard M, Fourrier-Réglat A, Bezin J.","Pharmacoepidemiol Drug Saf. 2017 Oct;26(10):1233-1241. doi: 10.1002/pds.4282. Epub 2017 Aug 3.","Bosco-Lévy P","Pharmacoepidemiol Drug Saf","2017","2017/08/04","","","10.1002/pds.4282"
"28758289","Changes in misuse and abuse of prescription opioids following implementation of Extended-Release and Long-Acting Opioid Analgesic Risk Evaluation and Mitigation Strategy","Bucher Bartelson B, Le Lait MC, Green JL, Cepeda MS, Coplan PM, Maziere JY, Wedin GP, Dart RC.","Pharmacoepidemiol Drug Saf. 2017 Sep;26(9):1061-1070. doi: 10.1002/pds.4257. Epub 2017 Jul 31.","Bucher Bartelson B","Pharmacoepidemiol Drug Saf","2017","2017/08/01","","","10.1002/pds.4257"
"28758284","New oral anticoagulant prescription rate and risk of bleeding in an Italian region","Valent F.","Pharmacoepidemiol Drug Saf. 2017 Oct;26(10):1205-1212. doi: 10.1002/pds.4279. Epub 2017 Jul 31.","Valent F","Pharmacoepidemiol Drug Saf","2017","2017/08/01","","","10.1002/pds.4279"
"28758274","Pregnancy and infant outcomes including major congenital malformations among women with chronic inflammatory arthritis or psoriasis, with and without etanercept use","Carman WJ, Accortt NA, Anthony MS, Iles J, Enger C.","Pharmacoepidemiol Drug Saf. 2017 Sep;26(9):1109-1118. doi: 10.1002/pds.4261. Epub 2017 Jul 31.","Carman WJ","Pharmacoepidemiol Drug Saf","2017","2017/08/01","","","10.1002/pds.4261"
"28758270","Prescription drug use during pregnancy in France: a study from the national health insurance permanent sample","Demailly R, Escolano S, Quantin C, Tubert-Bitter P, Ahmed I.","Pharmacoepidemiol Drug Saf. 2017 Sep;26(9):1126-1134. doi: 10.1002/pds.4265. Epub 2017 Jul 30.","Demailly R","Pharmacoepidemiol Drug Saf","2017","2017/08/01","","","10.1002/pds.4265"
"28752672","Risk factors for stomatitis in patients with lymphangioleiomyomatosis during treatment with sirolimus: A multicenter investigator-initiated prospective study","Kitamura N, Seyama K, Inoue Y, Nagai K, Suzuki M, Moriyama H, Takada T, Tazawa R, Hirai T, Mishima M, Hayashida M, Hirose M, Arai T, Sugimoto C, Hattori N, Watanabe K, Tamada T, Akazawa K, Tanaka T, Nakata K.","Pharmacoepidemiol Drug Saf. 2017 Oct;26(10):1182-1189. doi: 10.1002/pds.4259. Epub 2017 Jul 28.","Kitamura N","Pharmacoepidemiol Drug Saf","2017","2017/07/29","","","10.1002/pds.4259"
"28752670","Use of direct oral anticoagulants in patients with atrial fibrillation in Scotland: Applying a coherent framework to drug utilisation studies","Mueller T, Alvarez-Madrazo S, Robertson C, Bennie M.","Pharmacoepidemiol Drug Saf. 2017 Nov;26(11):1378-1386. doi: 10.1002/pds.4272. Epub 2017 Jul 28.","Mueller T","Pharmacoepidemiol Drug Saf","2017","2017/07/29","PMC5697642","","10.1002/pds.4272"
"28752620","Population-based incidence of diabetic ketoacidosis in type 2 diabetes: medical claims data analysis in Japan","Takeuchi M, Kawamura T, Sato I, Kawakami K.","Pharmacoepidemiol Drug Saf. 2018 Jan;27(1):123-126. doi: 10.1002/pds.4271. Epub 2017 Jul 28.","Takeuchi M","Pharmacoepidemiol Drug Saf","2018","2017/07/29","","","10.1002/pds.4271"
"28752560","Adherence with direct oral anticoagulants in nonvalvular atrial fibrillation new users and associated factors: a French nationwide cohort study","Maura G, Pariente A, Alla F, Billionnet C.","Pharmacoepidemiol Drug Saf. 2017 Nov;26(11):1367-1377. doi: 10.1002/pds.4268. Epub 2017 Jul 28.","Maura G","Pharmacoepidemiol Drug Saf","2017","2017/07/29","PMC5697683","","10.1002/pds.4268"
"28745019","Identifying cancer drug regimens in French health insurance database: An application in multiple myeloma patients","Palmaro A, Gauthier M, Despas F, Lapeyre-Mestre M.","Pharmacoepidemiol Drug Saf. 2017 Dec;26(12):1492-1499. doi: 10.1002/pds.4266. Epub 2017 Jul 25.","Palmaro A","Pharmacoepidemiol Drug Saf","2017","2017/07/27","","","10.1002/pds.4266"
"28744981","The concordance between self-reported medication use and pharmacy records in pregnant women","Cheung K, El Marroun H, Elfrink ME, Jaddoe VWV, Visser LE, Stricker BHC.","Pharmacoepidemiol Drug Saf. 2017 Sep;26(9):1119-1125. doi: 10.1002/pds.4264. Epub 2017 Jul 25.","Cheung K","Pharmacoepidemiol Drug Saf","2017","2017/07/27","","","10.1002/pds.4264"
"28722244","Risk of liver decompensation with cumulative use of mitochondrial toxic nucleoside analogues in HIV/hepatitis C virus coinfection","Lo Re V Rd, Zeldow B, Kallan MJ, Tate JP, Carbonari DM, Hennessy S, Kostman JR, Lim JK, Goetz MB, Gross R, Justice AC, Roy JA.","Pharmacoepidemiol Drug Saf. 2017 Oct;26(10):1172-1181. doi: 10.1002/pds.4258. Epub 2017 Jul 19.","Lo Re V Rd","Pharmacoepidemiol Drug Saf","2017","2017/07/20","PMC5624832","NIHMS900366","10.1002/pds.4258"
"28722235","Analysis of safety-related regulatory actions by Japan's pharmaceutical regulatory agency","Ishiguro C, Misu T, Iwasa E, Izawa T.","Pharmacoepidemiol Drug Saf. 2017 Nov;26(11):1314-1320. doi: 10.1002/pds.4252. Epub 2017 Jul 19.","Ishiguro C","Pharmacoepidemiol Drug Saf","2017","2017/07/20","","","10.1002/pds.4252"
"28722211","Using prescription monitoring program data to characterize out-of-pocket payments for opioid prescriptions in a state Medicaid program","Hartung DM, Ahmed SM, Middleton L, Van Otterloo J, Zhang K, Keast S, Kim H, Johnston K, Deyo RA.","Pharmacoepidemiol Drug Saf. 2017 Sep;26(9):1053-1060. doi: 10.1002/pds.4254. Epub 2017 Jul 19.","Hartung DM","Pharmacoepidemiol Drug Saf","2017","2017/07/20","PMC9926937","NIHMS1857684","10.1002/pds.4254"
"28722207","Antihypertensive drug associated angioedema: effect modification by race/ethnicity","Reichman ME, Wernecke M, Graham DJ, Liao J, Yap J, Chillarige Y, Southworth MR, Keeton S, Goulding MR, Mott K, Kelman JA.","Pharmacoepidemiol Drug Saf. 2017 Oct;26(10):1190-1196. doi: 10.1002/pds.4260. Epub 2017 Jul 19.","Reichman ME","Pharmacoepidemiol Drug Saf","2017","2017/07/20","","","10.1002/pds.4260"
"28696023","MCDA swing weighting and discrete choice experiments for elicitation of patient benefit-risk preferences: a critical assessment","Tervonen T, Gelhorn H, Sri Bhashyam S, Poon JL, Gries KS, Rentz A, Marsh K.","Pharmacoepidemiol Drug Saf. 2017 Dec;26(12):1483-1491. doi: 10.1002/pds.4255. Epub 2017 Jul 11.","Tervonen T","Pharmacoepidemiol Drug Saf","2017","2017/07/12","","","10.1002/pds.4255"
"28691404","'Delisting' OxyContin® to reduce prescription opioid-related harms in Ontario (Canada)-gauging effects 5 years later","Fischer B, Vojtila L, Kurdyak P.","Pharmacoepidemiol Drug Saf. 2017 Sep;26(9):1040-1043. doi: 10.1002/pds.4253. Epub 2017 Jul 9.","Fischer B","Pharmacoepidemiol Drug Saf","2017","2017/07/11","","","10.1002/pds.4253"
"28691251","Postmarketing withdrawal of human medicinal products because of adverse reactions in animals: a systematic review and analysis","Onakpoya IJ, Heneghan CJ, Aronson JK.","Pharmacoepidemiol Drug Saf. 2017 Nov;26(11):1328-1337. doi: 10.1002/pds.4256. Epub 2017 Jul 9.","Onakpoya IJ","Pharmacoepidemiol Drug Saf","2017","2017/07/11","","","10.1002/pds.4256"
"28691203","Previously undiagnosed risk factors and medication nonadherence are prevalent in young adults with first-ever stroke","Sung SF, Lai EC, Wu DP, Hsieh CY.","Pharmacoepidemiol Drug Saf. 2017 Dec;26(12):1458-1464. doi: 10.1002/pds.4250. Epub 2017 Jul 10.","Sung SF","Pharmacoepidemiol Drug Saf","2017","2017/07/11","","","10.1002/pds.4250"
"28671317","Response to ""use of domperidone and risk of ventricular arrhythmia in the postpartum period: Getting to the heart of the matter""","Smolina K, Morgan S, Mintzes B, Hanley G, Oberlander T.","Pharmacoepidemiol Drug Saf. 2017 Jul;26(7):865-866. doi: 10.1002/pds.4229.","Smolina K","Pharmacoepidemiol Drug Saf","2017","2017/07/04","","","10.1002/pds.4229"
"28671316","Use of domperidone and risk of ventricular arrhythmia in the postpartum period: getting to the heart of the matter","Grzeskowiak LE, Smithers LG.","Pharmacoepidemiol Drug Saf. 2017 Jul;26(7):863-864. doi: 10.1002/pds.4133.","Grzeskowiak LE","Pharmacoepidemiol Drug Saf","2017","2017/07/04","","","10.1002/pds.4133"
"28665012","Prescribing trends and indications of antipsychotic medication in Hong Kong from 2004 to 2014: General and vulnerable patient groups","Lao KSJ, Tam AWY, Wong ICK, Besag FMC, Man KKC, Chui CSL, Chan EW.","Pharmacoepidemiol Drug Saf. 2017 Nov;26(11):1387-1394. doi: 10.1002/pds.4244. Epub 2017 Jun 30.","Lao KSJ","Pharmacoepidemiol Drug Saf","2017","2017/07/01","","","10.1002/pds.4244"
"28657162","CodeMapper: semiautomatic coding of case definitions. A contribution from the ADVANCE project","Becker BFH, Avillach P, Romio S, van Mulligen EM, Weibel D, Sturkenboom MCJM, Kors JA; ADVANCE consortium.","Pharmacoepidemiol Drug Saf. 2017 Aug;26(8):998-1005. doi: 10.1002/pds.4245. Epub 2017 Jun 28.","Becker BFH","Pharmacoepidemiol Drug Saf","2017","2017/06/29","PMC5575526","","10.1002/pds.4245"
"28653802","Safety profile of H1-antihistamines in pediatrics: an analysis based on data from VigiBase","Motola D, Donati M, Biagi C, Calamelli E, Cipriani F, Melis M, Monaco L, Vaccheri A, Ricci G.","Pharmacoepidemiol Drug Saf. 2017 Oct;26(10):1164-1171. doi: 10.1002/pds.4246. Epub 2017 Jun 27.","Motola D","Pharmacoepidemiol Drug Saf","2017","2017/06/28","","","10.1002/pds.4246"
"28653790","vigiRank for statistical signal detection in pharmacovigilance: First results from prospective real-world use","Caster O, Sandberg L, Bergvall T, Watson S, Norén GN.","Pharmacoepidemiol Drug Saf. 2017 Aug;26(8):1006-1010. doi: 10.1002/pds.4247. Epub 2017 Jun 27.","Caster O","Pharmacoepidemiol Drug Saf","2017","2017/06/28","PMC5575476","","10.1002/pds.4247"
"28653782","Changes in drug use patterns reported on the web after the introduction of ADF OxyContin: findings from the Researched Abuse, Diversion, and Addiction-Related Surveillance (RADARS) System Web Monitoring Program","Vosburg SK, Haynes C, Besharat A, Green JL.","Pharmacoepidemiol Drug Saf. 2017 Sep;26(9):1044-1052. doi: 10.1002/pds.4248. Epub 2017 Jun 27.","Vosburg SK","Pharmacoepidemiol Drug Saf","2017","2017/06/28","","","10.1002/pds.4248"
"28620909","Pregabalin and heart failure: A population-based study","Ho JM, Macdonald EM, Luo J, Gomes T, Antoniou T, Mamdani MM, Juurlink DN.","Pharmacoepidemiol Drug Saf. 2017 Sep;26(9):1087-1092. doi: 10.1002/pds.4239. Epub 2017 Jun 16.","Ho JM","Pharmacoepidemiol Drug Saf","2017","2017/06/17","","","10.1002/pds.4239"
"28612964","Has cost inhibited the uptake of more potent statins in England?","Chapman SR, Fitzpatrick RW, Aladul MI.","Pharmacoepidemiol Drug Saf. 2017 Aug;26(8):984-991. doi: 10.1002/pds.4231. Epub 2017 Jun 14.","Chapman SR","Pharmacoepidemiol Drug Saf","2017","2017/06/15","","","10.1002/pds.4231"
"28612945","Comparative study of the number of report and time-to-onset of the reported adverse event between the biosimilars and the originator of filgrastim","Kobayashi T, Kamada I, Komura J, Toyoshima S, Ishii-Watabe A.","Pharmacoepidemiol Drug Saf. 2017 Aug;26(8):917-924. doi: 10.1002/pds.4218. Epub 2017 Jun 14.","Kobayashi T","Pharmacoepidemiol Drug Saf","2017","2017/06/15","","","10.1002/pds.4218"
"28608510","Agreement and validity of electronic health record prescribing data relative to pharmacy claims data: A validation study from a US electronic health record database","Rowan CG, Flory J, Gerhard T, Cuddeback JK, Stempniewicz N, Lewis JD, Hennessy S.","Pharmacoepidemiol Drug Saf. 2017 Aug;26(8):963-972. doi: 10.1002/pds.4234. Epub 2017 Jun 12.","Rowan CG","Pharmacoepidemiol Drug Saf","2017","2017/06/14","","","10.1002/pds.4234"
"28594145","Use of antidepressant medication in pregnancy and adverse neonatal outcomes: A population-based investigation","Cantarutti A, Merlino L, Giaquinto C, Corrao G.","Pharmacoepidemiol Drug Saf. 2017 Sep;26(9):1100-1108. doi: 10.1002/pds.4242. Epub 2017 Jun 8.","Cantarutti A","Pharmacoepidemiol Drug Saf","2017","2017/06/09","","","10.1002/pds.4242"
"28594077","Trends in antidepressant prescribing to children and adolescents in Canadian primary care: A time-series analysis","Morkem R, Williamson T, Patten S, Queenan JA, Wong ST, Manca D, Barber D.","Pharmacoepidemiol Drug Saf. 2017 Sep;26(9):1093-1099. doi: 10.1002/pds.4240. Epub 2017 Jun 8.","Morkem R","Pharmacoepidemiol Drug Saf","2017","2017/06/09","","","10.1002/pds.4240"
"28594076","The future of safety science is happening now: The modernization of the benefit-risk paradigm","Lievano F, Scarazzini L, Shen F, Duhig J, Jokinen J.","Pharmacoepidemiol Drug Saf. 2017 Aug;26(8):869-874. doi: 10.1002/pds.4241. Epub 2017 Jun 8.","Lievano F","Pharmacoepidemiol Drug Saf","2017","2017/06/09","","","10.1002/pds.4241"
"28585776","Comparison of adverse events following pentavalent and diphtheria-tetanus-pertussis vaccines among Nigerian children","Sadoh AE, Nwaneri DU, Ogboghodo BC, Sadoh WE.","Pharmacoepidemiol Drug Saf. 2018 Jan;27(1):119-122. doi: 10.1002/pds.4243. Epub 2017 Jun 6.","Sadoh AE","Pharmacoepidemiol Drug Saf","2018","2017/06/07","","","10.1002/pds.4243"
"28585409","A population-based study of risk perceptions of paracetamol use among Swedes-with a special focus on young adults","Håkonsen H, Hedenrud T.","Pharmacoepidemiol Drug Saf. 2017 Aug;26(8):992-997. doi: 10.1002/pds.4238. Epub 2017 Jun 5.","Håkonsen H","Pharmacoepidemiol Drug Saf","2017","2017/06/07","","","10.1002/pds.4238"
"28573827","Does serious consequential masking exist? An update","Hauben M, Maignen F.","Pharmacoepidemiol Drug Saf. 2017 Jun;26(6):727-729. doi: 10.1002/pds.4209.","Hauben M","Pharmacoepidemiol Drug Saf","2017","2017/06/03","","","10.1002/pds.4209"
"28573786","Real-life patterns of use, safety and effectiveness of sunitinib in first-line therapy of metastatic renal cell carcinoma: the SANTORIN cohort study","Noize P, Grelaud A, Bay JO, Chevreau C, Gross-Goupil M, Culine S, Ferrière JM, Moulin F, Robinson P, Balestra A, Lamarque S, Bernard MA, Lassalle R, Rouyer M, Droz-Perroteau C, Moore N, Fourrier-Réglat A, Ravaud A.","Pharmacoepidemiol Drug Saf. 2017 Dec;26(12):1561-1569. doi: 10.1002/pds.4228. Epub 2017 Jun 1.","Noize P","Pharmacoepidemiol Drug Saf","2017","2017/06/03","","","10.1002/pds.4228"
"28556303","Screening approach for identifying candidate drugs and drug-drug interactions related to hip fracture risk in persons with Alzheimer disease","Tolppanen AM, Taipale H, Koponen M, Tanskanen A, Lavikainen P, Paananen J, Tiihonen J, Hartikainen S.","Pharmacoepidemiol Drug Saf. 2017 Aug;26(8):875-889. doi: 10.1002/pds.4232. Epub 2017 May 29.","Tolppanen AM","Pharmacoepidemiol Drug Saf","2017","2017/05/31","","","10.1002/pds.4232"
"28556206","The differences in the incidence of diabetes mellitus and prediabetes according to the type of HMG-CoA reductase inhibitors prescribed in Korean patients","Kim TM, Kim H, Jeong YJ, Baik SJ, Yang SJ, Lee SH, Cho JH, Lee H, Yim HW, Choi IY, Yoon KH, Kim HS.","Pharmacoepidemiol Drug Saf. 2017 Oct;26(10):1156-1163. doi: 10.1002/pds.4237. Epub 2017 May 29.","Kim TM","Pharmacoepidemiol Drug Saf","2017","2017/05/31","","","10.1002/pds.4237"
"28547787","Prescribing and Research in Medicines Management (UK & Ireland) Annual Conference 2017, University of Coventry London Campus, January 28(th) 2017: ""Deprescribing - is less more?""","","Pharmacoepidemiol Drug Saf. 2017 May;26 Suppl 1:3-20. doi: 10.1002/pds.4221.","","Pharmacoepidemiol Drug Saf","2017","2017/05/27","","","10.1002/pds.4221"
"28544284","The national healthcare system claims databases in France, SNIIRAM and EGB: Powerful tools for pharmacoepidemiology","Bezin J, Duong M, Lassalle R, Droz C, Pariente A, Blin P, Moore N.","Pharmacoepidemiol Drug Saf. 2017 Aug;26(8):954-962. doi: 10.1002/pds.4233. Epub 2017 May 24.","Bezin J","Pharmacoepidemiol Drug Saf","2017","2017/05/26","","","10.1002/pds.4233"
"28544026","Immobilization and high platelet count are associated with thromboembolic complications in heparin-induced thrombocytopenia","Bolbrinker J, Garbe E, Douros A, Huber M, Bronder E, Klimpel A, Andersohn F, Meyer O, Salama A, Kreutz R.","Pharmacoepidemiol Drug Saf. 2017 Oct;26(10):1149-1155. doi: 10.1002/pds.4235. Epub 2017 May 24.","Bolbrinker J","Pharmacoepidemiol Drug Saf","2017","2017/05/26","","","10.1002/pds.4235"
"28543978","The impact of the boxed warning on the duration of use for depot medroxprogesterone acetate","Eworuke E, Lee JY, Soule L, Popat V, Moeny DG.","Pharmacoepidemiol Drug Saf. 2017 Jul;26(7):827-836. doi: 10.1002/pds.4227. Epub 2017 May 23.","Eworuke E","Pharmacoepidemiol Drug Saf","2017","2017/05/26","","","10.1002/pds.4227"
"28524293","The contribution of direct patient reported ADRs to drug safety signals in the Netherlands from 2010 to 2015","van Hunsel F, de Waal S, Härmark L.","Pharmacoepidemiol Drug Saf. 2017 Aug;26(8):977-983. doi: 10.1002/pds.4236. Epub 2017 May 19.","van Hunsel F","Pharmacoepidemiol Drug Saf","2017","2017/05/20","","","10.1002/pds.4236"
"28503870","Correcting hazard ratio estimates for outcome misclassification using multiple imputation with internal validation data","Ni J, Leong A, Dasgupta K, Rahme E.","Pharmacoepidemiol Drug Saf. 2017 Aug;26(8):925-934. doi: 10.1002/pds.4223. Epub 2017 May 15.","Ni J","Pharmacoepidemiol Drug Saf","2017","2017/05/16","","","10.1002/pds.4223"
"28497594","The impact of regulatory action on the co-prescribing of renin-angiotensin system blockers in UK primary care","Allen C, Donegan K.","Pharmacoepidemiol Drug Saf. 2017 Jul;26(7):858-862. doi: 10.1002/pds.4219. Epub 2017 May 11.","Allen C","Pharmacoepidemiol Drug Saf","2017","2017/05/13","","","10.1002/pds.4219"
"28493425","Law enforcement-derived data on gabapentin diversion and misuse, 2002-2015: diversion rates and qualitative research findings","Buttram ME, Kurtz SP, Dart RC, Margolin ZR.","Pharmacoepidemiol Drug Saf. 2017 Sep;26(9):1083-1086. doi: 10.1002/pds.4230. Epub 2017 May 10.","Buttram ME","Pharmacoepidemiol Drug Saf","2017","2017/05/12","","","10.1002/pds.4230"
"28485129","Evaluation of algorithms to identify incident cancer cases by using French health administrative databases","Ajrouche A, Estellat C, De Rycke Y, Tubach F.","Pharmacoepidemiol Drug Saf. 2017 Aug;26(8):935-944. doi: 10.1002/pds.4225. Epub 2017 May 9.","Ajrouche A","Pharmacoepidemiol Drug Saf","2017","2017/05/10","","","10.1002/pds.4225"
"28485111","Disclosure of industry payments to prescribers: industry payments might be a factor impacting generic drug prescribing","Qian J, Hansen RA, Surry D, Howard J, Kiptanui Z, Harris I.","Pharmacoepidemiol Drug Saf. 2017 Jul;26(7):819-826. doi: 10.1002/pds.4224. Epub 2017 May 9.","Qian J","Pharmacoepidemiol Drug Saf","2017","2017/05/10","PMC5856251","NIHMS948551","10.1002/pds.4224"
"28485014","Evaluation of algorithms to identify delirium in administrative claims and drug utilization database","Kim DH, Lee J, Kim CA, Huybrechts KF, Bateman BT, Patorno E, Marcantonio ER.","Pharmacoepidemiol Drug Saf. 2017 Aug;26(8):945-953. doi: 10.1002/pds.4226. Epub 2017 May 9.","Kim DH","Pharmacoepidemiol Drug Saf","2017","2017/05/10","PMC5583076","NIHMS900358","10.1002/pds.4226"
"28474439","Estimating medication stopping fraction and real-time prevalence of drug use in pharmaco-epidemiologic databases. An application of the reverse waiting time distribution","Støvring H, Pottegård A, Hallas J.","Pharmacoepidemiol Drug Saf. 2017 Aug;26(8):909-916. doi: 10.1002/pds.4217. Epub 2017 May 4.","Støvring H","Pharmacoepidemiol Drug Saf","2017","2017/05/06","","","10.1002/pds.4217"
"28466973","Refining estimates of prescription durations by using observed covariates in pharmacoepidemiological databases: an application of the reverse waiting time distribution","Støvring H, Pottegård A, Hallas J.","Pharmacoepidemiol Drug Saf. 2017 Aug;26(8):900-908. doi: 10.1002/pds.4216. Epub 2017 May 3.","Støvring H","Pharmacoepidemiol Drug Saf","2017","2017/05/04","","","10.1002/pds.4216"
"28449404","Changes in prescribing and healthcare resource utilization after FDA Drug Safety Communications involving zolpidem-containing medications","Kesselheim AS, Donneyong M, Dal Pan GJ, Zhou EH, Avorn J, Schneeweiss S, Seeger JD.","Pharmacoepidemiol Drug Saf. 2017 Jun;26(6):712-721. doi: 10.1002/pds.4215. Epub 2017 Apr 27.","Kesselheim AS","Pharmacoepidemiol Drug Saf","2017","2017/04/28","","","10.1002/pds.4215"
"28449197","Safety profile of medication used during pregnancy: results of a multinational European study","Trønnes JN, Lupattelli A, Nordeng H.","Pharmacoepidemiol Drug Saf. 2017 Jul;26(7):802-811. doi: 10.1002/pds.4213. Epub 2017 Apr 27.","Trønnes JN","Pharmacoepidemiol Drug Saf","2017","2017/04/28","PMC5518438","","10.1002/pds.4213"
"28444852","The renal elimination of apixaban: the totality of data relating to the renal clearance of apixaban in patients with impaired renal function: response to Hellfritzsch et al","Byon W, Cirincione B, Di Russo G, LaCreta F, Boyd R.","Pharmacoepidemiol Drug Saf. 2017 May;26(5):603-605. doi: 10.1002/pds.4163.","Byon W","Pharmacoepidemiol Drug Saf","2017","2017/04/27","","","10.1002/pds.4163"
"28422339","Prenatal exposure to β2-adrenoreceptor agonists and the risk of autism spectrum disorders in offspring","Su X, Yuan W, Chen J, Miao M, Olsen J, Pedersen LH, Liang H, Li J.","Pharmacoepidemiol Drug Saf. 2017 Jul;26(7):812-818. doi: 10.1002/pds.4214. Epub 2017 Apr 19.","Su X","Pharmacoepidemiol Drug Saf","2017","2017/04/20","","","10.1002/pds.4214"
"28397412","Prevalence, incidence, indication, and choice of antidepressants in patients with and without chronic kidney disease: a matched cohort study in UK Clinical Practice Research Datalink","Iwagami M, Tomlinson LA, Mansfield KE, McDonald HI, Smeeth L, Nitsch D.","Pharmacoepidemiol Drug Saf. 2017 Jul;26(7):792-801. doi: 10.1002/pds.4212. Epub 2017 Apr 11.","Iwagami M","Pharmacoepidemiol Drug Saf","2017","2017/04/12","PMC5516188","","10.1002/pds.4212"
"28397352","Effects of expanding the look-back period to all available data in the assessment of covariates","Nakasian SS, Rassen JA, Franklin JM.","Pharmacoepidemiol Drug Saf. 2017 Aug;26(8):890-899. doi: 10.1002/pds.4210. Epub 2017 Apr 11.","Nakasian SS","Pharmacoepidemiol Drug Saf","2017","2017/04/12","","","10.1002/pds.4210"
"28397317","Evaluating the effectiveness of risk minimisation measures: the application of a conceptual framework to Danish real-world dabigatran data","Nyeland ME, Laursen MV, Callréus T.","Pharmacoepidemiol Drug Saf. 2017 Jun;26(6):607-614. doi: 10.1002/pds.4203. Epub 2017 Apr 11.","Nyeland ME","Pharmacoepidemiol Drug Saf","2017","2017/04/12","","","10.1002/pds.4203"
"28374491","Corrigendum","","Pharmacoepidemiol Drug Saf. 2017 Apr;26(4):477. doi: 10.1002/pds.4178.","","Pharmacoepidemiol Drug Saf","2017","2017/04/05","","","10.1002/pds.4178"
"28374490","Corrigendum","","Pharmacoepidemiol Drug Saf. 2017 Apr;26(4):478. doi: 10.1002/pds.4182.","","Pharmacoepidemiol Drug Saf","2017","2017/04/05","","","10.1002/pds.4182"
"28374489","Improving medical record retrieval for validation studies in Medicare data","Wright NC, Delzell ES, Smith WK, Xue F, Auroa T, Curtis JR.","Pharmacoepidemiol Drug Saf. 2017 Apr;26(4):393-401. doi: 10.1002/pds.4131. Epub 2016 Nov 7.","Wright NC","Pharmacoepidemiol Drug Saf","2017","2017/04/05","","","10.1002/pds.4131"
"28371079","Validity of major osteoporotic fracture diagnosis codes in the Clinical Data Analysis and Reporting System in Hong Kong","Sing CW, Woo YC, Lee ACH, Lam JKY, Chu JKP, Wong ICK, Cheung CL.","Pharmacoepidemiol Drug Saf. 2017 Aug;26(8):973-976. doi: 10.1002/pds.4208. Epub 2017 Apr 3.","Sing CW","Pharmacoepidemiol Drug Saf","2017","2017/04/04","","","10.1002/pds.4208"
"28370905","Exposure to statins is associated to fracture risk reduction in elderly people with cardiovascular disease: evidence from the AIFA-I-GrADE observational project","Rea F, Bonassi S, Vitale C, Trifirò G, Cascini S, Roberto G, Chinellato A, Lucenteforte E, Mugelli A, Corrao G; I-GrADE investigators.","Pharmacoepidemiol Drug Saf. 2017 Jul;26(7):775-784. doi: 10.1002/pds.4206. Epub 2017 Mar 31.","Rea F","Pharmacoepidemiol Drug Saf","2017","2017/04/04","","","10.1002/pds.4206"
"28370875","Adherence to disease-modifying therapies for multiple sclerosis and subsequent hospitalizations","Evans C, Marrie RA, Zhu F, Leung S, Lu X, Kingwell E, Zhao Y, Tremlett H.","Pharmacoepidemiol Drug Saf. 2017 Jun;26(6):702-711. doi: 10.1002/pds.4207. Epub 2017 Apr 3.","Evans C","Pharmacoepidemiol Drug Saf","2017","2017/04/04","","","10.1002/pds.4207"
"28370857","Gastrointestinal toxicity among patients taking selective COX-2 inhibitors or conventional NSAIDs, alone or combined with proton pump inhibitors: a case-control study","Bakhriansyah M, Souverein PC, de Boer A, Klungel OH.","Pharmacoepidemiol Drug Saf. 2017 Oct;26(10):1141-1148. doi: 10.1002/pds.4183. Epub 2017 Mar 31.","Bakhriansyah M","Pharmacoepidemiol Drug Saf","2017","2017/04/04","PMC5655916","","10.1002/pds.4183"
"28370798","Differential Use of Screening Mammography in Older Women Initiating Metformin versus Sulfonylurea","Hong JL, Henderson LM, Jonsson Funk M, Lund JL, Buse JB, Pate V, Stürmer T.","Pharmacoepidemiol Drug Saf. 2017 Jun;26(6):666-675. doi: 10.1002/pds.4195. Epub 2017 Mar 29.","Hong JL","Pharmacoepidemiol Drug Saf","2017","2017/04/04","PMC5457352","NIHMS860288","10.1002/pds.4195"
"28370746","Low-dose naltrexone and opioid consumption: a drug utilization cohort study based on data from the Norwegian prescription database","Raknes G, Småbrekke L.","Pharmacoepidemiol Drug Saf. 2017 Jun;26(6):685-693. doi: 10.1002/pds.4201. Epub 2017 Mar 29.","Raknes G","Pharmacoepidemiol Drug Saf","2017","2017/04/04","PMC5485080","","10.1002/pds.4201"
"28370652","Do patients trust the FDA?: a survey assessing how patients view the generic drug approval process","Kesselheim AS, Gagne JJ, Franklin JM, Eddings W, Fulchino LA, Campbell EG.","Pharmacoepidemiol Drug Saf. 2017 Jun;26(6):694-701. doi: 10.1002/pds.4205. Epub 2017 Mar 31.","Kesselheim AS","Pharmacoepidemiol Drug Saf","2017","2017/04/04","","","10.1002/pds.4205"
"28370596","Identifying rare diseases using electronic medical records: the example of allergic bronchopulmonary aspergillosis","Maguire A, Johnson ME, Denning DW, Ferreira GLC, Cassidy A.","Pharmacoepidemiol Drug Saf. 2017 Jul;26(7):785-791. doi: 10.1002/pds.4204. Epub 2017 Mar 31.","Maguire A","Pharmacoepidemiol Drug Saf","2017","2017/04/04","PMC5573984","","10.1002/pds.4204"
"28345306","The burden and management of cytochrome P450 2D6 (CYP2D6)-mediated drug-drug interaction (DDI): co-medication of metoprolol and paroxetine or fluoxetine in the elderly","Bahar MA, Hak E, Bos JHJ, Borgsteede SD, Wilffert B.","Pharmacoepidemiol Drug Saf. 2017 Jul;26(7):752-765. doi: 10.1002/pds.4200. Epub 2017 Mar 26.","Bahar MA","Pharmacoepidemiol Drug Saf","2017","2017/03/28","","","10.1002/pds.4200"
"28345245","Pain, depressive symptoms and medication in German patients with rheumatoid arthritis-results from the linking patient-reported outcomes with claims data for health services research in rheumatology (PROCLAIR) study","Jobski K, Luque Ramos A, Albrecht K, Hoffmann F.","Pharmacoepidemiol Drug Saf. 2017 Jul;26(7):766-774. doi: 10.1002/pds.4202. Epub 2017 Mar 26.","Jobski K","Pharmacoepidemiol Drug Saf","2017","2017/03/28","","","10.1002/pds.4202"
"28345151","Registries in European post-marketing surveillance: a retrospective analysis of centrally approved products, 2005-2013","Bouvy JC, Blake K, Slattery J, De Bruin ML, Arlett P, Kurz X.","Pharmacoepidemiol Drug Saf. 2017 Dec;26(12):1442-1450. doi: 10.1002/pds.4196. Epub 2017 Mar 26.","Bouvy JC","Pharmacoepidemiol Drug Saf","2017","2017/03/28","","","10.1002/pds.4196"
"28337823","Interest of the trajectory method for the evaluation of outcomes after in utero drug exposure: example of anxiolytics and hypnotics","Hurault-Delarue C, Chouquet C, Savy N, Lacroix I, Beau AB, Montastruc JL, Damase-Michel C.","Pharmacoepidemiol Drug Saf. 2017 May;26(5):561-569. doi: 10.1002/pds.4199. Epub 2017 Mar 24.","Hurault-Delarue C","Pharmacoepidemiol Drug Saf","2017","2017/03/25","","","10.1002/pds.4199"
"28326633","Bias from depletion of susceptibles: the example of hormone replacement therapy and the risk of venous thromboembolism","Renoux C, Dell'Aniello S, Brenner B, Suissa S.","Pharmacoepidemiol Drug Saf. 2017 May;26(5):554-560. doi: 10.1002/pds.4197. Epub 2017 Mar 22.","Renoux C","Pharmacoepidemiol Drug Saf","2017","2017/03/23","","","10.1002/pds.4197"
"28317314","Assessing disruptions in adherence to antidepressant treatments after breast cancer diagnosis","Chou YT, Winn AN, Rosenstein DL, Dusetzina SB.","Pharmacoepidemiol Drug Saf. 2017 Jun;26(6):676-684. doi: 10.1002/pds.4198. Epub 2017 Mar 19.","Chou YT","Pharmacoepidemiol Drug Saf","2017","2017/03/21","PMC5457339","NIHMS860289","10.1002/pds.4198"
"28317274","Quality of warfarin therapy and risk of stroke, bleeding, and mortality among patients with atrial fibrillation: results from the nationwide FinWAF Registry","Lehto M, Niiranen J, Korhonen P, Mehtälä J, Khanfir H, Hoti F, Lassila R, Raatikainen P.","Pharmacoepidemiol Drug Saf. 2017 Jun;26(6):657-665. doi: 10.1002/pds.4194. Epub 2017 Mar 19.","Lehto M","Pharmacoepidemiol Drug Saf","2017","2017/03/21","","","10.1002/pds.4194"
"28295882","Identifying atrial fibrillation in outpatients initiating oral anticoagulants based on medico-administrative data: results from the French national healthcare databases","Billionnet C, Alla F, Bérigaud É, Pariente A, Maura G.","Pharmacoepidemiol Drug Saf. 2017 May;26(5):535-543. doi: 10.1002/pds.4192. Epub 2017 Mar 14.","Billionnet C","Pharmacoepidemiol Drug Saf","2017","2017/03/16","","","10.1002/pds.4192"
"28295862","Sample size of the reference sample in a case-augmented study","Ghosh P, Dewanji A.","Pharmacoepidemiol Drug Saf. 2017 May;26(5):528-534. doi: 10.1002/pds.4191. Epub 2017 Mar 13.","Ghosh P","Pharmacoepidemiol Drug Saf","2017","2017/03/16","","","10.1002/pds.4191"
"28295821","Economic impact of medication error: a systematic review","Walsh EK, Hansen CR, Sahm LJ, Kearney PM, Doherty E, Bradley CP.","Pharmacoepidemiol Drug Saf. 2017 May;26(5):481-497. doi: 10.1002/pds.4188. Epub 2017 Mar 13.","Walsh EK","Pharmacoepidemiol Drug Saf","2017","2017/03/16","","","10.1002/pds.4188"
"28266748","Immeasurable time bias due to hospitalization in medico-administrative databases: which impact for pharmacoepidemiological studies?","Palmaro A, Boucherie Q, Dupouy J, Micallef J, Lapeyre-Mestre M.","Pharmacoepidemiol Drug Saf. 2017 May;26(5):544-553. doi: 10.1002/pds.4193. Epub 2017 Mar 7.","Palmaro A","Pharmacoepidemiol Drug Saf","2017","2017/03/08","","","10.1002/pds.4193"
"28266092","Six-year multi-centre, observational, post-marketing surveillance of the safety of the HPV-16/18 AS04-adjuvanted vaccine in women aged 10-25 years in Korea","Kim CJ, Song R, Chen J, Tavares Da Silva F, Gopala KB, Kim JH, Bi D, Park JS.","Pharmacoepidemiol Drug Saf. 2017 Jul;26(7):837-842. doi: 10.1002/pds.4175. Epub 2017 Mar 7.","Kim CJ","Pharmacoepidemiol Drug Saf","2017","2017/03/08","PMC5516175","","10.1002/pds.4175"
"28266090","Trends in antipsychotic prescriptions for Japanese outpatients during 2006-2012: a descriptive epidemiological study","Kochi K, Sato I, Nishiyama C, Tanaka-Mizuno S, Doi Y, Arai M, Fujii Y, Matsunaga T, Ogawa Y, Furukawa TA, Kawakami K.","Pharmacoepidemiol Drug Saf. 2017 Jun;26(6):642-656. doi: 10.1002/pds.4187. Epub 2017 Mar 7.","Kochi K","Pharmacoepidemiol Drug Saf","2017","2017/03/08","","","10.1002/pds.4187"
"28247547","Consumer Healthcare Products Association response to Major et al., ""Trends in rates of acetaminophen-related adverse events in the United States"", Pharmacoepidemiology & Drug Safety, May 2016, 25: 590-8","Sirois JE.","Pharmacoepidemiol Drug Saf. 2017 Mar;26(3):353-354. doi: 10.1002/pds.4129.","Sirois JE","Pharmacoepidemiol Drug Saf","2017","2017/03/02","PMC5347952","","10.1002/pds.4129"
"28247546","Response to Consumer Healthcare Products Association letter to ""Trend in rates of acetaminophen-related adverse events in the United States""","Pham T, Major JM, Chai G, Moeny D, Wang C, Blum MD.","Pharmacoepidemiol Drug Saf. 2017 Mar;26(3):355. doi: 10.1002/pds.4172.","Pham T","Pharmacoepidemiol Drug Saf","2017","2017/03/02","PMC5739514","NIHMS916497","10.1002/pds.4172"
"28247528","ACE inhibitors and the risk of acute pancreatitis-a population-based case-control study","Kuoppala J, Enlund H, Pulkkinen J, Kastarinen H, Jyrkkä J, Happonen P, Paajanen H.","Pharmacoepidemiol Drug Saf. 2017 Jul;26(7):853-857. doi: 10.1002/pds.4179. Epub 2017 Mar 1.","Kuoppala J","Pharmacoepidemiol Drug Saf","2017","2017/03/02","","","10.1002/pds.4179"
"28239929","A tutorial on the use of instrumental variables in pharmacoepidemiology","Ertefaie A, Small DS, Flory JH, Hennessy S.","Pharmacoepidemiol Drug Saf. 2017 Apr;26(4):357-367. doi: 10.1002/pds.4158. Epub 2017 Feb 27.","Ertefaie A","Pharmacoepidemiol Drug Saf","2017","2017/02/28","","","10.1002/pds.4158"
"28239922","Diverging approaches of pharmacovigilance and pharmacoepidemiology to assessing drug safety: epistemological and ethical implications","Coste J.","Pharmacoepidemiol Drug Saf. 2017 May;26(5):600-602. doi: 10.1002/pds.4190. Epub 2017 Feb 27.","Coste J","Pharmacoepidemiol Drug Saf","2017","2017/02/28","","","10.1002/pds.4190"
"28233421","Burden of hospitalizations related to adverse drug events in the USA: a retrospective analysis from large inpatient database","Poudel DR, Acharya P, Ghimire S, Dhital R, Bharati R.","Pharmacoepidemiol Drug Saf. 2017 Jun;26(6):635-641. doi: 10.1002/pds.4184. Epub 2017 Feb 24.","Poudel DR","Pharmacoepidemiol Drug Saf","2017","2017/02/25","","","10.1002/pds.4184"
"28233367","Medical specialists' attitudes to prescribing biosimilars","Hemmington A, Dalbeth N, Jarrett P, Fraser AG, Broom R, Browett P, Petrie KJ.","Pharmacoepidemiol Drug Saf. 2017 May;26(5):570-577. doi: 10.1002/pds.4186. Epub 2017 Feb 24.","Hemmington A","Pharmacoepidemiol Drug Saf","2017","2017/02/25","","","10.1002/pds.4186"
"28220993","Antiemetic use among pregnant women in the United States: the escalating use of ondansetron","Taylor LG, Bird ST, Sahin L, Tassinari MS, Greene P, Reichman ME, Andrade SE, Haffenreffer K, Toh S.","Pharmacoepidemiol Drug Saf. 2017 May;26(5):592-596. doi: 10.1002/pds.4185. Epub 2017 Feb 21.","Taylor LG","Pharmacoepidemiol Drug Saf","2017","2017/02/22","","","10.1002/pds.4185"
"28220982","New-user designs with conditional propensity scores: a unified complement to the traditional active comparator new-user approach","Gagne JJ.","Pharmacoepidemiol Drug Saf. 2017 Apr;26(4):469-471. doi: 10.1002/pds.4189. Epub 2017 Feb 21.","Gagne JJ","Pharmacoepidemiol Drug Saf","2017","2017/02/22","","","10.1002/pds.4189"
"28220974","Advancing regulatory science, advancing regulatory practice","Kurz X.","Pharmacoepidemiol Drug Saf. 2017 Jun;26(6):722-726. doi: 10.1002/pds.4181. Epub 2017 Feb 21.","Kurz X","Pharmacoepidemiol Drug Saf","2017","2017/02/22","PMC5484349","","10.1002/pds.4181"
"28198116","Periodic benefit-risk evaluation reports have substantial promise to guide patient care and should be made publicly available","Fralick M, Kesselheim AS.","Pharmacoepidemiol Drug Saf. 2017 May;26(5):597-599. doi: 10.1002/pds.4177. Epub 2017 Feb 15.","Fralick M","Pharmacoepidemiol Drug Saf","2017","2017/02/16","","","10.1002/pds.4177"
"28198064","Real-life practices for preventing venous thromboembolism in multiple myeloma patients: a cohort study from the French health insurance database","Palmaro A, Rougé-Bugat ME, Gauthier M, Despas F, Moulis G, Lapeyre-Mestre M.","Pharmacoepidemiol Drug Saf. 2017 May;26(5):578-586. doi: 10.1002/pds.4180. Epub 2017 Feb 15.","Palmaro A","Pharmacoepidemiol Drug Saf","2017","2017/02/16","","","10.1002/pds.4180"
"28176447","Statins during pregnancy: a cohort study using the General Practice Research Database to investigate pregnancy loss","McGrogan A, Snowball J, Charlton RA.","Pharmacoepidemiol Drug Saf. 2017 Jul;26(7):843-852. doi: 10.1002/pds.4176. Epub 2017 Feb 8.","McGrogan A","Pharmacoepidemiol Drug Saf","2017","2017/02/09","","","10.1002/pds.4176"
"28176407","Types, frequencies, and burden of nonspecific adverse events of drugs: analysis of randomized placebo-controlled clinical trials","Mahr A, Golmard C, Pham E, Iordache L, Deville L, Faure P.","Pharmacoepidemiol Drug Saf. 2017 Jul;26(7):731-741. doi: 10.1002/pds.4169. Epub 2017 Feb 7.","Mahr A","Pharmacoepidemiol Drug Saf","2017","2017/02/09","","","10.1002/pds.4169"
"28168780","Preterm births and use of medication in early adulthood: a population-based registry study","Engeland A, Bjørge T, Klungsøyr K, Skurtveit S, Furu K.","Pharmacoepidemiol Drug Saf. 2017 Jul;26(7):742-751. doi: 10.1002/pds.4174. Epub 2017 Feb 7.","Engeland A","Pharmacoepidemiol Drug Saf","2017","2017/02/08","","","10.1002/pds.4174"
"28168770","Language competence and communication skills in 3-year-old children after prenatal exposure to analgesic opioids","Skovlund E, Handal M, Selmer R, Brandlistuen RE, Skurtveit S.","Pharmacoepidemiol Drug Saf. 2017 Jun;26(6):625-634. doi: 10.1002/pds.4170. Epub 2017 Feb 7.","Skovlund E","Pharmacoepidemiol Drug Saf","2017","2017/02/08","","","10.1002/pds.4170"
"28156036","Assessing recording delays in general practice records to inform near real-time vaccine safety surveillance using the Clinical Practice Research Datalink (CPRD)","Leite A, Andrews NJ, Thomas SL.","Pharmacoepidemiol Drug Saf. 2017 Apr;26(4):437-445. doi: 10.1002/pds.4173. Epub 2017 Feb 3.","Leite A","Pharmacoepidemiol Drug Saf","2017","2017/02/04","PMC5396331","","10.1002/pds.4173"
"28133890","Characterization of new users of cilostazol in the UK, Spain, Sweden, and Germany","Castellsague J, Perez-Gutthann S, Calingaert B, Bui C, Varas-Lorenzo C, Arana A, Prados-Torres A, Poblador-Plou B, Gonzalez-Rubio F, Giner-Soriano M, Roso-Llorach A, Linder M, Citarella A, Scholle O, Blenk T, Garbe E.","Pharmacoepidemiol Drug Saf. 2017 Jun;26(6):615-624. doi: 10.1002/pds.4167. Epub 2017 Jan 30.","Castellsague J","Pharmacoepidemiol Drug Saf","2017","2017/01/31","PMC5484386","","10.1002/pds.4167"
"28124399","Comparative effectiveness of recommended versus less intensive drug combinations in secondary prevention of acute coronary syndrome","Bezin J, Groenwold RH, Ali MS, Lassalle R, Robinson P, de Boer A, Moore N, Klungel OH, Pariente A.","Pharmacoepidemiol Drug Saf. 2017 Mar;26(3):285-293. doi: 10.1002/pds.4171. Epub 2017 Jan 26.","Bezin J","Pharmacoepidemiol Drug Saf","2017","2017/01/27","","","10.1002/pds.4171"
"28120552","Quantification of missing prescriptions in commercial claims databases: results of a cohort study","Cepeda MS, Fife D, Denarié M, Bradford D, Roy S, Yuan Y.","Pharmacoepidemiol Drug Saf. 2017 Apr;26(4):386-392. doi: 10.1002/pds.4165. Epub 2017 Jan 25.","Cepeda MS","Pharmacoepidemiol Drug Saf","2017","2017/01/26","PMC5396298","","10.1002/pds.4165"
"28120359","Misclassification of incident hospitalized and outpatient heart failure in administrative claims data: the Atherosclerosis Risk in Communities (ARIC) study","Camplain R, Kucharska-Newton A, Cuthbertson CC, Wright JD, Alonso A, Heiss G.","Pharmacoepidemiol Drug Saf. 2017 Apr;26(4):421-428. doi: 10.1002/pds.4162. Epub 2017 Jan 25.","Camplain R","Pharmacoepidemiol Drug Saf","2017","2017/01/26","PMC5380482","NIHMS848070","10.1002/pds.4162"
"28101968","Defined daily doses (DDD) do not accurately reflect opioid doses used in contemporary chronic pain treatment","Nielsen S, Gisev N, Bruno R, Hall W, Cohen M, Larance B, Campbell G, Shanahan M, Blyth F, Lintzeris N, Pearson S, Mattick R, Degenhardt L.","Pharmacoepidemiol Drug Saf. 2017 May;26(5):587-591. doi: 10.1002/pds.4168. Epub 2017 Jan 19.","Nielsen S","Pharmacoepidemiol Drug Saf","2017","2017/01/20","","","10.1002/pds.4168"
"28097730","Exposure to reactive intermediate-inducing drugs during pregnancy and the incident use of psychotropic medications among children","Tran YH, Groen H, Bergman JE, Hak E, Wilffert B.","Pharmacoepidemiol Drug Saf. 2017 Mar;26(3):265-273. doi: 10.1002/pds.4161. Epub 2017 Jan 18.","Tran YH","Pharmacoepidemiol Drug Saf","2017","2017/01/19","","","10.1002/pds.4161"
"28083980","Increased availability of paracetamol in Sweden and incidence of paracetamol poisoning: using laboratory data to increase validity of a population-based registry study","Gedeborg R, Svennblad B, Holm L, Sjögren H, Bardage C, Personne M, Sjöberg G, Feltelius N, Zethelius B.","Pharmacoepidemiol Drug Saf. 2017 May;26(5):518-527. doi: 10.1002/pds.4166. Epub 2017 Jan 13.","Gedeborg R","Pharmacoepidemiol Drug Saf","2017","2017/01/14","","","10.1002/pds.4166"
"28083936","ADHD medications and cardiovascular adverse events in children and adolescents: cross-national comparison of risk communication in drug labeling","Sieluk J, Palasik B, dosReis S, Doshi P.","Pharmacoepidemiol Drug Saf. 2017 Mar;26(3):274-284. doi: 10.1002/pds.4164. Epub 2017 Jan 13.","Sieluk J","Pharmacoepidemiol Drug Saf","2017","2017/01/14","","","10.1002/pds.4164"
"28083935","Propacetamol poses a potential harm of adverse hypotension in male and older patients","Lee HY, Ban GY, Jeong CG, Lee JH, Park SH, Kim SH, Lee YH, Ye YM.","Pharmacoepidemiol Drug Saf. 2017 Mar;26(3):256-264. doi: 10.1002/pds.4159. Epub 2017 Jan 13.","Lee HY","Pharmacoepidemiol Drug Saf","2017","2017/01/14","","","10.1002/pds.4159"
"28083886","Incidence and risk estimate of drug-induced agranulocytosis in Hong Kong Chinese. A population-based case-control study","Sing CW, Wong IC, Cheung BM, Chan JC, Chu JK, Cheung CL.","Pharmacoepidemiol Drug Saf. 2017 Mar;26(3):248-255. doi: 10.1002/pds.4156. Epub 2017 Jan 13.","Sing CW","Pharmacoepidemiol Drug Saf","2017","2017/01/14","","","10.1002/pds.4156"
"28074520","Assessing the accuracy of opioid overdose and poisoning codes in diagnostic information from electronic health records, claims data, and death records","Green CA, Perrin NA, Janoff SL, Campbell CI, Chilcoat HD, Coplan PM.","Pharmacoepidemiol Drug Saf. 2017 May;26(5):509-517. doi: 10.1002/pds.4157. Epub 2017 Jan 10.","Green CA","Pharmacoepidemiol Drug Saf","2017","2017/01/12","","","10.1002/pds.4157"
"28071845","Influence of age, sex and seriousness on reporting of adverse drug reactions in Sweden","Holm L, Ekman E, Jorsäter Blomgren K.","Pharmacoepidemiol Drug Saf. 2017 Mar;26(3):335-343. doi: 10.1002/pds.4155. Epub 2017 Jan 10.","Holm L","Pharmacoepidemiol Drug Saf","2017","2017/01/11","","","10.1002/pds.4155"
"28067454","Concomitant use of calcium channel blockers with dual antiplatelet therapy and re-hospitalization for acute coronary syndrome","Wang CY, Lin ZF, Lee CM, Tsai YW, Huang TY, Shen LJ, Hsiao FY.","Pharmacoepidemiol Drug Saf. 2017 Mar;26(3):229-238. doi: 10.1002/pds.4147. Epub 2017 Jan 9.","Wang CY","Pharmacoepidemiol Drug Saf","2017","2017/01/10","","","10.1002/pds.4147"
"28067434","Pioglitazone and bladder cancer: FDA's assessment","Hampp C, Pippins J.","Pharmacoepidemiol Drug Saf. 2017 Feb;26(2):117-118. doi: 10.1002/pds.4154. Epub 2017 Jan 9.","Hampp C","Pharmacoepidemiol Drug Saf","2017","2017/01/10","","","10.1002/pds.4154"
"28054412","Identifying birth defects in automated data sources in the Vaccine Safety Datalink","Kharbanda EO, Vazquez-Benitez G, Romitti PA, Naleway AL, Cheetham TC, Lipkind HS, Sivanandam S, Klein NP, Lee GM, Jackson ML, Hambidge SJ, Olsen A, McCarthy N, DeStefano F, Nordin JD.","Pharmacoepidemiol Drug Saf. 2017 Apr;26(4):412-420. doi: 10.1002/pds.4153. Epub 2017 Jan 4.","Kharbanda EO","Pharmacoepidemiol Drug Saf","2017","2017/01/06","PMC6506837","NIHMS1024702","10.1002/pds.4153"
"28052554","Antiepileptic drugs and risk of suicide attempts: a case-control study exploring the impact of underlying medical conditions","Grimaldi-Bensouda L, Nordon C, Rossignol M, Jardon V, Boss V, Warembourg F, Reynolds R, Kurz X, Rouillon F, Abenhaim L; PROTECT-WP6 study group.","Pharmacoepidemiol Drug Saf. 2017 Mar;26(3):239-247. doi: 10.1002/pds.4160. Epub 2017 Jan 3.","Grimaldi-Bensouda L","Pharmacoepidemiol Drug Saf","2017","2017/01/05","","","10.1002/pds.4160"
"28052483","Natural language processing to ascertain two key variables from operative reports in ophthalmology","Liu L, Shorstein NH, Amsden LB, Herrinton LJ.","Pharmacoepidemiol Drug Saf. 2017 Apr;26(4):378-385. doi: 10.1002/pds.4149. Epub 2017 Jan 3.","Liu L","Pharmacoepidemiol Drug Saf","2017","2017/01/05","PMC5380560","NIHMS832904","10.1002/pds.4149"
"28028914","A systematic review of pregnancy exposure registries: examination of protocol-specified pregnancy outcomes, target sample size, and comparator selection","Gelperin K, Hammad H, Leishear K, Bird ST, Taylor L, Hampp C, Sahin L.","Pharmacoepidemiol Drug Saf. 2017 Feb;26(2):208-214. doi: 10.1002/pds.4150. Epub 2016 Dec 27.","Gelperin K","Pharmacoepidemiol Drug Saf","2017","2016/12/29","","","10.1002/pds.4150"
"28028867","The clinical status and economic savings associated with remission among patients with rheumatoid arthritis: leveraging linked registry and claims data for synergistic insights","Curtis JR, Chen L, Greenberg JD, Harrold L, Kilgore ML, Kremer JM, Solomon DH, Yun H.","Pharmacoepidemiol Drug Saf. 2017 Mar;26(3):310-319. doi: 10.1002/pds.4126. Epub 2016 Dec 28.","Curtis JR","Pharmacoepidemiol Drug Saf","2017","2016/12/29","PMC5332325","NIHMS825002","10.1002/pds.4126"
"28000298","The feasibility of using multiple databases to study rare outcomes: the potential effect of long-acting beta agonists with inhaled corticosteroid therapy on asthma mortality","Johannes CB, McQuay LJ, Midkiff KD, Calingaert B, Andrews EB, Tennis P, Brown JS, Camargo CA Jr, DiSantostefano RL, Rothman KJ, Stürmer T, Lanes S, Davis KJ.","Pharmacoepidemiol Drug Saf. 2017 Apr;26(4):446-458. doi: 10.1002/pds.4151. Epub 2016 Dec 21.","Johannes CB","Pharmacoepidemiol Drug Saf","2017","2016/12/22","","","10.1002/pds.4151"
"28000295","Drug availability adjustments in population-based studies of prescription opioid abuse","Secora A, Trinidad JP, Zhang R, Gill R, Dal Pan G.","Pharmacoepidemiol Drug Saf. 2017 Feb;26(2):180-191. doi: 10.1002/pds.4139. Epub 2016 Dec 21.","Secora A","Pharmacoepidemiol Drug Saf","2017","2016/12/22","","","10.1002/pds.4139"
"27935151","Patient-related characteristics associated with non-persistence with statin therapy in elderly patients following an ischemic stroke","Wawruch M, Zatko D, Wimmer G Jr, Luha J, Hricak V Jr, Murin J, Kukumberg P, Tesar T, Hloska A, Shah R.","Pharmacoepidemiol Drug Saf. 2017 Feb;26(2):201-207. doi: 10.1002/pds.4148. Epub 2016 Dec 9.","Wawruch M","Pharmacoepidemiol Drug Saf","2017","2016/12/10","","","10.1002/pds.4148"
"27935150","Trends in potentially inappropriate medication prescribing to nursing home patients: comparison of three cross-sectional studies","Halvorsen KH, Selbaek G, Ruths S.","Pharmacoepidemiol Drug Saf. 2017 Feb;26(2):192-200. doi: 10.1002/pds.4142. Epub 2016 Dec 9.","Halvorsen KH","Pharmacoepidemiol Drug Saf","2017","2016/12/10","","","10.1002/pds.4142"
"27921360","Mortality in patients who discontinue low-dose acetylsalicylic acid therapy after upper gastrointestinal bleeding","González-Pérez A, Sáez ME, Johansson S, Nagy P, García Rodríguez LA.","Pharmacoepidemiol Drug Saf. 2017 Feb;26(2):215-222. doi: 10.1002/pds.4140. Epub 2016 Dec 6.","González-Pérez A","Pharmacoepidemiol Drug Saf","2017","2016/12/07","","","10.1002/pds.4140"
"27910218","Octreotide use and safety in infants with hyperinsulinism","McMahon AW, Wharton GT, Thornton P, De Leon DD.","Pharmacoepidemiol Drug Saf. 2017 Jan;26(1):26-31. doi: 10.1002/pds.4144. Epub 2016 Dec 2.","McMahon AW","Pharmacoepidemiol Drug Saf","2017","2016/12/03","PMC5286465","NIHMS844740","10.1002/pds.4144"
"27910177","Comparison of pharmacy-based and diagnosis-based comorbidity measures from medical administrative data","Cortaredona S, Pambrun E, Verdoux H, Verger P.","Pharmacoepidemiol Drug Saf. 2017 Apr;26(4):402-411. doi: 10.1002/pds.4146. Epub 2016 Dec 2.","Cortaredona S","Pharmacoepidemiol Drug Saf","2017","2016/12/03","","","10.1002/pds.4146"
"27891698","Vaccination and unexplained sudden death risk in Taiwanese infants","Huang WT, Chen RT, Hsu YC, Glasser JW, Rhodes PH.","Pharmacoepidemiol Drug Saf. 2017 Jan;26(1):17-25. doi: 10.1002/pds.4141. Epub 2016 Nov 28.","Huang WT","Pharmacoepidemiol Drug Saf","2017","2016/11/29","","","10.1002/pds.4141"
"27889931","New use of prescription drugs prior to a cancer diagnosis","Pottegård A, Hallas J.","Pharmacoepidemiol Drug Saf. 2017 Feb;26(2):223-227. doi: 10.1002/pds.4145. Epub 2016 Nov 27.","Pottegård A","Pharmacoepidemiol Drug Saf","2017","2016/11/28","PMC5299521","","10.1002/pds.4145"
"27878889","Decision making in drug safety-a literature review of criteria used to prioritize newly detected safety issues","Pacurariu AC, Coloma PM, Gross-Martirosyan L, Sturkenboom MC, Straus SM.","Pharmacoepidemiol Drug Saf. 2017 Mar;26(3):327-334. doi: 10.1002/pds.4128. Epub 2016 Nov 23.","Pacurariu AC","Pharmacoepidemiol Drug Saf","2017","2016/11/24","","","10.1002/pds.4128"
"27868282","Validation of Stevens-Johnson syndrome or toxic epidermal necrolysis diagnoses in the Clinical Practice Research Datalink","Frey N, Bircher A, Bodmer M, Jick SS, Meier CR, Spoendlin J.","Pharmacoepidemiol Drug Saf. 2017 Apr;26(4):429-436. doi: 10.1002/pds.4124. Epub 2016 Nov 20.","Frey N","Pharmacoepidemiol Drug Saf","2017","2016/11/22","","","10.1002/pds.4124"
"27868278","Differences in VigiBase® reporting of aminoglycoside and capreomycin-suspected ototoxicity during tuberculosis treatment","Sagwa EL, Souverein PC, Ribeiro I, Leufkens HG, Mantel-Teeuwisse AK.","Pharmacoepidemiol Drug Saf. 2017 Jan;26(1):1-8. doi: 10.1002/pds.4125. Epub 2016 Nov 20.","Sagwa EL","Pharmacoepidemiol Drug Saf","2017","2016/11/22","","","10.1002/pds.4125"
"27868277","Outpatient antidepressant drug use in children and adolescents in Germany between 2004 and 2011","Schröder C, Dörks M, Kollhorst B, Blenk T, Dittmann RW, Garbe E, Riedel O.","Pharmacoepidemiol Drug Saf. 2017 Feb;26(2):170-179. doi: 10.1002/pds.4138. Epub 2016 Nov 20.","Schröder C","Pharmacoepidemiol Drug Saf","2017","2016/11/22","","","10.1002/pds.4138"
"27868275","Effectiveness and safety of drugs used for stroke prevention in a cohort of non-valvular atrial fibrillation patients from a primary care electronic database","Giner-Soriano M, Roso-Llorach A, Vedia Urgell C, Castells X, Capellà D, Ferreira-González I, Elorza-Ricart JM, Casajuana M, Troncoso Mariño A, Diògene E, Bolíbar B, Violan C, Morros R.","Pharmacoepidemiol Drug Saf. 2017 Jan;26(1):97-107. doi: 10.1002/pds.4137. Epub 2016 Nov 20.","Giner-Soriano M","Pharmacoepidemiol Drug Saf","2017","2016/11/22","","","10.1002/pds.4137"
"27862608","Assessing prescription drug abuse using functional principal component analysis (FPCA) of wastewater data","Salvatore S, Røislien J, Baz-Lomba JA, Bramness JG.","Pharmacoepidemiol Drug Saf. 2017 Mar;26(3):320-326. doi: 10.1002/pds.4127. Epub 2016 Nov 11.","Salvatore S","Pharmacoepidemiol Drug Saf","2017","2016/11/19","","","10.1002/pds.4127"
"27862597","Impact of an opioid risk reduction initiative on motor vehicle crash risk among chronic opioid therapy patients","Hansen RN, Walker RL, Shortreed SM, Dublin S, Saunders K, Ludman EJ, Von Korff M.","Pharmacoepidemiol Drug Saf. 2017 Jan;26(1):47-55. doi: 10.1002/pds.4130. Epub 2016 Nov 14.","Hansen RN","Pharmacoepidemiol Drug Saf","2017","2016/11/19","","","10.1002/pds.4130"
"27862588","Comparative analysis of the cost and effectiveness of generic and brand-name antibiotics: the case of uncomplicated urinary tract infection","Lin YS, Jan IS, Cheng SH.","Pharmacoepidemiol Drug Saf. 2017 Mar;26(3):301-309. doi: 10.1002/pds.4122. Epub 2016 Nov 8.","Lin YS","Pharmacoepidemiol Drug Saf","2017","2016/11/19","","","10.1002/pds.4122"
"27862587","Are non-allergic drug reactions commonly documented as medication ""allergies""? A national cohort of Veterans' admissions from 2000 to 2014","McConeghy KW, Caffrey AR, Morrill HJ, Trivedi AN, LaPlante KL.","Pharmacoepidemiol Drug Saf. 2017 Apr;26(4):472-476. doi: 10.1002/pds.4134. Epub 2016 Nov 13.","McConeghy KW","Pharmacoepidemiol Drug Saf","2017","2016/11/19","","","10.1002/pds.4134"
"27859947","Long-term use of proton pump inhibitors and prevalence of disease- and drug-related reasons for gastroprotection-a cross-sectional population-based study","Wallerstedt SM, Fastbom J, Linke J, Vitols S.","Pharmacoepidemiol Drug Saf. 2017 Jan;26(1):9-16. doi: 10.1002/pds.4135. Epub 2016 Nov 16.","Wallerstedt SM","Pharmacoepidemiol Drug Saf","2017","2016/11/19","PMC5248645","","10.1002/pds.4135"
"27859943","A comparison of entropy balance and probability weighting methods to generalize observational cohorts to a population: a simulation and empirical example","Harvey RA, Hayden JD, Kamble PS, Bouchard JR, Huang JC.","Pharmacoepidemiol Drug Saf. 2017 Apr;26(4):368-377. doi: 10.1002/pds.4121. Epub 2016 Nov 13.","Harvey RA","Pharmacoepidemiol Drug Saf","2017","2016/11/19","","","10.1002/pds.4121"
"27859924","Older adults with heart failure treated with carvedilol, bisoprolol, or metoprolol tartrate: risk of mortality","Perreault S, de Denus S, White M, White-Guay B, Bouvier M, Dorais M, Dubé MP, Rouleau JL, Tardif JC, Jenna S, Haibe-Kains B, Leduc R, Deblois D.","Pharmacoepidemiol Drug Saf. 2017 Jan;26(1):81-90. doi: 10.1002/pds.4132. Epub 2016 Nov 16.","Perreault S","Pharmacoepidemiol Drug Saf","2017","2016/11/19","","","10.1002/pds.4132"
"27859873","Impact of an intervention on the prescription of aliskiren after new evidence on safety reported","Rosich Martí I, Allepuz A, Rodriguez Palomar G, Ortin Font F, Soler Cera M.","Pharmacoepidemiol Drug Saf. 2017 Jan;26(1):91-96. doi: 10.1002/pds.4136. Epub 2016 Nov 16.","Rosich Martí I","Pharmacoepidemiol Drug Saf","2017","2016/11/19","","","10.1002/pds.4136"
"27807907","Trends in incident use of benzodiazepines and Z-drugs in France from 2006 to 2012: a population-based study","Bénard-Laribière A, Noize P, Pambrun E, Bazin F, Verdoux H, Tournier M, Bégaud B, Pariente A.","Pharmacoepidemiol Drug Saf. 2017 Feb;26(2):162-169. doi: 10.1002/pds.4123. Epub 2016 Nov 3.","Bénard-Laribière A","Pharmacoepidemiol Drug Saf","2017","2016/11/04","","","10.1002/pds.4123"
"27804174","Monitoring safety in a phase III real-world effectiveness trial: use of novel methodology in the Salford Lung Study","Collier S, Harvey C, Brewster J, Bakerly ND, Elkhenini HF, Stanciu R, Williams C, Brereton J, New JP, McCrae J, McCorkindale S, Leather D.","Pharmacoepidemiol Drug Saf. 2017 Mar;26(3):344-352. doi: 10.1002/pds.4118. Epub 2016 Nov 1.","Collier S","Pharmacoepidemiol Drug Saf","2017","2016/11/03","PMC5347861","","10.1002/pds.4118"
"27790805","Drug use among complete responders, partial responders and non-responders in a longitudinal survey of nonagenarians: analysis of prescription register data","Wastesson JW, Rasmussen L, Oksuzyan A, Hallas J, Christensen K, Pottegård A.","Pharmacoepidemiol Drug Saf. 2017 Feb;26(2):152-161. doi: 10.1002/pds.4120. Epub 2016 Oct 28.","Wastesson JW","Pharmacoepidemiol Drug Saf","2017","2016/10/30","","","10.1002/pds.4120"
"27670850","Differences between the United States and Japan in labels of oncological drugs","Jayaputra K, Ono S.","Pharmacoepidemiol Drug Saf. 2017 Feb;26(2):143-151. doi: 10.1002/pds.4111. Epub 2016 Sep 26.","Jayaputra K","Pharmacoepidemiol Drug Saf","2017","2016/09/28","","","10.1002/pds.4111"
"27730699","Cross-sectional investigation of drug-related problems among adults in a medical center outpatient clinic: application of virtual medicine records in the cloud","Wang HY, Yeh MK, Ho CH, Hu MK, Huang YB.","Pharmacoepidemiol Drug Saf. 2017 Jan;26(1):71-80. doi: 10.1002/pds.4117. Epub 2016 Oct 12.","Wang HY","Pharmacoepidemiol Drug Saf","2017","2016/10/13","","","10.1002/pds.4117"
"27686457","The effect of statins on influenza-like illness morbidity and mortality","Brassard P, Wu JW, Ernst P, Dell'Aniello S, Smiechowski B, Suissa S.","Pharmacoepidemiol Drug Saf. 2017 Jan;26(1):63-70. doi: 10.1002/pds.4112. Epub 2016 Sep 30.","Brassard P","Pharmacoepidemiol Drug Saf","2017","2016/10/01","","","10.1002/pds.4112"
"27670755","A sudden and unprecedented increase in low dose naltrexone (LDN) prescribing in Norway. Patient and prescriber characteristics, and dispense patterns. A drug utilization cohort study","Raknes G, Småbrekke L.","Pharmacoepidemiol Drug Saf. 2017 Feb;26(2):136-142. doi: 10.1002/pds.4110. Epub 2016 Sep 26.","Raknes G","Pharmacoepidemiol Drug Saf","2017","2016/09/28","PMC5298009","","10.1002/pds.4110"
"27642000","Patterns of anti-diabetic medication use in patients with type 2 diabetes mellitus in England and Wales","Datta-Nemdharry P, Thomson A, Beynon J, Donegan K.","Pharmacoepidemiol Drug Saf. 2017 Feb;26(2):127-135. doi: 10.1002/pds.4092. Epub 2016 Sep 19.","Datta-Nemdharry P","Pharmacoepidemiol Drug Saf","2017","2016/09/20","","","10.1002/pds.4092"
"27610604","Prevalent new-user cohort designs for comparative drug effect studies by time-conditional propensity scores","Suissa S, Moodie EE, Dell'Aniello S.","Pharmacoepidemiol Drug Saf. 2017 Apr;26(4):459-468. doi: 10.1002/pds.4107. Epub 2016 Sep 9.","Suissa S","Pharmacoepidemiol Drug Saf","2017","2016/09/10","","","10.1002/pds.4107"
"27594167","Relative preferences in the abuse of immediate-release versus extended-release opioids in a sample of treatment-seeking opioid abusers","Cicero TJ, Ellis MS, Kasper ZA.","Pharmacoepidemiol Drug Saf. 2017 Jan;26(1):56-62. doi: 10.1002/pds.4078. Epub 2016 Sep 4.","Cicero TJ","Pharmacoepidemiol Drug Saf","2017","2016/09/06","","","10.1002/pds.4078"
"27530106","Assessing the impact of prescribing directives on opioid prescribing practices among Veterans Health Administration providers","Barber C, Gagnon D, Fonda J, Cho K, Hermos J, Miller M.","Pharmacoepidemiol Drug Saf. 2017 Jan;26(1):40-46. doi: 10.1002/pds.4066. Epub 2016 Aug 16.","Barber C","Pharmacoepidemiol Drug Saf","2017","2016/08/18","","","10.1002/pds.4066"
"27528454","The appropriateness and persistence of testosterone replacement therapy in Ontario","Martins D, Yao Z, Tadrous M, Shah BR, Juurlink DN, Mamdani MM, Gomes T; Ontario Drug Policy Research Network.","Pharmacoepidemiol Drug Saf. 2017 Feb;26(2):119-126. doi: 10.1002/pds.4083. Epub 2016 Aug 16.","Martins D","Pharmacoepidemiol Drug Saf","2017","2016/08/17","","","10.1002/pds.4083"
"27528185","How valid are IMS DA summary statistics of children's vaccination status?","El-Turki A, Long P, Wong IC, Smith H.","Pharmacoepidemiol Drug Saf. 2017 Jan;26(1):108-111. doi: 10.1002/pds.4080. Epub 2016 Aug 16.","El-Turki A","Pharmacoepidemiol Drug Saf","2017","2016/08/17","","","10.1002/pds.4080"
"27527987","Confounding of the association between statins and Parkinson disease: systematic review and meta-analysis","Bykov K, Yoshida K, Weisskopf MG, Gagne JJ.","Pharmacoepidemiol Drug Saf. 2017 Mar;26(3):294-300. doi: 10.1002/pds.4079. Epub 2016 Aug 16.","Bykov K","Pharmacoepidemiol Drug Saf","2017","2016/08/17","","","10.1002/pds.4079"
"27501410","Development of an adverse events reporting form for Korean folk medicine","Park JH, Choi SM, Moon S, Kim S, Kim B, Kim MK, Lee S.","Pharmacoepidemiol Drug Saf. 2017 May;26(5):498-508. doi: 10.1002/pds.4077. Epub 2016 Aug 8.","Park JH","Pharmacoepidemiol Drug Saf","2017","2016/08/09","PMC5434846","","10.1002/pds.4077"
"27193415","Medication-related adverse events during hospitalization: a retrospective patient record review study in The Netherlands","Damen NL, Baines R, Wagner C, Langelaan M.","Pharmacoepidemiol Drug Saf. 2017 Jan;26(1):32-39. doi: 10.1002/pds.4037. Epub 2016 May 19.","Damen NL","Pharmacoepidemiol Drug Saf","2017","2016/05/20","","","10.1002/pds.4037"
"26075570","PRESCRIBING AND RESEARCH IN MEDICINES MANAGEMENT (UK & IRELAND) CONFERENCE 2015 IMPERIAL HOTEL LONDON JANUARY 23(rd) 2015 ""ONE FOR ALL AND ALL FOR ONE - DIFFERENT PERSPECTIVES IN MEDICINES OPTIMISATION""","","Pharmacoepidemiol Drug Saf. 2018 Jul;27(7):O15-O44. doi: 10.1002/pds.3812. Epub 2015 Jun 15.","","Pharmacoepidemiol Drug Saf","2018","2015/06/16","","","10.1002/pds.3812"
